{
 "cells": [
  {
   "cell_type": "code",
   "execution_count": null,
   "id": "62fcfabf-df18-4180-8322-70146658fb8d",
   "metadata": {},
   "outputs": [],
   "source": [
    "!python -m pip install -U -q 'anthropic[vertex]'"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 2,
   "id": "1587241c-920a-4343-82ff-7119f9a30646",
   "metadata": {
    "tags": []
   },
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Creating gs://my-project-0004-346516-asia-notebooks/...\n",
      "\u001b[1;31mERROR:\u001b[0m (gcloud.storage.buckets.create) HTTPError 409: Your previous request to create the named bucket succeeded and you already own it.\n"
     ]
    }
   ],
   "source": [
    "# Please enter your name/initials (no spaces or special characters allowed), ensure that it is unique\n",
    "UNIQUE_PREFIX=\"asia-notebooks\" ### PLEASE UPDATE THIS\n",
    "\n",
    "# Cloud project id.\n",
    "PROJECT_IDS = !(gcloud config get-value core/project)\n",
    "PROJECT_ID = PROJECT_IDS[0]  # @param {type:\"string\"}\n",
    "\n",
    "# The region you want to launch jobs in.\n",
    "REGION = \"asia-southeast1\"  # @param {type:\"string\"}\n",
    "\n",
    "# The Cloud Storage bucket for storing experiments output. Fill it without the 'gs://' prefix.\n",
    "GCS_BUCKET = f\"{PROJECT_ID}-{UNIQUE_PREFIX}\"  # @param {type:\"string\"} \n",
    "BUCKET_URI = f\"gs://{GCS_BUCKET}\"  # @param {type:\"string\"}\n",
    "\n",
    "# The service account for deploying fine tuned model.\n",
    "SERVICE_ACCOUNT = !(gcloud config get-value core/account)  # @param {type:\"string\"}\n",
    "SERVICE_ACCOUNT = SERVICE_ACCOUNT[0]\n",
    "\n",
    "! gcloud storage buckets create {BUCKET_URI} --project={PROJECT_ID} --location={REGION}\n"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 1,
   "id": "5d160940-fccd-4a01-ae38-acf8bbd9f769",
   "metadata": {},
   "outputs": [],
   "source": [
    "import os\n",
    "\n",
    "import streamlit as st\n",
    "import vertexai\n",
    "from vertexai.preview.language_models import TextGenerationModel\n",
    "\n",
    "PROJECT_ID = os.environ.get(\"GCP_PROJECT\")  # Your Google Cloud Project ID\n",
    "LOCATION = os.environ.get(\"GCP_REGION\")  # Your Google Cloud Project Region\n",
    "vertexai.init(project=PROJECT_ID, location=LOCATION)\n",
    "\n",
    "\n",
    "# @st.cache_resource\n",
    "def get_model():\n",
    "    generation_model = TextGenerationModel.from_pretrained(\"text-bison@002\")\n",
    "    return generation_model\n",
    "\n",
    "\n",
    "def get_text_generation(prompt=\"\", **parameters):\n",
    "    generation_model = get_model()\n",
    "    response = generation_model.predict(prompt=prompt, **parameters)\n",
    "\n",
    "    return response.text"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 39,
   "id": "8d167204-391e-4a6c-bc30-0b14ca1d1783",
   "metadata": {},
   "outputs": [],
   "source": [
    "import vertexai\n",
    "from vertexai.preview.generative_models import GenerativeModel, Part\n",
    "\n",
    "# input_prompt = \"\"\"can you give me details of paracetamol\"\"\"\n",
    "\n",
    "def generate(input_prompt):\n",
    "    model = GenerativeModel(\"gemini-ultra\")\n",
    "    responses = model.generate_content(\n",
    "        input_prompt ,\n",
    "    generation_config={\n",
    "        \"max_output_tokens\": 2048,\n",
    "        \"temperature\": 0.2,\n",
    "        \"top_p\": 1,\n",
    "        \"top_k\": 32\n",
    "    },\n",
    "        safety_settings=[],\n",
    "        stream=True,\n",
    "    )\n",
    "    \n",
    "    all_response  = []\n",
    "    \n",
    "    for response in responses:\n",
    "        # print(response.text, end=\"\")\n",
    "        all_response.append(response.text)\n",
    "    \n",
    "    # print (all_response)\n",
    "    \n",
    "    return(\" \".join(all_response))\n",
    "    \n",
    "\n",
    "def generate_pro(input_prompt):\n",
    "    model = GenerativeModel(\"gemini-pro\")\n",
    "    responses = model.generate_content(\n",
    "    input_prompt,\n",
    "    generation_config={\n",
    "        \"max_output_tokens\": 2048,\n",
    "        \"temperature\": 0.2,\n",
    "        \"top_p\": 1\n",
    "    },stream=True,)\n",
    "    \n",
    "    all_response  = []\n",
    "    \n",
    "    for response in responses:\n",
    "        all_response.append(response.text)\n",
    "    \n",
    "    # print (all_response)\n",
    "    \n",
    "    return(\" \".join(all_response))\n"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 40,
   "id": "19823354-6d4f-4651-955b-ab7294953a3e",
   "metadata": {},
   "outputs": [],
   "source": [
    "from google.cloud import aiplatform\n",
    "from google.cloud.aiplatform.gapic.schema import predict\n",
    "from google.protobuf import json_format\n",
    "from google.protobuf.struct_pb2 import Value\n",
    "\n",
    "# The AI Platform services require regional API endpoints.\n",
    "client_options = {\"api_endpoint\": \"us-central1-autopush-aiplatform.sandbox.googleapis.com\"}\n",
    "# Initialize client that will be used to create and send requests.\n",
    "# This client only needs to be created once, and can be reused for multiple requests.\n",
    "client = aiplatform.gapic.PredictionServiceClient(\n",
    "    client_options=client_options\n",
    ")\n",
    "\n",
    "def generate_medlpalm(input_prompt):\n",
    "    instance_dict = {\n",
    "        \"content\": input_prompt\n",
    "    }\n",
    "    instance = json_format.ParseDict(instance_dict, Value())\n",
    "    instances = [instance]\n",
    "    parameters_dict = {\n",
    "        \"maxOutputTokens\": 1024,\n",
    "        \"temperature\": 0.2,\n",
    "        \"topP\": 0.8,\n",
    "        \"topK\": 40\n",
    "    }\n",
    "    parameters = json_format.ParseDict(parameters_dict, Value())\n",
    "    response = client.predict(\n",
    "        endpoint=\"projects/cloud-llm-preview1/locations/us-central1/publishers/google/models/medpalm2@latest\", instances=instances, parameters=parameters,\n",
    "    )\n",
    "    print(\"response\")\n",
    "    \n",
    "    predictions = response.predictions\n",
    "    all_response  = []\n",
    "\n",
    "    for prediction in predictions:\n",
    "        # print(\" prediction:\", dict(prediction)[\"content\"])\n",
    "        all_response.append(dict(prediction)[\"content\"])\n",
    "        \n",
    "    return(\" \".join(all_response))\n",
    "    "
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 41,
   "id": "3038e5c4-02a2-4c34-bd21-157458bf67ce",
   "metadata": {},
   "outputs": [],
   "source": [
    "from google.cloud import aiplatform\n",
    "from google.cloud.aiplatform.gapic.schema import predict\n",
    "from google.protobuf import json_format\n",
    "from google.protobuf.struct_pb2 import Value\n",
    "\n",
    "# The AI Platform services require regional API endpoints.\n",
    "client_options = {\"api_endpoint\": \"us-central1-autopush-aiplatform.sandbox.googleapis.com\"}\n",
    "# Initialize client that will be used to create and send requests.\n",
    "# This client only needs to be created once, and can be reused for multiple requests.\n",
    "client = aiplatform.gapic.PredictionServiceClient(\n",
    "    client_options=client_options\n",
    ")\n",
    "\n",
    "def generate_medllms_v1(input_prompt):\n",
    "\n",
    "    instance_dict = {\n",
    "        \"content\": input_prompt\n",
    "    }\n",
    "    instance = json_format.ParseDict(instance_dict, Value())\n",
    "    instances = [instance]\n",
    "    parameters_dict = {\n",
    "        \"candidateCount\": 1,\n",
    "        \"maxOutputTokens\": 1024,\n",
    "        \"temperature\": 0.2,\n",
    "        \"topP\": 0.8,\n",
    "        \"topK\": 40\n",
    "    }\n",
    "    parameters = json_format.ParseDict(parameters_dict, Value())\n",
    "    response = client.predict(\n",
    "        endpoint=\"projects/cloud-llm-preview1/locations/us-central1/publishers/google/models/medlm-large\", instances=instances, parameters=parameters,\n",
    "    )\n",
    "    print(\"response\")\n",
    "    predictions = response.predictions\n",
    "\n",
    "\n",
    "    all_response  = []\n",
    "\n",
    "    for prediction in predictions:\n",
    "        # print(\" prediction:\", dict(prediction))\n",
    "        # print(\" two\" ,  dict(prediction)[\"content\"] )\n",
    "        all_response.append(dict(prediction)[\"content\"])\n",
    "        \n",
    "    return(\" \".join(all_response))"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 42,
   "id": "7474b7bc-6070-4f9f-8531-4c53437329dd",
   "metadata": {},
   "outputs": [],
   "source": [
    "import vertexai\n",
    "from vertexai.language_models import TextGenerationModel\n",
    "\n",
    "vertexai.init(project=\"cloud-llm-preview1\", location=\"us-central1\")\n",
    "parameters = {\n",
    "    \"candidate_count\": 1,\n",
    "    \"max_output_tokens\": 1024,\n",
    "    \"temperature\": 1,\n",
    "    \"top_k\": 40\n",
    "}\n",
    "\n",
    "def generate_palm_unicorn_v1(input_prompt):\n",
    "    \n",
    "    model = TextGenerationModel.from_pretrained(\"text-unicorn@001\")\n",
    "\n",
    "    response = model.predict(\n",
    "        input_prompt,\n",
    "        **parameters\n",
    "    )\n",
    "    print(f\"Response from Model: {response.text}\")\n",
    "    \n",
    "    return(response.text)\n",
    "\n",
    "def generate_palm_bison32k(input_prompt):\n",
    "    \n",
    "    model = TextGenerationModel.from_pretrained(\"text-bison-32k\")\n",
    "\n",
    "    response = model.predict(\n",
    "        input_prompt,\n",
    "        **parameters\n",
    "    )\n",
    "    print(f\"Response from Model: {response.text}\")\n",
    "    \n",
    "    return(response.text)\n"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "c5b7815d-efa0-49d9-87a6-3fcdacd1c973",
   "metadata": {},
   "source": [
    "### Anthropic model now included"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 14,
   "id": "2740fdde-d723-4910-8e5c-41aec7733f2c",
   "metadata": {
    "tags": []
   },
   "outputs": [],
   "source": [
    "from anthropic import AnthropicVertex\n",
    "\n",
    "LOCATION=\"us-central1\" # or \"europe-west4\"\n",
    "\n",
    "client = AnthropicVertex(region=LOCATION, project_id=PROJECT_ID)\n",
    "\n",
    "def generate_anthropic_response(input_prompt):\n",
    "  \"\"\"Generates a text response using the AnthropicVertex client.\n",
    "\n",
    "  Args:\n",
    "    input_prompt: The text prompt for the model.\n",
    "\n",
    "  Returns:\n",
    "    The generated text response.\n",
    "  \"\"\"\n",
    "  message = client.messages.create(\n",
    "    max_tokens=1024,\n",
    "    messages=[\n",
    "      {\n",
    "        \"role\": \"user\",\n",
    "        \"content\": input_prompt,\n",
    "      }\n",
    "    ],\n",
    "    model=\"claude-3-haiku@20240307\",  # or any other desired model\n",
    "  )\n",
    "\n",
    "  response_text = message.model_dump_json(indent=2)  # Accessing response\n",
    "  print(f\"Response from Model: {response_text}\")\n",
    "\n",
    "  return response_text \n",
    "\n",
    "def generate_anthropic_response_sonnet(input_prompt):\n",
    "  \"\"\"Generates a text response using the AnthropicVertex client.\n",
    "\n",
    "  Args:\n",
    "    input_prompt: The text prompt for the model.\n",
    "\n",
    "  Returns:\n",
    "    The generated text response.\n",
    "  \"\"\"\n",
    "  message = client.messages.create(\n",
    "    max_tokens=1024,\n",
    "    messages=[\n",
    "      {\n",
    "        \"role\": \"user\",\n",
    "        \"content\": input_prompt,\n",
    "      }\n",
    "    ],\n",
    "    # model=\"claude-3-haiku@20240307\",  # or any other desired model\n",
    "    model = \"claude-3-sonnet@20240229\" \n",
    "  )\n",
    "\n",
    "  response_text = message.model_dump_json(indent=2)  # Accessing response\n",
    "  print(f\"Response from Model: {response_text}\")\n",
    "\n",
    "  return response_text "
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 15,
   "id": "d244aaa4-df39-403a-9442-b266bdbe62ca",
   "metadata": {
    "tags": []
   },
   "outputs": [],
   "source": [
    "# input_prompt = \"What are the symptoms of influenza?\" \n",
    "\n",
    "# x = generate_pro(input_prompt)\n",
    "# generate_medllms_v1(input_prompt)\n",
    "# generate_palm_unicorn_v1(input_prompt)\n",
    "# input_prompt = \"What are the symptoms of influenza?\" \n",
    "# generate_medlpalm(input_prompt)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 16,
   "id": "d14778d8-a95a-4b04-9388-9325ec7a2e6e",
   "metadata": {
    "tags": []
   },
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "healthcare_gemini_models_v1.ipynb\n"
     ]
    }
   ],
   "source": [
    "!ls"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "0bd1bdb2-9a61-4e42-b6f6-5f10922ef5b0",
   "metadata": {},
   "source": [
    "### First file"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 35,
   "id": "a4e0a795-ce43-4501-80cb-2a13f4db9da6",
   "metadata": {
    "scrolled": true,
    "tags": []
   },
   "outputs": [],
   "source": [
    "import pandas as pd\n",
    "filename = \"./data/Anaes 16 Clinical scenarios RAG response.csv\"\n",
    "df = pd.read_csv(filename)\n",
    "df['combine_prompt'] = df['System Prompts'] + ' ' +df['RAG Results'] + ' '+ df['User Question']\n",
    "\n",
    "\n",
    "# print(df['System Prompts'], df['RAG Results'] ,df['User Question'] )\n",
    "# print(selected_column[0])"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 36,
   "id": "5c5c5884-8516-4d04-a3ff-59dcaa8f8628",
   "metadata": {},
   "outputs": [],
   "source": [
    "# generate_medlpalm(df.loc[0 ,'combine_prompt'])"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 37,
   "id": "a3c82c7f-1ff6-49cd-877e-64c2b420cdc2",
   "metadata": {
    "scrolled": true,
    "tags": []
   },
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "iteration # 0\n",
      "['**Medical Colleague Instructions:**\\n\\n1. Doctor\\n2. Fast for 6 hours for solids and 2 hours for clear fluids prior to surgery.\\n3. No\\n4. **Medication Instructions:**\\n   - Continue Ventolin PRN as needed.\\n5. NA\\n6. **Preoperative', ' Optimization:**\\n   - Diabetes: Refer to Internal Medicine for optimization of blood glucose control.\\n7. No\\n8. **Department Protocols:**\\n   - Guidelines on Preoperative Assessment of Obese Patients:\\n     - Discuss risks of difficult airway, major adverse cardiac events, and other complications related to obesity.\\n', '     - Prescribe gastroprophylaxis with ranitidine.\\n   - ERAS Spine Protocol:\\n     - Optimize blood glucose control if HbA1c > 8.5%.\\n   - Anaesthesia Protocol for ERAS Spine:\\n     - Consider IV ketamine bolus at induction.\\n     -', ' Administer IV paracetamol at the end of surgery.\\n     - Administer IV dexamethasone for PONV prophylaxis if not diabetic or if HbA1c < 8.\\n     - Administer IV ondansetron at the end of surgery.\\n     - Administer IV tranexamic acid at the', ' start of surgery.\\n\\n**Patient Instructions:**\\n\\n1. **Medication Instructions:**\\n   - You can use your Ventolin inhaler as needed before the surgery.\\n\\n2. **Anesthesia Consent:**\\n   - You may receive general anesthesia, which means you will be asleep during the surgery.\\n   -', ' You may also receive regional anesthesia, which means that the area of your body where the surgery is being done will be numbed.\\n   - Specific risks related to your medical history include:\\n     - Difficult airway due to your high BMI.\\n     - Increased risk of complications due to your diabetes.']\n",
      "['**Medical Colleague Instructions:**\\n\\n1. Doctor\\n2. Fast for 6 hours for solids and 2 hours for clear fluids before surgery.\\n3. No\\n4. **Medication Instructions:**\\n   - Continue Ventolin PRN as needed.\\n5. NA\\n6. **Preoperative Optimization', ':**\\n   - Optimize diabetes control (HbA1c 9.4%).\\n7. No\\n8. **Department Protocols:**\\n   - Guidelines on Preoperative Assessment of Obese Patients: Discuss risks of difficult airway, major adverse cardiac events, and positioning difficulties. Prescribe gastroprophylaxis with raniti', 'dine.\\n   - Anaesthesia Protocol for ERAS Spine: Consider IV ketamine bolus at induction and IV paracetamol at the end of surgery.\\n   - Preoperative assessment of Respiratory Disease: Counsel for regional or local anesthesia over general anesthesia if possible. Advise the patient to bring inhalers on the day', ' of surgery.\\n\\n**Patient Instructions:**\\n\\n**Medication Instructions:**\\n\\n* Continue taking your Ventolin inhaler as needed.\\n\\n**Consent for Anesthesia:**\\n\\n* You may receive regional anesthesia (numbing medication injected near the nerves) or general anesthesia (medication that puts you to sleep).\\n* Specific risks', ' to highlight:\\n    * Difficult airway due to high BMI\\n    * Increased risk of complications due to severe OSA']\n",
      "['**Preoperative Anesthesia Instructions for Medical Colleagues**\\n\\n1. **Doctor/Nurse:** Doctor\\n2. **Fasting instructions:** Clear fluids up to 2 hours before surgery, solids up to 6 hours before surgery.\\n3. **Preoperative carbohydrate loading:** No\\n4. **Medication instructions:**\\n', '   - Continue Ventolin PRN as needed.\\n5. **Instructions for healthcare team:**\\n   - Standby post-operative high dependency/ICU beds due to severe OSA.\\n6. **Preoperative optimization required:**\\n   - Diabetes: Refer to internal medicine for optimization of blood glucose control.\\n7', '. **Need to delay operation:** No\\n8. **Department protocols:**\\n   - Guidelines on Preoperative Assessment of Obese Patients: Discuss risks of difficult airway, major adverse cardiac events, and postoperative ventilation with patient. Prescribe gastroprophylaxis.\\n   - Anaesthesia Protocol for ERAS Spine: Consider IV', ' ketamine bolus at induction and IV tranexamic acid at the start of surgery.\\n   - Supporting Documents for Preoperative Assessment of Respiratory Disease: Counsel for regional anesthesia over general anesthesia if possible.\\n\\n**Instructions for the Patient**\\n\\n**Medication instructions:**\\n\\n* You can use your Ventolin inhaler', ' as needed before surgery.\\n\\n**Consent for anesthesia:**\\n\\n* You may receive regional anesthesia (numbing medication injected near the nerves) or general anesthesia (medication that puts you to sleep) for this surgery.\\n* Specific risks to be aware of due to your medical history include:\\n    * Difficult airway due to', ' obesity\\n    * Increased risk of heart problems due to obesity and severe sleep apnea\\n    * Need for close monitoring and possible admission to the high dependency unit or ICU after surgery due to severe sleep apnea']\n",
      "['1. Should the patient be seen by a Doctor or a Nurse - Doctor\\n2. Fasting instructions - Patient should fast for 8 hours before the time of surgery.\\n3. Suitability for preoperative carbohydrate loading - No\\n4. Medication instructions:\\n   - Ventolin: Continue taking as prescribed.\\n', '5. Any instructions for the healthcare team:\\n   - Arrange for preoperative blood group matching and cross-matching.\\n   - Arrange for standby post-operative high dependency/ICU beds.\\n6. Any preoperative optimization required for the patient:\\n   - Optimize diabetes control.\\n   - Optimize CPAP settings.', \"\\n7. Any need to delay the operation for further medical workup and preoperative optimization?\\n   - No\\n8. Any specific department protocols to follow for this patient:\\n   - Follow the department's protocol for preoperative assessment of obese patients.\\n   - Follow the department's protocol for preoperative assessment of patients with diabetes.\\n   - Follow the department's protocol for preoperative assessment of patients with OSA.\\n\\nPatient Instructions:\\n\\n1. Medication instructions to take leading up to the surgery:\\n   - Continue taking your Ventolin as prescribed.\\n2. Consent for the types of anesthesia that the patient needs to\", ' be aware of for this surgery, and any specific risks to highlight due to the operation and the patient’s medical history:\\n   - You will be given general anesthesia for your surgery.\\n   - There are some risks associated with general anesthesia, including:\\n     - Nausea and vomiting\\n     - Sore throat\\n     - Difficulty breathing\\n     - Allergic reaction to the anesthesia\\n   - There are also some specific risks associated with your surgery, including:\\n     - Bleeding\\n     - Infection\\n     - Damage to the nerves or blood vessels in your face\\n     - Difficulty breathing after surgery\\n   - We will take all', ' necessary precautions to minimize these risks.']\n",
      "response\n",
      " prediction: 1. Should the patient be seen by a Doctor or Nurse - Doctor\n",
      "2. Fasting instructions - list instructions based on the number of hours before the time of the listed surgery - NPO after midnight\n",
      "3. Suitability for preoperative carbohydrate loading - No\n",
      "4. Medication instructions - name each medication and give the instructions for the day of the operation and days leading up to the operation as required. - Continue Ventolin PRN\n",
      "5. Any instructions for the healthcare team - for example, preoperative blood group matching, arranging for preoperative dialysis, or standby post-operative high dependency/ICU beds. - Consider arterial blood gas and echocardiography if there are accompanying cardiac/pulmonary conditions, or oximetry on air is <93% – consult senior anaesthetist (rule out lung disease and/or obesity hypoventilation syndrome)\n",
      "6. Any preoperative optimization required for the patient - list what needs to be optimized. - Consider arterial blood gas and echocardiography if there are accompanying cardiac/pulmonary conditions, or oximetry on air is <93% – consult senior anaesthetist (rule out lung disease and/or obesity hypoventilation syndrome)\n",
      "7. Any need to delay the operation for further medical workup and preoperative optimization? - No\n",
      "8. Any specific department protocols to follow for this patient - name as many as necessary, and give short reasoning for using these protocols. - Obesity protocol - increased risk of difficult airway, aspiration pneumonitis, hypoxia, neurological damage and death, major adverse cardiac event, difficult iv line insertions, positioning (peripheral nerve damage), deep vein thrombosis, post-operative ventilation and SICU stay, difficult regional anaesthesia (if RA is the planned technique)\n",
      "- OSA protocol - increased risk of difficult airway, aspiration pneumonitis, hypoxia, neurological damage and death, major adverse cardiac event, difficult iv line insertions, positioning (peripheral nerve damage), deep vein thrombosis, post-operative ventilation and SICU stay, difficult regional anaesthesia (if RA is the planned technique)\n",
      "- Diabetes protocol - increased risk of infection, poor wound healing, delayed gastric emptying, autonomic neuropathy, hypoglycemia, hyperglycemia\n",
      "\n",
      "In addition, please give the following instructions to the patient in lay language: \n",
      "1. Medication instructions to take leading up to the surgery. - Continue Ventolin PRN\n",
      "2. Consent for the types of anesthesia that the patient needs to be aware of for this surgery, and any specific risks to highlight due to the operation and the patient’s medical history. - General anaesthesia or regional anaesthesia (e.g. spinal or epidural) may be used for your surgery. The type of anaesthesia will be discussed with you by the anaesthetist before your surgery.\n",
      "- There are some specific risks associated with your surgery and medical history that you should be aware of.\n",
      " - Your obesity increases the risk of complications such as difficulty breathing, blood clots, and wound infections.\n",
      " - Your sleep apnoea increases the risk of complications during anaesthesia, such as difficulty breathing and low oxygen levels.\n",
      " - Your diabetes increases the risk of complications such as infection, poor wound healing, and high blood sugar levels.\n",
      "The anaesthetist will take all necessary precautions to minimize these risks and ensure your safety during surgery.\n",
      "Response from Model:  **Doctor/Nurse**: Doctor\n",
      "\n",
      "**Fasting instructions**: Fasting for solids for 6 hours and clear fluids for 2 hours before the surgery.\n",
      "\n",
      "**Preoperative carbohydrate loading**: No\n",
      "\n",
      "**Medication instructions**: \n",
      "- Ventolin: Take as usual.\n",
      "\n",
      "**Instructions for the healthcare team**: \n",
      "- Arrange for preoperative blood group matching and cross-matching. \n",
      "- Arrange for standby post-operative high dependency/ICU bed due to patient's severe OSA and high BMI.\n",
      "\n",
      "**Preoperative optimization required**: \n",
      "- Diabetes: HbA1c is elevated at 9.4%. Refer to the outpatient diabetic clinic for optimization.\n",
      "- Weight loss: Consider referral to a weight loss program to reduce surgical risks associated with obesity. \n",
      "- OSA: Optimize CPAP settings and ensure patient is compliant with CPAP therapy.\n",
      "\n",
      "**Need to delay the operation**: It may be necessary to delay the operation until the patient's diabetes and OSA are better controlled. \n",
      "\n",
      "**Specific department protocols to follow**: \n",
      "- ERAS Spine protocol: Implement ERAS protocol to enhance recovery after surgery.\n",
      "- Obesity protocol: Follow the departmental protocol for the preoperative assessment and optimization of obese patients.\n",
      "- OSA protocol: Follow the departmental protocol for the preoperative assessment and management of patients with OSA.\n",
      "\n",
      "**Patient instructions**: \n",
      "- Take Ventolin as prescribed.\n",
      "- Inform the anesthesia team of any allergies or medical conditions.\n",
      "- Consent for general anesthesia and be aware of the risks associated with the surgery and medical history, including the possibility of difficult airway management due to OSA and high BMI.\n",
      "iteration # 1\n",
      "['**Preoperative Anesthesia Instructions**\\n\\n1. **Doctor/Nurse:** Nurse\\n2. **Fasting Instructions:**\\n   - Clear fluids up to 2 hours before surgery\\n   - Solid foods up to 6 hours before surgery\\n3. **Preoperative Carbohydrate Loading:** No\\n4. **Medication', ' Instructions:**\\n   - No medications required\\n5. **Instructions for Healthcare Team:** NA\\n6. **Preoperative Optimization:** NA\\n7. **Need to Delay Operation:** No\\n8. **Department Protocols:**\\n   - Preoperative Assessment of Obese Patients: Patient has a BMI of 26.', '9, which is below the threshold for additional considerations.\\n\\n**Patient Instructions**\\n\\n**Medication Instructions:**\\n\\n- You do not need to take any medications before surgery.\\n\\n**Consent for Anesthesia:**\\n\\n- You will likely receive general anesthesia for this surgery. This means that you will be completely asleep and unaware during', ' the procedure.\\n- There are no specific risks to highlight for this surgery due to your medical history.']\n",
      "['**Preoperative Anesthesia Instructions**\\n\\n1. **Doctor/Nurse:** Nurse\\n2. **Fasting Instructions:**\\n   - Clear fluids up to 2 hours before surgery\\n   - Solid food up to 6 hours before surgery\\n3. **Preoperative Carbohydrate Loading:** No\\n4. **Medication', ' Instructions:**\\n   - No medications required\\n5. **Instructions for Healthcare Team:** NA\\n6. **Preoperative Optimization:** NA\\n7. **Need to Delay Operation:** No\\n8. **Department Protocols:**\\n   - Preoperative Assessment of Obese Patients: Patient has a BMI of 26.', '9, which is below the threshold for additional considerations.\\n\\n**Patient Instructions**\\n\\n**Medication Instructions:**\\n\\n- You do not need to take any medications before surgery.\\n\\n**Consent for Anesthesia:**\\n\\n- You will likely receive general anesthesia for this surgery. This means that you will be completely asleep and unaware during', ' the procedure.\\n- There are no specific risks to highlight for this surgery due to your medical history.']\n",
      "['**Preoperative Anesthesia Instructions for Medical Colleagues**\\n\\n1. **Doctor/Nurse:** Nurse\\n2. **Fasting Instructions:**\\n    - Clear fluids up to 2 hours before surgery\\n    - Solid food up to 6 hours before surgery\\n3. **Preoperative Carbohydrate Loading:** No\\n4', '. **Medication Instructions:**\\n    - No medications required\\n5. **Instructions for Healthcare Team:** NA\\n6. **Preoperative Optimization:** NA\\n7. **Need to Delay Operation:** No\\n8. **Department Protocols:**\\n    - Preoperative Cardiac Assessment Protocol: Patient has an elevated cardiac risk (R', \"CRI ≥ 2) due to a history of ischemic heart disease. However, the patient's cardiac condition appears to be stable based on the previous echocardiogram.\\n    - Preoperative Assessment of Obese Patients Protocol: Patient has a BMI > 25 but < 35. No specific precautions are required\", '.\\n\\n**Instructions for the Patient**\\n\\n1. **Medication Instructions:**\\n    - You do not need to take any medications before surgery.\\n2. **Consent for Anesthesia:**\\n    - You will likely receive general anesthesia for this surgery. This means that you will be completely asleep and unaware during the procedure', '.\\n    - There are some risks associated with general anesthesia, such as nausea, vomiting, and sore throat. However, these risks are generally minor and temporary.']\n",
      "['1. Should the patient be seen by a Doctor or Nurse - Doctor\\n2. Fasting instructions - Fast for at least 6 hours before the time of surgery.\\n3. Suitability for preoperative carbohydrate loading - Yes\\n4. Medication instructions - Nil chronic medications\\n5. Any instructions for the healthcare team - NA', '\\n6. Any preoperative optimization required for the patient - NA\\n7. Any need to delay the operation for further medical workup and preoperative optimization? - No\\n8. Any specific department protocols to follow for this patient - NA\\n\\nPatient instructions:\\n1. Do not eat or drink anything, including water, for', ' at least 6 hours before your surgery. You may brush your teeth and rinse your mouth with water, but do not swallow the water.\\n2. You will need to sign a consent form for the type of anesthesia that will be used during your surgery. The most common types of anesthesia are general anesthesia, which will put you to sleep during the surgery, and regional anesthesia, which will numb the area of your body where the surgery will be performed. Your anesthesiologist will discuss the risks and benefits of each type of anesthesia with you and help you choose the best option for you.']\n",
      "response\n",
      " prediction:  Singapore General Hospital  \n",
      "Policy & Procedure  \n",
      " \n",
      "Title :  \n",
      "Guidelines on Preoperative Assessment of Obese \n",
      "Patients  Document No:  \n",
      " Page 2 of 2 \n",
      "Issued By : Perioperative Services,  Dept of \n",
      "Anaesthesiology (Dr Hairil Abdullah)  \n",
      "Initial Date Issued : 5/9/2012  \n",
      "Date Revised : 2/5/2017   \n",
      "Revision number : 2 Approved By:  \n",
      "A/P Ruban Poopalalingam Head, Department of \n",
      "Anaesthesia  \n",
      " \n",
      " \n",
      "a. Risk of difficult airway - should include dental injury, aspiration pneumonitis, hypoxia, neurological \n",
      "damage and death  \n",
      "b. Major Adverse Cardiac Event  \n",
      "c. Difficult iv line insertions  \n",
      "d. Positioning (peripheral nerve damage)  \n",
      "e. Deep vein thrombosis  \n",
      "f. Postoperative ventilation and SICU stay  \n",
      "g. Difficult regional anaesthesia (if RA is the planned technique)  \n",
      " \n",
      "4. PLAN  \n",
      "a. Prescribe gastro prophylaxis (PO ranitidine 150 mg 10 pm and 6 am, before surgery with sips of \n",
      "water)  \n",
      "b. Not for ASC Day Surgery, for ASC SSW/SDA – to discuss with PAC consultant  \n",
      "d. Documentation - Under section \"Notes\" : Document discussion with Consult ant and patient onto \n",
      "Pre-operative assessment chart, under \"Instructions\" : Docum ent instructions for follow up eg \n",
      "pending investigations/referrals; CPAP/BIPAP machine for use in PACU, SICU/HD/ICA booking  \n",
      "FOR B ODY MASS INDEX > 45:  \n",
      "ALL OF THE ABOVE AND :  \n",
      "1. Consider Arterial Blood Gas and Echocardiography if there are accompanying \n",
      "cardiac/pulmonary conditions, or oximetry on air is <93% – consult senior anaesthetist (rule \n",
      "out lung disease and/or obesity hypoventilation syndrome)  \n",
      "2. Assess the need for SICU/ICA b ooking postop  \n",
      "3.  Inform Principal Anaesthetist on Friday (once duty roster is out)  \n",
      "4.  Offer referral to LIFE Center (4377) for obesity management if not on follow up yet.\n",
      "\n",
      "---\n",
      "\n",
      "Singapore General Hospital  \n",
      "  \n",
      "SUPPORTING DOCUMENTS  \n",
      "TITLE:  Preoperative i nvestigation guidelines  for \n",
      "patients presenting for elective surgery  \n",
      " DOCUMENT NO.  \n",
      "75400 -SD-006 Page 1 of 3 \n",
      "ISSUING DEPARTMENT: Preoperative Evaluation Clinic  \n",
      "ISSUED BY: Angie Au Yong , Hairil Rizal Bin Abdullah  \n",
      "DATE REVISED: 11 June  2021  \n",
      "VERSION NUMBER: 3 APPROVED BY:  \n",
      "Tan Kian Hian  \n",
      "Head and Senior Consultant  \n",
      "Department  of Anaesthesiology  \n",
      " \n",
      " \n",
      " \n",
      " \n",
      " \n",
      " \n",
      " \n",
      " \n",
      " \n",
      " ASA\n",
      "1\n",
      "Age <60\n",
      "Minor\n",
      "FBC for \n",
      "femalesAge >60\n",
      "Refer to ASA 22\n",
      "Minor surgery\n",
      "FBC, renal \n",
      "panel/ \n",
      "glucoseIntermediate/ \n",
      "Major surgery\n",
      "FBC, PT/PTT, \n",
      "renal panel/ \n",
      "glucose, CXR3/4\n",
      "Minor surgery\n",
      "FBC, renal \n",
      "panel/ \n",
      "glucoseIntermediate/ \n",
      "Major surgery\n",
      "FBC, PT/PTT, \n",
      "renal panel/ \n",
      "glucose, CXR\n",
      "\n",
      "---\n",
      "\n",
      "Singapore General Hospital  \n",
      " \n",
      " \n",
      "TITLE:  \n",
      "Guideline s on Preoperative Assessment and optimizati on of \n",
      "patients with HYPERTENSION  DOCUMENT NO:  \n",
      "75400-SD -001 Page 4 of 7 \n",
      "ISSUED BY: Dr Hairil Abdullah , Director and Senior \n",
      "Consultant, Preoperative Evaluation Clinic, Dept of \n",
      "Anesthesiology, SGH  \n",
      "INITIAL DATE ISSUED: 1/05/2014  \n",
      "Updated by:  \n",
      "Dr He Yingke, Associate Consultant, De pt of Anesthesiology  \n",
      "Dr Shum Koin Lon, Consultant, Dept of Internal Medicine  \n",
      "DATE REVISED: 4/6/2020 , REVISION NUMBER: 4 Approved by:  \n",
      "Dr Tan Kian Hian  \n",
      "Senior Consultant and Head , Dept \n",
      "of Anesthesiology , SGH  \n",
      " \n",
      "A/P Soh Chai Rick  \n",
      "Senior Consultant, Chairman, \n",
      "Division of Anesthesiology, SGH  \n",
      " \n",
      "• Hypokalemia  hyperaldosteronism  \n",
      "• Look through available CT abdomen for adrenal masses  \n",
      " Refer young hypertensive patients and patients with signs of secondary hypertension to \n",
      "IMPT for work up prior to surgery  (discuss with surgeon regarding benefit\n",
      "Response from Model:  **Preoperative assessment** \n",
      "- Doctor \n",
      "\n",
      "**Fasting instructions**\n",
      "- Fast for at least 6 hours for solids and 2 hours for clear fluids before the surgery.\n",
      "\n",
      "**Preoperative carbohydrate loading**\n",
      "- No\n",
      "\n",
      "**Medication instructions** \n",
      "- Continue all current medications except for ACE inhibitors and ARBs, which should be stopped 24 hours before surgery.\n",
      "\n",
      "**Instructions to the healthcare team**\n",
      "- Consider arterial blood gas and echocardiography if there are accompanying cardiac/pulmonary conditions, or oxygen saturation on air is <93% - consult senior anesthetist (rule out lung disease and/or obesity hypoventilation syndrome)\n",
      "- Assess the need for SICU/ICA booking postop\n",
      "- Offer referral to LIFE Center (4377) for obesity management if not on follow up yet.\n",
      "\n",
      "**Preoperative optimization**\n",
      "- Weight loss \n",
      "- Smoking cessation\n",
      "\n",
      "**Need to delay operation** \n",
      "- No \n",
      "\n",
      "**Specific department protocols**\n",
      "- Singapore General Hospital (SGH) Guideline on Preoperative Assessment of Obese Patients\n",
      "- SGH Guideline on Preoperative Cardiac Assessment\n",
      "\n",
      "**Instructions to the patient** \n",
      "\n",
      "- Fasting instructions: Fast for at least 6 hours for solids and 2 hours for clear fluids before the surgery.\n",
      "- Medication instructions: Continue all current medications except for ACE inhibitors and ARBs, which should be stopped 24 hours before surgery.\n",
      "- Consent for anesthesia: You will likely require general anesthesia for your surgery. This involves breathing through a tube that will be inserted into your windpipe. There are risks associated with general anesthesia, including but not limited to sore throat, hoarseness, nausea, vomiting, and temporary confusion. We will discuss these risks in more detail on the day of surgery.\n",
      "- Specific risks: Your weight and smoking history may increase your risk of complications during and after surgery. We will take steps to minimize these risks, but it is important for you to be aware of them.\n",
      "iteration # 2\n",
      "['**Preoperative Anesthesia Instructions for Medical Colleagues**\\n\\n1. **Doctor/Nurse:** Nurse\\n2. **Fasting instructions:** Clear fluids up to 2 hours before surgery, solids up to 6 hours before surgery.\\n3. **Preoperative carbohydrate loading:** Yes\\n4. **Medication instructions:**\\n', '   - Continue Paracetamol 1g TDS up to and including the day of surgery.\\n   - Continue Pregabalin 60mg OM up to and including the day of surgery.\\n5. **Instructions for healthcare team:** NA\\n6. **Preoperative optimization required:** NA\\n7. **Need', ' to delay operation:** No\\n8. **Department protocols:**\\n   - Anaesthesia Protocol for Total/Unicompartmental Knee Arthroplasty (TKA/UKA) ERAS: For carbohydrate loading and perioperative analgesia.\\n   - Obesity Protocol: For risk assessment and disclosure due to BMI > 3', '0.\\n   - Diabetes Protocol: For perioperative blood glucose management.\\n\\n**Instructions for Patient**\\n\\n1. **Medication instructions:**\\n   - Continue taking your regular pain relief medication (paracetamol) and nerve pain medication (pregabalin) as usual, including on the day of surgery.\\n\\n2', '. **Consent for anesthesia:**\\n   - You will likely receive spinal anesthesia for this surgery. This will numb your legs and make it so that you do not feel pain during the operation.\\n   - There is a small risk of difficulty breathing or nerve damage with spinal anesthesia.']\n",
      "['**Preoperative Anesthesia Instructions**\\n\\n1. **Doctor/Nurse:** Doctor\\n2. **Fasting instructions:**\\n   - Clear fluids up to 2 hours before surgery\\n   - No solid food for 6 hours before surgery\\n3. **Preoperative carbohydrate loading:** Yes\\n4. **Medication instructions', ':**\\n   - **Paracetamol:** Take 1g three times a day as usual.\\n   - **Pregabalin:** Take 60mg once a day as usual.\\n5. **Instructions for healthcare team:** NA\\n6. **Preoperative optimization required:**\\n   - Hypertension: Refer to', ' IMPT for further workup and optimization.\\n7. **Need to delay operation:** Yes, for further medical workup and preoperative optimization of hypertension.\\n8. **Department protocols:**\\n   - Hypertension Protocol: Refer to IMPT for evaluation and management of hypertension.\\n   - Obese Patient Protocol: Consider', ' arterial blood gas and echocardiography if there are accompanying cardiac/pulmonary conditions or oximetry on air is <93%.\\n   - Total/Unicompartmental Knee Arthroplasty ERAS Protocol: Administer carbohydrate drink 2 hours before surgery.\\n\\n**Patient Instructions**\\n\\n**Medication instructions:**\\n\\n* Continue', ' taking your paracetamol and pregabalin as usual.\\n\\n**Consent for anesthesia:**\\n\\n* You will likely receive spinal anesthesia for this surgery. This involves numbing the lower half of your body so that you will not feel pain during the operation.\\n* There is a small risk of complications with spinal anesthesia, such', ' as headache, back pain, and nerve damage.\\n* Your medical history of hypertension may increase your risk of complications from anesthesia. It is important to discuss this with your doctor before the surgery.']\n",
      "['**Preoperative Anesthesia Instructions**\\n\\n1. **Doctor/Nurse:** Doctor\\n2. **Fasting instructions:** Clear fluids up to 2 hours before surgery, nothing by mouth after that.\\n3. **Preoperative carbohydrate loading:** Yes\\n4. **Medication instructions:**\\n    - Continue taking Pregab', 'alin 60mg once a day.\\n    - Take Paracetamol 1g three times a day as needed for pain.\\n5. **Instructions for healthcare team:** NA\\n6. **Preoperative optimization:**\\n    - Hypertension: Refer to IMPT for evaluation and management.\\n    - Obesity:', ' Consider arterial blood gas and echocardiography if oximetry on air is <93%. Assess the need for SICU/ICA booking postoperatively.\\n7. **Need to delay operation:** Yes, for further medical workup and preoperative optimization of hypertension.\\n8. **Department protocols:**\\n    - ERAS Spine', ' Protocol\\n    - Total/Unicompartmental Knee Arthroplasty (TKA/UKA) ERAS Protocol\\n    - Guidelines on Preoperative Assessment of Obese Patients\\n    - Guidelines on Perioperative Management of Diabetes Mellitus\\n    - Guidelines on Preoperative Cardiac Assessment\\n\\n**Patient Instructions**\\n\\n**Medication', ' instructions:**\\n\\n* Continue taking your Pregabalin medication as usual.\\n* You can take Paracetamol for pain as needed.\\n\\n**Consent for anesthesia:**\\n\\n* For this surgery, you will most likely receive spinal anesthesia. This will numb the lower half of your body so that you do not feel pain during the', ' operation.\\n* There is a small risk of complications with spinal anesthesia, such as headache, back pain, and nerve damage.\\n* Your medical history suggests that you may be at an increased risk for sleep apnea. This means that you may have pauses in your breathing during sleep. If you have sleep apnea, you', ' may need to use a special machine called a CPAP machine after surgery to help you breathe properly.']\n",
      "['1. Doctor\\n2. Fasting for solids for 6 hours and clear fluids for 2 hours before the surgery.\\n3. Yes\\n4. \\n- Paracetamol: Continue taking as usual.\\n- Pregabalin: Continue taking as usual.\\n5. NA\\n6. NA\\n7.', ' No\\n8. \\n- ERAS Spine Protocol: To optimize pain management and reduce postoperative complications.\\n- Total/Unicompartmental Knee Arthroplasty (TKA/UKA) ERAS Protocol: To optimize pain management and reduce postoperative complications.\\n- Preoperative Assessment of Obese Patients: To identify', ' and manage risks associated with obesity.\\n- Preoperative Cardiac Assessment: To assess and manage cardiac risks associated with surgery.\\n- Preoperative Investigation Guidelines for Patients Presenting for Elective Surgery: To ensure appropriate preoperative investigations are performed.\\n\\nPatient Instructions:\\n\\n1. Continue taking Paracetamol and Pregabalin as usual.\\n2. You will be given a carbohydrate drink to consume 2 hours before your surgery.\\n3. You will be given general anesthesia for your surgery. This means that you will be asleep during the procedure and will not feel any pain.\\n4. There are some risks associated with anesthesia, including nausea, vomiting,', ' and sore throat. These risks are usually mild and go away within a few days.\\n5. There are also some risks associated with your surgery, including infection, blood clots, and pain. Your surgeon will discuss these risks with you in more detail.']\n",
      "response\n",
      " prediction: \n",
      "\n",
      "1. Should the patient be seen by a Doctor or Nurse - Doctor\n",
      "2. Fasting instructions - 6 hours\n",
      "3. Suitability for preoperative carbohydrate loading - Yes\n",
      "4. Medication instructions - \n",
      " - Continue Paracetamol 1g TDS up to the day of surgery\n",
      " - Stop Pregabalin 60mg OM the day before surgery\n",
      "5. Any instructions for the healthcare team - \n",
      " - Consider preoperative blood group matching and cross-matching\n",
      " - Arrange for preoperative physiotherapy assessment\n",
      "6. Any preoperative optimization required for the patient - \n",
      " - Consider preoperative weight loss\n",
      " - Consider preoperative CPAP/BiPAP therapy for OSA\n",
      "7. Any need to delay the operation for further medical workup and preoperative optimization? - No\n",
      "8. Any specific department protocols to follow for this patient - \n",
      " - ERAS TKA protocol\n",
      " - OSA protocol\n",
      "\n",
      "In addition, please give the following instructions to the patient in lay language: \n",
      "1. Medication instructions to take leading up to the surgery. \n",
      " - Continue taking Paracetamol 1g TDS up to the day of surgery\n",
      " - Stop taking Pregabalin 60mg OM the day before surgery\n",
      "2. Consent for the types of anesthesia that the patient needs to be aware of for this surgery, and any specific risks to highlight due to the operation and the patient’s medical history. \n",
      " - The patient will likely receive a spinal anesthetic for this surgery. \n",
      " - The risks of spinal anesthesia include:\n",
      "  - Back pain\n",
      "  - Headache\n",
      "  - Nerve damage\n",
      "  - Infection\n",
      " - The patient will also receive general anesthesia, which carries its own risks, including:\n",
      "  - Nausea and vomiting\n",
      "  - Sore throat\n",
      "  - Difficulty breathing\n",
      "  - Awareness during surgery\n",
      " - The patient should discuss the risks and benefits of anesthesia with the anesthesiologist before surgery.\n",
      "Response from Model:  **Preoperative anesthesia instructions:**\n",
      "\n",
      "**To be seen by:** Doctor\n",
      "\n",
      "**Fasting instructions:** Fast for 8 hours before the surgery.\n",
      "\n",
      "**Carbohydrate loading:** Yes, carbohydrate loading is suitable.\n",
      "\n",
      "**Medication instructions:**\n",
      "\n",
      "* Paracetamol 1g TDS: Take as usual up to the day before surgery.\n",
      "* Pregabalin 60mg OM: Take as usual up to the day before surgery.\n",
      "\n",
      "**Instructions for the healthcare team:**\n",
      "\n",
      "* Arrange for preoperative blood group matching.\n",
      "* Consider standby post-operative high dependency/ICU bed due to patient's BMI and risk of postoperative complications.\n",
      "\n",
      "**Preoperative optimization:**\n",
      "\n",
      "* Optimize weight management.\n",
      "* Consider preoperative CPAP/BiPAP therapy for suspected sleep apnea.\n",
      "\n",
      "**Need to delay operation:** No, the operation does not need to be delayed.\n",
      "\n",
      "**Specific department protocols:**\n",
      "\n",
      "* Follow the ERAS Spine protocol for the surgery.\n",
      "* Follow the guidelines on preoperative assessment of obese patients.\n",
      "\n",
      "**Patient instructions:**\n",
      "\n",
      "* Take all medications as instructed up to the day before surgery, except for any medications that are specifically advised to be stopped.\n",
      "* You will be given a carbohydrate drink to consume 2 hours before surgery.\n",
      "* You will be given a general anesthetic for the surgery, which means that you will be completely asleep and pain-free during the procedure.\n",
      "* There are specific risks associated with this surgery and your medical history, including the risk of deep vein thrombosis (DVT), pulmonary embolism (PE), and pneumonia. Your anesthesiologist will discuss these risks with you in detail before the surgery.\n",
      "iteration # 3\n",
      "['**Preoperative Anesthesia Instructions**\\n\\n1. **Doctor/Nurse:** Doctor\\n2. **Fasting instructions:**\\n   - Clear fluids up to 2 hours before surgery\\n   - Solid foods up to 6 hours before surgery\\n3. **Preoperative carbohydrate loading:** Yes\\n4. **Medication instructions', ':**\\n   - Continue Keppra on the day of surgery\\n   - Take Paracetamol with a sip of water at 6am on the day of surgery\\n   - Do not take Tramadol on the day of surgery\\n5. **Instructions for the healthcare team:** NA\\n6. **Preoperative optimization', ' required:**\\n   - Anemia (Hb 9.3 g/dL): Refer to IMPT for consideration of IV iron treatment. Discuss with surgeon the possibility of delaying surgery for 2-4 weeks for hemoglobin response to treatment.\\n7. **Need to delay operation:** Discuss with surgeon the possibility of delaying surgery', ' for anemia optimization.\\n8. **Department protocols:**\\n   - Enhanced Recovery after Surgery for Benign Hysterectomy / Cystectomy / Myomectomy: Preoperative carbohydrate loading, goal-directed fluid therapy, opioid-sparing pain management techniques.\\n\\n**Patient Instructions**\\n\\n1. **Medication instructions:**\\n', '   - Continue taking your epilepsy medication (Keppra) as usual.\\n   - On the morning of surgery, take Paracetamol with a small amount of water.\\n   - Do not take Tramadol on the day of surgery.\\n2. **Consent for anesthesia:**\\n   - You may receive regional anesthesia', ' (such as a spinal or epidural), which will numb the lower part of your body.\\n   - You may also receive general anesthesia, which will make you unconscious during the surgery.\\n   - Specific risks to highlight:\\n      - Your history of epilepsy may increase your risk of seizures during or after surgery.', ' However, your epilepsy is well-controlled with medication, so this risk is low.']\n",
      "['**Preoperative Anesthesia Instructions**\\n\\n1. **Doctor/Nurse:** Doctor\\n2. **Fasting instructions:**\\n   - Clear fluids up to 2 hours before surgery\\n   - Solid foods up to 6 hours before surgery\\n3. **Preoperative carbohydrate loading:** Yes\\n4. **Medication instructions', ':**\\n   - Continue Keppra on the day of surgery\\n   - Take Paracetamol with a sip of water at 6am on the day of surgery\\n   - Do not take Tramadol on the day of surgery\\n5. **Instructions for the healthcare team:** NA\\n6. **Preoperative optimization', ' required:**\\n   - Anemia (Hb 9.3 g/dL): Refer to IMPT for consideration of IV iron treatment. Discuss with surgeon about potentially delaying surgery for 2-4 weeks for hemoglobin response to treatment.\\n7. **Need to delay operation for further medical workup and preoperative optimization:** Yes', ', potentially for anemia optimization.\\n8. **Specific department protocols to follow:**\\n   - Enhanced Recovery after Surgery for Benign Hysterectomy / Cystectomy / Myomectomy: Preoperative carbohydrate loading, goal-directed fluid therapy, opioid-sparing pain management techniques.\\n   - ERAS Spine: Pre', 'operative anemia optimization, smoking cessation counseling.\\n\\n**Patient Instructions**\\n\\n1. **Medication instructions to take leading up to the surgery:**\\n   - Continue taking your epilepsy medication (Keppra) as usual.\\n2. **Consent for the types of anesthesia that the patient needs to be aware of for this surgery', ':**\\n   - You may receive general anesthesia, which will make you unconscious during the surgery.\\n   - You may also receive regional anesthesia, such as an epidural or spinal block, which will numb the lower part of your body.\\n   - There is a small risk of complications with both types of anesthesia,', ' such as nausea, vomiting, and pain. Your medical history of epilepsy may increase your risk of complications.']\n",
      "['**Preoperative Anesthesia Instructions**\\n\\n1. **Doctor/Nurse:** Doctor\\n2. **Fasting instructions:**\\n   - Clear fluids up to 2 hours before surgery\\n   - Solid foods up to 6 hours before surgery\\n3. **Preoperative carbohydrate loading:** Yes\\n4. **Medication instructions', ':**\\n   - Continue Keppra on the day of surgery\\n   - Take Paracetamol with a sip of water at 6am on the day of surgery\\n   - Do not take Tramadol on the day of surgery\\n5. **Instructions for the healthcare team:** NA\\n6. **Preoperative optimization', ' required:**\\n   - Anemia (Hb 9.3 g/dL): Refer to IMPT for consideration of IV iron treatment. Discuss with surgeon about potentially delaying surgery for 2-4 weeks for hemoglobin response to treatment.\\n7. **Need to delay operation:** Yes, potentially for anemia optimization.\\n8', '. **Department protocols:**\\n   - Enhanced Recovery after Surgery for Benign Hysterectomy/Cystectomy/Myomectomy: Preoperative carbohydrate loading, nutritional optimization, and goal-directed fluid therapy.\\n   - ERAS Spine: Preoperative carbohydrate loading, multimodal analgesia, and normothermia.\\n\\n**', 'Patient Instructions**\\n\\n1. **Medication instructions:**\\n   - Continue taking your epilepsy medication (Keppra) as usual.\\n   - On the morning of surgery, take your paracetamol tablet with a small amount of water.\\n   - Do not take Tramadol on the day of surgery.\\n\\n2.', ' **Consent for anesthesia:**\\n   - You may receive regional anesthesia (such as a spinal or epidural), which will numb the lower part of your body.\\n   - You may also receive general anesthesia, which will make you unconscious during the surgery.\\n   - Specific risks related to your medical history include the possibility', ' of seizures during the surgery, although this is unlikely as your epilepsy is well-controlled.']\n",
      "['1. Should the patient be seen by a Doctor or a Nurse - Doctor\\n2. Fasting instructions - Patient should fast for 8 hours before the time of surgery.\\n3. Suitability for preoperative carbohydrate loading - Yes\\n4. Medication instructions:\\n - Keppra: Continue taking as usual.\\n -', ' Paracetamol: Take 1g 6 hours before the time of surgery.\\n - Tramadol: Take as needed for pain relief.\\n5. Any instructions for the healthcare team - NA\\n6. Any preoperative optimization required for the patient - Optimize anemia\\n7. Any need to delay the operation for further medical', ' workup and preoperative optimization? - No\\n8. Any specific department protocols to follow for this patient - Enhanced Recovery After Surgery (ERAS) protocol for hysterectomy.\\n\\nInstructions to the patient:\\n1. Medication instructions:\\n - Continue taking Keppra as usual.\\n - Take 1g of Paracetamol 6 hours before the time of surgery.\\n - Take Tramadol as needed for pain relief.\\n2. Consent for the types of anesthesia and specific risks:\\n - You will be given a general anesthetic for your surgery. This means that you will be asleep during the procedure and will not feel any pain.\\n', ' - There are some risks associated with general anesthesia, including nausea, vomiting, and sore throat. \\n - In your case, there is also a small risk of complications related to your epilepsy, such as seizures. However, this risk is very low, especially since your epilepsy is well-controlled on medication.\\n - The benefits of surgery outweigh the risks, and your doctor has recommended that you proceed with the procedure.']\n",
      "response\n",
      " prediction: \n",
      "\n",
      "1. Should the patient be seen by a Doctor or Nurse - Doctor\n",
      "2. Fasting instructions - Clear fluids until 2 hours before the surgery\n",
      "3. Suitability for preoperative carbohydrate loading - Yes\n",
      "4. Medication instructions - \n",
      " - Keppra: Continue taking as usual\n",
      " - Paracetamol: Continue taking as usual\n",
      " - Tramadol: Take as needed for pain\n",
      "5. Any instructions for the healthcare team - \n",
      " - Consider preoperative blood group matching and cross-matching in case of significant blood loss\n",
      "6. Any preoperative optimization required for the patient - \n",
      " - Consider optimizing anemia if Hb <10 g/dL\n",
      " - Consider preoperative physiotherapy to improve respiratory function\n",
      "7. Any need to delay the operation for further medical workup and preoperative optimization? - No\n",
      "8. Any specific department protocols to follow for this patient - \n",
      " - Enhanced Recovery After Surgery (ERAS) protocol for hysterectomy\n",
      " - ERAS Spine protocol\n",
      "\n",
      "In addition, please give the following instructions to the patient in lay language: \n",
      "1. Medication instructions to take leading up to the surgery. \n",
      " - Continue taking your Keppra, paracetamol, and tramadol as usual.\n",
      "2. Consent for the types of anesthesia that the patient needs to be aware of for this surgery, and any specific risks to highlight due to the operation and the patient’s medical history.\n",
      " - You will need to have a general anesthetic for this surgery, which means that you will be asleep and pain-free during the operation.\n",
      " - There are some specific risks associated with general anesthesia, such as the risk of nausea and vomiting, and the risk of complications from the breathing tube.\n",
      " - Your doctor will discuss these risks with you in more detail before the surgery.\n",
      "Response from Model:  **Instructions:**\n",
      "\n",
      "**Doctor/Nurse:** Doctor\n",
      "\n",
      "**Fasting instructions:**\n",
      "- Fast for at least 8 hours before the time of surgery.\n",
      "- Avoid drinking milk or milk products for at least 6 hours before the surgery.\n",
      "- Clear fluids (water, black coffee, or tea without sugar) can be taken up to 2 hours before the surgery.\n",
      "\n",
      "**Preoperative carbohydrate loading:** Yes\n",
      "\n",
      "**Medication instructions:**\n",
      "- Keppra: Continue taking as usual.\n",
      "- Paracetamol: Take your regular dose on the morning of surgery, but avoid taking it within 4 hours of the surgery.\n",
      "- Tramadol: Do not take this medication on the day of surgery.\n",
      "\n",
      "**Instructions for the healthcare team:**\n",
      "- Ensure that the patient has a recent history of epilepsy and is currently well controlled on medications.\n",
      "\n",
      "**Preoperative optimization:**\n",
      "- Consider referral to the Internal Medicine Perioperative Team (IMPT) for evaluation and management of anemia (hemoglobin 9.3 g/dL) and renal function (creatinine 87 umol/L).\n",
      "- Encourage smoking cessation.\n",
      "- Ensure adequate hydration and electrolyte balance.\n",
      "\n",
      "**Delay of operation:**\n",
      "- Consider delaying the operation until the anemia and renal function are optimized.\n",
      "\n",
      "**Specific department protocols:**\n",
      "- Follow the department protocol for Enhanced Recovery After Surgery (ERAS) for hysterectomy.\n",
      "- Consider the use of regional anesthesia (e.g., spinal or epidural) instead of general anesthesia, as appropriate.\n",
      "\n",
      "**Patient instructions:**\n",
      "\n",
      "- Continue taking your regular medications, except for Tramadol, on the day of surgery.\n",
      "- You will be given a carbohydrate drink to take the evening before and 2 hours before the surgery.\n",
      "- You will be given specific instructions on how to prepare for the surgery, including any dietary restrictions and hygiene measures.\n",
      "- You will be asked to sign a consent form for the type of anesthesia that will be used during the surgery.\n",
      "- Please inform the healthcare team if you have any questions or concerns.\n",
      "iteration # 4\n",
      "['**Preoperative Anesthesia Instructions**\\n\\n1. **Doctor/Nurse:** Nurse\\n2. **Fasting Instructions:**\\n   - No solid food from 12 midnight the night before surgery.\\n   - Clear fluids allowed up to 2 hours before surgery.\\n3. **Preoperative Carbohydrate Loading:**', ' No\\n4. **Medication Instructions:**\\n   - No specific medication instructions.\\n5. **Instructions for Healthcare Team:** NA\\n6. **Preoperative Optimization:** NA\\n7. **Need to Delay Operation:** No\\n8. **Department Protocols:**\\n   - Preoperative Assessment of Obese Patients: Not', \" applicable as patient's BMI is less than 45.\\n   - Preoperative Assessment and Optimization of Patients with Hypertension: Not applicable as patient's blood pressure is within normal range.\\n   - Preoperative Assessment of Patients with Chronic Kidney Disease: Not applicable as patient's creatinine level is within normal range\", '.\\n   - Perioperative Management of Diabetes Mellitus: Not applicable as patient does not have diabetes.\\n   - Preoperative Cardiac Assessment: Not applicable as patient is ASA 1 and undergoing minor surgery.\\n\\n**Patient Instructions**\\n\\n1. **Medication Instructions:**\\n   - You do not need to take any', ' specific medications before surgery.\\n2. **Consent for Anesthesia:**\\n   - You will likely receive general anesthesia for this surgery. This means that you will be completely asleep and will not feel any pain during the procedure.\\n   - There are some risks associated with general anesthesia, such as nausea, vomiting, and', ' sore throat. However, these risks are generally minor and temporary.']\n",
      "['**Preoperative Anesthesia Instructions**\\n\\n1. **Doctor/Nurse:** Nurse\\n2. **Fasting Instructions:**\\n   - No solid food from 12 midnight the night before surgery.\\n   - Clear fluids allowed up to 2 hours before surgery.\\n3. **Preoperative Carbohydrate Loading:**', ' No\\n4. **Medication Instructions:**\\n   - No specific medication instructions.\\n5. **Instructions for Healthcare Team:** NA\\n6. **Preoperative Optimization:** NA\\n7. **Need to Delay Operation:** No\\n8. **Department Protocols:**\\n   - Preoperative Management of Diabetes Mellitus: Patient', ' should be scheduled for the morning list, if possible.\\n\\n**Patient Instructions**\\n\\n1. **Medication Instructions:**\\n   - There are no specific medication instructions for you.\\n2. **Consent for Anesthesia:**\\n   - You may receive general anesthesia for this surgery. This means that you will be completely asleep', ' and unaware of the surgery.\\n   - There are some risks associated with general anesthesia, but these are rare. Your anesthesiologist will discuss these risks with you in more detail.']\n",
      "['**Preoperative Anesthesia Instructions**\\n\\n1. **Doctor/Nurse:** Nurse\\n2. **Fasting Instructions:** No solid food from 12 midnight. Allow clear fluids up to 2 hours before the procedure.\\n3. **Preoperative Carbohydrate Loading:** NA\\n4. **Medication Instructions:** None', '\\n5. **Instructions for Healthcare Team:** NA\\n6. **Preoperative Optimization:** NA\\n7. **Need to Delay Operation:** No\\n8. **Department Protocols:**\\n   - Preoperative Fasting Protocol\\n\\n**Patient Instructions**\\n\\n1. **Medication Instructions:**\\n   - There are no medications to take', ' leading up to the surgery.\\n\\n2. **Consent for Anesthesia:**\\n   - You may receive general anesthesia for this surgery. This means that you will be completely asleep during the procedure.\\n   - There are no specific risks to highlight due to the operation or your medical history.']\n",
      "['1. Should the patient be seen by a Doctor or a Nurse - Doctor\\n2. Fasting instructions - Patient is allowed to drink clear fluids up to 2 hours before the time of surgery.\\n3. Suitability for preoperative carbohydrate loading - No\\n4. Medication instructions - \\n- Continue all anti-hyper', 'tensives on the day of operation except ACEi/ARB (refer to below)\\n- Take with sip of water at 6am on day of surgery\\n- Beta-blockers\\n - Patients with ≥ 3 revised cardiac risk index ( RCRI) factors or intermediate/high cardiac risk on preoperative tests,', ' it may be reasonable to begin beta blockers before surgery – discuss with cardiologist or PEC consultant if it should be started\\n - Beta blockers should not be initiated within 24h of surgery\\n- Diuretics\\n - Watch out for hypokalemia and evaluate patient’s volume status on the day of operation\\n- Angiotension converting enzyme inhibitors (ACEi)/ Angiotensin-receptor blockers (ARBs)\\n - ACEi can cause refractory post induction hypotension if not stopped preoperatively\\n - In non-cardiac surgery, consider discontinuation 24 hours preoperatively and restart within 48 hours after operation in patients with', ' well controlled hypertension unless clinically contraindicated\\n - Continue ACEi preoperatively if there is impaired LV systolic function or heart failure or if BP is poorly controlled\\n5. Any instructions for the healthcare team - NA\\n6. Any preoperative optimization required for the patient - NA\\n7. Any need to delay the operation for further medical workup and preoperative optimization? - No\\n8. Any specific department protocols to follow for this patient - NA\\n\\nPatient instructions:\\n1. Medication instructions to take leading up to the surgery. \\n- Continue all anti-hypertensives on the day of operation except ACEi/ARB (refer to above', ')\\n- Take with sip of water at 6am on day of surgery\\n- Beta-blockers\\n - Patients with ≥ 3 revised cardiac risk index ( RCRI) factors or intermediate/high cardiac risk on preoperative tests, it may be reasonable to begin beta blockers before surgery – discuss with cardiologist or PEC consultant if it should be started\\n - Beta blockers should not be initiated within 24h of surgery\\n- Diuretics\\n - Watch out for hypokalemia and evaluate patient’s volume status on the day of operation\\n- Angiotension converting enzyme inhibitors (ACEi)/ Angiotensin-receptor blockers (ARBs)\\n - ACEi can cause refractory post induction hypotension if not stopped preoperatively\\n - In non-cardiac surgery, consider discontinuation 24 hours preoperatively and restart within 48 hours after operation in patients with well controlled hypertension unless clinically contraindicated\\n - Continue ACEi preoperatively if there', ' is impaired LV systolic function or heart failure or if BP is poorly controlled\\n2. Consent for the types of anesthesia that the patient needs to be aware of for this surgery, and any specific risks to highlight due to the operation and the patient’s medical history.\\n- General anesthesia will be administered for the surgery.\\n- Risks of general anesthesia include but are not limited to:\\n - Nausea and vomiting\\n - Sore throat\\n - Hoarseness\\n - Difficulty breathing\\n - Allergic reaction to anesthesia\\n- Risks of the surgery include but are not limited to:\\n - Infection\\n - Bleeding\\n - Pain\\n - Nerve damage\\n - Scarring']\n",
      "response\n",
      " prediction:  Singapore General Hospital  \n",
      "  \n",
      " \n",
      "TITLE:  \n",
      "Guideline s on Preoperative Assessment and optimizati on of \n",
      "patients with HYPERTENSION  DOCUMENT NO:  \n",
      "75400-SD -001 Page 4 of 7 \n",
      "ISSUED BY: Dr Hairil Abdullah , Director and Senior \n",
      "Consultant, Preoperative Evaluation Clinic, Dept of \n",
      "Anesthesiology, SGH  \n",
      "INITIAL DATE ISSUED: 1/05/2014  \n",
      "Updated by:  \n",
      "Dr He Yingke, Associate Consultant, De pt of Anesthesiology  \n",
      "Dr Shum Koin Lon, Consultant, Dept of Internal Medicine  \n",
      "DATE REVISED: 4/6/2020 , REVISION NUMBER: 4 Approved by:  \n",
      "Dr Tan Kian Hian  \n",
      "Senior Consultant and Head , Dept \n",
      "of Anesthesiology , SGH  \n",
      " \n",
      "A/P Soh Chai Rick  \n",
      "Senior Consultant, Chairman, \n",
      "Division of Anesthesiology, SGH  \n",
      " \n",
      " \n",
      " \n",
      " \n",
      " \n",
      " \n",
      " \n",
      " \n",
      " \n",
      " \n",
      " \n",
      " \n",
      " \n",
      " \n",
      " \n",
      " \n",
      " \n",
      " \n",
      " \n",
      " \n",
      " \n",
      " \n",
      " \n",
      " \n",
      " \n",
      " \n",
      " \n",
      " \n",
      " \n",
      " \n",
      " \n",
      " \n",
      " \n",
      " \n",
      " \n",
      " \n",
      " \n",
      " \n",
      " \n",
      " \n",
      " \n",
      " \n",
      " \n",
      " \n",
      " \n",
      " \n",
      " \n",
      " \n",
      " \n",
      " \n",
      " \n",
      " \n",
      " \n",
      " \n",
      " \n",
      " \n",
      " \n",
      " \n",
      " \n",
      " \n",
      " \n",
      " \n",
      " \n",
      " \n",
      " \n",
      " \n",
      " \n",
      " \n",
      " \n",
      " \n",
      " \n",
      " \n",
      " \n",
      " \n",
      " \n",
      " \n",
      " \n",
      " \n",
      " \n",
      " \n",
      " \n",
      " \n",
      " \n",
      " \n",
      " \n",
      " \n",
      " \n",
      " \n",
      " \n",
      " \n",
      " \n",
      " \n",
      " \n",
      " \n",
      " \n",
      " \n",
      " \n",
      " \n",
      " \n",
      " \n",
      " \n",
      " \n",
      " \n",
      " \n",
      " \n",
      " \n",
      " \n",
      " \n",
      " \n",
      " \n",
      " \n",
      " \n",
      " \n",
      " \n",
      " \n",
      " \n",
      " \n",
      " \n",
      " \n",
      " \n",
      " \n",
      " \n",
      " \n",
      " \n",
      " \n",
      " \n",
      " \n",
      " \n",
      " \n",
      " \n",
      " \n",
      " \n",
      " \n",
      " \n",
      " \n",
      " \n",
      " \n",
      " \n",
      " \n",
      " \n",
      " \n",
      " \n",
      " \n",
      " \n",
      " \n",
      " \n",
      " \n",
      " \n",
      " \n",
      " \n",
      " \n",
      " \n",
      " \n",
      " \n",
      " \n",
      " \n",
      " \n",
      " \n",
      " \n",
      " \n",
      " \n",
      " \n",
      " \n",
      " \n",
      " \n",
      " \n",
      " \n",
      " \n",
      " \n",
      " \n",
      " \n",
      " \n",
      " \n",
      " \n",
      " \n",
      " \n",
      " \n",
      " \n",
      " \n",
      " \n",
      " \n",
      " \n",
      " \n",
      " \n",
      " \n",
      " \n",
      " \n",
      " \n",
      " \n",
      " \n",
      " \n",
      " \n",
      " \n",
      " \n",
      " \n",
      " \n",
      " \n",
      " \n",
      " \n",
      " \n",
      " \n",
      " \n",
      " \n",
      " \n",
      " \n",
      " \n",
      " \n",
      " \n",
      " \n",
      " \n",
      " \n",
      " \n",
      " \n",
      " \n",
      " \n",
      " \n",
      " \n",
      " \n",
      " \n",
      " \n",
      " \n",
      " \n",
      " \n",
      " \n",
      " \n",
      " \n",
      " \n",
      " \n",
      " \n",
      " \n",
      " \n",
      " \n",
      " \n",
      " \n",
      " \n",
      " \n",
      " \n",
      " \n",
      " \n",
      " \n",
      " \n",
      " \n",
      " \n",
      " \n",
      " \n",
      " \n",
      " \n",
      " \n",
      " \n",
      " \n",
      " \n",
      " \n",
      " \n",
      " \n",
      " \n",
      " \n",
      " \n",
      " \n",
      " \n",
      " \n",
      " \n",
      " \n",
      " \n",
      " \n",
      " \n",
      " \n",
      " \n",
      " \n",
      " \n",
      " \n",
      " \n",
      " \n",
      " \n",
      " \n",
      " \n",
      " \n",
      " \n",
      " \n",
      " \n",
      " \n",
      " \n",
      " \n",
      " \n",
      " \n",
      " \n",
      " \n",
      " \n",
      " \n",
      " \n",
      " \n",
      " \n",
      " \n",
      " \n",
      " \n",
      " \n",
      " \n",
      " \n",
      " \n",
      " \n",
      " \n",
      " \n",
      " \n",
      " \n",
      " \n",
      " \n",
      " \n",
      " \n",
      " \n",
      " \n",
      " \n",
      " \n",
      " \n",
      " \n",
      " \n",
      " \n",
      " \n",
      " \n",
      " \n",
      " \n",
      " \n",
      " \n",
      " \n",
      " \n",
      " \n",
      " \n",
      " \n",
      " \n",
      " \n",
      " \n",
      " \n",
      " \n",
      " \n",
      " \n",
      " \n",
      " \n",
      " \n",
      " \n",
      " \n",
      " \n",
      " \n",
      " \n",
      " \n",
      " \n",
      " \n",
      " \n",
      " \n",
      " \n",
      " \n",
      " \n",
      " \n",
      " \n",
      " \n",
      " \n",
      " \n",
      " \n",
      " \n",
      " \n",
      " \n",
      " \n",
      " \n",
      " \n",
      " \n",
      " \n",
      " \n",
      " \n",
      " \n",
      " \n",
      " \n",
      " \n",
      " \n",
      " \n",
      " \n",
      " \n",
      " \n",
      " \n",
      " \n",
      " \n",
      " \n",
      " \n",
      " \n",
      " \n",
      " \n",
      " \n",
      " \n",
      " \n",
      " \n",
      " \n",
      " \n",
      " \n",
      " \n",
      " \n",
      " \n",
      " \n",
      " \n",
      " \n",
      " \n",
      " \n",
      " \n",
      " \n",
      " \n",
      " \n",
      " \n",
      " \n",
      "Response from Model:  ### Preoperative Instructions\n",
      "\n",
      "**1. Should the patient be seen by a Doctor or Nurse?** \n",
      "- Doctor\n",
      "\n",
      "**2. Fasting instructions**\n",
      "- Fasting for solids for at least 8 hours \n",
      "- Allowed clear fluids up to 2 hours before surgery\n",
      "\n",
      "**3. Suitability for preoperative carbohydrate loading**\n",
      "- No\n",
      "\n",
      "**4. Medication instructions**\n",
      "\n",
      "- **All current medications**, except **ACE inhibitors/ARB** (angiotensin-converting enzyme inhibitors/angiotensin-receptor blockers), to be taken on the day of surgery with a sip of water 6 am in the morning. \n",
      "- **ACE inhibitors/ARBs**: \n",
      " - For non-cardiac surgery, consider stopping 24 hours before surgery and restart within 48 hours after the operation in patients with well-controlled hypertension unless clinically contraindicated.\n",
      " - Continue ACEi preoperatively if there is impaired LV systolic function, heart failure, or poorly controlled BP.\n",
      "- Stop **smoking and alcohol** before surgery. \n",
      "\n",
      "**5. Instructions for the healthcare team**\n",
      "- Nil\n",
      "\n",
      "**6. Preoperative optimization**\n",
      "- Nil\n",
      "\n",
      "**7. Need to delay the operation for further medical workup and preoperative optimization?**\n",
      "- No\n",
      "\n",
      "**8. Specific department protocols to follow for this patient**\n",
      "- **ASA (American Society of Anesthesiologists) Physical Status Classification**\n",
      " - Patient is classified as **ASA 1**, indicating that she is a healthy patient with no significant medical problems.\n",
      "\n",
      "**Instructions to the patient:**\n",
      "\n",
      "- **Medication instructions:** \n",
      " - Continue all current medications except ACE inhibitors/ARBs as per instructions above.\n",
      "- **Consent for anesthesia:** \n",
      " - General anesthesia will be administered for the surgery. \n",
      " - Risks associated with general anesthesia, such as potential complications during intubation and risks associated with the surgery itself, will be discussed in detail before the procedure.\n",
      "iteration # 5\n",
      "['**Preoperative Anesthesia Instructions**\\n\\n1. **Should the patient be seen by a Doctor or a Nurse:** Doctor\\n2. **Fasting instructions:**\\n   - Clear fluids up to 2 hours before surgery\\n   - Solid food for 6 hours before surgery\\n3. **Suitability for preoperative carbohydrate', ' loading:** Yes\\n4. **Medication instructions:**\\n   - Continue Perindopril 2mg OM, Omeprazole 20mg OM, Bisoprolol 1.25mg OM, Atorvastatin 40mg ON, and Amlodipine 2.5mg OM on', ' the day of operation with a sip of water.\\n   - Stop Aspirin 100mg OM 7 days before surgery.\\n5. **Instructions for the healthcare team:** NA\\n6. **Preoperative optimization required for the patient:**\\n   - Smoking cessation\\n7. **Any need to delay', ' the operation for further medical workup and preoperative optimization:** No\\n8. **Specific department protocols to follow for this patient:**\\n   - Preoperative Assessment of Obese Patients: Patient has a BMI > 45, so consider arterial blood gas and echocardiography if there are accompanying cardiac/pulmonary conditions. Assess the', ' need for SICU/ICA booking postoperatively.\\n   - Preoperative Assessment and Optimization of Patients with Hypertension: Patient has poorly controlled hypertension (BP>180/110). Refer to the Internal Medicine Perioperative Team (IMPT) for preoperative optimization.\\n   - Preoperative Cardiac Assessment: Patient', ' has a Revised Cardiac Risk Index (RCRI) score of 2 or more. Discuss with a cardiologist or PEC consultant if beta-blockers should be started before surgery.\\n   - Preoperative Assessment of Respiratory Disease: Patient is a smoker. Encourage smoking cessation and refer to physiotherapy for assessment and exercises.\\n', '   - Preoperative Investigation Guidelines: Patient is above 70 years old, so a chest X-ray is indicated.\\n   - Preoperative Assessment and Optimization of Patients with Thyroid Disease: Patient has nonspecific R thyroid calcification. Refer to the Internal Medicine Perioperative Clinic (IMPT) for further evaluation.', '\\n\\n**Patient Instructions in Lay Language**\\n\\n1. **Medication instructions to take leading up to the surgery:**\\n   - Continue taking your regular medications (Perindopril, Omeprazole, Bisoprolol, Atorvastatin, and Amlodipine) on the day of surgery with a small sip of', ' water.\\n   - Stop taking Aspirin a week before surgery.\\n2. **Consent for the types of anesthesia that the patient needs to be aware of for this surgery, and any specific risks to highlight due to the operation and the patient’s medical history:**\\n   - You will likely receive general anesthesia for', ' this surgery, which means you will be completely asleep and unaware during the procedure.\\n   - There are some risks associated with general anesthesia, such as nausea, vomiting, and sore throat.\\n   - Due to your history of heart disease and smoking, you may have an increased risk of complications during surgery. Your doctor', ' will discuss these risks with you in more detail.']\n",
      "['**Preoperative Anesthesia Instructions**\\n\\n1. **Should the patient be seen by a Doctor or a Nurse:** Doctor\\n2. **Fasting instructions:**\\n   - Clear fluids up to 2 hours before surgery\\n   - Solids up to 6 hours before surgery\\n3. **Suitability for preoperative carbohydrate', ' loading:** Yes\\n4. **Medication instructions:**\\n   - Continue Perindopril 2mg OM, Omeprazole 20mg OM, Bisoprolol 1.25mg OM, Atorvastatin 40mg ON, and Amlodipine 2.5mg OM on', ' the day of operation with a sip of water.\\n   - Discontinue Aspirin 100mg OM 7 days before surgery.\\n5. **Instructions for the healthcare team:**\\n   - Arrange for preoperative blood group matching.\\n6. **Preoperative optimization required:**\\n   - Smoking cessation\\n', \"7. **Need to delay the operation for further medical workup and preoperative optimization:** No\\n8. **Specific department protocols to follow:**\\n   - Preoperative Assessment of Obese Patients: Patient's BMI is within the normal range, so no specific protocols are required.\\n   - Preoperative Assessment and Optimization\", \" of Patients with Hypertension: Patient's blood pressure is well-controlled, so no specific protocols are required.\\n   - Preoperative Cardiac Assessment: Patient has a low to moderate cardiovascular risk, so no specific protocols are required.\\n   - Preoperative Assessment and Optimization of Patients with Thyroid Disease: Patient does not have\", ' a known thyroid disease, so no specific protocols are required.\\n   - Preoperative Assessment of Respiratory Disease: Patient is a smoker, so smoking cessation counseling is recommended.\\n   - Enhanced Functional Status: Patient is going for major abdominal surgery, so physiotherapy assessment and education on physical exercises may be beneficial.\\n   -', ' Malnutrition Risk: Patient is not at risk of malnutrition, so no specific protocols are required.\\n\\n**Patient Instructions in Lay Language**\\n\\n1. **Medication instructions to take leading up to the surgery:**\\n   - Continue taking your regular medications as prescribed, except for aspirin.\\n   - Stop taking aspirin a week', ' before surgery.\\n2. **Consent for the types of anesthesia that the patient needs to be aware of for this surgery:**\\n   - You will likely receive general anesthesia for this surgery. This means that you will be completely asleep and will not feel any pain during the operation.\\n   - You may also receive regional', ' anesthesia, such as an epidural or spinal block. This will numb the area of your body where the surgery is being performed.\\n   - There is a small risk of complications from anesthesia, such as nausea, vomiting, and difficulty breathing. However, these complications are usually temporary and can be managed by the anesthesia team', '.']\n",
      "['**Preoperative Anesthesia Instructions**\\n\\n1. **Should the patient be seen by a Doctor or a Nurse:** Doctor\\n2. **Fasting instructions:**\\n   - Clear fluids up to 2 hours before surgery\\n   - Solid food for 6 hours before surgery\\n3. **Suitability for preoperative carbohydrate', ' loading:** Yes\\n4. **Medication instructions:**\\n   - Continue Perindopril 2mg OM, Omeprazole 20mg OM, Bisoprolol 1.25mg OM, Atorvastatin 40mg ON, and Amlodipine 2.5mg OM on', ' the day of operation with a sip of water.\\n   - Stop Aspirin 100mg OM 7 days before the operation.\\n5. **Instructions for the healthcare team:** NA\\n6. **Preoperative optimization required for the patient:**\\n   - Smoking cessation\\n7. **Need to delay', ' the operation for further medical workup and preoperative optimization:** No\\n8. **Specific department protocols to follow for this patient:**\\n   - Preoperative assessment of obese patients (BMI > 45)\\n   - Preoperative assessment and optimization of patients with hypertension\\n   - Preoperative cardiac assessment\\n   - Pre', 'operative assessment of respiratory disease\\n   - Preoperative investigation guidelines\\n   - Preoperative assessment and optimization of patients with thyroid disease\\n   - Enhanced recovery after surgery (ERAS) protocol due to major abdominal surgery\\n\\n**Patient Instructions in Lay Language:**\\n\\n1. **Medication instructions to take leading up to the surgery:**\\n', '   - Continue taking your regular medications, except for aspirin.\\n   - Stop taking aspirin a week before the surgery.\\n2. **Consent for the types of anesthesia that the patient needs to be aware of for this surgery:**\\n   - You will likely receive general anesthesia, which means you will be completely asleep during', ' the surgery.\\n   - You may also receive regional anesthesia, such as an epidural or spinal block, to numb the area of the surgery.\\n   - There is a small risk of complications from anesthesia, such as nausea, vomiting, and difficulty breathing. These risks are increased if you smoke.']\n",
      "['1. Doctor\\n2. Fasting for solids for 8 hours and clear fluids', ' for 2 hours before the surgery.\\n3. No\\n4. ', '\\n- Perindopril 2mg: Take as usual on the morning of surgery with a sip of water.\\n- Omeprazole 20', 'mg: Take as usual on the morning of surgery with a sip of water.\\n- Bisoprolol 1.25mg: Take as usual on', ' the morning of surgery with a sip of water.\\n- Atorvastatin 40mg: Take as usual on the morning of surgery with a sip of water.\\n- Aspirin 100mg: Take as usual on', ' the morning of surgery with a sip of water.\\n- Amlodipine 2.5mg: Take as usual on the morning of surgery with a sip of water.\\n5. NA\\n6. NA\\n7. No', '\\n8. NA\\n\\nPatient instructions:\\n1. Take all your regular medications as usual on the morning of surgery with a sip of water, except for Atorvastatin.\\n2. You will be given a general anesthetic for your surgery. This means that you will be asleep during the surgery and will not feel any', ' pain. There are some risks associated with general anesthesia, including nausea, vomiting, and sore throat. The anesthesiologist will discuss these risks with you in more detail before your surgery.']\n",
      "response\n",
      " prediction:  Singapore General Hospital  \n",
      "Policy & Procedure  \n",
      " \n",
      "Title:  \n",
      "Guidelines on Preoperative Assessment of Obese \n",
      "Patients  Document No:  \n",
      " Page 2 of 2 \n",
      "Issued By : Perioperative Services,  Dept of \n",
      "Anaesthesiology (Dr Hairil Abdullah)  \n",
      "Initial Date Issued : 5/9/2012  \n",
      "Date Revised : 2/5/2017   \n",
      "Revision number : 2 Approved By:  \n",
      "A/P Ruban Poopalalingam Head, Department of \n",
      "Anaesthesia  \n",
      " \n",
      " \n",
      "a. Risk of difficult airway - should include dental injury, aspiration pneumonitis, hypoxia, neurological \n",
      "damage and death  \n",
      "b. Major Adverse Cardiac Event  \n",
      "c. Difficult iv line insertions  \n",
      "d. Positioning (peripheral nerve damage)  \n",
      "e. Deep vein thrombosis  \n",
      "f. Postoperative ventilation and SICU stay  \n",
      "g. Difficult regional anaesthesia (if RA is the planned technique)  \n",
      " \n",
      "4. PLAN  \n",
      "a. Prescribe gastro prophylaxis (PO ranitidine 150 mg 10 pm and 6 am, before surgery with sips of \n",
      "water)  \n",
      "b. Not for ASC Day Surgery, for ASC SSW/SDA – to discuss with PAC consultant  \n",
      "d. Documentation - Under section \"Notes\" : Document discussion with Consult ant and patient onto \n",
      "Pre-operative assessment chart, under \"Instructions\" : Docum ent instructions for follow up eg \n",
      "pending investigations/referrals; CPAP/BIPAP machine for use in PACU, SICU/HD/ICA booking  \n",
      "FOR B ODY MASS INDEX > 45:  \n",
      "ALL OF THE ABOVE AND :  \n",
      "1. Consider Arterial Blood Gas and Echocardiography if there are accompanying \n",
      "cardiac/pulmonary conditions, or oximetry on air is <93% – consult senior anaesthetist (rule \n",
      "out lung disease and/or obesity hypoventilation syndrome)  \n",
      "2. Assess the need for SICU/ICA b ooking postop  \n",
      "3.  Inform Principal Anaesthetist on Friday (once duty roster is out)  \n",
      "4.  Offer referral to LIFE Center (4377) for obesity management if not on follow up yet.\n",
      "\n",
      "---\n",
      "\n",
      "Singapore General Hospital  \n",
      " \n",
      " \n",
      "TITLE:  \n",
      "Guideline s on Preoperative Assessment and optimizati on of \n",
      "patients with HYPERTENSION  DOCUMENT NO:  \n",
      "75400-SD -001 Page 4 of 7 \n",
      "ISSUED BY: Dr Hairil Abdullah , Director and Senior \n",
      "Consultant, Preoperative Evaluation Clinic, Dept of \n",
      "Anesthesiology, SGH  \n",
      "INITIAL DATE ISSUED: 1/05/2014  \n",
      "Updated by:  \n",
      "Dr He Yingke, Associate Consultant, De pt of Anesthesiology  \n",
      "Dr Shum Koin Lon, Consultant, Dept of Internal Medicine  \n",
      "DATE REVISED: 4/6/2020 , REVISION NUMBER: 4 Approved by:  \n",
      "Dr Tan Kian Hian  \n",
      "Senior Consultant and Head , Dept \n",
      "of Anesthesiology , SGH  \n",
      " \n",
      "A/P Soh Chai Rick  \n",
      "Senior Consultant, Chairman, \n",
      "Division of Anesthesiology, SGH  \n",
      " \n",
      " \n",
      " Refer young hypertensives and patients with signs of secondary hypertension to \n",
      "IMPT for work up prior to surgery  (discuss with surgeon regarding benefit of \n",
      "postponing operation for further work up vs risk of delaying surgery)  \n",
      " Low threshold for referral to IMPT for young hypertensives  \n",
      " If no suspicion of secondary hypertension, manage as for pre -existing hypertension  \n",
      " \n",
      "PERIOPERATIVE OPTIMIZATION OF MEDICATIONS  \n",
      " Continue all anti-hypertensives on the day of operation except ACEi/ARB (refer to below)   \n",
      " Take with sip of water at 6am on day of surgery \n",
      " Beta-blockers  \n",
      " Patients with ≥ 3 revised cardiac risk index ( RCRI)  factors or intermediate/high cardiac \n",
      "risk on preoperative tests, it may be reasonable to begin beta blockers before surgery – \n",
      "discuss with cardiologist or PEC consultant if it should be started  \n",
      " Beta blockers should not be initiated within 24h of surgery \n",
      " Diuretics  \n",
      " Watch out for hypokalemia and evaluate patient’s volume status on the day of operation  \n",
      " Angiotension converting enzyme inhibitors (ACEi)/ Angiotensin-receptor blockers (ARBs)  \n",
      " ACEi can cause refractory post induction hypotension if not stopped preoperatively  \n",
      " In non-cardiac surgery, consider discontinuation 24 hours preoperatively and restart within 48 hours after operation in patients with well controlled hypertension unless \n",
      "clin\n",
      "Response from Model:  **Doctor/Nurse**: Doctor\n",
      "\n",
      "**Fasting instructions**: \n",
      "\n",
      "- For solids: Nil oral intake for at least 6 hours before the scheduled surgery time.\n",
      "- For fluids: Clear fluids (water, black coffee or tea without milk, fruit juice without pulp) are allowed up to 2 hours before the scheduled surgery time. \n",
      "\n",
      "**Preoperative carbohydrate loading**: Yes\n",
      "\n",
      "**Medication instructions**: \n",
      "\n",
      "- Perindopril 2mg: Continue taking the usual dose on the morning of surgery with a sip of water. \n",
      "- Bisoprolol 1.25mg: Continue taking the usual dose on the morning of surgery with a sip of water. \n",
      "- Atorvastatin 40mg: Take the usual dose on the night before surgery. \n",
      "- Aspirin 100mg: Take the usual dose on the morning of surgery with a sip of water. \n",
      "- Amlodipine 2.5mg: Continue taking the usual dose on the morning of surgery with a sip of water.\n",
      "- Omeprazole 20mg: Take the usual dose on the morning of surgery with a sip of water. \n",
      "\n",
      "**Instructions for the healthcare team**: \n",
      "\n",
      "- Preoperative blood group matching: Yes\n",
      "- Arrange for standby post-operative high dependency/ICU bed: No\n",
      "\n",
      "**Preoperative optimization required for the patient**: \n",
      "\n",
      "- Smoking cessation counseling: Offer referral to the preoperative smoking cessation counseling sessions by PEC nurses.\n",
      "- Consider Dietitian review if the patient is going for major abdominal surgery or vascular angioplasty with lower limb wounds. \n",
      "- Consider Physiotherapy review if the patient has EFS total score >=6 or Functional independence + functional performance score >=3. \n",
      "\n",
      "**Need to delay the operation for further medical workup and preoperative optimization**: No\n",
      "\n",
      "**Specific department protocols to follow for this patient**: \n",
      "\n",
      "- Obesity: The patient has a BMI of 21 and is not obese. Therefore, the obesity protocol does not apply.\n",
      "- Hypertension: The patient's current BP is 130/71 mmHg, which is not poorly controlled. Therefore, the hypertension protocol does not apply.\n",
      "- Thyroid disease: The patient has nonspecific R thyroid calcification. Consider referral to IMPT.\n",
      "- Cardiac risk assessment: The patient has a history of IHD and is on medical therapy. The patient should be reviewed by a CVM to assess the cardiac risk and determine the need for further investigations or optimization.\n",
      "- Preoperative respiratory risk assessment: The patient has a history of smoking and is undergoing major abdominal surgery. The patient should be counseled for increased risks of postoperative pulmonary complications and consider preoperative smoking cessation counseling.\n",
      "\n",
      "**Patient instructions**: \n",
      "\n",
      "- Medication instructions: Follow the medication instructions provided by the doctor.\n",
      "- Consent for anesthesia: The patient should be consented for general anesthesia and regional anesthesia (spinal or epidural) as the planned techniques for the surgery. The risks of general anesthesia include awareness, airway complications, and nausea and vomiting. The risks of regional anesthesia include nerve damage, bleeding, and infection. The patient should also be informed about the risks of the surgery, including the risk of bleeding, infection, and damage to surrounding organs.\n",
      "iteration # 6\n",
      "['**Preoperative Anesthesia Instructions**\\n\\n1. **Doctor or Nurse:** Doctor\\n2. **Fasting instructions:**\\n   - Clear fluids up to 2 hours before surgery\\n   - Solid food for 6 hours before surgery\\n3. **Suitability for preoperative carbohydrate loading:** No\\n4. **Medication', ' instructions:**\\n   - **Day of operation:**\\n      - Take aspirin 100mg, clopidogrel 75mg, bisoprolol 2.5mg, empagliflozin 10mg, Entresto 0.5tab, spironolactone 25', 'mg, and dutasteride 0.5mg with a sip of water at 6am.\\n      - Omit metformin and frusemide.\\n   - **Days leading up to the operation:**\\n      - Continue all other medications as prescribed.\\n5. **Instructions for the healthcare team', ':**\\n   - Arrange for preoperative dialysis on Sunday, Wednesday, and Friday.\\n6. **Preoperative optimization required:**\\n   - None\\n7. **Need to delay the operation for further medical workup and preoperative optimization:** No\\n8. **Specific department protocols to follow:**\\n   - Hypertension Protocol:', \" Patient's blood pressure is well-controlled.\\n   - Cardiac Assessment Protocol: Patient has a history of severe coronary artery disease with an EF of 20%. Anesthesiologist should be aware of this and monitor the patient closely during surgery.\\n   - Chronic Kidney Disease Protocol: Patient is on dialysis and\", ' will require preoperative dialysis as per instructions.\\n\\n**Patient Instructions in Lay Language:**\\n\\n1. **Medication instructions to take leading up to the surgery:**\\n   - Continue taking all your regular medications except for metformin and frusemide.\\n   - On the morning of the surgery, take your aspirin, clopid', 'ogrel, bisoprolol, empagliflozin, Entresto, spironolactone, and dutasteride with a small sip of water at 6am.\\n2. **Consent for the types of anesthesia that the patient needs to be aware of for this surgery, and any specific risks to', ' highlight due to the operation and the patient’s medical history:**\\n   - You will likely receive general anesthesia for this surgery, which means you will be completely asleep and unaware during the procedure.\\n   - Due to your history of heart disease, you are at an increased risk of complications during surgery. The anesthes', 'iologist will be monitoring you closely to ensure your safety.']\n",
      "['**Preoperative Anesthesia Instructions**\\n\\n1. **Doctor/Nurse:** Doctor\\n2. **Fasting instructions:**\\n   - Clear fluids up to 2 hours before surgery\\n   - Solid food for 6 hours before surgery\\n3. **Suitability for preoperative carbohydrate loading:** No\\n4. **Medication', ' instructions:**\\n   - **Day of operation:**\\n      - Take aspirin 100mg, clopidogrel 75mg, bisoprolol 2.5mg, empagliflozin 10mg, Entresto 0.5tab, spironolactone 25', 'mg, and dutasteride 0.5mg with a sip of water at 6am.\\n      - Omit metformin and frusemide.\\n   - **Days leading up to the operation:**\\n      - Continue all other medications as prescribed.\\n5. **Instructions for the healthcare team', ':**\\n   - Arrange for preoperative dialysis on 1/3/5.\\n6. **Preoperative optimization required:**\\n   - None\\n7. **Need to delay the operation for further medical workup and preoperative optimization:** No\\n8. **Specific department protocols to follow:**\\n   - Hypertension Management Protocol', \": Patient's blood pressure is well-controlled.\\n   - Preoperative Cardiac Assessment Protocol: Patient has known IHD with severe pulmonary hypertension and reduced EF. Cardiology referral may be considered for further evaluation and optimization.\\n   - Chronic Kidney Disease Protocol: Patient is on regular dialysis. Ensure appropriate dialysis arrangements are made\", '.\\n\\n**Patient Instructions**\\n\\n1. **Medication instructions to take leading up to the surgery:**\\n   - Continue taking all your medications as usual, except for metformin and frusemide.\\n   - On the morning of the surgery, take your aspirin, clopidogrel, bisoprolol, em', 'pagliflozin, Entresto, spironolactone, and dutasteride with a small sip of water at 6am.\\n\\n2. **Consent for the types of anesthesia that the patient needs to be aware of for this surgery, and any specific risks to highlight due to the operation and the patient', '’s medical history:**\\n   - You will likely receive regional anesthesia (such as a spinal or epidural block) for this surgery. This will numb the area of your body where the surgery is being performed.\\n   - You may also receive general anesthesia, which will make you unconscious during the surgery.\\n   ', '- Due to your history of heart disease and pulmonary hypertension, there is an increased risk of complications during anesthesia. Your anesthesiologist will discuss these risks with you in more detail.']\n",
      "['**Preoperative Anesthesia Instructions:**\\n\\n1. **Doctor or Nurse:** Doctor\\n2. **Fasting instructions:**\\n   - Clear fluids up to 2 hours before surgery\\n   - Solid foods for 6 hours before surgery\\n3. **Suitability for preoperative carbohydrate loading:** No\\n4. **Medication', ' instructions:**\\n   - **Day of operation:**\\n      - Take aspirin 100mg, clopidogrel 75mg, bisoprolol 2.5mg, empagliflozin 10mg, Entresto 0.5tab, spironolactone 25', 'mg, and dutasteride 0.5mg with a sip of water at 6am.\\n      - Omit metformin and frusemide.\\n   - **Days leading up to the operation:**\\n      - Continue all other medications as prescribed.\\n5. **Instructions for the healthcare team', ':**\\n   - Arrange for preoperative dialysis on 1/3/5.\\n6. **Preoperative optimization required:**\\n   - None\\n7. **Need to delay the operation for further medical workup and preoperative optimization:** No\\n8. **Specific department protocols to follow:**\\n   - Hypertension Protocol:', \" Patient's blood pressure is well-controlled.\\n   - Preoperative Cardiac Assessment Protocol: Patient has known IHD with severe pulmonary hypertension and EF 20%. Cardiology referral may be considered for further evaluation and optimization.\\n   - Chronic Kidney Disease Protocol: Patient is on dialysis. Ensure appropriate dialysis arrangements are made\", '.\\n\\n**Patient Instructions:**\\n\\n1. **Medication instructions to take leading up to the surgery:**\\n\\n   - Continue taking all your medications as usual, except for metformin and frusemide.\\n   - On the morning of the surgery, take the following medications with a small sip of water at 6am', ': aspirin, clopidogrel, bisoprolol, empagliflozin, Entresto, spironolactone, and dutasteride.\\n\\n2. **Consent for the types of anesthesia that the patient needs to be aware of for this surgery, and any specific risks to highlight due to the operation', ' and the patient’s medical history:**\\n\\n   - You will likely receive regional anesthesia (such as a spinal or epidural block) for this surgery. This will numb the lower part of your body so that you do not feel any pain during the procedure.\\n   - You may also receive sedation or general anesthesia,', ' which will make you sleepy or unconscious during the surgery.\\n   - Due to your history of heart disease and pulmonary hypertension, there is an increased risk of complications during surgery. Your anesthesiologist will discuss these risks with you in more detail.']\n",
      "['1. Doctor\\n2. Fasting for solids for 6 hours and clear fluids', ' for 2 hours before the surgery.\\n3. No\\n4. ', '\\n- Aspirin 100mg: Continue as usual.\\n- Clopidogrel 75mg: Continue as usual.\\n- Bis', 'oprolol 2.5mg: Continue as usual.\\n- Empagliflozin 10mg: Hold on the morning of surgery.\\n', '- Metformin 250mg: Hold on the morning of surgery.\\n- Entresto 0.5tab: Continue as usual.\\n- Spironolactone 25mg: Continue as usual.\\n- Fru', 'semide 40mg: Continue as usual.\\n- Dutasteride 0.5mg: Continue as usual.\\n5. Arrange for preoperative blood group matching and cross-matching.\\n6. Optimize pulmonary hypertension.', '\\n7. No\\n8. \\n- Guideline on Preoperative Assessment and Optimization of Patients with Hypertension: Patient has hypertension and is on multiple antihypertensive medications.\\n- Guideline on Preoperative Cardiac Assessment: Patient has a history of ischemic heart disease, heart failure, and pulmonary hypertension.\\n- Guideline on Pre', 'operative Assessment of Obese Patients: Patient has a BMI of 24.7.\\n- Guideline on Preoperative Assessment and Optimization of Patients with Chronic Kidney Disease: Patient has ESRD on dialysis.']\n",
      "response\n",
      " prediction:  Singapore General Hospital  \n",
      " \n",
      " \n",
      "TITLE:  \n",
      "Guideline s on Preoperative Assessment and optimizati on of \n",
      "patients with HYPERTENSION  DOCUMENT NO:  \n",
      "75400-SD -001 Page 4 of 7 \n",
      "ISSUED BY: Dr Hairil Abdullah , Director and Senior \n",
      "Consultant, Preoperative Evaluation Clinic, Dept of \n",
      "Anesthesiology, SGH  \n",
      "INITIAL DATE ISSUED: 1/05/2014  \n",
      "Updated by:  \n",
      "Dr He Yingke, Associate Consultant, De pt of Anesthesiology  \n",
      "Dr Shum Koin Lon, Consultant, Dept of Internal Medicine  \n",
      "DATE REVISED: 4/6/2020 , REVISION NUMBER: 4 Approved by:  \n",
      "Dr Tan Kian Hian  \n",
      "Senior Consultant and Head , Dept \n",
      "of Anesthesiology , SGH  \n",
      " \n",
      "A/P Soh Chai Rick  \n",
      "Senior Consultant, Chairman, \n",
      "Division of Anesthesiology, SGH  \n",
      " \n",
      "• Hypokalemia  hyperaldosteronism  \n",
      "• Look through available CT abdomen for adrenal masses  \n",
      " Refer young hypertensives and patients with signs of secondary hypertension to \n",
      "IMPT for work up prior to surgery  (discuss with surgeon regarding benefit of \n",
      "postponing operation for further work up vs risk of delaying surgery)  \n",
      " Low threshold for referral to IMPT for young hypertensives  \n",
      " If no suspicion of secondary hypertension, manage as for pre -existing hypertension  \n",
      " \n",
      "PERIOPERATIVE OPTIMIZATION OF MEDICATIONS  \n",
      " Continue all anti-hypertensives on the day of operation except ACEi/ARB (refer to below)   \n",
      " Take with sip of water at 6am on day of surgery \n",
      " Beta-blockers  \n",
      " Patients with ≥ 3 revised cardiac risk index ( RCRI)  factors or intermediate/high cardiac \n",
      "risk on preoperative tests, it may be reasonable to begin beta blockers before surgery – \n",
      "discuss with cardiologist or PEC consultant if it should be started  \n",
      " Beta blockers should not be initiated within 24h of surgery \n",
      " Diuretics  \n",
      " Watch out for hypokalemia and evaluate patient’s volume status on the day of operation  \n",
      " Angiotension converting enzyme inhibitors (ACEi)/ Angiotensin-receptor blockers (ARBs)  \n",
      " ACEi can cause refractory post induction hypotension if not stopped preoperatively  \n",
      " In non-cardiac surgery, consider discontinuation 24 hours preoperatively and restart within 48 hours after operation in patients with well controlled hypertension unless \n",
      "clinically contraindicated  \n",
      " Continue ACEi preoperatively  if there is impaired LV systolic function or heart \n",
      "failure or if BP is poorly controlled\n",
      "\n",
      "---\n",
      "\n",
      "Singapore General Hospital  \n",
      "Policy & Procedure  \n",
      " \n",
      "Title :  \n",
      "Guidelines on Preoperative Assessment of Obese \n",
      "Patients  Document No:  \n",
      " Page 2 of 2 \n",
      "Issued By : Perioperative Services,  Dept of \n",
      "Anaesthesiology (Dr Hairil Abdullah)  \n",
      "Initial Date Issued : 5/9/2012  \n",
      "Date Revised : 2/5/2017   \n",
      "Revision number : 2 Approved By:  \n",
      "A/P Ruban Poopalalingam Head, Department of \n",
      "Anaesthesia  \n",
      " \n",
      " \n",
      "a. Risk of difficult airway - should include dental injury, aspiration pneumonitis, hypoxia, neurological \n",
      "damage and death  \n",
      "b. Major Adverse Cardiac Event  \n",
      "c. Difficult iv line insertions  \n",
      "d. Positioning (peripheral nerve damage)  \n",
      "e. Deep vein thrombosis  \n",
      "f. Postoperative ventilation and SICU stay  \n",
      "g. Difficult regional anaesthesia (if RA is the planned technique)  \n",
      " \n",
      "4. PLAN  \n",
      "a. Prescribe gastro prophylaxis (PO ranitidine 150 mg 10 pm and 6 am, before surgery with sips of \n",
      "water)  \n",
      "b. Not for ASC Day Surgery, for ASC SSW/SDA – to discuss with PAC consultant  \n",
      "d. Documentation - Under section \"Notes\" : Document discussion with Consult ant and patient onto \n",
      "Pre-operative assessment chart, under \"Instructions\" : Docum ent instructions for follow up eg \n",
      "pending investigations/referrals; CPAP/BIPAP machine for use in PACU, SICU/HD/ICA booking  \n",
      "FOR B ODY MASS INDEX > 45:  \n",
      "ALL OF THE ABOVE AND :  \n",
      "1. Consider Arterial Blood Gas and Echocardiography if there are accompanying \n",
      "cardiac/pulmonary conditions, or oximetry on air is <93% – consult senior anaesthetist (rule \n",
      "out lung disease and/or obesity hypoventilation syndrome)  \n",
      "2. Assess the need for SICU/\n",
      "Response from Model:  **Preoperative Instructions**\n",
      "\n",
      "**To be seen by:** Doctor\n",
      "\n",
      "**Fasting instructions:** \n",
      "\n",
      "- Clear fluids up to 2 hours before the scheduled surgery time.\n",
      "- No solid food after midnight before surgery.\n",
      "\n",
      "**Preoperative carbohydrate loading:** No\n",
      "\n",
      "**Medication instructions:**\n",
      "\n",
      "- Continue taking aspirin 100mg OM, clopidogrel 75mg OM, bisoprolol 2.5mg OM, empagliflozin 10mg OM, metformin 250mg BD, Entresto 0.5tab BD, spironolactone 25mg OM, and dutasteride 0.5mg OM as usual.\n",
      "- Hold frusemide 40mg OM on the morning of surgery.\n",
      "\n",
      "**Instructions for the healthcare team:**\n",
      "\n",
      "- Arrange for preoperative blood group matching and cross-matching.\n",
      "- Consider standby postoperative high dependency or ICU bed due to patient's significant medical history.\n",
      "\n",
      "**Preoperative optimization:**\n",
      "\n",
      "- Optimize the patient's renal function and control hypertension.\n",
      "- Consider further cardiovascular workup and optimization if the patient's exercise tolerance remains significantly decreased or if there are any new symptoms suggestive of unstable angina or congestive heart failure.\n",
      "\n",
      "**Need to delay the operation:** No\n",
      "\n",
      "**Specific department protocols:**\n",
      "\n",
      "- Follow the departmental protocol for preoperative assessment and optimization of patients with hypertension.\n",
      "- Follow the departmental protocol for preoperative assessment and optimization of patients with chronic kidney disease.\n",
      "- Follow the departmental protocol for preoperative cardiac assessment.\n",
      "\n",
      "**Patient Instructions:**\n",
      "\n",
      "**Medication instructions:**\n",
      "\n",
      "- Continue taking all medications as prescribed, except for frusemide 40mg OM, which should be held on the morning of surgery.\n",
      "- Bring all medications, including over-the-counter medications and herbal supplements, to the hospital on the day of surgery.\n",
      "\n",
      "**Consent for anesthesia:**\n",
      "\n",
      "- The patient should be informed that general anesthesia will be used for the surgery.\n",
      "- The patient should be made aware of the risks of anesthesia, including the risk of complications related to the patient's medical history, such as hypertension, chronic kidney disease, and coronary artery disease.\n",
      "iteration # 7\n",
      "['**Preoperative Anesthesia Instructions**\\n\\n1. **Doctor or Nurse:** Doctor\\n2. **Fasting instructions:** Clear fluids up to 2 hours before surgery, nothing by mouth after that.\\n3. **Suitability for preoperative carbohydrate loading:** Yes\\n4. **Medication instructions:**\\n   - **Day', ' of operation:**\\n     - Take Losartan 25mg, Pravastatin 20mg, Neurobion 2 tablets, and Omeprazole 20mg with a sip of water at 6am.\\n     - Do not take Pregabalin 50mg.\\n   - **Days', ' leading up to the operation:**\\n     - Continue all medications as prescribed.\\n5. **Instructions for the healthcare team:**\\n   - Arrange for preoperative blood group matching.\\n6. **Preoperative optimization required:**\\n   - Optimization of hypertension: Refer to IMPT for evaluation and management.\\n7. **', 'Need to delay the operation for further medical workup and preoperative optimization:**\\n   - Yes, delay the operation for a cardiac catheterization to assess the EF drop.\\n8. **Specific department protocols to follow:**\\n   - Enhanced Recovery after Surgery (ERAS) for Colorectal Surgery: To minimize postoperative complications and facilitate', ' early recovery.\\n   - Guidelines on Preoperative Assessment and Optimization of Patients with Hypertension: To manage hypertension perioperatively.\\n\\n**Patient Instructions**\\n\\n**Medication instructions to take leading up to the surgery:**\\n\\n* Continue taking all your regular medications as prescribed by your doctor.\\n\\n**Consent for the types of anesthesia', ' that you need to be aware of for this surgery:**\\n\\n* You will likely receive general anesthesia, which means you will be completely asleep during the surgery.\\n* You may also receive regional anesthesia, such as an epidural or spinal block, which will numb the lower part of your body.\\n\\n**Specific risks to', ' highlight due to the operation and your medical history:**\\n\\n* Due to your history of hypertension and the recent drop in your ejection fraction, you are at an increased risk of complications during and after surgery. Your doctor will discuss these risks with you in more detail.']\n",
      "['**Preoperative Anesthesia Instructions**\\n\\n1. **Doctor or Nurse:** Doctor\\n2. **Fasting instructions:** Clear fluids up to 2 hours before surgery, nothing by mouth after that.\\n3. **Suitability for preoperative carbohydrate loading:** Yes\\n4. **Medication instructions:**\\n    - **Day', ' of operation:**\\n        - Take Losartan 25mg, Pravastatin 20mg, Neurobion 2 tabs, and Omeprazole 20mg with a sip of water at 6am.\\n        - Do not take Pregabalin 50mg.\\n    - **Days', ' leading up to the operation:**\\n        - Continue all medications as prescribed.\\n5. **Instructions for the healthcare team:**\\n    - Arrange for preoperative blood group matching.\\n6. **Preoperative optimization required:**\\n    - Optimization of hypertension: Refer to IMPT for evaluation and management.\\n7. **', 'Need to delay the operation for further medical workup and preoperative optimization:**\\n    - Yes, delay the operation for a cardiac catheterization to assess the EF drop.\\n8. **Specific department protocols to follow:**\\n    - **Enhanced Recovery after Surgery (ERAS) for Colorectal Surgery:**\\n        - Preoperative', ' carbohydrate loading\\n        - Multimodal, opioid-sparing analgesia\\n    - **Guidelines on Preoperative Assessment and Optimization of Patients with Hypertension:**\\n        - Discontinue ACEi/ARBs (Losartan) 24 hours preoperatively.\\n\\n**Patient Instructions**\\n\\n1. **Medication instructions to take', ' leading up to the surgery:**\\n\\n   - Continue taking all your regular medications except for Pregabalin.\\n   - On the morning of the surgery, take your blood pressure medication, cholesterol medication, vitamins, and stomach ulcer medication with a small sip of water.\\n\\n2. **Consent for the types of anesthesia that', ' you need to be aware of for this surgery:**\\n\\n   - You will likely receive general anesthesia, which means you will be completely asleep during the surgery.\\n   - You may also receive regional anesthesia, such as an epidural or spinal block, which will numb the area of the surgery.\\n   - There is', ' a small risk of complications from anesthesia, such as nausea, vomiting, and difficulty breathing. However, these complications are usually temporary and can be managed by the anesthesia team.']\n",
      "['**Preoperative Anesthesia Instructions**\\n\\n1. **Doctor or Nurse:** Doctor\\n2. **Fasting instructions:** Clear fluids up to 2 hours before surgery, nothing by mouth after that.\\n3. **Suitability for preoperative carbohydrate loading:** Yes\\n4. **Medication instructions:**\\n   - **Day', ' of operation:**\\n     - Take Losartan 25mg, Pravastatin 20mg, Neurobion 2 tab, and Omeprazole 20mg with a sip of water at 6am.\\n     - Do not take Pregabalin 50mg.\\n   - **Days', ' leading up to the operation:**\\n     - Continue all medications as prescribed.\\n5. **Instructions for the healthcare team:**\\n   - Arrange for preoperative blood group matching.\\n6. **Preoperative optimization required:**\\n   - Optimization of hypertension: Refer to cardiologist for evaluation and management of EF drop and planned', ' catheterization.\\n7. **Need to delay the operation for further medical workup and preoperative optimization:**\\n   - Yes, delay the operation until after the cardiac catheterization and optimization of hypertension.\\n8. **Specific department protocols to follow:**\\n   - Enhanced Recovery after Surgery (ERAS) for Colorectal Surgery', ': To minimize postoperative complications and promote early recovery.\\n   - Guidelines on Preoperative Assessment and Optimization of Patients with Hypertension: To manage hypertension perioperatively.\\n   - Guidelines on Preoperative Assessment of Patients with Chronic Kidney Disease: To assess and manage renal function perioperatively.\\n\\n**Patient Instructions**\\n\\n**', 'Medication instructions to take leading up to the surgery:**\\n\\n- Continue taking all your regular medications as prescribed by your doctor.\\n\\n**Consent for the types of anesthesia that you need to be aware of for this surgery:**\\n\\n- You will likely receive general anesthesia, which means you will be completely asleep during the surgery.\\n', '- You may also receive regional anesthesia, such as an epidural or spinal block, which will numb the area of your body being operated on.\\n\\n**Specific risks to highlight due to the operation and your medical history:**\\n\\n- Due to your hypertension and reduced heart function, you are at an increased risk of complications during', ' and after surgery.\\n- The surgery may also be delayed if your hypertension is not well-controlled before the operation.']\n",
      "['1. Doctor\\n2. Fasting for solids for 8 hours and clear fluids', ' for 2 hours prior to surgery.\\n3. Yes\\n4. ', '\\n- Losartan 25mg: Take as usual on the day of surgery with a sip of water.\\n- Pravastatin 20mg:', ' Take as usual on the day of surgery with a sip of water.\\n- Neurobion 2 tab: Take as usual on the day of surgery with a', ' sip of water.\\n- Omeprazole 20mg: Take as usual on the day of surgery with a sip of water.\\n- Pregabalin 50mg: Take as usual on the day of surgery with a', ' sip of water.\\n5. NA\\n6. \\n- Optimize blood pressure control.\\n- Optimize cardiac function.\\n7. No\\n8. \\n- Enhanced Recovery after Surgery (ERAS) protocol for colorectal surgery: This', ' protocol aims to improve patient outcomes after colorectal surgery by optimizing perioperative care.\\n- Preoperative carbohydrate loading: This is recommended to reduce the risk of postoperative insulin resistance and enhance recovery of bowel function.\\n- Preoperative optimization of medical comorbidities: This is important to reduce the risk of complications during and after surgery.']\n",
      "response\n",
      " prediction:  Singapore General Hospital  \n",
      "Policy & Procedure  \n",
      " \n",
      "Title :  \n",
      "Guidelines on Preoperative Assessment of Obese \n",
      "Patients  Document No:  \n",
      " Page 2 of 2 \n",
      "Issued By : Perioperative Services,  Dept of \n",
      "Anaesthesiology (Dr Hairil Abdullah)  \n",
      "Initial Date Issued : 5/9/2012  \n",
      "Date Revised : 2/5/2017   \n",
      "Revision number : 2 Approved By:  \n",
      "A/P Ruban Poopalalingam Head, Department of \n",
      "Anaesthesia  \n",
      " \n",
      " \n",
      "a. Risk of difficult airway - should include dental injury, aspiration pneumonitis, hypoxia, neurological \n",
      "damage and death  \n",
      "b. Major Adverse Cardiac Event  \n",
      "c. Difficult iv line insertions  \n",
      "d. Positioning (peripheral nerve damage)  \n",
      "e. Deep vein thrombosis  \n",
      "f. Postoperative ventilation and SICU stay  \n",
      "g. Difficult regional anaesthesia (if RA is the planned technique)  \n",
      " \n",
      "4. PLAN  \n",
      "a. Prescribe gastro prophylaxis (PO ranitidine 150 mg 10 pm and 6 am, before surgery with sips of \n",
      "water)  \n",
      "b. Not for ASC Day Surgery, for ASC SSW/SDA – to discuss with PAC consultant  \n",
      "d. Documentation - Under section \"Notes\" : Document discussion with Consult ant and patient onto \n",
      "Pre-operative assessment chart, under \"Instructions\" : Docum ent instructions for follow up eg \n",
      "pending investigations/referrals; CPAP/BIPAP machine for use in PACU, SICU/HD/ICA booking  \n",
      "FOR B ODY MASS INDEX > 45:  \n",
      "ALL OF THE ABOVE AND :  \n",
      "1. Consider Arterial Blood Gas and Echocardiography if there are accompanying \n",
      "cardiac/pulmonary conditions, or oximetry on air is <93% – consult senior anaesthetist (rule \n",
      "out lung disease and/or obesity hypoventilation syndrome)  \n",
      "2. Assess the need for SICU/ICA b ooking postop  \n",
      "3.  Inform Principal Anaesthetist on Friday (once duty roster is out)  \n",
      "4.  Offer referral to LIFE Center (4377) for obesity management if not on follow up yet.\n",
      "\n",
      "---\n",
      "\n",
      "Singapore General Hospital  \n",
      "Policy & Procedure  \n",
      " \n",
      "Title :  \n",
      "Guidelines on Preoperative Assessment of Obese \n",
      "Patients  Document No:  \n",
      " Page 1 of 2 \n",
      "Issued By : Perioperative Services,  Dept of \n",
      "Anaesthesiology (Dr Hairil Abdullah)  \n",
      "Initial Date Issued : 5/9/2012  \n",
      "Date Revised : 2/5/2017   \n",
      "Revision number : 2 Approved By:  \n",
      "A/P Ruban Poopalalingam Head, Department of \n",
      "Anaesthesia  \n",
      " \n",
      " \n",
      "1. BACKGROUND  \n",
      "a. Obesity is a relatively common condition, that can have a profound impact on \n",
      "morbidity/mortality and anesthesia. Careful attention should be given to airway anatomy \n",
      "and the potential physiological derangements.  \n",
      "b. Communication: non -pejorative, while not avoiding important risks and issues, aiming to \n",
      "avoid distress and allow bette r communication with patient and relatives.  \n",
      "2. ASSESSMENT  \n",
      "FOR BODY MASS INDEX >35  \n",
      "i. HISTORY  \n",
      "1. Cardio status – Hypertension, Ischaemic Heart Disease, Effort tolerance, Symptoms of \n",
      "heart failure, deep vein thrombosis  \n",
      "2. Respiratory status – Screen for  Obstructive Sleep Apnea using STOPBang tool (if high risk \n",
      "for moderate -severe OSA , refer OSA protocol ),  Asthma  \n",
      "3. Gastro -esophageal reflux, Diabetes Mellitus  \n",
      "4. Airway – Review old records for history of difficult intubations  \n",
      "ii. EXAMINATION  \n",
      "1. Airwa y – Mouth opening, Mallampati, Neck extension and circumference  \n",
      "2. Dentition – loose, crowns and bridges  \n",
      "iii. INVESTIGATIONS  \n",
      "1. Bloods – FBC/UE,  CREAT,  GLU  \n",
      "2. ECG – specifically looking for – LV hypertrophy or strain, RBBB or Rt axis deviation, P -\n",
      "pulmo nale  \n",
      "3. CXR – specifically looking for – cardiomegaly, evidence of heart failure  \n",
      "3. RISK DISCLOSURE\n",
      "\n",
      "---\n",
      "\n",
      "Singapore General Hospital  \n",
      "Policy & Procedure  \n",
      " \n",
      "Title : Enhanced Recovery after Surgery for Colorectal surgery \n",
      "(Laparoscopic/Robotic/Open)  Document No:  \n",
      " Page 3 of 8 \n",
      "Issued By :  \n",
      "Dr Eileen Sim , Dr Hairil Rizal Abdullah,  Perioperative Services Dept  of \n",
      "Anaesthesiology  \n",
      "Dr Chang Meihuan , NC Cherry Pincel Bacani ,  \n",
      "NC\n",
      "Response from Model:  **Doctor/Nurse:** Doctor\n",
      "\n",
      "**Fasting instructions:** Nil by mouth after midnight.\n",
      "\n",
      "**Preoperative carbohydrate loading:** Yes\n",
      "\n",
      "**Medication instructions:**\n",
      "\n",
      "- Losartan 25mg: Take as usual on the morning of surgery.\n",
      "- Pravastatin 20mg: Take as usual on the morning of surgery.\n",
      "- Neurobion 2 tab: Take as usual on the morning of surgery.\n",
      "- Omeprazole 20mg: Take as usual on the morning of surgery.\n",
      "- Pregabalin 50mg: Take as usual on the morning of surgery.\n",
      "\n",
      "**Instructions for the healthcare team:**\n",
      "\n",
      "- Arrange for preoperative blood group matching.\n",
      "- Consider preoperative colonoscopy and/or sigmoidoscopy to assess for any other colorectal lesions.\n",
      "- Consider preoperative echocardiogram to assess for any changes in cardiac function since the last echocardiogram.\n",
      "\n",
      "**Preoperative optimization:**\n",
      "\n",
      "- Optimize blood pressure control.\n",
      "- Optimize cholesterol levels.\n",
      "- Treat anemia if present.\n",
      "\n",
      "**Need to delay operation:** No\n",
      "\n",
      "**Specific department protocols to follow:**\n",
      "\n",
      "- Enhanced Recovery After Surgery (ERAS) protocol for colorectal surgery.\n",
      "- Preoperative Assessment Clinic (PAC) protocol for patients with CKD.\n",
      "- Preoperative Assessment Clinic (PAC) protocol for patients with hypertension.\n",
      "\n",
      "**Patient instructions:**\n",
      "\n",
      "- Take all medications as prescribed, including on the morning of surgery.\n",
      "- Do not eat or drink anything after midnight on the night before surgery.\n",
      "- Inform the anesthesiologist if you develop any cold or flu symptoms before surgery.\n",
      "- You will be given a consent form to sign before surgery. This form will explain the risks and benefits of the surgery and anesthesia. Please read the form carefully and ask any questions you have.\n",
      "iteration # 8\n",
      "['**Preoperative Anesthesia Instructions for Medical Colleagues:**\\n\\n1. **Should the patient be seen by a Doctor or a Nurse:** Doctor\\n\\n2. **Fasting instructions:**\\n   - Clear fluids up to 2 hours before surgery\\n   - Light meal 6 hours before surgery\\n\\n3. **Suitability for', ' preoperative carbohydrate loading:** Yes\\n\\n4. **Medication instructions:**\\n   - Levothyroxine: Continue taking as usual\\n   - Amlodipine: Take with a sip of water at 6am on the day of surgery\\n   - Atenlol: Take with a sip of water at 6am', ' on the day of surgery\\n\\n5. **Instructions for the healthcare team:** NA\\n\\n6. **Preoperative optimization required for the patient:**\\n   - Thyroid function optimization\\n\\n7. **Need to delay the operation for further medical workup and preoperative optimization:** Yes\\n\\n8. **Specific department protocols to follow for this', ' patient:**\\n   - Refer to the Internal Medicine Perioperative Clinic (IMPT) for thyroid function optimization, as per the \"Guidelines on Preoperative Assessment and optimization of patients with thyroid disease\"\\n   - Consider postponing the operation if hypertension is poorly controlled, as per the \"Guideline s on Preoperative Assessment', ' and optimizati on of patients with HYPERTENSION\"\\n\\n**Instructions for the Patient in Lay Language:**\\n\\n1. **Medication instructions to take leading up to the surgery:**\\n   - Continue taking your thyroid medication as usual.\\n   - Take your blood pressure medications with a small sip of water in the morning', ' of the surgery.\\n\\n2. **Consent for the types ofesthesia that the patient needs to be aware of for this surgery, and any specific risks to highlight due to the operation and the patient’s medical history:**\\n   - You will be given general anaesthesia for this surgery, which means you will be completely asleep', ' during the procedure.\\n   - There is a small risk of complications related to your history of thyroid surgery, such as difficulty breathing.']\n",
      "['**Preoperative Anesthesia Instructions**\\n\\n1. **Doctor/Nurse:** Doctor\\n2. **Fasting instructions:**\\n   - Clear fluids up to 2 hours before surgery\\n   - Solid food for 6 hours before surgery\\n3. **Suitability for preoperative carbohydrate loading:** Yes\\n4. **Medication', ' instructions:**\\n   - Day of operation:\\n      - Take levothyroxine, amlodipine, and atenolol with a sip of water at 6 AM.\\n   - Days leading up to operation:\\n      - Continue taking levothyroxine, amlodipine, and', ' atenolol as prescribed.\\n5. **Instructions for healthcare team:** NA\\n6. **Preoperative optimization required:**\\n   - Thyroid function optimization\\n7. **Need to delay operation for further medical workup and preoperative optimization:** Yes\\n8. **Specific department protocols to follow:**\\n   - Guidelines on', ' Preoperative Assessment and Optimization of Patients with Thyroid Disease\\n   - Guidelines on Preoperative Assessment and Optimization of Patients with Hypertension\\n\\n**Instructions to Patient**\\n\\n1. **Medication instructions to take leading up to the surgery:**\\n\\n   - Continue taking your thyroid medication (levothyroxine), blood pressure medications (am', 'lodipine and atenolol) as usual.\\n   - On the morning of the surgery, take these medications with a small sip of water at 6 AM.\\n\\n2. **Consent for types of anesthesia and specific risks:**\\n\\n   - You will likely receive general anesthesia for this surgery, which means you', ' will be completely asleep and unaware during the procedure.\\n   - There is a small risk of complications with general anesthesia, such as difficulty breathing or an allergic reaction.\\n   - Due to your history of a difficult airway during your previous surgery, there may be an increased risk of difficulty with intubation (inserting a', ' breathing tube).']\n",
      "['**Preoperative Anesthesia Instructions for Medical Colleagues:**\\n\\n1. **Doctor/Nurse:** Doctor\\n2. **Fasting instructions:**\\n   - Clear fluids up to 2 hours before surgery\\n   - Solid food for 6 hours before surgery\\n3. **Suitability for preoperative carbohydrate loading:** Yes\\n4', '. **Medication instructions:**\\n   - Levothyroxine: Take as usual on the day of surgery with a sip of water\\n   - Amlodipine: Take as usual on the day of surgery with a sip of water\\n   - Atenlol: Take as usual on the day of surgery with a', ' sip of water\\n5. **Instructions for the healthcare team:** NA\\n6. **Preoperative optimization required:**\\n   - Thyroid function: Refer to the Internal Medicine Perioperative Clinic (IMPT) as the patient is not known to Endocrine.\\n7. **Need to delay the operation for further medical workup', ' and preoperative optimization:** No\\n8. **Specific department protocols to follow:**\\n   - Guidelines on Preoperative Assessment and Optimization of Patients with Thyroid Disease: To refer to IMPT for thyroid function optimization as the patient is not known to Endocrine.\\n\\n**Instructions for the Patient in Lay Language:**\\n\\n1. **Medication', ' instructions to take leading up to the surgery:**\\n   - Continue taking your thyroid medication, blood pressure medications, and any other regular medications as usual.\\n2. **Consent for the types of anesthesia that the patient needs to be aware of for this surgery:**\\n   - You will likely receive general anesthesia for this surgery', ', which means you will be completely asleep and unaware during the procedure.\\n   - There is a small risk of complications with general anesthesia, such as nausea, vomiting, and sore throat. However, these are usually temporary and can be managed with medication.']\n",
      "['1. Doctor\\n2. Fasting for solids for 6 hours and clear fluids for 2 hours before the surgery.\\n3. Yes\\n4. \\n- Levothyroxine: Take as usual on the day of surgery.\\n- Amlodipine: Take as usual on the day of surgery', '.\\n- Atenlol: Take as usual on the day of surgery.\\n- Salbutamol inhaler: Bring along and use as needed.\\n5. NA\\n6. NA\\n7. No\\n8. NA\\n\\nPatient instructions:\\n\\n1. Take your Levothyroxine, Amlodi', 'pine, and Atenlol as usual on the day of surgery.\\n2. Bring your salbutamol inhaler with you to the hospital.\\n3. You will be given general anesthesia for your surgery. This means that you will be asleep and pain-free during the operation.\\n4. There are some risks associated with general anesthesia, including nausea, vomiting, and sore throat. These risks are usually mild and go away within a few days.\\n5. You may also experience some pain after surgery. This pain can be managed with pain medication.']\n",
      "response\n",
      " prediction: Singapore General Hospital  \n",
      "TITLE:  \n",
      "Guidelines on Preoperative Assessment and optimization \n",
      "of patients with thyroid disease  DOCUMENT NO:  \n",
      "85300 -PP-012 Page 1 of 5 \n",
      "ISSUED BY:  \n",
      "Dr He Yingke, Dr Hairil Abdullah, Dept of Anesthesiology  \n",
      "Dr Shum Koin Lon, Dr Yee Yucai, Dept of Internal Medicine  \n",
      "Dr Chng Chiaw Ling, Dr Adoree Lim Yi Ying, Dr Yew Jielin, \n",
      "Department of Endocrinology  \n",
      " \n",
      "Date of Issue: Oct 2020 , Version 3.0  Approved by:  \n",
      "Dr Tan Kian Hian  \n",
      "Senior Consultant and Head, Dept of \n",
      "Anesthesiology, SGH  \n",
      " \n",
      "A/P Soh Chai Rick  \n",
      "Senior Consultant, Chairman, \n",
      "Division of Anesthesiology, SGH  \n",
      " \n",
      "Recommendations  for Elective Non-thyroid surgery  \n",
      "1. Please refer to the indications for TFT before ordering for tests  \n",
      "o We recommend to send for Free T4 and TSH  \n",
      "o We do not recommend routine testing for FT3 for all patients  \n",
      " \n",
      "2. Please refer to the suggested workflows (a) – (c) after FT4 and TSH are out  \n",
      "o If patient is known to Endocrine  \n",
      "- Please  contact the primary endocrinologist directly on weekdays 8AM -\n",
      "5PM  \n",
      "- In the event  primary endocrinologist is not available or outside office \n",
      "hours – to contact on -call Endocrine registrar  \n",
      "o If patient is not known to Endocrine, please refer to the Internal Medicine \n",
      "Perioperative Clinic (IMPT) , except in special circumstances where patien t has \n",
      "history of DTC (refer to workflow (c))  \n",
      " \n",
      " \n",
      "Legend of Terminology  \n",
      "Thyroid disease  \n",
      "Primary Hyperthyroidism  Elevated FT4 + TSH below reference range  \n",
      "Primary Hypothyroidism  Low FT4 + TSH above reference range  \n",
      "Subclinical  Hyperthyroidism  Normal FT4 + TSH below reference range  \n",
      "Subclinical Hypothyroidism  Normal FT4 + TSH above reference range  \n",
      "Thyroid Medication  \n",
      "Thionamides  \n",
      "(Antithyroid medications)  Carbimazole / Methimazole/ Thiamazole  \n",
      "Propylthiouracil (PTU)  \n",
      "Levothyroxine  -\n",
      "\n",
      "---\n",
      "\n",
      "Singapore General Hospital  \n",
      "TITLE:  \n",
      "Guidelines on Preoperative Assessment and optimization \n",
      "of patients with thyroid disease  DOCUMENT NO:  \n",
      "85300 -PP-012 Page 3 of 5 \n",
      "ISSUED BY:  \n",
      "Dr He Yingke, Dr Hairil Abdullah, Dept of Anesthesiology  \n",
      "Dr Shum Koin Lon, Dr Yee Yucai, Dept of Internal Medicine  \n",
      "Dr Chng Chiaw Ling, Dr Adoree Lim Yi Ying, Dr Yew Jielin, \n",
      "Department of Endocrinology  \n",
      " \n",
      "Date of Issue: Oct 2020 , Version 3.0  Approved by:  \n",
      "Dr Tan Kian Hian  \n",
      "Senior Consultant and Head, Dept of \n",
      "Anesthesiology, SGH  \n",
      " \n",
      "A/P Soh Chai Rick  \n",
      "Senior Consultant, Chairman, \n",
      "Division of Anesthesiology, SGH  \n",
      " \n",
      " \n",
      "Suggested workflows  \n",
      "(a) Patients undergoing elective non -thyroid surgery with history of hyperthyroidism on \n",
      "thionamides or no past history of thyroid disease  \n",
      "(b) Patients undergoing elective non -thyroid surgery with history of hypothyroidism on \n",
      "levothyroxine replacement  \n",
      "(c) Patients undergoing elective non -thyroid surgery with Differentiated Thyroid Cancer \n",
      "(DTC)  \n",
      " \n",
      " \n",
      "a) Patients undergoing elective non -thyroid surgery with history of hyperthyroidism on \n",
      "thionamides or no past history of thyroid disease   \n",
      " \n",
      "*If not known to Endocrine,  to contact IMPT as first line\n",
      "\n",
      "---\n",
      "\n",
      "Singapore General Hospital  \n",
      "TITLE:  \n",
      "Guidelines on Preoperative Assessment and optimization \n",
      "of patients with thyroid disease  DOCUMENT NO:  \n",
      "85300 -PP-012 Page 4 of 5 \n",
      "ISSUED BY:  \n",
      "Dr He Yingke, Dr Hairil Abdullah, Dept of Anesthesiology  \n",
      "Dr Shum Koin Lon, Dr Yee Yucai, Dept of Internal Medicine  \n",
      "Dr Chng Chiaw Ling, Dr Adoree Lim Yi Ying, Dr Yew Jielin, \n",
      "Department of Endocrinology  \n",
      " \n",
      "Date of Issue: Oct 2020 , Version 3.0  Approved by:  \n",
      "Dr Tan Kian Hian  \n",
      "Senior Consultant and Head, Dept of \n",
      "Anesthesiology, SGH  \n",
      " \n",
      "A/P Soh Chai Rick  \n",
      "Senior Consultant, Chairman, \n",
      "Division of Anesthesiology, SGH\n",
      "Response from Model:  **Preoperative anesthesia instructions**\n",
      "\n",
      "**To: Fellow Medical Colleagues**\n",
      "\n",
      "**From: [Your Name]**\n",
      "\n",
      "**Date: [Current Date]**\n",
      "\n",
      "**Patient: 50-year-old Chinese female**\n",
      "\n",
      "**Medical History**\n",
      "- Hypertension (HTN)\n",
      "- Hyperlipidemia (HLD)\n",
      "- Multinodular goiter (MNG), status post total thyroidectomy\n",
      "- Childhood asthma (well-controlled, last attack 1 year ago)\n",
      "\n",
      "**Current Medications**\n",
      "- Levothyroxine 100 mcg 5 times per week, 75 mcg twice per week\n",
      "- Amlodipine 5 mg once daily\n",
      "- Atenolol 50 mg once daily\n",
      "\n",
      "**Preoperative Investigations**\n",
      "- Blood tests:\n",
      " - T3: 5.5\n",
      " - T4: 16.5\n",
      " - TSH: 0.328\n",
      " - Hb: 13.2 g/dL\n",
      " - TW: 8\n",
      " - Plt: 209 x 10^9/L\n",
      " - PT: 10.2 seconds\n",
      " - APTT: 29.9 seconds\n",
      "\n",
      "**Preoperative Instructions**\n",
      "\n",
      "1. **Doctor/Nurse:** Doctor\n",
      "2. **Fasting:**\n",
      " - Solids: Nothing to eat after midnight before the surgery.\n",
      " - Liquids: Clear fluids (e.g., water, black coffee, tea without milk or sugar) are allowed up to 2 hours before the surgery.\n",
      "3. **Preoperative carbohydrate loading:** No\n",
      "4. **Medication instructions:**\n",
      " - Continue taking Levothyroxine as prescribed.\n",
      " - Continue taking Amlodipine and Atenolol as prescribed until the morning of surgery.\n",
      "5. **Instructions to the healthcare team:**\n",
      " - Preoperative blood group matching: Yes\n",
      " - Preoperative thyroid function tests: TSH and FT4 (if not done within the last 6 weeks)\n",
      "6. **Preoperative optimization:**\n",
      " - Optimize thyroid function if necessary.\n",
      " - Control blood pressure.\n",
      "7. **Delay of operation:**\n",
      " - Not necessary.\n",
      "8. **Specific department protocols:**\n",
      " - Follow the department's guidelines for preoperative assessment and optimization of patients with thyroid disease and hypertension.\n",
      "\n",
      "**Patient Instructions**\n",
      "\n",
      "**Medication instructions:**\n",
      "- Continue taking Levothyroxine as prescribed.\n",
      "- Continue taking Amlodipine and Atenolol as prescribed until the morning of surgery.\n",
      "\n",
      "**Consent for anesthesia:**\n",
      "- General anesthesia will be administered.\n",
      "- Risks associated with general anesthesia and the surgery will be discussed with you in detail before the procedure.\n",
      "\n",
      "**Specific risks:**\n",
      "- Due to your history of childhood asthma, there is a slightly increased risk of respiratory complications during anesthesia.\n",
      "- Your thyroid surgery may have altered your anatomy, which may make intubation slightly more difficult.\n",
      "iteration # 9\n",
      "['**Preoperative Anesthesia Instructions**\\n\\n1. **Doctor/Nurse:** Nurse\\n2. **Fasting instructions:** Clear fluids up to 2 hours before surgery, nothing by mouth after that.\\n3. **Suitability for preoperative carbohydrate loading:** No\\n4. **Medication instructions:**\\n   - Continue N', 'iften 50mg/20mg Cap, Lisinopril Tablet 10 mg, Simvastatin Tablet 10 mg, and Terazosin Tablet 1 mg as usual.\\n   - Take all medications with a sip of water at 6am on the day of surgery.\\n5.', \" **Instructions for the healthcare team:** NA\\n6. **Preoperative optimization required:** None\\n7. **Need to delay the operation for further medical workup and preoperative optimization:** No\\n8. **Specific department protocols to follow:**\\n   - Preoperative Assessment of Patients with Hypertension: Patient's blood pressure is\", \" well-controlled, no further action required.\\n   - Preoperative Cardiac Assessment: Patient has no active cardiac conditions or significant changes from baseline, no further action required.\\n   - Guidelines on Preoperative Assessment of Obese Patients: Patient's BMI is 27, which is below the threshold for additional considerations\", '.\\n\\n**Patient Instructions**\\n\\n**Medication instructions to take leading up to the surgery:**\\n\\n* Continue taking all your regular medications as prescribed.\\n\\n**Consent for the types of anesthesia that the patient needs to be aware of for this surgery, and any specific risks to highlight due to the operation and the patient’s', ' medical history:**\\n\\n* You will be receiving local anesthesia for this procedure. This means that the area where the biopsy will be taken will be numbed.\\n* There are no specific risks to highlight due to your medical history or the operation.']\n",
      "['**Preoperative Anesthesia Instructions**\\n\\n1. **Doctor/Nurse:** Nurse\\n2. **Fasting instructions:** Clear fluids up to 2 hours before surgery, nothing by mouth after that.\\n3. **Suitability for preoperative carbohydrate loading:** No\\n4. **Medication instructions:**\\n   - Take N', 'iften 50mg/20mg Cap, Simvastatin Tablet 10 mg, and Terazosin Tablet 1 mg with a sip of water at 6am on the day of surgery.\\n   - Do not take Lisinopril Tablet on the day of surgery.\\n5. **Instructions', \" for the healthcare team:** NA\\n6. **Preoperative optimization required:** None\\n7. **Need to delay the operation:** No\\n8. **Specific department protocols:**\\n   - Preoperative Hypertension Management Protocol: Patient's blood pressure is well-controlled, no further action required.\\n   - Preoperative\", \" Cardiac Assessment Protocol: Patient has no active cardiac conditions or significant changes in effort tolerance, no further action required.\\n   - Obesity Management Protocol: Patient's BMI is 27, which is considered overweight but not obese, no further action required.\\n\\n**Patient Instructions**\\n\\n**Medication instructions:**\\n\\n* Take\", ' your regular medications Niften, Simvastatin, and Terazosin with a small sip of water on the morning of your surgery.\\n* Do not take Lisinopril on the day of your surgery.\\n\\n**Consent for anesthesia:**\\n\\n* You will be having an MRI targeted prostate biopsy, which is a procedure', ' to take a sample of your prostate gland.\\n* You will be given a sedative to help you relax and fall asleep during the procedure.\\n* There are no specific risks to highlight due to your medical history or the operation.']\n",
      "['**Preoperative Anesthesia Instructions**\\n\\n1. **Doctor/Nurse:** Nurse\\n2. **Fasting instructions:** Clear fluids up to 2 hours before surgery, nothing by mouth after that.\\n3. **Suitability for preoperative carbohydrate loading:** No\\n4. **Medication instructions:**\\n    - Continue N', 'iften 50mg/20mg Cap (atenolol and nifedipine) with a sip of water at 6am on the day of surgery.\\n    - Continue Lisinopril Tablet 10 mg every night.\\n    - Continue Simvastatin Tablet 10 mg every night', '.\\n    - Continue Terazosin Tablet 1 mg every night.\\n    - Continue ranitidine as prescribed.\\n5. **Instructions for the healthcare team:** NA\\n6. **Preoperative optimization required:** None\\n7. **Need to delay the operation for further medical workup and preoperative optimization:** No', \"\\n8. **Specific department protocols to follow:**\\n    - Preoperative Assessment of Patients with Hypertension: Patient's blood pressure is well-controlled, no further action required.\\n    - Preoperative Cardiac Assessment: Patient has no active cardiac conditions or significant changes in baseline effort tolerance, no further action required.\\n\", \"    - Guidelines on Preoperative Assessment of Obese Patients: Patient's BMI is 27, which is below the threshold for special considerations.\\n\\n**Patient Instructions**\\n\\n**Medication instructions to take leading up to the surgery:**\\n\\n* Continue taking your regular medications as prescribed, including atenolol, nifedip\", 'ine, lisinopril, simvastatin, terazosin, and ranitidine.\\n\\n**Consent for the types of anesthesia that the patient needs to be aware of for this surgery, and any specific risks to highlight due to the operation and the patient’s medical history:**\\n\\n* You will be receiving local anesthesia', ' for the MRI targeted prostate biopsy. This means that the area where the biopsy will be taken will be numbed.\\n* There are no specific risks to highlight due to your medical history or the operation.']\n",
      "['1. Doctor\\n2. Fasting for solids for 6 hours and clear fluids for 2 hours before the surgery.\\n3. No\\n4. \\n- Niften 50mg/20mg Cap: Take 1 capsule with a sip of water at 6am on the day of', ' surgery.\\n- Lisinopril Tablet 10 mg: Take 1 tablet with a sip of water at 6am on the day of surgery.\\n- Simvastatin Tablet 10 mg: Take 1 tablet with a sip of water at 6am on the day of surgery.\\n-', ' Terazosin Tablet 1 mg: Take 1 tablet with a sip of water at 6am on the day of surgery.\\n5. NA\\n6. NA\\n7. No\\n8. NA\\n\\nPatient instructions:\\n1. Take all your medications as instructed above.\\n2. You will be given general anesthesia for your surgery. This means that you will be asleep and pain-free during the procedure. There are some risks associated with general anesthesia, including nausea, vomiting, and sore throat. The anesthesiologist will discuss these risks with you in more detail before the surgery.']\n",
      "response\n",
      " prediction: \n",
      "\n",
      "1. Should the patient be seen by a Doctor or Nurse - Doctor\n",
      "2. Fasting instructions - Fast from midnight before the day of surgery\n",
      "3. Suitability for preoperative carbohydrate loading - No\n",
      "4. Medication instructions - \n",
      "- Continue all medications except ACEi/ARB (Lisinopril) on the day of surgery. Take with a sip of water at 6am on day of surgery.\n",
      "- Stop Terazosin 1mg daily 24 hours before surgery\n",
      "- Continue Niften 50mg/20mg Cap 1 cap - PO - OM (atenolol and nifedipine) and Simvastatin Tablet 10 mg - EVERY NIGHT\n",
      "5. Any instructions for the healthcare team - NA\n",
      "6. Any preoperative optimization required for the patient - Stop Terazosin 1mg daily 24 hours before surgery\n",
      "7. Any need to delay the operation for further medical workup and preoperative optimization? - No\n",
      "8. Any specific department protocols to follow for this patient - NA\n",
      "\n",
      "Patient Instructions:\n",
      "1. Medication instructions to take leading up to the surgery. \n",
      "- Continue all medications except ACEi/ARB (Lisinopril) on the day of surgery. Take with a sip of water at 6am on day of surgery.\n",
      "- Stop Terazosin 1mg daily 24 hours before surgery\n",
      "- Continue Niften 50mg/20mg Cap 1 cap - PO - OM (atenolol and nifedipine) and Simvastatin Tablet 10 mg - EVERY NIGHT\n",
      "2. Consent for the types of anesthesia that the patient needs to be aware of for this surgery, and any specific risks to highlight due to the operation and the patient’s medical history.\n",
      "- The types of anesthesia that may be used for this surgery include general anesthesia (where you will be completely asleep) or regional anesthesia (where only a part of your body will be numbed). The type of anesthesia that is used will be discussed with you by the anesthesia team before the surgery.\n",
      "- There are some specific risks to consider for this surgery, including the risk of bleeding and infection. The anesthesia team will take steps to minimize these risks, but it is important to be aware of them before you consent to the surgery.\n",
      "Response from Model:  ## Preoperative anesthesia instructions:\n",
      "\n",
      "**Doctor/Nurse**: Doctor\n",
      "\n",
      "**Fasting instructions**: \n",
      "- Solids: Nil oral intake for at least 6 hours before the surgery.\n",
      "- Liquids: Clear fluids are allowed up to 2 hours before the surgery.\n",
      "\n",
      "**Preoperative carbohydrate loading**: No\n",
      "\n",
      "**Medication instructions**:\n",
      "- Niften 50mg/20mg Cap 1 cap PO OM: Continue as per usual.\n",
      "- Lisinopril Tablet 10 mg EVERY NIGHT: Continue as per usual.\n",
      "- Simvastatin Tablet 10 mg EVERY NIGHT: Continue as per usual.\n",
      "- Terazosin Tablet 1 mg EVERY NIGHT: Continue as per usual.\n",
      "- Ranitidine 150mg: Take the night before and the morning of surgery with sips of water.\n",
      "- Stop TCM for BPH.\n",
      "\n",
      "**Instructions for the healthcare team**: \n",
      "- Routine preoperative blood group matching.\n",
      "\n",
      "**Preoperative optimization**: \n",
      "- Optimize hypertension. \n",
      "\n",
      "**Need to delay the operation**: No\n",
      "\n",
      "**Specific department protocols**: \n",
      "- Hypertension protocol:\n",
      " - Continue all anti-hypertensives on the day of operation except ACEi/ARB (refer to the hypertension protocol).\n",
      " - Take with a sip of water at 6am on the day of surgery.\n",
      " - If BP remains poorly controlled on the day of surgery, consider postponing the operation.\n",
      "- Smoking cessation protocol:\n",
      " - Advise patient on the benefits of smoking cessation.\n",
      " - Encourage patient to set a quit date and provide resources for smoking cessation.\n",
      "- Obesity protocol: \n",
      " - Consider arterial blood gas and echocardiography if there are accompanying cardiac/pulmonary conditions, or oximetry on air is <93% – consult senior anaesthetist (rule out lung disease and/or obesity hypoventilation syndrome).\n",
      " - Assess the need for SICU/ICA booking postop.\n",
      "\n",
      "**Patient instructions**: \n",
      "- Continue taking all medications as per usual, except for ACEi/ARB (refer to the hypertension protocol).\n",
      "- Follow the fasting instructions provided.\n",
      "- Stop TCM for BPH.\n",
      "- Inform the anesthesia team if you develop any new symptoms or if your medical condition changes.\n",
      "- You may experience some discomfort from the injection of the local anesthetic.\n",
      "- You may feel drowsy or nauseous after the procedure.\n",
      "- You will be closely monitored after the procedure and will be discharged when you are stable.\n",
      "iteration # 10\n",
      "['**Preoperative Anesthesia Instructions**\\n\\n1. **Doctor/Nurse:** Doctor\\n2. **Fasting instructions:** 6 hours for solids, 2 hours for clear fluids\\n3. **Suitability for preoperative carbohydrate loading:** Yes\\n4. **Medication instructions:**\\n   - **Day of operation:**\\n', '     - Take Losartan, Fenofibrate, and Seratide with a sip of water at 6 am.\\n   - **Days leading up to the operation:**\\n     - Continue taking all medications as prescribed.\\n5. **Instructions for the healthcare team:** NA\\n6. **Preoperative optimization required', ':**\\n   - Encourage CPAP compliance for obstructive sleep apnea.\\n7. **Need to delay the operation:** No\\n8. **Specific department protocols to follow:**\\n   - Preoperative Assessment and Optimization of Patients with Hypertension Protocol\\n   - Preoperative Assessment of Obese Patients Protocol\\n   - ERAS Spine', ' Protocol\\n\\n**Patient Instructions**\\n\\n1. **Medication instructions to take leading up to the surgery:**\\n\\n   - Continue taking all your medications as usual.\\n\\n2. **Consent for the types of anesthesia and specific risks:**\\n\\n   - You will likely receive general anesthesia for this surgery. This means you will be completely', ' asleep and will not feel any pain.\\n   - There is a risk of complications with general anesthesia, such as difficulty breathing, heart problems, and allergic reactions.\\n   - Due to your history of obstructive sleep apnea, you may be at a higher risk of breathing problems during and after surgery. Your doctor will take', ' steps to minimize this risk, such as using a CPAP machine if necessary.']\n",
      "['**Preoperative Anesthesia Instructions**\\n\\n1. **Doctor/Nurse:** Doctor\\n2. **Fasting instructions:** 6 hours for solids and 2 hours for clear fluids prior to surgery\\n3. **Suitability for preoperative carbohydrate loading:** Yes\\n4. **Medication instructions:**\\n    - **Day of', ' operation:**\\n        - Take Losartan, Fenofibrate, and Seratide with a sip of water at 6 AM\\n    - **Days leading up to the operation:**\\n        - Continue taking all medications as prescribed\\n5. **Instructions for the healthcare team:** NA\\n6. **Preoperative optimization', ' required:**\\n    - Encourage CPAP compliance for obstructive sleep apnea\\n7. **Need to delay the operation for further medical workup and preoperative optimization:** No\\n8. **Specific department protocols to follow:**\\n    - Preoperative Assessment and Optimization of Patients with Hypertension Protocol\\n    - Preoperative Assessment of Obese', ' Patients Protocol\\n    - ERAS Spine Protocol\\n\\n**Patient Instructions**\\n\\n1. **Medication instructions to take leading up to the surgery:**\\n\\n   - Continue taking all your medications as usual.\\n\\n2. **Consent for the types of anesthesia that the patient needs to be aware of for this surgery, and any specific', ' risks to highlight due to the operation and the patient’s medical history:**\\n\\n   - You may receive general anesthesia, which will make you unconscious during the surgery.\\n   - Due to your history of obstructive sleep apnea, there is an increased risk of breathing problems during and after surgery. We will take special precautions to', ' monitor your breathing and ensure your safety.']\n",
      "['**Preoperative Anesthesia Instructions**\\n\\n1. **Doctor/Nurse:** Doctor\\n2. **Fasting instructions:** 6 hours for solids and 2 hours for clear fluids\\n3. **Suitability for preoperative carbohydrate loading:** Yes\\n4. **Medication instructions:**\\n   - **Day of operation:**\\n', '     - Take Losartan, Fenofibrate, and Seratide with a sip of water at 6 am.\\n   - **Days leading up to the operation:**\\n     - Continue taking all medications as prescribed.\\n5. **Instructions for the healthcare team:** NA\\n6. **Preoperative optimization required', ':**\\n   - Encourage CPAP compliance for obstructive sleep apnea.\\n7. **Need to delay the operation for further medical workup and preoperative optimization:** No\\n8. **Specific department protocols to follow:**\\n   - Preoperative Assessment and Optimization of Patients with Hypertension Protocol\\n   - Preoperative Assessment of Obese', ' Patients Protocol\\n   - ERAS Spine Protocol\\n\\n**Patient Instructions**\\n\\n1. **Medication instructions to take leading up to the surgery:**\\n   - Continue taking all your medications as your doctor has told you.\\n\\n2. **Consent for the types of anesthesia that the patient needs to be aware of for this surgery', ', and any specific risks to highlight due to the operation and the patient’s medical history:**\\n\\n   - You may receive general anesthesia, which will make you unconscious during the surgery.\\n   - Due to your history of obstructive sleep apnea, you may be at an increased risk of breathing problems during and after surgery.', ' Your anesthesiologist will take special precautions to monitor your breathing and ensure your safety.']\n",
      "['1. Should the patient be seen by a Doctor or a Nurse - Doctor\\n2. Fasting instructions - Nil by mouth for solids or liquids for at least 6 hours before the surgery.\\n3. Suitability for preoperative carbohydrate loading - Yes\\n4. Medication instructions \\n - Losartan: Take with a sip', ' of water at 6am on day of surgery\\n - Fenofibrate: Stop 2 days before surgery\\n - Neurobion: Take as usual\\n - Seretide: Take as usual\\n - Salbutamol: Use as needed\\n5. Any instructions for the healthcare team - NA\\n6. Any preoperative optimization', ' required for the patient - Optimize hypertension\\n7. Any need to delay the operation for further medical workup and preoperative optimization? - No\\n8. Any specific department protocols to follow for this patient - \\n - Preoperative assessment of obese patients\\n - Preoperative assessment and optimization of patients with hypertension\\n - Preoperative investigation guidelines for patients presenting for elective surgery\\n - Guidelines on perioperative management of diabetes mellitus\\n\\nPatient instructions:\\n1. Medication instructions to take leading up to the surgery:\\n - Take Losartan with a sip of water at 6am on the day of surgery.\\n - Stop taking Fenofibrate 2', ' days before surgery.\\n - Take Neurobion and Seretide as usual.\\n - Use Salbutamol as needed.\\n2. Consent for the types of anesthesia that the patient needs to be aware of for this surgery, and any specific risks to highlight due to the operation and the patient’s medical history:\\n - You will receive general anesthesia for your surgery. This means that you will be asleep and pain-free during the procedure.\\n - There are some risks associated with general anesthesia, including nausea, vomiting, and sore throat.\\n - There is also a small risk of complications, such as heart attack, stroke, and', ' death.\\n - Your medical history of hypertension and obesity increases your risk of complications from anesthesia.\\n - We will take steps to minimize these risks, such as monitoring your vital signs closely and giving you medications to help prevent complications.']\n",
      "response\n",
      " prediction:  Singapore General Hospital  \n",
      " \n",
      " \n",
      "TITLE:  \n",
      "Guideline s on Preoperative Assessment and optimizati on of \n",
      "patients with HYPERTENSION  DOCUMENT NO:  \n",
      "75400-SD -001 Page 4 of 7 \n",
      "ISSUED BY: Dr Hairil Abdullah , Director and Senior \n",
      "Consultant, Preoperative Evaluation Clinic, Dept of \n",
      "Anesthesiology, SGH  \n",
      "INITIAL DATE ISSUED: 1/05/2014  \n",
      "Updated by:  \n",
      "Dr He Yingke, Associate Consultant, De pt of Anesthesiology  \n",
      "Dr Shum Koin Lon, Consultant, Dept of Internal Medicine  \n",
      "DATE REVISED: 4/6/2020 , REVISION NUMBER: 4 Approved by:  \n",
      "Dr Tan Kian Hian  \n",
      "Senior Consultant and Head , Dept \n",
      "of Anesthesiology , SGH  \n",
      " \n",
      "A/P Soh Chai Rick  \n",
      "Senior Consultant, Chairman, \n",
      "Division of Anesthesiology, SGH  \n",
      " \n",
      " Refer young hypertensives and patients with signs of secondary hypertension to \n",
      "IMPT for work up prior to surgery  (discuss with surgeon regarding benefit of \n",
      "postponing operation for further work up vs risk of delaying surgery)  \n",
      " Low threshold for referral to IMPT for young hypertensives  \n",
      " If no suspicion of secondary hypertension, manage as for pre -existing hypertension  \n",
      " \n",
      "PERIOPERATIVE OPTIMIZATION OF MEDICATIONS  \n",
      " Continue all anti-hypertensives on the day of operation except ACEi/ARB (refer to below)   \n",
      " Take with sip of water at 6am on day of surgery \n",
      " Beta-blockers  \n",
      " Patients with ≥ 3 revised cardiac risk index ( RCRI)  factors or intermediate/high cardiac \n",
      "risk on preoperative tests, it may be reasonable to begin beta blockers before surgery – \n",
      "discuss with cardiologist or PEC consultant if it should be started  \n",
      " Beta blockers should not be initiated within 24h of surgery \n",
      " Diuretics  \n",
      " Watch out for hypokalemia and evaluate patient’s volume status on the day of operation  \n",
      " Angiotension converting enzyme inhibitors (ACEi)/ Angiotensin-receptor blockers (ARBs)  \n",
      " ACEi can cause refractory post induction hypotension if not stopped preoperatively  \n",
      " In non-cardiac surgery, consider discontinuation 24 hours preoperatively and restart within 48 hours after operation in patients with well controlled hypertension unless \n",
      "clinically contraindicated  \n",
      " Continue ACEi preoperatively  if there is impaired LV systolic function or heart \n",
      "failure or if BP is poorly controlled\n",
      "\n",
      "---\n",
      "\n",
      "Singapore General Hospital  \n",
      "Policy & Procedure  \n",
      " \n",
      "Title :  \n",
      "Guidelines on Preoperative Assessment of Obese \n",
      "Patients  Document No:  \n",
      " Page 2 of 2 \n",
      "Issued By : Perioperative Services,  Dept of \n",
      "Anaesthesiology (Dr Hairil Abdullah)  \n",
      "Initial Date Issued : 5/9/2012  \n",
      "Date Revised : 2/5/2017   \n",
      "Revision number : 2 Approved By:  \n",
      "A/P Ruban Poopalalingam Head, Department of \n",
      "Anaesthesia  \n",
      " \n",
      " \n",
      "a. Risk of difficult airway - should include dental injury, aspiration pneumonitis, hypoxia, neurological \n",
      "damage and death  \n",
      "b. Major Adverse Cardiac Event  \n",
      "c. Difficult iv line insertions  \n",
      "d. Positioning (peripheral nerve damage)  \n",
      "e. Deep vein thrombosis  \n",
      "f. Postoperative ventilation and SICU stay  \n",
      "g. Difficult regional anaesthesia (if RA is the planned technique)  \n",
      " \n",
      "4. PLAN  \n",
      "a. Prescribe gastro prophylaxis (PO ranitidine 150 mg 10 pm and 6 am, before surgery with sips of \n",
      "water)  \n",
      "b. Not for ASC Day Surgery, for ASC SSW/SDA – to discuss with PAC consultant  \n",
      "d. Documentation - Under section \"Notes\" : Document discussion with Consult ant and patient onto \n",
      "Pre-operative assessment chart, under \"Instructions\" : Docum ent instructions for follow up eg \n",
      "pending investigations/referrals; CPAP/BIPAP machine for use in PACU, SICU/HD/ICA booking  \n",
      "FOR B ODY MASS INDEX > 45:  \n",
      "ALL OF THE ABOVE AND :  \n",
      "1. Consider Arterial Blood Gas and Echocardiography if there are accompanying \n",
      "cardiac/pulmonary conditions, or oximetry on air is <93% – consult senior anaesthetist (rule \n",
      "out lung disease and/or obesity hypoventilation syndrome)  \n",
      "2. Assess the need for SICU/ICA b ooking postop  \n",
      "3.  Inform Principal Anaesthetist on Friday (once duty roster is\n",
      "Response from Model:  1. Should the patient be seen by a **Doctor** or Nurse - **Doctor**\n",
      "2. Fasting instructions - Fast for at least **6 hours** before the time of the listed surgery\n",
      "3. Suitability for preoperative carbohydrate loading - **Yes**\n",
      "4. Medication instructions \n",
      " - **Losartan**: Take as usual on the day of surgery with a sip of water.\n",
      " - **Fenofibrate**: Stop 5 days before surgery \n",
      " - **Neurobion**: Take as usual on the day of surgery.\n",
      " - **Seratide**: Take as usual on the day of surgery.\n",
      " - **Salbutamol**: Avoid on the day of surgery\n",
      "5. Any instructions for the healthcare team - Arrange for **preoperative blood group matching**\n",
      "6. Any preoperative optimization required for the patient \n",
      " - Optimize weight. \n",
      " - Optimize CPAP usage.\n",
      "7. Any need to delay the operation for further medical workup and preoperative optimization? - **No**\n",
      "8. Any specific department protocols to follow for this patient \n",
      " - **Obstructive sleep apnea protocol** due to history of OSA with AHI 60.2 and lowest sats 77%\n",
      " - **Obesity protocol** due to BMI 33.7\n",
      "\n",
      "---\n",
      "\n",
      "**Patient instructions**\n",
      "\n",
      "- **Medication instructions**: Continue taking your regular medications as prescribed, except for Fenofibrate which should be stopped 5 days before the surgery. Please bring all your medications with you to the hospital on the day of surgery. \n",
      "- **Anesthesia**: You will receive general anesthesia for your surgery. This means that you will be completely asleep and pain-free during the operation.\n",
      "- **Specific risks**: There are some specific risks associated with your surgery and medical history that you should be aware of. \n",
      " - **OSA**: Due to your history of obstructive sleep apnea, you are at increased risk of developing complications during anesthesia, such as difficulty breathing or oxygen desaturation. \n",
      " - **Obesity**: Obesity can also increase the risk of complications during surgery, such as wound infection or blood clots.\n",
      "We will take all necessary precautions to minimize these risks and ensure your safety during surgery. If you have any questions or concerns, please do not hesitate to ask your doctor or nurse.\n",
      "iteration # 11\n",
      "['**Preoperative Anesthesia Instructions**\\n\\n1. **Doctor/Nurse:** Doctor\\n2. **Fasting instructions:**\\n   - Clear fluids up to 2 hours before surgery\\n   - Solid food for 6 hours before surgery\\n3. **Suitability for preoperative carbohydrate loading:** Yes\\n4. **Medication', ' instructions:**\\n   - **Day of operation:**\\n      - Take all medications with a sip of water at 6am, except for ACE inhibitors and ARBs (if applicable).\\n   - **Days leading up to operation:**\\n      - Continue all medications as prescribed.\\n5. **Instructions for healthcare team', ':** NA\\n6. **Preoperative optimization required:**\\n   - Smoking cessation\\n7. **Need to delay operation for further medical workup and preoperative optimization:** No\\n8. **Specific department protocols to follow:**\\n   - ERAS Spine Protocol\\n   - Preoperative assessment and optimization of patients with COPD\\n', '   - Preoperative assessment and optimization of patients with hypertension\\n\\n**Patient Instructions**\\n\\n1. **Medication instructions to take leading up to the surgery:**\\n   - Continue taking all your medications as prescribed by your doctor.\\n2. **Consent for types of anesthesia and specific risks:**\\n   - You may receive general', ' anesthesia, which will make you unconscious during the surgery.\\n   - You may also receive regional anesthesia, such as a spinal or epidural block, which will numb the area of your body being operated on.\\n   - Due to your history of COPD, you may have an increased risk of breathing problems during or after', ' surgery.']\n",
      "['**Preoperative Anesthesia Instructions**\\n\\n1. **Doctor/Nurse:** Doctor\\n2. **Fasting instructions:** Clear fluids up to 2 hours before surgery, and no solid food for 6 hours before surgery.\\n3. **Preoperative carbohydrate loading:** Yes\\n4. **Medication instructions:**\\n    ', '- Continue taking Anoro ellipta 1 puff OM on the day of surgery.\\n    - Continue taking Theophylline 125mg BD leading up to and on the day of surgery.\\n    - Take Salbutamol accuhaler 1 puff QDS PRN as needed leading up to surgery', '.\\n    - Take Diazepam 1 tab OM PRN as needed leading up to surgery.\\n    - Take Imipramine and Zopiclone as usual leading up to surgery.\\n5. **Instructions for healthcare team:** NA\\n6. **Preoperative optimization required:**\\n    - Smoking cessation\\n7', '. **Need to delay operation:** No\\n8. **Department protocols:**\\n    - ERAS Spine Protocol\\n    - Preoperative assessment of respiratory disease\\n    - Preoperative optimization of patients with hypertension\\n\\n**Patient Instructions**\\n\\n1. **Medication instructions:**\\n    - Continue taking your regular medications, including the', ' inhalers for your COPD.\\n    - If you feel anxious or have trouble sleeping, you can take the medications that your doctor has prescribed for these symptoms.\\n\\n2. **Consent for anesthesia:**\\n    - You will likely receive general anesthesia for this surgery, which means you will be asleep during the procedure.\\n', '    - There is a small risk of complications from anesthesia, such as nausea, vomiting, and sore throat.\\n    - Due to your COPD, there is an increased risk of breathing problems during and after surgery. Your doctor will take steps to minimize these risks.']\n",
      "['**Preoperative Anesthesia Instructions**\\n\\n1. **Doctor/Nurse:** Doctor\\n2. **Fasting instructions:** Clear fluids up to 2 hours before surgery, solids up to 6 hours before surgery\\n3. **Suitability for preoperative carbohydrate loading:** Yes\\n4. **Medication instructions:**\\n    -', ' Continue taking Anoro ellipta 1 puff OM on the day of surgery.\\n    - Continue taking Theophylline 125mg BD leading up to and on the day of surgery.\\n    - Continue taking Salbutamol accuhaler 1 puff QDS PRN leading up to the surgery,', ' and bring it to the hospital on the day of surgery.\\n    - Take Diazepam 1 tab OM PRN the night before surgery.\\n    - Take Imipramine and Zopiclone as usual.\\n5. **Instructions for the healthcare team:** NA\\n6. **Preoperative optimization required:**\\n', '    - Smoking cessation\\n7. **Need to delay operation for further medical workup and preoperative optimization:** No\\n8. **Specific department protocols to follow:**\\n    - ERAS Spine Protocol\\n    - Preoperative assessment of respiratory disease protocol\\n    - Smoking cessation protocol\\n\\n**Patient Instructions**\\n\\n1. **', 'Medication instructions to take leading up to the surgery:**\\n    - Continue taking your regular medications for your breathing problems (Anoro, Theophylline, and Salbutamol inhaler).\\n    - Take a tablet called Diazepam the night before surgery to help you relax.\\n\\n2. **Consent for the types of', ' anesthesia that the patient needs to be aware of for this surgery, and any specific risks to highlight due to the operation and the patient’s medical history:**\\n\\n    - You will likely receive general anesthesia for this surgery, which means you will be completely asleep during the procedure.\\n    - You may also receive regional anesthesia', ', such as a spinal or epidural block, which will numb the area of your body being operated on.\\n    - Due to your history of COPD, there is a slightly increased risk of breathing problems during and after surgery. Your anesthesiologist will take special precautions to monitor your breathing and ensure your safety.']\n",
      "['1. Should the patient be seen by a Doctor or a Nurse - Doctor\\n2. Fasting instructions - Nil by mouth for solids or liquids for at least 6 hours before the surgery.\\n3. Suitability for preoperative carbohydrate loading - No\\n4. Medication instructions:\\n   - Imipramine: Continue taking', ' as usual.\\n   - Zopiclone: Continue taking as usual.\\n   - Diazepam: Continue taking as usual.\\n   - Salbutamol accuhaler: Continue taking as usual.\\n   - Theophylline: Continue taking as usual.\\n   - Anoro ellipta: Continue taking as', ' usual.\\n5. Any instructions for the healthcare team - NA\\n6. Any preoperative optimization required for the patient - Smoking cessation counseling.\\n7. Any need to delay the operation for further medical workup and preoperative optimization? - No\\n8. Any specific department protocols to follow for this patient - NA\\n\\nPatient instructions:\\n1. Medication instructions:\\n   - Continue taking all your medications as usual, except for any blood thinners or anti-inflammatory medications, which you should stop taking 7 days before surgery.\\n   - On the day of surgery, take your usual morning medications with a sip of water.\\n2', '. Consent for the types of anesthesia:\\n   - You will be given a general anesthetic, which means you will be asleep during the surgery.\\n   - There are some risks associated with general anesthesia, including nausea, vomiting, and sore throat.\\n   - In your case, there is also a small risk of developing pneumonia or other respiratory complications due to your COPD.\\n   - We will take steps to minimize these risks, such as giving you antibiotics before surgery and using a breathing tube to help you breathe during the surgery.']\n",
      "response\n",
      " prediction:  Singapore General Hospital  \n",
      "  \n",
      "SUPPORTING DOCUMENTS  \n",
      "TITLE: Preoperative assessment of Respiratory  Disease \n",
      "presenting for elective surgery (excluding thoracic surgery)  DOCUMENT NO:   \n",
      " 85300 -PP-031 Page 5 of 14 \n",
      "ISSUING DEPARTMENT:  Department of Anaesthesiology  and \n",
      "Perioperative Medicine  \n",
      "ISSUED BY: Dr. Angie Au Yong, Dr Chai Jia Xin, Dr Eileen Sim, \n",
      "Dr He Yingke, Dr Shum Koin Lon (Lead, Internal Medicine \n",
      "Perioperative Team)  \n",
      "DATE REVISED: 23 May  2023 \n",
      "VERSION NUMBER: 4 APPROVED BY:  \n",
      "A/Prof Hairil Rizal Abdullah, Clinical \n",
      "Director, Perioperative Services; and  \n",
      "Dr Kenny Loh , Head  of Department  \n",
      "  \n",
      "Department of Anaesthesiology  \n",
      " \n",
      " \n",
      " c. Optimization strategies  \n",
      " \n",
      " \n",
      "6. SMOKING CESSATION  \n",
      " \n",
      "a. All smokers should be  actively encouraged to quit smoking regardless of time frame prior \n",
      "to surgery  as cessation even on the day before surgery is beneficial.  \n",
      " \n",
      "b. All patients are screened for smoking history  during nursing assessmen t, and active \n",
      "smokers are offered enrolment int o the preoperative smoking cessation counselling \n",
      "sessions by PEC nurses .  \n",
      "▪ These sessions will educate  the patient  on smoking related postoperative \n",
      "complications and benefits of perioperative smoking cessation . \n",
      "▪ Nicotine Replacement Therapy (NRT) may  be offered if patients are keen and \n",
      "there are no contraindications. After the counselling session, PEC nurse will issue \n",
      "the recommended intervention and MO will help to  order the prescription for \n",
      "NRT. MO to refer to Annex for ‘NRT Prescription Table for use in PAC’.  \n",
      "▪ HPB quit for life brochure and hospital support hotline will be given by PEC nurse.  \n",
      " \n",
      "c. Patients who decline the preoperative smoking cessation counselling by PEC nurses can \n",
      "still be referred t o SGH smoking cessation clinic if they are  keen.  \n",
      " \n",
      "7. RISK COUNSELLING  \n",
      " \n",
      "a. For patients with risk factors for postoperative pulmonary complications (refer to Section \n",
      "3a), counsel patient for increased risks of:  \n",
      "i. Pneumonia, respiratory failure, prolonged mechanical ventilation, bronchospasm, \n",
      "atelectasis, and exacerbation of underlying chronic lung disease .  \n",
      "ii. Possible High dependency/ICU admission, prolonged hospit al stay (average increase of \n",
      "1-2 weeks) with increased morbidity and mortality.  \n",
      "iii. Risk increases with greater number of pulmonary risk factors present.  \n",
      " Conditions  How to optimize  \n",
      "EFS Total score >=6 or  \n",
      "Functional independence + functional \n",
      "performance  score  >=3, going for major \n",
      "abdominal surgery  or vascular angioplasty with \n",
      "lower limb wound  Refer to physiotherapy for assessment, \n",
      "education on physical exercises +/- inspiratory \n",
      "muscle training.  \n",
      "Malnutrition risk (MUST score >=2) , going for  \n",
      "major abdominal surgery , cancer surgery , or \n",
      "vascular angi oplasty with lower limb wounds.  Refer to Dietiti an for assessment, nutritional \n",
      "education , +/- prescription of oral nutrition \n",
      "supplements for nutritional support\n",
      "\n",
      "---\n",
      "\n",
      "Singapore General Hospital  \n",
      " \n",
      " \n",
      "TITLE:  \n",
      "Guideline s on Preoperative Assessment and optimizati on of \n",
      "patients with HYPERTENSION  DOCUMENT NO:  \n",
      "75400-SD -001 Page 6 of 7 \n",
      "ISSUED BY: Dr Hairil Abdullah , Director and Senior \n",
      "Consultant, Preoperative Evaluation Clinic, Dept of \n",
      "Anesthesiology, SGH  \n",
      "INITIAL DATE ISSUED: 1/05/2014  \n",
      "Updated by:  \n",
      "Dr He Yingke, Associate Consultant, De pt of Anesthesiology  \n",
      "Dr Shum Koin Lon, Consultant, Dept of Internal Medicine  \n",
      "DATE REVISED: 4/6/2020 , REVISION NUMBER: 4 Approved by:  \n",
      "Dr Tan Kian Hian  \n",
      "Senior Consultant and Head , Dept \n",
      "of Anesthesiology , SGH  \n",
      " \n",
      "A/P Soh Chai Rick  \n",
      "Senior Consultant, Chairman, \n",
      "Division of Anesthesiology, SGH  \n",
      " \n",
      "Figure 1. Workflow for perioperative management of hypertensive patients  \n",
      " \n",
      " \n",
      " \n",
      " \n",
      " \n",
      " \n",
      " \n",
      "  \n",
      " \n",
      " \n",
      " \n",
      " \n",
      " \n",
      " \n",
      " \n",
      " \n",
      " \n",
      " \n",
      " \n",
      " \n",
      " \n",
      "Elevated BP?  \n",
      " Proceed with operation  \n",
      "No \n",
      "Known HTN  \n",
      " Newly \n",
      "diagnosed  \n",
      "Refer to guideline \n",
      " \n",
      "BP 140 -180/9\n",
      "Response from Model:  **Doctor/Nurse:** Doctor\n",
      "\n",
      "**Fasting instructions:** \n",
      "- Fast for solids for 6 hours before the surgery.\n",
      "- Only clear fluids are allowed up to 2 hours before the surgery.\n",
      "\n",
      "**Preoperative carbohydrate loading:** No\n",
      "\n",
      "**Medication instructions:** \n",
      "\n",
      "- **Diazepam:** Take 1 tablet by mouth once a night if required.\n",
      "- **Salbutamol accuhaler:** Use as needed, maximum of 1 puff every 4-6 hours.\n",
      "- **Theophylline 125mg:** Take 1 tablet by mouth twice daily.\n",
      "- **Anoro ellipta:** Continue taking 1 puff by mouth once daily in the morning.\n",
      "- **Imipramine:** Take as prescribed.\n",
      "- **Zopiclone 0.5 tab:** Take 0.5 tablet by mouth at bedtime if required.\n",
      "\n",
      "**Instructions for the healthcare team:** \n",
      "- Arrange for a preoperative ECG.\n",
      "- Arrange for a preoperative chest x-ray.\n",
      "- Start preoperative smoking cessation counseling.\n",
      "- Order preoperative pulmonary function tests.\n",
      "- Consider a referral to a respiratory therapist for pulmonary rehabilitation.\n",
      "\n",
      "**Preoperative optimization required:** \n",
      "- Optimize COPD management.\n",
      "- Smoking cessation.\n",
      "- Weight optimization.\n",
      "\n",
      "**Need to delay the operation:** No\n",
      "\n",
      "**Specific department protocols to follow:** \n",
      "- Preoperative assessment of respiratory disease protocol.\n",
      "- Smoking cessation protocol.\n",
      "\n",
      "---\n",
      "**Patient instructions:**\n",
      "\n",
      "**Medications:** \n",
      "\n",
      "- Continue taking all your regular medications as prescribed.\n",
      "- Bring all your medications with you to the hospital on the day of surgery.\n",
      "\n",
      "**Consent for anesthesia:** \n",
      "\n",
      "- General anesthesia will be used for your surgery.\n",
      "- Risks of general anesthesia include:\n",
      " - Awareness during surgery\n",
      " - Difficulty breathing\n",
      " - Nausea and vomiting\n",
      " - Sore throat\n",
      " - Hoarseness\n",
      " - Muscle pain\n",
      " - Nerve damage\n",
      " - Death\n",
      "\n",
      "- You will be asked to sign an anesthesia consent form before your surgery.\n",
      "\n",
      "**Specific risks:** \n",
      "\n",
      "- Your COPD may increase your risk of complications during and after surgery.\n",
      "- Smoking may also increase your risk of complications.\n",
      "iteration # 12\n",
      "['**Preoperative Anesthesia Instructions for Medical Colleagues**\\n\\n1. **Doctor/Nurse:** Nurse\\n2. **Fasting instructions:** Clear fluids up to 2 hours before surgery, nil per oral for 6 hours before surgery.\\n3. **Preoperative carbohydrate loading:** No\\n4. **Medication instructions:**', \"\\n    - Continue Aspirin on the day of surgery.\\n5. **Instructions for healthcare team:** NA\\n6. **Preoperative optimization required:** NA\\n7. **Need to delay operation:** No\\n8. **Department protocols:**\\n    - Preoperative Cardiac Assessment Protocol: To assess the patient's\", ' cardiac risk and provide guidance on pharmacological management.\\n\\n**Instructions for the Patient**\\n\\n1. **Medication instructions:**\\n    - Continue taking your aspirin as usual.\\n2. **Consent for anesthesia:**\\n    - You will be receiving general anesthesia for this surgery. This means that you will be completely asleep and unaware', ' during the procedure.\\n    - There are some risks associated with general anesthesia, such as nausea, vomiting, and sore throat. However, these risks are generally minor and temporary.']\n",
      "['**Preoperative Anesthesia Instructions for Medical Colleagues**\\n\\n1. **Should the patient be seen by a Doctor or a Nurse:** Doctor\\n2. **Fasting instructions:** Clear fluids up to 2 hours before surgery, nil per oral for 6 hours before surgery.\\n3. **Suitability for preoperative carbohydrate', ' loading:** No\\n4. **Medication instructions:**\\n    - Continue Aspirin on the day of surgery.\\n5. **Instructions for the healthcare team:** NA\\n6. **Preoperative optimization required:**\\n    - Hypertension: Refer to Internal Medicine Perioperative Team (IMPT) for optimization.\\n7.', ' **Need to delay the operation for further medical workup and preoperative optimization:** Yes, if hypertension is not optimized.\\n8. **Specific department protocols to follow:**\\n    - Guidelines on Preoperative Assessment of Patients with Hypertension: To assess and optimize hypertension.\\n    - Guidelines on Preoperative Cardiac Assessment: To assess', ' cardiac risk and guide management.\\n\\n**Instructions to the Patient in Lay Language**\\n\\n1. **Medication instructions to take leading up to the surgery:**\\n    - Continue taking your aspirin as usual.\\n2. **Consent for the types of anesthesia that the patient needs to be aware of for this surgery, and any', ' specific risks to highlight due to the operation and the patient’s medical history:**\\n\\n    - You will likely receive general anesthesia for this surgery, which means you will be completely asleep during the procedure.\\n    - Due to your history of high blood pressure, you may be at an increased risk of complications during surgery.', ' The medical team will take steps to manage this risk.']\n",
      "['**Preoperative Anesthesia Instructions for Medical Colleagues**\\n\\n1. **Doctor/Nurse:** Nurse\\n2. **Fasting instructions:** Clear fluids up to 2 hours before surgery, nil by mouth for solids 6 hours before surgery.\\n3. **Preoperative carbohydrate loading:** No\\n4. **Medication instructions', ':**\\n   - Continue Aspirin on the day of surgery.\\n5. **Instructions for healthcare team:** NA\\n6. **Preoperative optimization required:** NA\\n7. **Need to delay operation:** No\\n8. **Department protocols:**\\n   - Preoperative Cardiac Assessment Protocol: Patient has known IHD', ' and previous PCI, but recent exercise stress echo is negative for ischemia. No further cardiac evaluation is required.\\n\\n**Instructions for the Patient**\\n\\n1. **Medication instructions:**\\n   - Take your aspirin as usual on the day of surgery.\\n2. **Consent for anesthesia:**\\n   - You will be having', ' an MRI-guided prostate biopsy.\\n   - You will likely receive a local anesthetic to numb the area where the biopsy will be taken.\\n   - You may also receive sedation to help you relax during the procedure.\\n   - There are no specific risks related to your medical history that you need to be aware of', ' for this procedure.']\n",
      "['1. Doctor\\n2. Fasting for solids for 6 hours and clear fluids for 2 hours before the surgery.\\n3. Yes\\n4. \\n- Aspirin: Continue taking as usual.\\n- Continue all anti-hypertensives on the day of operation except ACEi/ARB (refer to', ' below)\\n- Take with sip of water at 6am on day of surgery\\n- Beta-blockers should not be initiated within 24h of surgery\\n- Diuretics: Watch out for hypokalemia and evaluate patient’s volume status on the day of operation\\n- Angiotension converting enzyme', ' inhibitors (ACEi)/ Angiotensin-receptor blockers (ARBs):\\n- ACEi can cause refractory post induction hypotension if not stopped preoperatively\\n- In non-cardiac surgery, consider discontinuation 24 hours preoperatively and restart within 48 hours after operation in patients with well controlled hypertension unless clinically contraindicated\\n- Continue ACEi preoperatively if there is impaired LV systolic function or heart failure or if BP is poorly controlled\\n5. NA\\n6. \\n- Optimize DM control if HbA1c > 8.5% (refer to IMPT as per DM protocol)\\n- Optimize Hb (', 'as per Anaemia protocol)\\n7. No\\n8. \\n- ERAS Spine protocol:\\n- Optimize Hb (as per Anaemia protocol)\\n- Optimize DM control if HbA1c > 8.5% (refer to IMPT as per DM protocol)\\n- Smoking cessation counselling (preferably 4 weeks before surgery)\\n- Identify patients with chronic opioid usage and inform surgeon (they may not be suitable for ERAS)\\n- On the day of surgery (To be prescribed at PAC):\\n- Carbohydrate drink 2 hours before surgery if no contraindications (BMI >35, reflux,', ' diabetes mellitus)\\n- Patients already on gabapentinoids should continue taking it perioperatively\\n- On the day of surgery (To be prescribed at DS/SDA):\\n- All EXCEPT ACDF and TLIF surgeries: PO Arcoxia 120mg with PO omeprazole, unless contraindicated.\\n- Contraindications include drug allergy to NSAIDs/Cox2-inhibitors/aspirin, renal impairment, history of GI ulcers or bleeds, ischaemic heart disease, cerebrovascular disease, peripheral arterial disease, and moderate to severe heart failure.\\n- Preoperative Cardiac Assessment:\\n- New symptoms suggestive of angina or congestive heart failure\\n- New onset murmur\\n- Change in baseline effort tolerance without apparent cause\\n- Abnormal investigations (not previously known or investigated)\\n- Changes in ECG suggestive of ischemia or previous infarct\\n- Changes in rhythm\\n- Left bundle branch block\\n- Right bundle branch block in symptomatic', ' patients or asymptomatic above 50 years old\\n- Atrial fibrillation\\n- Premature ventricular contractions causing symptoms or in patients with underlying structural heart disease, coronary artery disease or low ejection fraction\\n- Preoperative Assessment and Optimization of Patients with Hypertension:\\n- Poorly controlled BP>180/110\\n- Newly diagnosed hypertension\\n- Known hypertensive']\n",
      "response\n",
      " prediction: \n",
      "\n",
      "---\n",
      "\n",
      "Singapore General Hospital  \n",
      "Policy & Procedure  \n",
      " \n",
      "Title:  \n",
      "Guidelines on Preoperative Assessment of Obese \n",
      "Patients  Document No:  \n",
      " Page 2 of 2 \n",
      "Issued By : Perioperative Services,  Dept of \n",
      "Anaesthesiology (Dr Hairil Abdullah)  \n",
      "Initial Date Issued : 5/9/2012  \n",
      "Date Revised : 2/5/2017   \n",
      "Revision number : 2 Approved By:  \n",
      "A/P Ruban Poopalalingam Head, Department of \n",
      "Anaesthesia  \n",
      " \n",
      " \n",
      " \n",
      "a. Risk of difficult airway - should include dental injury, aspiration pneumonitis, hypoxia, neurological \n",
      "damage and death  \n",
      "b. Major Adverse Cardiac Event  \n",
      "c. Difficult iv line insertions  \n",
      "d. Positioning (peripheral nerve damage)  \n",
      "e. Deep vein thrombosis  \n",
      "f. Postoperative ventilation and SICU stay  \n",
      "g. Difficult regional anaesthesia (if RA is the planned technique)  \n",
      " \n",
      "4. PLAN  \n",
      "a. Prescribe gastro prophylaxis (PO ranitidine 150 mg 10 pm and 6 am, before surgery with sips of \n",
      "water)  \n",
      "b. Not for ASC Day Surgery, for ASC SSW/SDA – to discuss with PAC consultant  \n",
      "d. Documentation - Under section \"Notes\" : Document discussion with Consult ant and patient onto \n",
      "Pre-operative assessment chart, under \"Instructions\" : Docum ent instructions for follow up eg \n",
      "pending investigations/referrals; CPAP/BIPAP machine for use in PACU, SICU/HD/ICA booking  \n",
      "FOR B ODY MASS INDEX > 45:  \n",
      "ALL OF THE ABOVE AND :  \n",
      "1. Consider Arterial Blood Gas and Echocardiography if there are accompanying \n",
      "cardiac/pulmonary conditions, or oximetry on air is <93% – consult senior anaesthetist (rule \n",
      "out lung disease and/or obesity hypoventilation syndrome)  \n",
      "2. Assess the need for SICU/ICA b ooking postop  \n",
      "3.  Inform Principal Anaesthetist on Friday (once duty roster is out)  \n",
      "4.  Offer referral to LIFE Center (4377) for obesity management if not on follow up yet.\n",
      "\n",
      "---\n",
      "\n",
      "Singapore General Hospital  \n",
      " \n",
      " \n",
      "TITLE:  \n",
      "Guideline s on Preoperative Assessment and optimizati on of \n",
      "patients with HYPERTENSION  DOCUMENT NO:  \n",
      "75400-SD -001 Page 4 of 7 \n",
      "ISSUED BY: Dr Hairil Abdullah , Director and Senior \n",
      "Consultant, Preoperative Evaluation Clinic, Dept of \n",
      "Anesthesiology, SGH  \n",
      "INITIAL DATE ISSUED: 1/05/2014  \n",
      "Updated by:  \n",
      "Dr He Yingke, Associate Consultant, De pt of Anesthesiology  \n",
      "Dr Shum Koin Lon, Consultant, Dept of Internal Medicine  \n",
      "DATE REVISED: 4/6/2020 , REVISION NUMBER: 4 Approved by:  \n",
      "Dr Tan Kian Hian  \n",
      "Senior Consultant and Head , Dept \n",
      "of Anesthesiology , SGH  \n",
      " \n",
      "A/P Soh Chai Rick  \n",
      "Senior Consultant, Chairman, \n",
      "Division of Anesthesiology, SGH  \n",
      " \n",
      "• Hypokalemia  hyperaldosteronism  \n",
      "• Look through available CT abdomen for adrenal masses  \n",
      " Refer young hypertensives and patients with signs of secondary hypertension to \n",
      "IMPT for work up prior to surgery  (discuss with surgeon regarding benefit of \n",
      "postponing operation for further work up vs risk of delaying surgery)  \n",
      " Low threshold for referral to IMPT for young hypertensives  \n",
      " If no suspicion of secondary hypertension, manage as for pre -existing hypertension  \n",
      " \n",
      "PERIOPERATIVE OPTIMIZATION OF MEDICATIONS  \n",
      " Continue all anti-hypertensives on the day of operation except ACEi/ARB (refer to below)   \n",
      " Take with sip of water at 6am on day of surgery \n",
      " Beta-blockers  \n",
      " Patients with ≥ 3 revised cardiac risk index ( RCRI)  factors or intermediate/high cardiac \n",
      "risk on preoperative tests, it may be reasonable to begin beta blockers before surgery – \n",
      "discuss with cardiologist or PEC consultant if it should be started  \n",
      " Beta blockers should not be initiated within 24h of surgery \n",
      " Diuretics  \n",
      " Watch out for hypokalemia and evaluate patient’s volume status on the day of operation  \n",
      " Angiotension converting enzyme inhibitors (ACEi)/ Angiotensin-receptor blockers (ARBs)  \n",
      " ACEi can cause refractory post induction hypotension if not stopped preoperatively  \n",
      " In non-cardiac surgery, consider discontin\n",
      "Response from Model:  1. Should the patient be seen by a: **Doctor**\n",
      "2. Fasting instructions: \n",
      " - **Solids**: Nil oral intake for at least 6 hours before the surgery. \n",
      " - **Fluids**: Only sips of water are allowed up to 2 hours before the surgery. \n",
      "3. Suitability for preoperative carbohydrate loading: **No**\n",
      "4. Medication instructions: \n",
      " - **Aspirin**: Continue taking as usual.\n",
      " - **All other medications**: To be stopped on the morning of surgery except for hypertensive medications, which should be taken with a sip of water at 6 am on the day of surgery.\n",
      "5. Any instructions for the healthcare team: \n",
      " - **Preoperative blood group matching**: Not required.\n",
      " - **Preoperative dialysis**: Not required.\n",
      " - **Standby postoperative high dependency/ICU beds**: Not required.\n",
      "6. Any preoperative optimization required for the patient: \n",
      " - **Hypertension**: Optimize blood pressure control. If blood pressure is >180/110 mmHg on the day of surgery, the surgery may be postponed.\n",
      " - **Diabetes mellitus**: Optimize glucose control. HbA1c should be <8.5%.\n",
      "7. Any need to delay the operation for further medical workup and preoperative optimization?: **No**\n",
      "8. Any specific department protocols to follow for this patient: \n",
      " - **Preoperative assessment of obese patients**: The patient's BMI is 26, which does not meet the criteria for obesity (BMI ≥ 30 kg/m2). Therefore, this protocol does not apply.\n",
      " - **Guidelines on preoperative assessment and optimization of patients with hypertension**: The patient's blood pressure is 178/84 mmHg, which is considered stage 2 hypertension. Therefore, this protocol applies.\n",
      " - **ERAS Spine protocol**: This protocol is not applicable as the patient is not undergoing spine surgery.\n",
      "\n",
      "**Patient instructions:**\n",
      "1. **Medication instructions**: \n",
      " - Continue taking your regular medications as usual, except for those that have been specifically advised to be stopped.\n",
      " - Take your hypertensive medications with a sip of water at 6 am on the day of surgery.\n",
      "2. **Consent for anesthesia**: You will be given a consent form to sign before the surgery. This form will explain the different types of anesthesia that may be used for your surgery, as well as the risks and benefits of each.\n",
      " - The types of anesthesia that may be used for your surgery include:\n",
      "    - **General anesthesia**: You will be completely unconscious during the surgery.\n",
      "    - **Regional anesthesia**: This type of anesthesia numbs a specific part of your body, such as your lower body or your arm.\n",
      "    - **Local anesthesia**: This type of anesthesia numbs a small area of your body, such as the area around the incision.\n",
      " - The risks of anesthesia include:\n",
      "    - **Nausea and vomiting**.\n",
      "    - **Headache**.\n",
      "    - **Sore throat**.\n",
      "    - **Difficulty breathing**.\n",
      "    - **Bleeding**.\n",
      "    - **Infection**.\n",
      "    - **Death**.\n",
      " - The benefits of anesthesia include:\n",
      "    - **You will be pain-free during the surgery**.\n",
      "    - **You will be unconscious during the surgery, so you will not be aware of what is happening**.\n",
      " - Please discuss any concerns you have about anesthesia with your doctor or nurse.\n",
      "iteration # 13\n",
      "['**Preoperative Anesthesia Instructions**\\n\\n1. **Should the patient be seen by a Doctor or a Nurse:** Doctor\\n2. **Fasting instructions:** NPO after midnight on the day of surgery\\n3. **Suitability for preoperative carbohydrate loading:** Yes\\n4. **Medication instructions:** None\\n5.', ' **Instructions for the healthcare team:** Arrange for preoperative blood group matching\\n6. **Preoperative optimization required:** Anemia\\n7. **Need to delay the operation for further medical workup and preoperative optimization:** No\\n8. **Specific department protocols to follow:**\\n   - Preoperative assessment and optimization of patients with hypertension', '\\n   - Enhanced Recovery after Surgery for Open and Laparoscopic Liver Surgeries\\n   - Preoperative assessment of respiratory disease\\n   - Preoperative cardiac assessment\\n   - Smoking cessation protocol\\n\\n**Instructions to the Patient**\\n\\n1. **Medication instructions to take leading up to the surgery:**\\n   - None\\n\\n', '2. **Consent for the types of anaesthesia that the patient needs to be aware of for this surgery, and any specific risks to highlight due to the operation and the patient’s medical history:**\\n   - You will likely receive general anaesthesia for this surgery. This means that you will be completely asleep during the operation.', '\\n   - There are some risks associated with general anaesthesia, such as nausea, vomiting, and sore throat.\\n   - You have a history of smoking, which increases your risk of developing complications from anaesthesia, such as problems with your lungs.\\n   - You have anemia, which may require a blood transfusion during or', ' after surgery.']\n",
      "['**Preoperative Anesthesia Instructions**\\n\\n1. **Should the patient be seen by a Doctor or a Nurse:** Doctor\\n2. **Fasting instructions:** Patient should fast for 6 hours prior to surgery.\\n3. **Suitability for preoperative carbohydrate loading:** Yes\\n4. **Medication instructions:** No medications', ' are listed in the clinical summary.\\n5. **Instructions for the healthcare team:** Arrange for preoperative blood group matching.\\n6. **Preoperative optimization required:** Anemia\\n7. **Need to delay the operation for further medical workup and preoperative optimization:** No\\n8. **Specific department protocols to follow:**\\n', '   - Preoperative assessment and optimization of patients with hypertension\\n   - Enhanced Recovery after Surgery for Open and Laparoscopic Liver Surgeries\\n   - Preoperative assessment of Respiratory Disease\\n   - Preoperative Cardiac Assessment\\n   - Guidelines on Preoperative Assessment of Obese Patients\\n\\n**Instructions to the Patient**\\n\\n1', '. **Medication instructions to take leading up to the surgery:**\\n   - None\\n\\n2. **Consent for the types of anaesthesia that the patient needs to be aware of for this surgery, and any specific risks to highlight due to the operation and the patient’s medical history:**\\n   - General anaesthesia is planned for', ' this surgery.\\n   - Specific risks to highlight:\\n      - Anemia may increase the risk of complications during surgery.\\n      - Smoking may increase the risk of breathing problems during and after surgery.']\n",
      "['**Preoperative Anesthesia Instructions**\\n\\n1. **Should the patient be seen by a Doctor or a Nurse:** Doctor\\n2. **Fasting instructions:** Patient should fast for 6 hours before the surgery.\\n3. **Suitability for preoperative carbohydrate loading:** Yes\\n4. **Medication instructions:** No medications', ' are mentioned in the clinical summary.\\n5. **Instructions for the healthcare team:** Arrange for preoperative blood group matching.\\n6. **Preoperative optimization required:** Anemia\\n7. **Need to delay the operation for further medical workup and preoperative optimization:** No\\n8. **Specific department protocols to follow:**\\n', '   - Preoperative assessment and optimization of patients with hypertension\\n   - Enhanced Recovery after Surgery for Open and Laparoscopic Liver Surgeries\\n   - Preoperative assessment of respiratory disease\\n   - Smoking cessation\\n   - Preoperative cardiac assessment\\n\\n**Instructions to the Patient**\\n\\n1. **Medication instructions to take leading', ' up to the surgery:**\\n   - None\\n\\n2. **Consent for the types of anaesthesia that the patient needs to be aware of for this surgery, and any specific risks to highlight due to the operation and the patient’s medical history:**\\n   - General anaesthesia is planned for this surgery.\\n   - Specific', ' risks to highlight:\\n      - Anemia may increase the risk of complications during surgery.\\n      - Smoking increases the risk of respiratory problems during and after surgery.']\n",
      "['1. Doctor\\n2. Fasting for solids and liquids for at least 6 hours before the surgery.\\n3. Yes\\n4. \\n- Continue all anti-hypertensives on the day of operation except ACEi/ARB (refer to below)   \\n\\uf0b2 Take with sip of water at 6', 'am on day of surgery \\n\\uf0b2 Beta-blockers  \\n\\uf0fc Patients with ≥ 3 revised cardiac risk index ( RCRI)  factors or intermediate/high cardiac \\nrisk on preoperative tests, it may be reasonable to begin beta blockers before surgery – \\ndiscuss with cardiologist or PEC consultant if it', ' should be started  \\n\\uf0fc Beta blockers should not be initiated within 24h of surgery \\n\\uf0b2 Diuretics  \\n\\uf0fc Watch out for hypokalemia and evaluate patient’s volume status on the day of operation  \\n\\uf0b2 Angiotension converting enzyme inhibitors (ACEi)/ Angiotensin-receptor blockers (ARBs)  \\n\\uf0fc ACEi can cause refractory post induction hypotension if not stopped preoperatively  \\n\\uf0fc In non-cardiac surgery, consider discontinuation 24 hours preoperatively and restart within 48 hours after operation in patients with well controlled hypertension unless \\nclinically contraindicated  \\n\\uf0fc Continue', ' ACEi preoperatively  if there is impaired LV systolic function or heart \\nfailure or if BP is poorly controlled\\n5. NA\\n6. Anemia\\n7. Yes, delay operation for further medical workup and preoperative optimization of anemia.\\n8. \\n- Enhanced Recovery after Surgery for Open and Laparoscopic Liver Surgeries: \\n- Preoperative carbohydrate drink to be taken the evening before surgery and 2 hours before surgery if no \\ncontraindications  (obesity, reflux, di abetes mellitus)  \\n- Malnutrition screening with MUST (Malnutrition Universal Screening Tool).  \\no If patients score', ' >=2 , and there is at least 7 days to surgery , and no preoperative enteral nutrition \\nhas been ordered by the surgeon , to raise referral to dietitian in PEC for preoperative nutritional \\noptimization.  \\n- Guidelines on Preoperative Cardiac Assessment: \\n- Beta-blockers should be continued in patients who are already receiving them  \\n- Patients with ≥ 3 RCRI factors or intermediate/high risk preoperative tests, it may be \\nreasonable to begin beta blockers before surgery  – discuss with cardiologist or PEC \\nconsultant if it should be started  \\n- Beta blockers should not be initiated  within 24h  of surgery\\n- Guidelines on Preoperative Assessment and optimization of patients with HYPERTENSION: \\n- Continue all anti-hypertensives on the day of operation except ACEi/ARB (refer to below)   \\n\\uf0b2 Take with sip of water at 6am on day', ' of surgery \\n\\uf0b2 Beta-blockers  \\n\\uf0fc Patients with ≥ 3 revised cardiac risk index ( RCRI)  factors or intermediate/high cardiac \\nrisk on preoperative tests, it may be reasonable to begin beta blockers before surgery – \\ndiscuss with cardiologist or PEC consultant if it should be started  \\n\\uf0fc Beta blockers should not be initiated within 24h of surgery \\n\\uf0b2 Diuretics  \\n\\uf0fc Watch out for hypokalemia and evaluate patient’s volume status on the day of operation  \\n\\uf0b2 Angiotension converting enzyme inhibitors (ACEi)/ Angiotensin-receptor blockers (ARBs)  \\n\\uf0fc ACEi can cause refractory post induction hypotension if not stopped preoperatively  \\n\\uf0fc In non-cardiac surgery, consider discontinuation 24 hours preoperatively and restart within 48 hours after operation in patients with well controlled hypertension unless \\nclinically contraindicated  \\n\\uf0fc Continue ACEi pre', 'operatively  if there is impaired LV systolic function or heart \\nfailure or if BP is poorly controlled\\n\\nPatient Instructions:\\n1. Continue all anti-hypertensives on the day of operation except ACEi/ARB (refer to below)   \\n\\uf0b2 Take with sip of water at 6am on day of surgery \\n\\uf0b2 Beta-blockers  \\n\\uf0fc Patients with ≥ 3 revised cardiac risk index ( RCRI)  factors or intermediate/high cardiac \\nrisk on preoperative tests, it may be reasonable to begin beta blockers before surgery – \\ndiscuss with cardiologist or PEC consultant if it should be started  \\n\\uf0fc Beta blockers should not be initiated within 24h of surgery \\n\\uf0b2 Diuretics  \\n\\uf0fc Watch out for hypokalemia and evaluate patient’s volume status on the day of operation  \\n\\uf0b2 Angiotension converting enzyme inhibitors (ACEi)/ Angiotensin-receptor blockers (ARBs)  \\n\\uf0fc ACEi can cause refractory post induction hypotension if not stopped preoperatively  \\n\\uf0fc In non-cardiac surgery, consider discontinuation 24 hours preoperatively and restart within 48 hours after operation in patients with well controlled hypertension unless \\nclinically contraindicated  \\n\\uf0fc Continue ACEi preoperatively', '  if there is impaired LV systolic function or heart \\nfailure or if BP is poorly controlled\\n2. You will be given a general anesthetic for your surgery. This means that you will be asleep during the surgery and will not feel any pain. There are some risks associated with general anesthesia, including nausea, vomiting, and sore throat. There is also a small risk of complications such as heart attack, stroke, and death. However, these risks are very rare.']\n",
      "response\n",
      " prediction: \n",
      "\n",
      "SUPPORTING DOCUMENTS  \n",
      "TITLE:  Preoperative i nvestigation guidelines  for \n",
      "patients presenting for elective surgery  \n",
      " DOCUMENT NO.  \n",
      "75400 -SD-006 Page 1 of 3 \n",
      "ISSUING DEPARTMENT: Preoperative Evaluation Clinic  \n",
      "ISSUED BY: Angie Au Yong , Hairil Rizal Bin Abdullah  \n",
      "DATE REVISED: 11 June  2021  \n",
      "VERSION NUMBER: 3 APPROVED BY:  \n",
      "Tan Kian Hian  \n",
      "Head and Senior Consultant  \n",
      "Department  of Anaesthesiology  \n",
      " \n",
      " \n",
      " \n",
      " \n",
      "1. ROUTINE INVESTIGATIONS  BY ASA STRATIFICATION  \n",
      " \n",
      " \n",
      " \n",
      " \n",
      "*Note:  \n",
      "- Validity of blood investigations is within 8 weeks  of surgery  \n",
      " \n",
      " \n",
      " \n",
      " \n",
      " \n",
      " \n",
      " \n",
      " \n",
      " \n",
      " ASA\n",
      "1\n",
      "Age <60\n",
      "Minor\n",
      "FBC for \n",
      "femalesAge >60\n",
      "Refer to ASA 22\n",
      "Minor surgery\n",
      "FBC, renal \n",
      "panel/ \n",
      "glucoseIntermediate/ \n",
      "Major surgery\n",
      "FBC, PT/PTT, \n",
      "renal panel/ \n",
      "glucose3/4\n",
      "Minor surgery\n",
      "FBC, renal \n",
      "panel/ \n",
      "glucoseIntermediate/ \n",
      "Major surgery\n",
      "FBC, PT/PTT, \n",
      "renal panel/ \n",
      "glucose, CXR\n",
      "\n",
      "---\n",
      "\n",
      "Singapore General Hospital  \n",
      "Policy & Procedure  \n",
      " \n",
      "Title :  \n",
      "Guidelines on Preoperative Assessment of Obese \n",
      "Patients  Document No:  \n",
      " Page 2 of 2 \n",
      "Issued By : Perioperative Services,  Dept of \n",
      "Anaesthesiology (Dr Hairil Abdullah)  \n",
      "Initial Date Issued : 5/9/2012  \n",
      "Date Revised : 2/5/2017   \n",
      "Revision number : 2 Approved By:  \n",
      "A/P Ruban Poopalalingam Head, Department of \n",
      "Anaesthesia  \n",
      " \n",
      " \n",
      "a. Risk of difficult airway - should include dental injury, aspiration pneumonitis, hypoxia, neurological \n",
      "damage and death  \n",
      "b. Major Adverse Cardiac Event  \n",
      "c. Difficult iv line insertions  \n",
      "d. Positioning (peripheral nerve damage)  \n",
      "e. Deep vein thrombosis  \n",
      "f. Postoperative ventilation and SICU stay  \n",
      "g. Difficult regional anaesthesia (if RA is the planned technique)  \n",
      " \n",
      "4. PLAN  \n",
      "a. Prescribe gastro prophylaxis (PO ranitidine 150 mg 10 pm and 6 am, before surgery with sips of \n",
      "water)  \n",
      "b. Not for ASC Day Surgery, for ASC SSW/SDA – to discuss with PAC consultant  \n",
      "d. Documentation - Under section \"Notes\" : Document discussion with Consult ant and patient onto \n",
      "Pre-operative assessment chart, under \"Instructions\" : Docum ent instructions for follow up eg \n",
      "pending investigations/referrals; CPAP/BIPAP machine for use in PACU, SICU/HD/ICA booking  \n",
      "FOR B ODY MASS INDEX > 45:  \n",
      "ALL OF THE ABOVE AND :  \n",
      "1. Consider Arterial Blood Gas and Echocardiography if there are accompanying \n",
      "cardiac/pulmonary conditions, or oximetry on air is <93% – consult senior anaesthetist (rule \n",
      "out lung disease and/or obesity hypoventilation syndrome)  \n",
      "2. Assess the need for SICU/ICA b ooking postop  \n",
      "3.  Inform Principal Anaesthetist on Friday (once duty roster is out)  \n",
      "4.  Offer referral to LIFE Center (4377) for obesity management if not on follow up yet.\n",
      "\n",
      "---\n",
      "\n",
      "Singapore General Hospital  \n",
      " \n",
      " \n",
      "TITLE:  \n",
      "Guideline s on Preoperative Assessment and optimizati on of \n",
      "patients with HYPERTENSION  DOCUMENT NO:  \n",
      "75400-SD -001 Page 4 of 7 \n",
      "ISSUED BY: Dr Hairil Abdullah , Director and Senior \n",
      "Consultant, Preoperative Evaluation Clinic, Dept of \n",
      "Anesthesiology, SGH  \n",
      "INITIAL DATE ISSUED: 1/05/2014  \n",
      "Updated by:  \n",
      "Dr He Yingke, Associate Consultant, De pt of Anesthesiology  \n",
      "Dr Shum Koin Lon, Consultant, Dept of Internal Medicine  \n",
      "DATE REVISED: 4/6/2020 , REVISION NUMBER: 4 Approved by:  \n",
      "Dr Tan Kian Hian  \n",
      "Senior Consultant and Head , Dept \n",
      "of Anesthesiology , SGH  \n",
      " \n",
      "A/P Soh Chai Rick  \n",
      "Senior Consultant, Chairman, \n",
      "Division of Anesthesiology, SGH  \n",
      " \n",
      " \n",
      "PERIOPERATIVE OPTIMIZATION OF MEDICATIONS  \n",
      "\n",
      "Response from Model:  **Doctor/Nurse:** Doctor\n",
      "\n",
      "**Fasting instructions:**\n",
      "\n",
      "-  NBM for at least 6 hours before the surgery.\n",
      "- Clear fluids are allowed up to 2 hours before surgery.\n",
      "\n",
      "**Preoperative carbohydrate loading:** No\n",
      "\n",
      "**Medication instructions:**\n",
      "\n",
      "- Continue all current medications up to the day of surgery unless otherwise specified.\n",
      "- Cease smoking at least 8 weeks before surgery.\n",
      "- Start Nicotine Replacement Therapy (NRT) if keen and there are no contraindications.\n",
      "\n",
      "**Instructions for the healthcare team:**\n",
      "\n",
      "- Schedule a preoperative blood group matching.\n",
      "- Arrange for preoperative dialysis if necessary.\n",
      "- Order preoperative respiratory function tests. \n",
      "- Plan for postoperative transfer to the high dependency unit or intensive care unit.\n",
      "\n",
      "**Preoperative optimization required:**\n",
      "\n",
      "- Optimize anemia.\n",
      "- Review previous chest x-ray and assess the need for a CT thorax.\n",
      "- Smoking cessation.\n",
      "- Consider preoperative nutritional optimization if the MUST score is ≥2. \n",
      "\n",
      "**Delay of operation:** Consider delaying the surgery if anemia is not optimized.\n",
      "\n",
      "**Specific department protocols to follow:**\n",
      "\n",
      "- Enhanced Recovery After Surgery (ERAS) protocol for open and laparoscopic liver surgeries.\n",
      "- Preoperative smoking cessation protocol.\n",
      "- Preoperative cardiac assessment protocol.\n",
      "- Preoperative respiratory assessment protocol.\n",
      "- Anemia management protocol.\n",
      "\n",
      "**Patient instructions:**\n",
      "\n",
      "- Take all current medications as prescribed up to the day of surgery unless otherwise specified.\n",
      "- Stop smoking at least 8 weeks before surgery.\n",
      "- Inform the anesthesiologist of any changes in medical history, medications, or symptoms.\n",
      "- Arrive at the hospital on time for the scheduled surgery.\n",
      "- Consent for general anesthesia and any necessary adjuncts such as intubation, blood transfusion, and central venous catheterization.\n",
      "- Risks of the surgery and anesthesia, including but not limited to bleeding, infection, and complications related to the underlying medical conditions, will be discussed in detail during the preoperative assessment.\n"
     ]
    }
   ],
   "source": [
    "for i in range(0, len(df)):\n",
    "\n",
    "    \n",
    "    if i<=100:\n",
    "        # df['Gemini_ultra_model_output'][i] = generate(df['combine_prompt'][i])\n",
    "        print(\"iteration #\", i)\n",
    "\n",
    "    df.loc[i, \"Gemini_ultra_model_output\"] = generate_pro(df.loc[i,'combine_prompt'])\n",
    "    df.loc[i, \"Gemini_ultra_model_output_v1\"] = generate_pro(df.loc[i,'combine_prompt'])\n",
    "    df.loc[i, \"Gemini_ultra_model_output_v2\"] = generate_pro(df.loc[i,'combine_prompt'])\n",
    "    \n",
    "    df.loc[i, \"Anthropic_haiko_model_output\"] = generate_anthropic_response(df.loc[i,'combine_prompt'])\n",
    "\n",
    "    # df.loc[i, \"medLM_model_output\"] = generate_medllms_v1(df.loc[i,'combine_prompt'])\n",
    "    df.loc[i, \"medpalm_model_output\"] = generate_medlpalm(df.loc[i,'combine_prompt'])\n",
    "    df.loc[i, \"palm_bison32k_output\"] = generate_palm_bison32k(df.loc[i,'combine_prompt'])\n",
    "\n",
    "# generate_medllms_v1(input_prompt)\n",
    "# generate_palm_unicorn_v1(input_prompt)\n",
    "# input_prompt = \"What are the symptoms of influenza?\" \n",
    "# generate_medlpalm(input_prompt)    \n",
    "    \n",
    "# print( \"/n output here ::\" , df['Gemini_ultra_model_output'][i])\n",
    "# df = df.assign(Gemini_ultra_model_output=generate(df.combine_prompt))\n",
    "# df['combine_prompt'].head(3)\n",
    "\n",
    "# df['Gemini_ultra_model_output'].head(3)\n"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 50,
   "id": "363111b5-15ff-4934-ac79-f309d880f18c",
   "metadata": {},
   "outputs": [],
   "source": [
    "# df.columns"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 51,
   "id": "89f75a2b-4cc8-42fc-b7c3-c59cd9666168",
   "metadata": {},
   "outputs": [],
   "source": [
    "# df columnsname(columns={'generate_pro_model_output': 'Gemini_pro_model_output'})  \n",
    "# df = df.rename(columns={'generate_pro_model_output': 'Gemini_pro_model_output'})  \n"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 49,
   "id": "24a32343-5ef4-404a-963d-0a95c2050849",
   "metadata": {},
   "outputs": [],
   "source": [
    "\n",
    "# Delete the 'col2' column\n",
    "df = df.drop('combine_prompt', axis=1)\n",
    "\n",
    "output1 = \"./output/O_Anaes 16 Clinical scenarios RAG response_output_gemini.csv\"\n",
    "\n",
    "df.to_csv(output1)\n"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "458307ee-8043-4386-a662-db088351c1b5",
   "metadata": {},
   "source": [
    "### Second file"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 52,
   "id": "5a5a6a8e-795b-4db0-8577-55c102375e2f",
   "metadata": {
    "scrolled": true,
    "tags": []
   },
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "iteration # 0\n",
      "response\n",
      "response\n",
      "Response from Model:  **Preoperative anesthesia instructions**\n",
      "\n",
      "**1. Should the patient be seen by a Doctor or Nurse?**\n",
      "Doctor\n",
      "\n",
      "**2. Fasting instructions**\n",
      "- NPO for solids after midnight\n",
      "- Clear fluids until 6 hours before the surgery\n",
      "\n",
      "**3. Suitability for preoperative carbohydrate loading**\n",
      "No\n",
      "\n",
      "**4. Medication instructions**\n",
      "- Ventolin: Continue using Ventolin as needed up until the morning of surgery.\n",
      "\n",
      "**5. Instructions for the healthcare team**\n",
      "- Arrange for preoperative blood group matching.\n",
      "- Consider standby postoperative high dependency/ICU bed due to the patient's severe OSA.\n",
      "\n",
      "**6. Any preoperative optimization required for the patient**\n",
      "- Diabetes control: The patient's HbA1c is elevated and she has not seen her doctor for over a year. She should be seen by her doctor for diabetes management and optimization prior to surgery.\n",
      "\n",
      "**7. Any need to delay the operation for further medical workup and preoperative optimization?**\n",
      "No\n",
      "\n",
      "**8. Any specific department protocols to follow for this patient**\n",
      "- OSA protocol: The patient has severe OSA and is on CPAP therapy. She should be managed according to the department's OSA protocol.\n",
      "- High BMI protocol: The patient has a high BMI and is at risk for perioperative complications. She should be managed according to the department's high BMI protocol.\n",
      "- Diabetes protocol: The patient has diabetes and is not well-controlled. She should be managed according to the department's diabetes protocol.\n",
      "\n",
      "**Patient instructions**\n",
      "- Continue taking your Ventolin as needed up until the morning of surgery.\n",
      "- You will need to stop eating and drinking (except clear fluids) after midnight on the night before your surgery.\n",
      "- You will be given general anesthesia for your surgery. This means that you will be completely unconscious and pain-free during the surgery.\n",
      "- There are some specific risks associated with your surgery and medical history that you should be aware of. These include:\n",
      " - Risk of respiratory complications due to your OSA.\n",
      " - Risk of bleeding and infection due to your diabetes.\n",
      " - Risk of postoperative nausea and vomiting.\n",
      "We will take all necessary precautions to minimize these risks and ensure your safety during surgery.\n",
      "Response from Model: **Instructions to the Anesthesia Team**\n",
      "\n",
      "1. Should the patient be seen by a Doctor or a Nurse: Doctor\n",
      "2. Fasting instructions: 6 hours for solids, 2 hours for clear fluids\n",
      "3. Suitability for preoperative carbohydrate loading: Yes\n",
      "4. Medication instructions:\n",
      "\n",
      " * Ventolin: Continue as usual\n",
      " * No other medications required on the day of surgery\n",
      "\n",
      "5. Any instructions for the healthcare team:\n",
      "\n",
      " * No specific instructions for the healthcare team at this time\n",
      "\n",
      "6. Any preoperative optimization required for the patient:\n",
      "\n",
      " * Optimize diabetes control with HbA1c < 7% prior to surgery\n",
      " * Consider weight loss prior to surgery\n",
      "\n",
      "7. Any need to delay the operation for further medical workup and preoperative optimization:\n",
      "\n",
      " * No need to delay surgery at this time\n",
      "\n",
      "8. Any specific department protocols to follow for this patient:\n",
      "\n",
      " * High-risk airway protocol due to severe OSA\n",
      " * Difficult airway cart in operating room\n",
      " * Consider awake fiberoptic intubation\n",
      "\n",
      "**Instructions to the Patient**\n",
      "\n",
      "1. Medication instructions to take leading up to the surgery:\n",
      "\n",
      " * Continue taking your Ventolin as usual\n",
      " * No other medications are required on the day of surgery\n",
      "\n",
      "2. Consent for the types of anesthesia that the patient needs to be aware of for this surgery, and any specific risks to highlight due to the operation and the patient’s medical history:\n",
      "\n",
      " * You will be given general anesthesia, which means you will be asleep during the surgery.\n",
      " * You will be given a breathing tube to help you breathe during the surgery.\n",
      " * You may have a sore throat after the surgery.\n",
      " * There is a small risk of bleeding and infection.\n",
      " * There is a small risk of damage to the teeth or gums.\n",
      " * There is a small risk of difficulty breathing after the surgery.\n",
      " * Your risk of complications is increased due to your severe OSA.\n",
      "iteration # 1\n",
      "response\n",
      "response\n",
      "Response from Model:  **Preoperative Instructions**\n",
      "\n",
      "1. Should the patient be seen by a Doctor or Nurse? **Nurse**\n",
      "2. Fasting instructions:\n",
      "- **Solids**: Nil oral intake for 6 hours before the surgery.\n",
      "- **Liquids**: Clear fluids up to 2 hours before the surgery.\n",
      "3. Suitability for preoperative carbohydrate loading: **Yes**\n",
      "4. Medication instructions:\n",
      "- **Day of the operation:** Nil oral medications.\n",
      "- **Days leading up to the operation:**\n",
      "  - **Hypertension:** Hold all antihypertensive medications on the morning of surgery.\n",
      "5. Instructions for the healthcare team:\n",
      "- Blood group matching: Group and save.\n",
      "- Preoperative dialysis: NA\n",
      "- Standby post-operative high dependency/ICU beds: NA\n",
      "6. Any preoperative optimization required for the patient:\n",
      "- Smoking cessation.\n",
      "7. Any need to delay the operation for further medical workup and preoperative optimization? **No**\n",
      "8. Any specific department protocols to follow for this patient:\n",
      "- **Nil per os** (NPO) guidelines for solids and liquids.\n",
      "- Preoperative blood group matching protocol.\n",
      "- Smoking cessation protocol.\n",
      "\n",
      "**Instructions to the Patient**\n",
      "\n",
      "1. Medication instructions to take leading up to the surgery:\n",
      "- Hold all antihypertensive medications on the morning of surgery.\n",
      "2. Consent for the types of anesthesia:\n",
      "- General anesthesia will be used to induce and maintain sleep during the surgery.\n",
      "- A breathing tube may be inserted into your windpipe to help you breathe during the surgery.\n",
      "- Regional anesthesia (nerve block) may be used to provide pain relief after the surgery.\n",
      "3. Specific risks to highlight due to the operation and the patient’s medical history:\n",
      "- The surgery may cause temporary pain, swelling, and bruising around the knee.\n",
      "- There is a small risk of infection, blood clots, and damage to the nerves and blood vessels around the knee.\n",
      "- The patient's history of smoking may increase the risk of complications after surgery.\n",
      "Response from Model: **Preoperative anesthesia instructions targeted to fellow medical colleagues**\n",
      "\n",
      "1. Nurse\n",
      "2. NPO for 6 hours prior to procedure. \n",
      "3. Yes\n",
      "4. NA\n",
      "5. NA\n",
      "6. NA\n",
      "7. NA\n",
      "8. NA\n",
      "\n",
      "**Instructions for the patient**\n",
      "\n",
      "1. You need to stop eating and drinking 6 hours before your surgery. You can have clear liquids up until 2 hours before your surgery.\n",
      "2. The types of anesthesia that you will be receiving include general anesthesia and local anesthesia. General anesthesia will put you into a deep sleep and you will not feel any pain. Local anesthesia will numb the area where the surgery is being performed.\n",
      "3. You will be given medication to help you relax before your surgery.\n",
      "4. You will be asked to breathe into a mask and you will fall asleep.\n",
      "5. The surgery will then be performed.\n",
      "6. You will wake up in the recovery room.\n",
      "7. You will be given pain medication as needed.\n",
      "8. You will be able to go home when you are fully awake and able to walk.\n",
      "iteration # 2\n",
      "response\n",
      "response\n",
      "Response from Model:  **Preoperative Anesthesia Instructions**\n",
      "\n",
      "**1. Should the patient be seen by a Doctor or Nurse?**\n",
      "Doctor\n",
      "\n",
      "**2. Fasting instructions**\n",
      "- Solids: Nil from midnight before the surgery \n",
      "- Clear fluids: Nil from 2 hours before the surgery \n",
      "\n",
      "**3. Suitability for preoperative carbohydrate loading**\n",
      "Yes.  Reason: Preoperative carbohydrate loading is beneficial in reducing postoperative insulin resistance and improving recovery.\n",
      "\n",
      "**4. Medication instructions**\n",
      "- Paracetamol: Continue as usual.\n",
      "- Pregabalin: Take the last dose the night before surgery, and omit the morning dose on the day of surgery. \n",
      "\n",
      "**5. Any instructions for the healthcare team**\n",
      "- Consider preoperative autologous blood donation as hemoglobin is slightly low.\n",
      "\n",
      "**6. Any preoperative optimization required for the patient**\n",
      "- Address any symptoms of sleep disordered breathing to reduce the risk of postoperative respiratory complications.\n",
      "\n",
      "**7. Any need to delay the operation for further medical workup and preoperative optimization?**\n",
      "No. \n",
      "\n",
      "**8. Any specific department protocols to follow for this patient**\n",
      "- Enhanced recovery after surgery (ERAS) protocol\n",
      "\n",
      "**Instructions to the patient**\n",
      "\n",
      "**1. Medication instructions to take leading up to the surgery.**\n",
      "- Paracetamol: Continue taking as usual.\n",
      "- Pregabalin: Take the last dose the night before surgery, and omit the morning dose on the day of surgery. \n",
      "\n",
      "**2. Consent for the types of anesthesia that the patient needs to be aware of for this surgery, and any specific risks to highlight due to the operation and the patient’s medical history.**\n",
      "- General anesthesia will be administered.\n",
      "- Specific risks include:\n",
      "  - Risk of deep vein thrombosis (DVT) and pulmonary embolism (PE) due to immobility during surgery and the patient's age and BMI. \n",
      "  - Risk of postoperative nausea and vomiting (PONV) due to the use of opioids for pain management.\n",
      "Response from Model: * **To the medical team**:\n",
      "    * **Seen by Doctor/Nurse**: Nurse\n",
      "    * **Fasting instructions**: Nil by mouth for 6 hours prior to surgery\n",
      "    * **Preoperative carbohydrate loading**: No\n",
      "    * **Medication instructions**:\n",
      "        * Paracetamol: Continue as normal\n",
      "        * Pregabalin: Continue as normal\n",
      "    * **Instructions for the healthcare team**:\n",
      "        * Preoperative blood group matching: Yes\n",
      "        * Standby post-operative high dependency/ICU beds: No\n",
      "    * **Any preoperative optimization required for the patient**: Nil\n",
      "    * **Any need to delay the operation for further medical workup and preoperative optimization**: No\n",
      "    * **Any specific department protocols to follow for this patient**:\n",
      "        * Enhanced Recovery After Surgery (ERAS) protocol: This protocol is designed to help patients recover more quickly and smoothly after surgery. It includes a number of measures, such as preoperative carbohydrate loading, early mobilization, and pain management.\n",
      "        * Venous thromboembolism (VTE) prophylaxis: This protocol is designed to prevent blood clots from forming in the legs after surgery. It includes a number of measures, such as wearing compression stockings, taking blood thinners, and getting up and moving around as soon as possible after surgery.\n",
      "\n",
      "* **To the patient**:\n",
      "    * **Medication instructions to take leading up to the surgery**:\n",
      "        * Continue taking your paracetamol and pregabalin as normal.\n",
      "    * **The types and forms of anesthesia that the patient needs to be aware of for this surgery**:\n",
      "        * You will most likely receive a spinal anesthetic, which will numb your lower body. You may also receive a sedative to help you relax.\n",
      "        * There is a small risk of complications with any type of anesthesia, but these risks are very low. The anesthesiologist will discuss the risks and benefits of anesthesia with you in more detail before your surgery.\n",
      "iteration # 3\n",
      "response\n",
      "response\n",
      "Response from Model:  **Preoperative anesthesia instructions**\n",
      "\n",
      "**To: Medical colleagues**\n",
      "\n",
      "**Doctor/Nurse:** Doctor\n",
      "\n",
      "**Fasting instructions:**\n",
      "\n",
      "- Nothing to eat for 6 hours before the time of surgery.\n",
      "- Clear fluids (water, black tea, coffee without milk, fruit juice without pulp) are allowed up to 2 hours before the time of surgery.\n",
      "\n",
      "**Preoperative carbohydrate loading:** No\n",
      "\n",
      "**Medication instructions:**\n",
      "\n",
      "- Keppra: Continue taking as usual.\n",
      "- Paracetamol: Take the usual dose the night before surgery and the morning of surgery.\n",
      "- Tramadol: Take the usual dose the night before surgery only. Discontinue on the day of the operation.\n",
      "\n",
      "**Instructions for the healthcare team:**\n",
      "\n",
      "- Preoperative blood group matching: Yes\n",
      "- Arrange for preoperative haemodialysis: No\n",
      "- Standby post-operative high dependency/ICU beds: No\n",
      "\n",
      "**Preoperative optimization required for the patient:**\n",
      "- Renal function: Consider further evaluation and management to address the raised creatinine level.\n",
      "\n",
      "**Need to delay the operation for further medical workup and preoperative optimization?:** No\n",
      "\n",
      "**Specific department protocols to follow for this patient:**\n",
      "\n",
      "- ASA (American Society of Anesthesiologists) Physical Status Classification System Class 2: This patient has mild systemic disease but no functional limitation. She is at increased risk of perioperative complications compared to a healthy patient.\n",
      "- Modified Mallampati Classification of 3: This patient may have a more difficult intubation due to limited visibility of the vocal cords.\n",
      "- Cervical spondylosis with root compression: This patient may have difficulty with positioning for surgery and may require special precautions to avoid nerve damage.\n",
      "\n",
      "**Instructions to the patient:**\n",
      "\n",
      "- **Medication instructions:**\n",
      " - Continue taking Keppra as usual.\n",
      " - Take the usual dose of Paracetamol the night before surgery and the morning of surgery.\n",
      " - Take the usual dose of Tramadol the night before surgery only. Discontinue on the day of the operation.\n",
      "\n",
      "- **Consent for anesthesia:**\n",
      " - General anesthesia will be used for your surgery. This involves placing a breathing tube through your mouth or nose to help you breathe during the procedure.\n",
      " - There are some risks associated with general anesthesia, including nausea, vomiting, sore throat, and muscle aches. In rare cases, more serious complications such as heart attack, stroke, or death can occur.\n",
      " - You will be asked to sign a consent form before your surgery. Please read the form carefully and ask any questions you have before signing it.\n",
      "\n",
      "- **Specific risks:**\n",
      " - Your medical history includes epilepsy, which may increase your risk of complications during surgery.\n",
      " - You also have a history of renal calculus and frank haematuria, which may increase your risk of bleeding during surgery.\n",
      " - Your cervical spondylosis may make it more difficult to position you for surgery and may require special precautions to avoid nerve damage.\n",
      "Response from Model: #### Instructions for fellow medical colleagues\n",
      "1. Nurse\n",
      "2. No solid food for 6 hours before surgery. Clear fluids up to 2 hours before surgery.\n",
      "3. Not suitable, patient is at risk of aspiration\n",
      "4. Continue Keppra, Paracetamol as per usual on the day of surgery with a small sip of water. Take Tramadol PRN orally on the day of surgery with a small sip of water.\n",
      "5. Crossmatch 2 units of packed red blood cells\n",
      "6. Optimize Haemoglobin level to 10-12 g/dL\n",
      "7. No\n",
      "8. None\n",
      "\n",
      "#### Instructions for patient\n",
      "1. Please continue to take your Keppra and Paracetamol as usual. On the day of surgery, you may take them with a little sip of water. Please also continue to take your TCM as usual. If you experience pain, you may take your Tramadol with a small sip of water.\n",
      "2. The types of anesthesia that you may receive for this surgery are:\n",
      "a. General anesthesia: This means that you will be put to sleep completely during the surgery.\n",
      "b. Regional anesthesia: This means that you will be numb from the waist down during the surgery.\n",
      "The specific type of anesthesia that you will receive will be decided by the anesthesiologist on the day of surgery.\n",
      "\n",
      "There are some specific risks to highlight due to your medical history. These include:\n",
      "a. Increased risk of aspiration: This means that you are more likely to vomit and inhale the vomit into your lungs. This can cause serious complications. To reduce this risk, you will be asked to fast for 6 hours before surgery.\n",
      "b. Increased risk of bleeding: This is because you have a low hemoglobin level. To reduce this risk, you may be given a blood transfusion before or after surgery.\n",
      "c. Increased risk of seizures: This is because you have a history of epilepsy. To reduce this risk, you will be asked to continue taking your Keppra as usual on the day of surgery.\n",
      "iteration # 4\n",
      "response\n",
      "response\n",
      "Response from Model:  **Preoperative assessment and instructions**\n",
      "\n",
      "**To: Medical Colleagues**\n",
      "\n",
      "**From: [Your name]**\n",
      "\n",
      "**Date:** [Date]\n",
      "\n",
      "**Patient name:** [Patient name]\n",
      "\n",
      "**Medical record number:** [Medical record number]\n",
      "\n",
      "**Surgery scheduled:** Left ring finger exploration KIV excise tendons, repair of pulleys, insert tendon rod KIV tenolysis\n",
      "\n",
      "**Preoperative assessment:**\n",
      "\n",
      "The patient is a 16-year-old Chinese female with a history of left RF Zone 2 laceration, and underwent repair of FDS and FDP with reconstruction of A2 pulley on 23/6/2018. She is currently scheduled for left ring finger exploration KIV excise tendons, repair of pulleys, and insertion of tendon rod KIV tenolysis.\n",
      "\n",
      "The patient is ASA 1, with a BMI of 19.6. Her vital signs are BP 96/65, HR 75, and SpO2 99% on room air. She is fully independent and community-ambulant. Her last menstrual period was 1.5 weeks ago.\n",
      "\n",
      "The patient is a social smoker and social drinker. She has been advised to avoid alcohol prior to surgery and to cease smoking.\n",
      "\n",
      "The patient's past medical history is unremarkable. She is currently taking no medications.\n",
      "\n",
      "The patient's laboratory investigations are all within normal limits. Her ECG is also normal.\n",
      "\n",
      "**Preoperative instructions:**\n",
      "\n",
      "1. **Doctor/Nurse:** Doctor\n",
      "2. **Fasting instructions:** NPO for solids after midnight the night before surgery and for fluids after 6 am on the day of surgery.\n",
      "3. **Carbohydrate loading:** Yes\n",
      "4. **Medication instructions:**\n",
      "    * Continue all regular medications up to the day of surgery.\n",
      "    * Discontinue aspirin and NSAIDs for 5 days prior to surgery.\n",
      "    * Start oral carbohydrate drink (e.g. Lucozade) on the evening before surgery and continue until 2 hours before surgery.\n",
      "5. **Instructions to surgeon:** Arrange for preoperative blood group matching.\n",
      "6. **Preoperative optimization:** Nil\n",
      "7. **Delay of operation:** No\n",
      "8. **Specific department protocols:**\n",
      "    * Follow department protocol for preoperative assessment of patients undergoing hand surgery.\n",
      "    * Follow department protocol for preoperative carbohydrate loading.\n",
      "    * Follow department protocol for blood group matching.\n",
      "\n",
      "**Patient instructions:**\n",
      "\n",
      "1. **Medication instructions:**\n",
      "    * Continue all regular medications up to the day of surgery.\n",
      "    * Discontinue aspirin and NSAIDs for 5 days prior to surgery.\n",
      "    * Start oral carbohydrate drink (e.g. Lucozade) on the evening before surgery and continue until 2 hours before surgery.\n",
      "2. **Types and forms of anesthesia:**\n",
      "    * General anesthesia with regional block.\n",
      "    * Risks of general anesthesia include nausea, vomiting, sore throat, and muscle aches.\n",
      "    * Risks of regional block include bleeding, infection, nerve damage, and incomplete block.\n",
      "3. **Consent:**\n",
      "    * The patient has been fully informed of the risks and benefits of the surgery and anesthesia, and has signed the consent form.\n",
      "Response from Model: Doctor's instructions to the medical team:\n",
      "1. This patient can be seen by a nurse on the day of surgery.\n",
      "2. Fasting instructions:\n",
      "Solid food - 6 hours preoperative\n",
      "Clear fluids - 2 hours preoperative\n",
      "3. Preoperative carbohydrate loading - not required.\n",
      "4. Medication instructions:\n",
      "Nil specific instructions\n",
      "5. Instructions to the surgeon: No further preoperative blood tests are necessary.\n",
      "6. Any preoperative optimization necessary for the patient: Nil\n",
      "7. Is it necessary to delay operation for any preoperative optimization: No\n",
      "8. Any specific department protocols to follow for this patient: No specific protocols need to be followed\n",
      "\n",
      "Assistant's instructions to the patient:\n",
      "1. Medication instructions to take leading up to the surgery: Please stop smoking cigarettes and consuming alcohol at 72 hours preoperative\n",
      "2. The types and forms of anesthesia that the patient needs to be aware of for this surgery: For this surgery the anesthesiologist will discuss with you three main types of anesthesia - general anesthesia, regional anesthesia (blocks), and nerve blocks. The anesthesiologist will discuss the risks and benefits of each technique and work with you to decide which is the best option for you.\n",
      "iteration # 5\n",
      "response\n",
      "response\n",
      "Response from Model:  Preoperative anesthesia instructions:\n",
      "\n",
      "**Doctor/Nurse:** Doctor\n",
      "\n",
      "**Fasting instructions:**\n",
      "- Clear fluids: Allowed until 6 hours before the surgery.\n",
      "- Light meal: Allowed up to 8 hours before the surgery.\n",
      "- No solid food: At least 12 hours before the surgery.\n",
      "\n",
      "**Suitability for preoperative carbohydrate loading:** Yes\n",
      "\n",
      "**Medication instructions:**\n",
      "\n",
      "- Perindopril 2mg OM: Continue as usual.\n",
      "- Omeprazole 20mg OM: Continue as usual.\n",
      "- Bisoprolol 1.25mg OM: Continue as usual.\n",
      "- Atorvastatin 40mg ON: Continue as usual.\n",
      "- Aspirin 100mg OM: Continue as usual.\n",
      "- Amlodipine 2.5mg OM: Continue as usual.\n",
      "\n",
      "**Instructions to surgeon:**\n",
      "- Check liver function test\n",
      "- Preoperative CEA trending \n",
      "- Consider blood group matching, this is based on the patient's colonic adenocarcinoma as it is associated with an increased risk of blood group antibodies.\n",
      "\n",
      "**Preoperative optimization:**\n",
      "- Optimize the patient's nutritional status.\n",
      "- Optimize the patient's respiratory function.\n",
      "\n",
      "**Need to delay operation for further medical workup and preoperative optimization?:** No\n",
      "\n",
      "**Specific department protocols to follow for this patient:**\n",
      "- Enhanced recovery after surgery (ERAS) protocol. This protocol is designed to reduce postoperative complications and improve recovery after surgery.\n",
      "- Modified fasting protocol. This protocol allows the patient to drink clear fluids up until 2 hours before surgery.\n",
      "\n",
      "**Patient instructions:**\n",
      "\n",
      "- Medication instructions: Continue taking all medications as usual unless otherwise instructed.\n",
      "- Consent for anesthesia: You will need to provide consent for the following types of anesthesia: general anesthesia.\n",
      "- Specific risks: Your medical history of colonic adenocarcinoma, IHD, and smoking increases your risk of complications during surgery and anesthesia. We will take steps to minimize these risks, but you should be aware of them before proceeding with surgery.\n",
      "Response from Model: ## Preoperative anesthesia instructions for medical colleagues:\n",
      "\n",
      "1. Should the patient be seen by a Doctor or a Nurse - Doctor\n",
      "2. Fasting instructions - 6 hours fasting for clear fluids, 8 hours fasting for solids, 2 hours fasting for breast milk\n",
      "3. Suitability for preoperative carbohydrate loading - yes\n",
      "4. Medication instructions -\n",
      "- Perindopril: continue\n",
      "- Omeprazole: continue\n",
      "- Bisoprolol: continue\n",
      "- Atorvastatin: continue\n",
      "- Aspirin: continue\n",
      "- Amlodipine: discontinue on day of surgery\n",
      "5. Any instructions for the healthcare team -\n",
      "- Book high dependency or ICU bed for postoperative care\n",
      "- Have blood available for transfusion\n",
      "6. Any preoperative optimization required for the patient -\n",
      "- Stop smoking\n",
      "- Improve nutritional status\n",
      "7. Any need to delay the operation for further medical workup and preoperative optimization? - no\n",
      "8. Any specific department protocols to follow for this patient -\n",
      "- Enhanced recovery after surgery (ERAS) protocol\n",
      "- Antimicrobial prophylaxis protocol\n",
      "\n",
      "## Instructions to patient:\n",
      "\n",
      "1. Medication instructions to take leading up to the surgery.\n",
      "- Continue taking all your regular medications as usual, except for amlodipine.\n",
      "- You should stop taking amlodipine on the day of your surgery.\n",
      "2. The types and forms of anesthesia that the patient needs to be aware of for this surgery.\n",
      "- You will be given general anesthesia for this surgery. This means that you will be asleep during the surgery and will not feel any pain.\n",
      "- You will also be given a regional anesthesia block. This will help to control pain after the surgery.\n",
      "- There are some risks associated with anesthesia, but these risks are generally very low. Your anesthesiologist will discuss these risks with you in more detail before your surgery.\n",
      "iteration # 6\n",
      "response\n",
      "response\n",
      "Response from Model:  **Preoperative anesthesia instructions:**\n",
      "\n",
      "**Doctor/Nurse:** Doctor\n",
      "\n",
      "**Fasting instructions:**\n",
      "- **Solids**: Nothing to eat for at least 6 hours before the surgery.\n",
      "- **Liquids**: Nothing to drink for at least 2 hours before the surgery, including water, juice, coffee, and tea.\n",
      "\n",
      "**Preoperative carbohydrate loading:** No\n",
      "\n",
      "**Medication instructions:**\n",
      "\n",
      "- **Aspirin 100mg OD:** Continue taking aspirin 100mg OD up to and including the morning of surgery. If taking aspirin once a day, it should be taken with food to avoid gastric irritation.\n",
      "- **Clopidogrel 75mg OD:** Continue taking clopidogrel 75mg OD up to and including 5 days before the surgery. \n",
      "- **Bisoprolol 2.5mg OD:** Continue taking bisoprolol 2.5mg OD up to and including the morning of surgery.\n",
      "- **Empagliflozin 10mg OD:** Hold empagliflozin on the morning of surgery.\n",
      "- **Metformin 250mg BD:** Hold metformin on the day of the surgery.\n",
      "- **Entresto 0.5tab BD:** Continue taking Entresto 0.5tab BD up to and including the morning of surgery.\n",
      "- **Spironolactone 25mg OD:** Continue taking spironolactone 25mg OD up to and including the morning of surgery.\n",
      "- **Frusemide 40mg OD:** Continue taking frusemide 40mg OD up to and including the morning of surgery.\n",
      "\n",
      "**Instructions to the surgeon:**\n",
      "- Consider arranging for 1 unit of blood to be crossmatched and available on the day of the procedure.\n",
      "- Consider standby postoperative high dependency/ICU bed due to the patient's poor ejection fraction and significant co-morbidities.\n",
      "\n",
      "**Preoperative optimization required:**\n",
      "- Renal optimization prior to the planned procedure.\n",
      "\n",
      "**Need to delay the operation for further medical workup and preoperative optimization?**\n",
      "- No.\n",
      "\n",
      "**Specific department protocols to follow for this patient:**\n",
      "- **Nil by mouth protocol**: Standard departmental protocol for all patients undergoing general anesthesia.\n",
      "- **Enhanced recovery after surgery (ERAS) protocol**: The patient meets the criteria for ERAS protocol due to their age, functional status, and medical co-morbidities. This protocol focuses on early mobilization, early feeding, and multimodal analgesia to reduce postoperative complications and length of hospital stay.\n",
      "- **High-risk surgical patient protocol**: Due to the patient's poor ejection fraction and significant co-morbidities, this patient will be managed according to the hospital's high-risk surgical patient protocol. This protocol includes preoperative risk assessment, optimization of medical co-morbidities, and close monitoring during the perioperative period.\n",
      "\n",
      "**Patient instructions:**\n",
      "\n",
      "- **Medication instructions:**\n",
      "\n",
      " - Continue taking your regular medications up until the day of the operation unless otherwise instructed (see medication instructions above).\n",
      "- **Fasting instructions:**\n",
      " - Do not eat or drink anything for at least 6 hours before your surgery, including water, juice, coffee, and tea. You may brush your teeth and rinse your mouth with water, but do not swallow the water.\n",
      "- **Consent for anesthesia:** \n",
      " - You will need to provide written consent for the types of anesthesia that you may receive during your surgery. These include general anesthesia (where you will be completely asleep during the operation) and regional anesthesia (where only the part of your body that is being operated on will be numbed).\n",
      " - We will discuss the risks and benefits of each type of anesthesia with you before the operation and you will have the opportunity to ask any questions that you may have.\n",
      "\n",
      "- **Specific risks to highlight:** \n",
      " - Your medical history of heart disease, kidney disease, and diabetes increases your risk of complications during and after surgery.\n",
      " - We will take precautions to minimize these risks, but it is important that you are aware of them.\n",
      "Response from Model: **Instructions to Fellow Medical Colleagues**\n",
      "1. Should the patient be seen by a Doctor or a Nurse: Doctor\n",
      "2. Fasting instructions: No solids 6 hours prior to operation. Clear fluids only (black coffee, clear juice) up to 2 hours prior to operation.\n",
      "3. Suitability for preoperative carbohydrate loading: Yes\n",
      "4. Medication instructions:\n",
      "    * Bisoprolol: continue on the morning of the operation.\n",
      "    * Spironolactone and Entresto: continue on the day of the operation, do not take on the morning of the operation.\n",
      "    * Aspirin: continue up until the day before the operation then hold.\n",
      "    * Clopidogrel: continue up until the day before the operation then hold.\n",
      "5. Any instructions for the healthcare team:\n",
      "    * The patient needs to have blood taken for urea, electrolytes, and creatinine the day before the operation.\n",
      "    * Dialysis is required on the day of the operation.\n",
      "    * HDU/ICU bed required postoperatively.\n",
      "6. Any preoperative optimization required for the patient:\n",
      "    * Fluid status should be optimized with preoperative dialysis.\n",
      "    * Blood pressure should be controlled.\n",
      "    * Aspirin and clopidogrel should be held on the day of the operation.\n",
      "7. Any need to delay the operation for further medical workup and preoperative optimization: No\n",
      "8. Any specific department protocols to follow for this patient:\n",
      "    * HDU/ICU protocol: The patient will be admitted to HDU/ICU postoperatively for close monitoring.\n",
      "    * Dialysis protocol: The patient will require dialysis on the day of the operation.\n",
      "    * Cardiac protocol: The patient will be monitored closely for cardiac events.\n",
      "\n",
      "**Instructions to Patient**\n",
      "\n",
      "1. Medication instructions:\n",
      "    * Bisoprolol: continue on the morning of the operation.\n",
      "    * Spironolactone and Entresto: continue on the day of the operation, do not take on the morning of the operation.\n",
      "    * Aspirin: continue up until the day before the operation then hold.\n",
      "    * Clopidogrel: continue up until the day before the operation then hold.\n",
      "2. The types and forms of anesthesia that the patient needs to be aware of for this surgery: The anesthesia for this surgery will likely be a general anesthetic. This means that you will be asleep during the surgery. You will be given medication through an intravenous line (IV) to make you fall asleep and to keep you asleep. You will also have a breathing tube inserted to help you breathe during the surgery.\n",
      "\n",
      "Your anesthesia will be managed by a team of experienced healthcare professionals. They will monitor your vital signs closely during the surgery and will make sure that you are safe and comfortable. You may experience some side effects from the anesthesia, such as nausea, vomiting, or sore throat. These side effects are usually temporary and will go away on their own.\n",
      "\n",
      "The anesthesia team will talk to you about the risks and benefits of general anesthesia before the surgery. They will also answer any questions that you have.\n",
      "iteration # 7\n",
      "response\n",
      "response\n",
      "Response from Model:  **Preoperative anesthesia instructions:**\n",
      "\n",
      "**1. Doctor or Nurse:** Doctor\n",
      "\n",
      "**2. Fasting instructions:**\n",
      "- Solids: Nil by mouth for 6 hours before the surgery\n",
      "- Fluids: Clear fluids (water, black coffee, tea without milk, fruit juice without pulp) up to 2 hours before the surgery\n",
      "\n",
      "**3. Preoperative carbohydrate loading:** Yes\n",
      "\n",
      "**4. Medication instructions:**\n",
      "\n",
      "- **Losartan 25mg OM:** Continue as usual.\n",
      "- **Pravastatin 20mg ON:** Continue as usual.\n",
      "- **Neurobion 2 tab OM:** Continue as usual.\n",
      "- **Omeprazole 20mg BD:** Continue as usual.\n",
      "- **Pregabalin 50mg ON:** Continue as usual.\n",
      "\n",
      "**5. Instructions for the healthcare team:**\n",
      "- Preoperative blood group matching.\n",
      "\n",
      "**6. Preoperative optimization:**\n",
      "- Optimize blood pressure control.\n",
      "\n",
      "**7. Delay of operation:**\n",
      "- No need to delay the operation.\n",
      "\n",
      "**8. Specific department protocols:**\n",
      "- **Preoperative blood group matching:** Due to the patient's history of blood transfusion.\n",
      "- **Optimize blood pressure control:** Due to the patient's history of hypertension.\n",
      "- **Preoperative carbohydrate loading:** To reduce the risk of postoperative insulin resistance.\n",
      "\n",
      "**Instructions to the patient:**\n",
      "\n",
      "**Medication instructions:**\n",
      "- Continue taking all your regular medications as prescribed.\n",
      "\n",
      "**Consent for anesthesia:**\n",
      "- General anesthesia will be administered.\n",
      "- There is a small risk of complications associated with anesthesia, including but not limited to nausea, vomiting, sore throat, and temporary nerve damage.\n",
      "- The risks of anesthesia may be increased due to the patient's medical history of hypertension and CKD.\n",
      "\n",
      "**Specific risks to highlight:**\n",
      "- The patient's history of hypertension increases the risk of intraoperative hypotension and postoperative hypertension.\n",
      "- The patient's history of CKD increases the risk of postoperative acute kidney injury.\n",
      "Response from Model: # Preoperative Anesthesia Instructions for Medical Colleagues:\n",
      "1. The patient should be seen by a Doctor.\n",
      "2. Fasting instructions:\n",
      "   * Clear fluids until 2 hours before the listed surgery.\n",
      "   * Solid foods until 6 hours before the listed surgery.\n",
      "3. Preoperative carbohydrate loading: No.\n",
      "4. Medication instructions:\n",
      "   * Losartan: Hold on the day of surgery.\n",
      "   * Pravastatin: Continue as usual.\n",
      "   * Neurobion: Continue as usual.\n",
      "   * Omeprazole: Continue as usual.\n",
      "   * Pregabalin: Continue as usual.\n",
      "5. Any instructions for the healthcare team:\n",
      "   * Preoperative blood group matching: Yes.\n",
      "   * Arranging for preoperative dialysis: No.\n",
      "   * Standby post-operative high dependency/ICU beds: No.\n",
      "6. Any preoperative optimization required for the patient:\n",
      "   * Blood pressure control: Yes.\n",
      "   * Cardiac workup: Yes.\n",
      "7. Any need to delay the operation for further medical workup and preoperative optimization:\n",
      "   * Yes. The patient needs to undergo a cardiac catheterization before surgery to assess the extent of their coronary artery disease.\n",
      "8. Any specific department protocols to follow for this patient:\n",
      "   * Enhanced Recovery After Surgery (ERAS) protocol: Yes. This protocol is designed to minimize the stress of surgery on the body and promote a faster recovery.\n",
      "   * Cardiac anesthesia protocol: Yes. This protocol is designed to minimize the risk of cardiac complications during surgery.\n",
      "\n",
      "# Instructions for the Patient:\n",
      "1. Medication instructions to take leading up to the surgery:\n",
      "   * Losartan: Hold on the day of surgery.\n",
      "   * Pravastatin: Continue as usual.\n",
      "   * Neurobion: Continue as usual.\n",
      "   * Omeprazole: Continue as usual.\n",
      "   * Pregabalin: Continue as usual.\n",
      "2. The types and forms of anesthesia that the patient needs to be aware of for this surgery:\n",
      "   * General anesthesia: This is a type of anesthesia that puts you to sleep and prevents you from feeling pain during surgery.\n",
      "   * Regional anesthesia: This is a type of anesthesia that numbs a specific area of your body.\n",
      "   * Local anesthesia: This is a type of anesthesia that numbs a small area of your body.\n",
      "\n",
      "The specific type of anesthesia that you will receive will depend on the type of surgery that you are having. Your anesthesiologist will discuss the different options with you and help you to choose the best option for you.\n",
      "iteration # 8\n",
      "response\n",
      "response\n",
      "Response from Model:  **Preoperative anesthesia instructions**\n",
      "\n",
      "**To be seen by:** Doctor\n",
      "\n",
      "**Fasting instructions:**\n",
      "- Solids: Nil by mouth after midnight\n",
      "- Liquids: Clear fluids up to 2 hours before the surgery\n",
      "\n",
      "**Preoperative carbohydrate loading:** No\n",
      "\n",
      "**Medication instructions:**\n",
      "- Amlodipine 5mg: Take as usual on the morning of surgery\n",
      "- Atenlol 50mg: Take as usual on the morning of surgery\n",
      "- Levothyroxine: Take as usual on the morning of surgery\n",
      "\n",
      "**Instructions to surgeon:** NA\n",
      "\n",
      "**Preoperative optimization:**\n",
      "- NA\n",
      "\n",
      "**Need to delay operation?:** No\n",
      "\n",
      "**Specific department protocols to follow:**\n",
      "- **Difficult Airway Protocol:** Grade 3 Larynx and previous difficult intubation\n",
      "- **Thyroid Storm Precautions:** Patient is a thyroidectomy patient on levothyroxine with symptoms suggestive of hyperthyroidism (hot flushes, constipation).\n",
      "\n",
      "**Patient instructions:**\n",
      "- Continue taking your regular medications as prescribed, unless otherwise instructed.\n",
      "- You will need to give consent for the following types of anesthesia:\n",
      " - General anesthesia\n",
      "- There are specific risks associated with the operation and your medical history that you should be aware of:\n",
      " - Difficulty with intubation due to previous grade 3 Larynx and history of difficult intubation\n",
      " - Risk of thyroid storm due to underlying hyperthyroidism\n",
      "Response from Model: ### Targeted to Fellow Medical Colleagues\n",
      "----\n",
      "1. Should the patient be seen by a Doctor or a Nurse - Nurse\n",
      "2. Fasting instructions - nil by mouth for 6 hours before surgery\n",
      "3. Suitability for preoperative carbohydrate loading - no\n",
      "4. Medication instructions: \n",
      " - Levothyroxine 100mcg on day of surgery\n",
      " - Amlodipine 5mg on day of surgery\n",
      " - Atenolol 50mg on day of surgery\n",
      "5. Any instructions for the healthcare team - NA\n",
      "6. Any preoperative optimization required for the patient - NA\n",
      "7. Any need to delay the operation for further medical workup and preoperative optimization - NA\n",
      "8. Any specific department protocols to follow for this patient: - NA\n",
      "\n",
      "### Targeted to Patient\n",
      "----\n",
      "1. Medication instructions to take leading up to the surgery - Take your regular medications with a sip of water the morning of surgery. \n",
      "2. The types and forms of anesthesia that the patient needs to be aware of for this surgery - The types of anesthesia that will be used during your surgery are general anesthesia and local anesthesia. General anesthesia will put you to sleep, while local anesthesia will numb the area of surgery. With general anesthesia, you will receive medication through an intravenous (IV) line to make you fall asleep. You will also have a breathing tube inserted into your throat to help you breathe during surgery. Local anesthesia will be given as an injection in the area of surgery to numb the area. In order to get better pain control after surgery, we would place an epidural catheter which provides excellent relief of pain in the tummy area where you are having the surgery. This epidural catheter would be placed during the surgery.\n",
      "iteration # 9\n",
      "response\n",
      "response\n",
      "Response from Model:  **Preoperative Anesthesia Instructions**\n",
      "\n",
      "**To: Healthcare Team**\n",
      "\n",
      "**Doctor/Nurse**: Doctor\n",
      "\n",
      "**Fasting Instructions**:\n",
      "\n",
      "- Patient should fast for a minimum of **6 hours** before the scheduled surgery time for solids and **2 hours** for clear fluids.\n",
      "\n",
      "**Preoperative Carbohydrate Loading**: No\n",
      "\n",
      "**Medication Instructions**:\n",
      "\n",
      "- **Niften 50mg/20mg Cap**: Discontinue the day before surgery.\n",
      "- **Lisinopril Tablet 10 mg**: Continue taking as usual.\n",
      "- **Simvastatin Tablet 10 mg**: Continue taking as usual.\n",
      "- **Terazosin Tablet 1 mg**: Discontinue the day before surgery.\n",
      "\n",
      "**Instructions to Surgeon**: NA\n",
      "\n",
      "**Preoperative Optimization**: None required.\n",
      "\n",
      "**Need to Delay Operation**: No\n",
      "\n",
      "**Department Protocols**:\n",
      "\n",
      "- **General Anesthesia Protocol**: Due to the patient's age and medical history, general anesthesia is recommended to ensure optimal safety and control during the procedure.\n",
      "- **Preoperative Assessment Clinic Protocol**: The patient should attend the preoperative assessment clinic to ensure all relevant medical information is obtained and any concerns are addressed.\n",
      "\n",
      "**Instructions to Patient**:\n",
      "\n",
      "**Medication Instructions**:\n",
      "\n",
      "- Stop taking Niften 50mg/20mg Cap the day before surgery.\n",
      "- Continue taking Lisinopril Tablet 10 mg and Simvastatin Tablet 10 mg as usual.\n",
      "- Stop taking Terazosin Tablet 1 mg the day before surgery.\n",
      "- Continue taking your medications for BPH as usual unless advised otherwise by your doctor.\n",
      "\n",
      "**Consent for Anesthesia**:\n",
      "\n",
      "- The patient will be given the opportunity to discuss the types of anesthesia available and any potential risks associated with their medical history and the procedure. Written consent will be obtained prior to surgery.\n",
      "\n",
      "- General anesthesia will be administered, involving the use of medications to keep the patient asleep and pain-free during the procedure.\n",
      "- Local anesthesia may be used to numb the area around the prostate during the biopsy, reducing discomfort.\n",
      "Response from Model: Preoperative anesthesia instructions:\n",
      "\n",
      "1. Should the patient be seen by a Doctor or a Nurse - Doctor\n",
      "2. Fasting instructions - 6 hours for solids and 2 hours for clear fluids\n",
      "3. Suitability for preoperative carbohydrate loading – No\n",
      "4. Medication instructions - continue all medications on the morning of surgery with a sip of water\n",
      "5. Any instructions for the healthcare team - NA\n",
      "6. Any preoperative optimization required for the patient - No\n",
      "7. Any need to delay the operation for further medical workup and preoperative optimization? – No\n",
      "8. Any specific department protocols to follow for this patient - NA\n",
      "\n",
      "Instructions to patient:\n",
      "\n",
      "1. Medication instructions to take leading up to the surgery: Continue all your usual medications with a sip of water on the morning of your surgery.\n",
      "2. The types and forms of anesthesia that the patient needs to be aware of for this surgery: The surgery will be performed under general anesthesia, which means that you will be asleep throughout the procedure. You will also be given a spinal block, which will numb the area from your waist down. This will help to reduce pain and discomfort after the surgery.\n",
      "iteration # 10\n",
      "response\n",
      "response\n",
      "Response from Model:  **Doctor/Nurse:** Doctor\n",
      "\n",
      "**Fasting instructions:** NPO from midnight (6 hours) before the time of the surgery. Clear fluids are allowed until 2 hours prior to the surgery.\n",
      "\n",
      "**Suitability for preoperative carbohydrate loading:** No\n",
      "\n",
      "**Medication instructions:**\n",
      "- Fenofibrate 200mg: Stop taking this medication 3 days before the operation.\n",
      "- Losartan: Take your last dose the night before the surgery.\n",
      "- Seretide 25/250: Take your usual dose on the morning of the operation, unless instructed otherwise by your doctor.\n",
      "- Stop taking herbal or alternative medications 1 week before the operation.\n",
      "\n",
      "**Instructions to surgeon:** \n",
      "- No specific instructions.\n",
      "\n",
      "**Preoperative optimization required:** \n",
      "- Consider CPAP titration for management of obstructive sleep apnea.\n",
      "\n",
      "**Need to delay operation for further medical workup and preoperative optimization?:** No\n",
      "\n",
      "**Specific department protocols to follow for this patient:**\n",
      "- Follow the ASA guidelines for preoperative assessment and management of patients with obstructive sleep apnea.\n",
      "\n",
      "**Patient Medication Instructions:**\n",
      "- Continue taking your regular medications as prescribed. \n",
      "- Stop taking Fenofibrate 200mg 3 days before the surgery.\n",
      "- Take your last dose of Losartan the night before the surgery.\n",
      "- Take your usual dose of Seretide 25/250 on the morning of the operation, unless instructed otherwise by your doctor.\n",
      "- Stop taking herbal or alternative medications 1 week before the operation.\n",
      "\n",
      "**Consent for Anesthesia**\n",
      "- General anesthesia will likely be required for your surgery, with an option of supplementing with nerve blocks.\n",
      "- Risks of general anesthesia include damage to teeth, risks associated with the use of breathing tubes and breathing difficulties.\n",
      "- Risks associated with the nerve block include incomplete nerve block, bleeding, infection and nerve damage.\n",
      "- Due to your medical history of hypertension and sleep apnea, there is a slightly increased risk of developing postoperative respiratory complications.\n",
      "Response from Model: <h1> Preoperative anesthesia instructions </h1>1. Should the patient be seen by a Doctor or a Nurse: <b> Doctor </b>\n",
      "2. Fasting instructions:  \n",
      "* <b> 6 hours before </b>the listed surgery time no solid food or milk\n",
      "* <b> 2 hours before </b>the listed surgery time no clear fluids including water, pulp-free juice, clear tea, and black coffee\n",
      "3. Suitability for preoperative carbohydrate loading: <b> No </b>\n",
      "4. Medication instructions: \n",
      "* Continue usual medications except for:\n",
      "    1. <b> Losartan </b>: to be omitted on the morning of surgery\n",
      "    2. <b> Seretide </b>: to be omitted on the morning of surgery\n",
      "    3. <b> Fenofibrate </b>: to be omitted on the morning of surgery\n",
      "5. Any instructions for the healthcare team: NA\n",
      "6. Any preoperative optimization required for the patient: NA\n",
      "7. Any need to delay the operation for further medical workup and preoperative optimization: <b> No </b>\n",
      "8. Any specific department protocols to follow for this patient:\n",
      " * <b>Obstructive sleep apnea protocol: </b>Continuous positive airway pressure (CPAP) machine will be available in the operating room and recovery area. The anesthesiologist will also consider using a nasal trumpet or nasopharyngeal airway to help keep the airway open during surgery. \n",
      " * <b>Obesity protocol: </b>Patient will be positioned in a semi-sitting position to help with breathing. The anesthesiologist will also use extra care when giving medications and monitoring the patient's vital signs.\n",
      " * <b>High blood pressure protocol: </b>Patient's blood pressure will be closely monitored during surgery. The anesthesiologist may give medications to keep the blood pressure within a safe range. \n",
      "\n",
      "Patient instructions:\n",
      "1. Medication instructions to take leading up to the surgery:\n",
      " You should omit the following medications on the morning of surgery:\n",
      " - Losartan\n",
      " - Seretide\n",
      " - Fenofibrate You should continue taking all your other medications as usual. \n",
      "\n",
      "\n",
      "2. Consent for the types of anesthesia that the patient needs to be aware of for this surgery:\n",
      "This operation should be done under General Anesthesia. Given that you've been diagnosed with obstructive sleep apnea and you had previous operations involving successful BMV ventilation, you are likely to be suitable for general anesthesia. We will place a breathing tube into your throat and use a machine to assist you with breathing. You will be unconscious throughout the operation and will not feel any pain. There is also an option for you to undergo regional anesthesia. Regional anesthesia involves injecting numbing medication into an area of your body to numb it. Your surgeon would be able to perform the operation while you are awake.\n",
      "There are some risks associated with both general and regional anesthesia, which you should be aware of. For general anesthesia, the risks may include nausea, vomiting, and sore throat. For regional anesthesia, the risks may include numbness, tingling, and bruising in the area where the medication is injected. The anesthesiologist will be able to discuss these risks in more detail with you on the day of your operation.\n",
      "iteration # 11\n",
      "response\n",
      "response\n",
      "Response from Model:  **Preoperative anesthesia instructions**\n",
      "\n",
      "**Doctor/Nurse:** Doctor\n",
      "\n",
      "**Fasting instructions:**\n",
      "- **Solids:** Nothing to eat for 6 hours before the surgery.\n",
      "- **Liquids:** Clear fluids are allowed up until 2 hours before the surgery. Avoid milk and dairy products, as well as any beverages containing caffeine or alcohol.\n",
      "\n",
      "**Preoperative carbohydrate loading:** No\n",
      "\n",
      "**Medication instructions:**\n",
      "\n",
      "- **Diazepam:** Take 1 tablet the night before the operation.\n",
      "- **Salbutamol accuhaler:** Take 1 puff 4 times a day as needed.\n",
      "- **Theophylline:** Take 125mg twice a day as prescribed.\n",
      "- **Anoro Ellipta:** Take 1 puff every morning as prescribed.\n",
      "- **Imipramine:** Take the last dose the night before surgery. \n",
      "- **Zopiclone:** Take the last dose the night before surgery. \n",
      "\n",
      "**Instructions for the healthcare team:**\n",
      "- Arrange for blood group matching.\n",
      "- Consider reserving a high dependency bed postoperatively due to the patient's COPD.\n",
      "\n",
      "**Preoperative optimization required for the patient:**\n",
      "- Optimize the patient's COPD with pulmonary rehabilitation and smoking cessation counseling.\n",
      "- Consider a medication review to assess for any potential drug-drug interactions or medication-related side effects.\n",
      "\n",
      "**Need to delay the operation for further medical workup and preoperative optimization:** No\n",
      "\n",
      "**Specific department protocols to follow for this patient:**\n",
      "- **COPD protocol:** The patient should be managed according to the department's COPD protocol, which includes preoperative pulmonary rehabilitation and smoking cessation counseling.\n",
      "- **ASA 3 protocol:** The patient should be managed according to the department's ASA 3 protocol, which includes a thorough preoperative assessment and optimization of medical conditions.\n",
      "\n",
      "**Patient instructions:**\n",
      "\n",
      "**Medication instructions:**\n",
      "- Take all medications as prescribed, except for Imipramine and Zopiclone, which should be discontinued the night before surgery.\n",
      "\n",
      "**Consent for anesthesia:**\n",
      "- The patient should be informed that they will likely require general anesthesia for their surgery.\n",
      "- The risks of general anesthesia, including the risk of death, should be discussed with the patient.\n",
      "- The patient should also be informed of the risk of postoperative complications, such as pneumonia, blood clots, and surgical site infection.\n",
      "Response from Model: **Instructions to fellow medical colleagues**\n",
      "\n",
      "Doctor.\n",
      "\n",
      "Fasting instructions as per departmental guidelines - Clear fluids until 2 hours before surgery. Solids up to 6 hours before surgery.\n",
      "\n",
      "Yes to carbohydrate loading.\n",
      "\n",
      "\n",
      "Imipramine - Continue.\n",
      "Zopiclone - Omit on the day of surgery.\n",
      "Diazepam - Omit on the day of surgery.\n",
      "Salbutamol - Continue.\n",
      "Theophylline - Continue.\n",
      "Anoro - Continue.\n",
      "\n",
      "Book high dependency/ICU bed.\n",
      "\n",
      "No preoperative optimization required.\n",
      "\n",
      "No need to delay the operation.\n",
      "\n",
      "Use departmental protocol for severe COPD.\n",
      "\n",
      "\n",
      "**Instructions to the patient**\n",
      "\n",
      "You can continue taking amitriptyline and theophylline. \n",
      "Your as needed medications such as zopiclone and diazepam are to be stopped on the day of your surgery.\n",
      "\n",
      "On the day of surgery you may have general anesthesia or regional anesthesia and you may have a nerve block to help with the pain after surgery. You will be able to discuss the options with the anesthesiologist on the day of surgery. As you have COPD, you may be more likely to develop breathing problems and chest infections after surgery. The anesthesiologist will look after you carefully after surgery to reduce the risk of you developing any problems.\n",
      "iteration # 12\n",
      "response\n",
      "response\n",
      "Response from Model:  **Preoperative instructions**\n",
      "\n",
      "**Doctor/Nurse:** Doctor\n",
      "\n",
      "**Fasting instructions:**\n",
      "\n",
      "- Solids: 6 hours\n",
      "- Liquids: 2 hours\n",
      "\n",
      "**Preoperative carbohydrate loading:** No\n",
      "\n",
      "**Medication instructions:**\n",
      "\n",
      "- Aspirin: Continue\n",
      "- All other medications: Continue as usual\n",
      "\n",
      "**Instructions to the surgeon:** None.\n",
      "\n",
      "**Preoperative optimization:** None\n",
      "\n",
      "**Need to delay the operation:** No\n",
      "\n",
      "**Specific department protocols:**\n",
      "\n",
      "- **Modified fasting**: This patient has a history of DM, so modified fasting is recommended to avoid hypoglycemia.\n",
      "- **CCB/Beta-blockade Stress Dose**: This patient has a history of IHD.\n",
      "\n",
      "**Instructions to the patient**\n",
      "\n",
      "**Medication instructions:**\n",
      "\n",
      "- Continue taking your regular medications as prescribed, except for Aspirin which you can continue.\n",
      "- Do not take any new medications or supplements without first talking to your doctor.\n",
      "\n",
      "**Consent for anesthesia**\n",
      "\n",
      "- General anesthesia with endotracheal intubation is planned for your surgery.\n",
      "- There are some potential risks associated with anesthesia. These risks include, but are not limited to:\n",
      " - Nausea and vomiting\n",
      " - Sore throat\n",
      " - Hoarseness\n",
      " - Difficulty breathing\n",
      " - Infection\n",
      " - Death\n",
      "- We will take all necessary precautions to minimize the risks of anesthesia.\n",
      "Response from Model: **Instructions to healthcare team**\n",
      "1. Patient to be seen by a Doctor on the day of admission.\n",
      "2. No solids or milk for six hours. Clear fluids up to two hours before surgery.\n",
      "3. No carbohydrate loading.\n",
      "4. Continue all usual medications.\n",
      "5. No specific instructions to surgeon.\n",
      "6. Preoperative optimization required: Optimize blood pressure preoperatively and arrange preoperative cardiology review if required.\n",
      "7. No need to delay the operation for any preoperative optimization.\n",
      "8. Department protocols: \n",
      "    - Use high-risk anesthesia protocol due to patient's high risk for cardiac complications.\n",
      "    - Use intraoperative goal-directed fluid therapy protocol to minimize the risk of postoperative complications.\n",
      "\n",
      "**Instructions to patient**\n",
      "1. Continue taking all of your usual medications, including your aspirin, up to and including the day of surgery.\n",
      "2. Do not eat or drink anything for six hours before your surgery. You can have clear fluids up to two hours before surgery.\n",
      "3. The types of anesthesia that you may be given for this surgery include general anesthesia, spinal anesthesia, or a combination of the two. General anesthesia will put you to sleep and you will not be aware of anything during the surgery. Spinal anesthesia will numb your lower body and you will be awake during the surgery, but you will not feel any pain. Your doctor will discuss the risks and benefits of each type of anesthesia with you and will help you to choose the best option for you.\n",
      "\n",
      "**Specific risks to highlight**\n",
      "1. Risk of cardiac complications due to patient's history of ischemic heart disease.\n",
      "2. Risk of bleeding due to patient's use of aspirin.\n",
      "3. Risk of infection due to patient's history of diabetes.\n",
      "iteration # 13\n",
      "response\n",
      "response\n",
      "Response from Model:  **Preoperative instructions**\n",
      "\n",
      "**Seen by:** Doctor\n",
      "\n",
      "**Fasting instructions:** \n",
      "- Solids: Nil from midnight before the surgery\n",
      "- Liquids: Nil from 3 hours before the surgery\n",
      "\n",
      "**Preoperative carbohydrate loading:** Yes\n",
      "\n",
      "**Medication instructions:** \n",
      "\n",
      "- Continue regular medications unless specified otherwise\n",
      "- Omit all antiplatelets and anticoagulants 5 days before surgery\n",
      "- Continue nicotine replacement therapy if usually used\n",
      "\n",
      "**Instructions to the surgeon:** \n",
      "- Arrange for preoperative blood group matching \n",
      "\n",
      "**Preoperative optimization required:**\n",
      "- Treat anemia \n",
      "\n",
      "**Need to delay the operation:** No\n",
      "\n",
      "**Specific department protocols to follow:** \n",
      "- ASA difficult airway protocol\n",
      "- Active smoking protocol\n",
      "- Anemia protocol\n",
      "\n",
      "**Instructions to the patient:** \n",
      "- Continue all regular medications unless specified otherwise.\n",
      "- Do not take antiplatelets or anticoagulants for 5 days before the surgery.\n",
      "- Continue nicotine replacement therapy if usually used.\n",
      "- You will be given a carbohydrate drink to consume the night before and on the morning of surgery.\n",
      "- You will need to fast from solids for at least 12 hours and from liquids for at least 3 hours before your surgery.\n",
      "- You may be consented for a variety of anesthetic techniques including general anesthesia. The specific type of anesthesia will be discussed with you in more detail by the anesthesia team before your surgery.\n",
      "- There are specific risks associated with your surgery and medical history. These include the risk of bleeding and infection due to your anemia, and the risk of respiratory complications due to your history of asthma. These risks will be discussed with you in more detail by the anesthesia team before your surgery.\n",
      "Response from Model: ## Instructions to the medical team: \n",
      "- Seen by: Nurse \n",
      "- Fasting instructions: Patient should be nil by mouth for at least 6 hours before the surgery. They should also avoid drinking clear fluids for at least 2 hours before the surgery.\n",
      "- Preoperative carbohydrate loading: Yes. \n",
      "- Medication instructions: \n",
      "    - No medications to be taken on the day of surgery. \n",
      "    - Patient should continue to take their usual medications as prescribed, unless otherwise advised by their doctor.\n",
      "- Instructions to the healthcare team:\n",
      "    - Preoperative blood group matching is not necessary. \n",
      "    - There is no need to arrange for preoperative dialysis. \n",
      "    - There is no need to standby post-operative high dependency/ICU beds.\n",
      "- Preoperative optimization required for the patient:\n",
      "    - Patient should stop smoking at least 2 weeks before the surgery. \n",
      "    - Patient should be referred to a hematologist for further workup of their anemia. \n",
      "- Need to delay the operation for further medical workup and preoperative optimization: No. \n",
      "- Any specific department protocols to follow for this patient:\n",
      "    - The patient should be given a preoperative carbohydrate drink 2 hours before the surgery. \n",
      "    - The patient should be given a dose of ondansetron 4 mg IV before the surgery to prevent postoperative nausea and vomiting. \n",
      "## Instructions to the patient: \n",
      "- Medication instructions to take leading up to the surgery: \n",
      "    - Patient should continue to take their usual medications as prescribed, unless otherwise advised by their doctor. \n",
      "    - Patient should stop smoking at least 2 weeks before the surgery. \n",
      "- The types and forms of anesthesia that the patient needs to be aware of for this surgery: \n",
      "    - The patient will be given general anesthesia for this surgery. \n",
      "    - General anesthesia is a type of anesthesia that puts the patient to sleep so that they do not feel any pain during the surgery. \n",
      "    - The patient will be given a breathing tube to help them breathe during the surgery. \n",
      "    - The patient will be monitored closely during the surgery by the anesthesia team. \n",
      "    - The patient will be given pain medication after the surgery to help with pain relief. \n",
      "    - The patient will be able to go home after the surgery once they have recovered from the anesthesia.\n"
     ]
    }
   ],
   "source": [
    "import pandas as pd\n",
    "filename2 = \"./data/Anaes 16 Clinical scenarios response base.csv\"\n",
    "df = pd.read_csv(filename2)\n",
    "df['combine_prompt'] = df['System Prompts'] + ' '+ df['User Prompts']\n",
    "\n",
    "\n",
    "for i in range(0, len(df)):\n",
    "\n",
    "    if i<=100:\n",
    "        # df['Gemini_ultra_model_output'][i] = generate(df['combine_prompt'][i])\n",
    "        print(\"iteration #\", i)\n",
    "\n",
    "    # df.loc[i, \"Gemini_ultra_model_output\"] = generate(df.loc[i,'combine_prompt'])\n",
    "    # df.loc[i, \"Gemini_ultra_model_output_v1\"] = generate(df.loc[i,'combine_prompt'])\n",
    "    # df.loc[i, \"Gemini_ultra_model_output_v2\"] = generate(df.loc[i,'combine_prompt'])\n",
    "    df.loc[i, \"Gemini_pro_model_output\"] = generate_pro(df.loc[i,'combine_prompt'])\n",
    "\n",
    "    df.loc[i, \"Anthropic_haiko_model_output\"] = generate_anthropic_response(df.loc[i,'combine_prompt'])\n",
    "\n",
    "    \n",
    "    # df.loc[i, \"medLM_model_output\"] = generate_medllms_v1(df.loc[i,'combine_prompt'])\n",
    "    df.loc[i, \"medpalm_model_output\"] = generate_medlpalm(df.loc[i,'combine_prompt'])\n",
    "    df.loc[i, \"palm_bison32k_output\"] = generate_palm_bison32k(df.loc[i,'combine_prompt'])\n",
    "    df.loc[i, \"palm_unicorn_output\"] = generate_palm_unicorn_v1(df.loc[i,'combine_prompt'])\n",
    "\n",
    "    # print( \"/n output here ::\" , df['Gemini_ultra_model_output'][i])\n",
    "\n",
    "df = df.drop('combine_prompt', axis=1)\n",
    "\n",
    "output2 = \"./output/O_Anaes 16 Clinical scenarios response base response_output_gemini.csv\"\n",
    "\n",
    "df.to_csv(output2)\n"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "aa8e8504-e87a-49e3-a3cb-a3b6b0fc974a",
   "metadata": {},
   "source": [
    "### third file Pharmbot1"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 55,
   "id": "ff356c22-a5eb-4eaa-87b8-d2074ddf8958",
   "metadata": {
    "scrolled": true,
    "tags": []
   },
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "iteration # 0\n",
      "response\n",
      "response\n",
      "response\n",
      "Response from Model:  Situation: The patient's current medication regimen includes multiple medications for various conditions. There are potential drug-related problems, including drug interactions, therapeutic duplication, omission of therapy, and dose adjustments needed due to renal impairment.\n",
      "\n",
      "Background: The patient has a history of poorly controlled diabetes mellitus, hypertension, hyperlipidemia, chronic kidney disease stage 4, necrotising fasciitis of the right lower limb, left foot osteomyelitis, large right medial thigh abscess, recurrent deep vein thrombosis and pulmonary embolism, and evolved anterior myocardial infarction. His current medications include Enoxaparin Sodium Injection, Actrapid, Lantus, Novorapid, Aspirin, Clopidogrel, Omeprazole, Glyceryl Trinitrate, Linagliptin, Bisoprolol Fumarate, Perindopril Erbumine, and Neurobion.\n",
      "\n",
      "Assessment:\n",
      "1. Drug Interactions:\n",
      "- Enoxaparin Sodium and Aspirin: Both have antiplatelet properties, increasing the risk of bleeding.\n",
      "- Enoxaparin Sodium and Clopidogrel: Similar to above, their combination can enhance the anticoagulant effect, increasing bleeding risk.\n",
      "- Clopidogrel and Omeprazole: Omeprazole may reduce the therapeutic effect of Clopidogrel.\n",
      "- Bisoprolol and other CYP3A4 inducers: Bisoprolol may interact with CYP3A4 inducers, potentially decreasing its effectiveness.\n",
      "\n",
      "2. Therapeutic Duplication: The patient is on multiple types of insulin (Actrapid, Lantus, and Novorapid), which should be reviewed for appropriate doses and timing.\n",
      "\n",
      "3. Omission of Therapy: The patient is on long-term warfarin for recurrent DVT and PE, but it's currently held off. Warfarin should be restarted as soon as it's safe to prevent further thrombotic events.\n",
      "\n",
      "4. Potential Drug-Disease Interactions:\n",
      "- CKD Stage 4: Enoxaparin, Perindopril, and other medications may require dose adjustments due to impaired renal function.\n",
      "- Poorly Controlled Diabetes: The current diabetes regimen may be ineffective given the patient's poor glycemic control.\n",
      "- Hypertension: Blood pressure is on the lower end of normal, suggesting a need for regimen adjustment.\n",
      "- Necrotising Fasciitis: Omeprazole may increase the risk of infections due to its acid-suppressing effects.\n",
      "\n",
      "5. Potential Drug-Allergy Interaction: The patient is allergic to Mefenamic Acid and Salicylate, which should be avoided.\n",
      "\n",
      "6. Monitoring: Close monitoring of lab values (hemoglobin, SCr, CrCl) and symptoms is crucial due to the patient's conditions and medication use.\n",
      "\n",
      "Recommendation:\n",
      "1. Consult with a pharmacist to perform a comprehensive medication review, addressing the identified drug-related problems and recommending appropriate medication adjustments, discontinuations, or additions.\n",
      "2. Monitor the patient's hemoglobin levels regularly due to the risk of bleeding with Enoxaparin, Aspirin, and Clopidogrel.\n",
      "3. Adjust the doses of Enoxaparin, Perindopril, and other renally cleared medications based on the patient's renal function (CrCl).\n",
      "4. Reevaluate the patient's diabetes management plan, including insulin doses and timing, to achieve better glycemic control.\n",
      "5. Consider adjusting the doses of Bisoprolol and other medications affected by CYP3A4 inducers.\n",
      "6. Ensure that warfarin is restarted as soon as it's safe to prevent thrombotic events.\n",
      "7. Monitor for signs of infection and adjust the use of Omeprazole if necessary.\n",
      "8. Avoid prescribing Mefenamic Acid and Salicylate due to the patient's allergies.\n",
      "9. Provide patient education on the importance of medication adherence, potential side effects, and the need for regular monitoring.\n",
      "Response from Model:  **Situation**:\n",
      "The patient has a history of recurrent deep vein thrombosis (DVT) and pulmonary embolism (PE) and is currently on enoxaparin sodium injection. The patient is also prescribed aspirin and clopidogrel, which are antiplatelet agents.\n",
      "\n",
      "**Background**:\n",
      "Enoxaparin sodium, aspirin, and clopidogrel all increase the risk of bleeding. Combining these medications can significantly increase the risk of bleeding.\n",
      "\n",
      "**Assessment**:\n",
      "The patient is at high risk of bleeding due to the combination of enoxaparin sodium, aspirin, and clopidogrel.\n",
      "\n",
      "**Recommendation**:\n",
      "The patient should be closely monitored for signs and symptoms of bleeding, such as bruising, nosebleeds, or blood in the urine or stool. The patient should also be advised to avoid activities that may increase the risk of bleeding, such as contact sports or using sharp objects. The patient's hemoglobin levels should also be monitored regularly.\n",
      "Response from Model:  **Situation:** The patient has multiple medical conditions and is on numerous medications, including anticoagulants, antiplatelets, insulin, antihypertensives, lipid-lowering agents, proton pump inhibitors, and vitamins.\n",
      "\n",
      "**Background:** \n",
      "\n",
      "- Medical conditions: Poorly controlled diabetes mellitus, hypertension, hyperlipidemia, chronic kidney disease stage 4, necrotizing fasciitis of the right lower limb, left foot osteomyelitis, large right medial thigh abscess, recurrent deep vein thrombosis and pulmonary embolism, and evolved anterior myocardial infarction.\n",
      "\n",
      "- Current medications: \n",
      " - Enoxaparin Sodium Injection\n",
      " - Actrapid, Lantus, and NovoRAPID (insulin products)\n",
      " - Aspirin and Clopidogrel (antiplatelet agents)\n",
      " - Omeprazole (proton pump inhibitor)\n",
      " - Glyceryl Trinitrate (for chest pain)\n",
      " - Linagliptin (for diabetes)\n",
      " - Bisoprolol Fumarate and Perindopril Erbumine (for hypertension and heart failure)\n",
      " - Neurobion (vitamin B complex)\n",
      "\n",
      "**Assessment:**\n",
      "\n",
      "1. **Potential for drug-drug interactions**: \n",
      " - Concomitant use of Enoxaparin, Aspirin, and Clopidogrel increases the risk of bleeding.\n",
      " - Omeprazole may reduce the effectiveness of Clopidogrel.\n",
      " - Bisoprolol may mask symptoms of hypoglycemia, which is a concern given the patient's diabetes.\n",
      "\n",
      "2. **Medication appropriateness:** \n",
      " - The prescribed medications are generally appropriate for the patient's conditions, but the doses may need to be adjusted due to renal impairment.\n",
      "\n",
      "3. **Drug allergy:** \n",
      " - The patient has a known allergy to mefenamic acid and salicylate. Salicylate is a component of Aspirin.\n",
      "\n",
      "4. **Therapeutic duplication**: \n",
      " - The patient is on multiple types of insulin (Actrapid, Lantus, and Novorapid), which may require careful monitoring of blood glucose levels to avoid hypoglycemia or hyperglycemia.\n",
      "\n",
      "5. **Omission of therapy:** \n",
      " - The patient's warfarin therapy has been held off, and he is currently bridged with enoxaparin. It is important to ensure that anticoagulation therapy is resumed as soon as it is safe to do so.\n",
      "\n",
      "**Recommendation:**\n",
      "\n",
      "1. **Monitor for drug-drug interactions**: \n",
      " - Closely monitor the patient for signs of bleeding, especially in light of the combination of anticoagulants and antiplatelet agents.\n",
      " - Monitor for any adverse effects from the interaction between Omeprazole and Clopidogrel.\n",
      " - Educate the patient about the importance of recognizing and reporting any symptoms of hypoglycemia, particularly given the use of Bisoprolol.\n",
      "\n",
      "2. **Assess renal function and adjust medication doses**: \n",
      " - Given the patient's chronic kidney disease, the doses of renally cleared medications (e.g., Enoxaparin, Perindopril) may need to be adjusted. Consult with a pharmacist or physician to ensure appropriate dosing.\n",
      "\n",
      "3. **Avoid allergy-triggering medications**: \n",
      " - Ensure that Aspirin is not administered due to the patient's salicylate allergy.\n",
      "\n",
      "4. **Optimize insulin therapy and monitor glucose levels**: \n",
      " - Work with the patient's healthcare team to ensure appropriate insulin dosing and provide education on glucose monitoring and management.\n",
      "\n",
      "5. **Ensure continuity of anticoagulation therapy**: \n",
      " - Coordinate with the healthcare team to ensure that warfarin therapy is resumed as soon as it is safe to do so.\n",
      "iteration # 1\n",
      "response\n",
      "response\n",
      "response\n",
      "Response from Model:  **Situation:**\n",
      "The patient is a 41-year-old male with a history of coronary artery disease (CAD), diabetes mellitus (DM), chronic kidney disease (CKD) stage 3, gout, and H. pylori infection. He is currently taking multiple medications, including insulin, metformin, sitagliptin, atorvastatin, glipizide, bisoprolol, colchicine, clarithromycin, metronidazole, omeprazole, aspirin, and ticagrelor.\n",
      "\n",
      "**Background:**\n",
      "The patient has a history of mixed chest pain, epigastric discomfort, dyspepsia, and frequent belching. He denies chest pain, shortness of breath, orthopnea, paroxysmal nocturnal dyspnea, and lower limb swelling. He is also experiencing worsening visual acuity.\n",
      "\n",
      "**Assessment:**\n",
      "\n",
      "1. **Potential Drug-Related Problems:**\n",
      "   - **Drug-Drug Interactions:**\n",
      "     - **Clarithromycin** is a strong inhibitor of CYP3A4, which can increase the serum concentration of **atorvastatin**, potentially leading to an increased risk of myopathy or rhabdomyolysis.\n",
      "     - **Omeprazole** can decrease the effectiveness of **ticagrelor**, an antiplatelet drug, by reducing its absorption. This interaction could increase the risk of thrombotic cardiovascular events.\n",
      "     - **Metformin** and **atorvastatin** can both potentially increase the risk of lactic acidosis, especially in patients with renal impairment. The patient has CKD stage 3, which increases this risk.\n",
      "   - **Contraindications and Cautions:**\n",
      "     - **Atorvastatin** can increase blood glucose levels. Regular monitoring of blood glucose levels is recommended.\n",
      "   - **Medication Compliance:**\n",
      "     - The patient claims to have complaints with all DM medications and statins. This could lead to poor control of his diabetes and hyperlipidemia.\n",
      "   - **Potential Overdose:**\n",
      "     - The patient is prescribed **colchicine** 500 mg TDS PRN for acute gout flare. However, the usual dose of colchicine for acute gout is 1.2 mg at the first sign of the flare followed by 0.6 mg one hour later. High doses of colchicine can cause serious side effects or death.\n",
      "   - **Medication Monitoring:**\n",
      "     - The patient is on multiple medications that require regular monitoring, including blood glucose levels for insulin and metformin, renal function for metformin, liver function for atorvastatin, and signs of bleeding for aspirin and ticagrelor.\n",
      "\n",
      "2. **Omission of Therapy:**\n",
      "   - The patient has a history of CAD and is not currently on any anti-anginal medication.\n",
      "\n",
      "3. **Therapeutic Duplication:**\n",
      "   - The patient is on **metformin** and **sitagliptin**, both of which are antidiabetic medications. While this is not necessarily a problem as they work through different mechanisms, it is important to monitor the patient's blood glucose levels to ensure they are not at risk of hypoglycemia.\n",
      "\n",
      "**Recommendation:**\n",
      "1. **Consult with a Pharmacist or Healthcare Provider:**\n",
      "   - The patient's medication regimen should be reviewed by a pharmacist or healthcare provider to address potential drug-related problems and medication-related issues, including interactions, contraindications, cautions, and dosage adjustments based on renal function.\n",
      "\n",
      "2. **Monitoring and Education:**\n",
      "   - The patient should be educated about the importance of medication compliance, proper use of colchicine, and the need for regular monitoring of blood glucose levels, renal function, liver function, and signs of bleeding.\n",
      "\n",
      "3. **Medication Adjustments:**\n",
      "   - Consider temporarily suspending **atorvastatin** during **clarithromycin** therapy to minimize the risk of drug interactions.\n",
      "   - Consider using an alternative to **omeprazole**, such as a H2 antagonist, to avoid reducing the effectiveness of **ticagrelor**.\n",
      "   - Closely monitor for signs of lactic acidosis if **metformin** and **atorvastatin** are continued.\n",
      "\n",
      "4. **Additional Therapy:**\n",
      "   - Consider adding an anti-anginal medication for the patient's history of CAD.\n",
      "\n",
      "5. **Review of Symptoms:**\n",
      "   - Further evaluate the patient's complaints with DM medications and statins to identify the specific concerns and address them appropriately.\n",
      "\n",
      "6. **Follow-Up:**\n",
      "   - Schedule a follow-up appointment to assess the patient's progress, monitor laboratory results, and make any necessary adjustments to the medication regimen.\n",
      "Response from Model:  Situation: The patient is a 41-year-old male with a history of coronary artery disease (CAD), diabetes mellitus (DM), chronic kidney disease (CKD) stage 3, gout, and H. pylori infection. He is currently being treated with multiple medications, including insulin, metformin, sitagliptin, atorvastatin, glipizide, bisoprolol, colchicine, clarithromycin, metronidazole, omeprazole, aspirin, and ticagrelor.\n",
      "\n",
      "Background: The patient has a history of poorly controlled diabetes, as evidenced by his elevated HbA1c levels. He is also at an increased risk of cardiovascular events due to his CAD and dyslipidemia. The patient's CKD further complicates his medical management, as it may affect the dosing and efficacy of some medications.\n",
      "\n",
      "Assessment:\n",
      "\n",
      "1. Potential for drug interactions: The patient is on a combination of medications that may interact with each other, increasing the risk of adverse effects. For example, metformin and colchicine can both cause lactic acidosis, especially in patients with impaired kidney function. Additionally, clarithromycin can inhibit the metabolism of atorvastatin, leading to an increased risk of myopathy.\n",
      "\n",
      "2. Inadequate management of diabetes: The patient's HbA1c levels are still elevated despite being on multiple antidiabetic medications. This suggests that his diabetes is not well-controlled and may require further medication adjustments or lifestyle modifications.\n",
      "\n",
      "3. Omission of anti-anginal therapy: The patient has a history of CAD but is not currently taking any anti-anginal medications. This could lead to inadequate management of his angina symptoms and increase the risk of cardiovascular events.\n",
      "\n",
      "4. Potential for adverse effects: The patient is on multiple medications, each with its own potential adverse effects. These effects should be carefully monitored, especially in light of the patient's underlying medical conditions.\n",
      "\n",
      "Recommendation:\n",
      "\n",
      "1. Review medications for potential interactions and contraindications: The patient's medication regimen should be carefully reviewed to identify any potential drug interactions or contraindications. Dose adjustments or alternative medications may be necessary to minimize the risk of adverse effects.\n",
      "\n",
      "2. Optimize diabetes management: The patient's diabetes management plan should be reassessed to achieve better glycemic control. This may involve adjusting medication doses, providing education on lifestyle modifications, or considering additional therapies.\n",
      "\n",
      "3. Consider adding anti-anginal therapy: An appropriate anti-anginal medication should be considered for the patient's CAD, taking into account his other medical conditions and medication profile.\n",
      "\n",
      "4. Monitor for adverse effects: The patient should be closely monitored for any signs or symptoms of adverse drug reactions, especially given his multiple medications and underlying medical conditions. Regular laboratory tests and clinical assessments may be necessary.\n",
      "\n",
      "By addressing these issues, we can aim to optimize the patient's medication therapy, improve his clinical outcomes, and reduce the risk of potential complications.\n",
      "Response from Model:  **Situation:** The patient is a 41-year-old male with a history of coronary artery disease (CAD), diabetes mellitus (DM), chronic kidney disease (CKD) stage 3, gout, and H. pylori infection. He is currently on multiple medications for these conditions.\n",
      "\n",
      "**Background:** The patient's medical history and current medications are as follows:\n",
      "\n",
      "* CAD: He presented with atypical chest pain and underwent investigations which revealed severe pLAD + Ramus stenosis, mod pLCx and dRCA stenosis. He is currently managed conservatively and is scheduled for coronary angiogram and possible PCI.\n",
      "* DM: The patient has a history of poorly controlled DM with an HbA1c of 11.6% on 20/07/24. His current medications for DM include Actrapid (Insulin Soluble), Metformin, Sitagliptin, and Glipizide.\n",
      "* CKD stage 3: The patient's creatinine level is 230 [54-101 MMOL/L], indicating impaired kidney function.\n",
      "* Gout: He experiences acute gout flare and is currently prescribed Colchicine for symptom relief.\n",
      "* H. pylori infection: The patient has been diagnosed with H. pylori infection and is prescribed a triple therapy of Clarithromycin, Metronidazole, and Omeprazole.\n",
      "\n",
      "**Assessment:**\n",
      "\n",
      "1. Potential drug-drug interactions:\n",
      "   - The patient is on Metformin and Sitagliptin, which can both lower blood sugar levels. This may increase the risk of hypoglycemia, especially since the patient also uses insulin.\n",
      "   - The combination of Aspirin and Ticagrelor increases the risk of bleeding.\n",
      "   - Clarithromycin can inhibit the metabolism of Atorvastatin, leading to increased levels of Atorvastatin in the body and an increased risk of muscle pain and rhabdomyolysis.\n",
      "\n",
      "2. Potential drug-disease interactions:\n",
      "   - Metformin is contraindicated in patients with severe renal impairment due to the risk of lactic acidosis. The patient's CKD stage 3 puts him at a higher risk for this adverse reaction.\n",
      "   - Bisoprolol, a beta-blocker, can mask symptoms of hypoglycemia, which can be problematic in a diabetic patient.\n",
      "\n",
      "3. Omission of therapy:\n",
      "   - The patient has a history of CAD but is not on any anti-anginal medications.\n",
      "   - The patient's lipid profile shows high LDL levels, but he is only on Atorvastatin.\n",
      "\n",
      "4. Therapeutic duplication:\n",
      "   - The patient is on two antidiabetic medications, Metformin and Sitagliptin, which work through different mechanisms but may have an additive effect in lowering blood glucose levels.\n",
      "\n",
      "5. Allergy:\n",
      "   - The patient has a penicillin allergy, which should be considered when prescribing new medications.\n",
      "\n",
      "**Recommendation:**\n",
      "\n",
      "1. Monitor the patient for signs and symptoms of hypoglycemia, especially when taking Metformin, Sitagliptin, and insulin together.\n",
      "2. Monitor for signs of bleeding, such as easy bruising or unexplained nosebleeds, due to the combination of Aspirin and Ticagrelor.\n",
      "3. Given the patient's CKD stage 3, consider reducing the dose of Metformin or switching to an alternative antidiabetic medication that is safer for renal impairment.\n",
      "4. Educate the patient about the importance of recognizing and managing symptoms of hypoglycemia, especially since he is on medications that can lower blood sugar levels.\n",
      "5. Consider adding an anti-anginal medication to the patient's regimen for the management of CAD.\n",
      "6. Consider adding a second lipid-lowering agent to the patient's regimen to improve lipid control.\n",
      "7. Review the need for therapeutic duplication of antidiabetic medications and adjust the doses accordingly to avoid excessive lowering of blood glucose levels.\n",
      "8. Ensure that no medications containing penicillin are prescribed due to the patient's allergy.\n",
      "iteration # 2\n",
      "response\n",
      "response\n",
      "response\n",
      "Response from Model:  **Situation**: A 66-year-old male patient with a history of hypertension, hyperlipidemia, diabetes mellitus, and a chronic left caudate nucleus infarct is admitted to the hospital with evolved inferior STEMI, left lower cellulitis, and acute kidney injury.\n",
      "\n",
      "**Background**: \n",
      "- The patient is currently prescribed several medications, including Lantus, Enoxaparin, Clarithromycin, Aspirin, Ticagrelor, Lisinopril, Gliclazide, Metformin, Sitagliptin, Atorvastatin, Bisoprolol, Nifedipine, Omeprazole, Isosorbide Mononitrate, and Sildenafil.\n",
      "\n",
      "**Assessment**: \n",
      "\n",
      "1. **Potential drug-related problems**:\n",
      "    - Therapeutic duplication: Aspirin and Ticagrelor are both antiplatelet agents, increasing the risk of bleeding.\n",
      "    - Omission of therapy: The patient has a history of hypertension but is not on any antihypertensive medications due to suspended Lisinopril and Nifedipine.\n",
      "    - Potential drug-disease interaction: Sildenafil is contraindicated with Isosorbide Mononitrate due to the risk of severe hypotension.\n",
      "    - Potential drug-disease interaction: Metformin can accumulate in chronic kidney disease (CKD) and increase the risk of lactic acidosis.\n",
      "    - Potential drug-drug interaction: Omeprazole may reduce the effectiveness of Ticagrelor, increasing the risk of cardiovascular events.\n",
      "    - Potential drug-disease interaction: Lisinopril can worsen renal function in patients with AKI.\n",
      "    - Potential drug-disease interaction: Bisoprolol can worsen peripheral edema.\n",
      "\n",
      "**Recommendations**:\n",
      "- **Discontinue** Ticagrelor due to the duplication of antiplatelet therapy with Aspirin.\n",
      "- **Reassess the need for antihypertensive therapy** once the patient's renal function improves.\n",
      "- **Discontinue Sildenafil** due to the contraindication with Isosorbide Mononitrate.\n",
      "- **Reassess the appropriateness of Metformin** in the context of the patient's renal function.\n",
      "- **Consider alternative medications or dose adjustments** for Omeprazole and Bisoprolol to minimize potential drug interactions and adverse effects.\n",
      "- **Monitor renal function closely** and adjust medication doses as needed.\n",
      "- **Educate the patient** about the potential drug-related problems and provide recommendations for safe medication use.\n",
      "\n",
      "Note: This assessment and recommendations are based on the provided information and should be further validated and discussed with the patient's healthcare team.\n",
      "Response from Model:  Situation: A 66-year-old male patient with a history of hypertension, hyperlipidemia, diabetes mellitus, and a recent left total knee replacement (L TKR) presents with complaints of left lower limb swelling, fever, and chest tightness. He is currently on multiple medications, including anticoagulants, antiplatelets, antibiotics, and various medications for managing his chronic conditions.\n",
      "\n",
      "Background: The patient's current medication regimen includes Lantus (insulin glargine), Enoxaparin, Clarithromycin, Aspirin, Ticagrelor, Lisinopril (suspended for acute kidney injury), Gliclazide, Metformin (suspended for Cath), Sitagliptin, Atorvastatin, Bisoprolol, Nifedipine (suspended), Omeprazole, Isosorbide Mononitrate, and Sildenafil. He has a known allergy to Benzylpenicillin.\n",
      "\n",
      "Assessment:\n",
      "\n",
      "1. Potential Drug-Drug Interactions:\n",
      "   - Enoxaparin, Aspirin, and Ticagrelor: Increased risk of bleeding due to combined antiplatelet and anticoagulant effects.\n",
      "   - Clarithromycin and Atorvastatin: Potential interaction, leading to increased serum concentration of Atorvastatin and risk of myopathy.\n",
      "   - Ticagrelor and Atorvastatin: Potential interaction, increasing the serum concentration of Atorvastatin.\n",
      "   - Sildenafil and Isosorbide Mononitrate: Contraindicated combination due to the risk of severe hypotension.\n",
      "   - Omeprazole and Ticagrelor: Potential interaction, reducing the effectiveness of Ticagrelor.\n",
      "   - Metformin and Lisinopril: Increased risk of lactic acidosis due to potential worsening of renal function by Lisinopril.\n",
      "\n",
      "2. Omission of Therapy:\n",
      "   - Lisinopril: This medication has been suspended due to acute kidney injury (AKI). It should be reassessed once renal function improves.\n",
      "   - Metformin: This medication has been suspended for Cath. Its appropriateness should be reviewed after renal function improves.\n",
      "\n",
      "3. Potential Adverse Drug Reactions:\n",
      "   - Enoxaparin, Aspirin, and Ticagrelor: Increased risk of bleeding.\n",
      "   - Clarithromycin: Potential for QT prolongation, which could be a concern given the patient's cardiac history.\n",
      "   - Atorvastatin: Potential for hepatotoxicity.\n",
      "   - Omeprazole: Potential for increased risk of gastric carcinoid tumors with long-term use.\n",
      "\n",
      "Recommendation:\n",
      "\n",
      "1. Drug-Drug Interactions:\n",
      "   - Closely monitor for signs of bleeding due to the combination of Enoxaparin, Aspirin, and Ticagrelor.\n",
      "   - Consider avoiding concurrent use of Clarithromycin and Atorvastatin or monitor for increased systemic effects of Atorvastatin.\n",
      "   - Advise the patient not to take Sildenafil within 24 hours of taking Isosorbide Mononitrate.\n",
      "   - Review the continued use of Omeprazole and Ticagrelor, considering the potential interaction.\n",
      "\n",
      "2. Omission of Therapy:\n",
      "   - Reintroduce Lisinopril once the patient's renal function improves to manage hypertension and provide renal protection.\n",
      "   - Reassess the appropriateness of Metformin after renal function improves.\n",
      "\n",
      "3. Potential Adverse Drug Reactions:\n",
      "   - Monitor for signs of bleeding, QT prolongation, hepatotoxicity, and any adverse reactions related to long-term use of Omeprazole.\n",
      "\n",
      "Regular monitoring of renal and liver function is recommended given the patient's medical conditions and medication regimen. The patient should be advised to report any new or worsening symptoms promptly.\n",
      "Response from Model:  **Situation:** 66-year-old male with a history of hypertension, hyperlipidemia, diabetes mellitus, minor CAD, chronic left caudate nucleus infarct, RTA, and L knee osteoarthritis status post L TKR, presents with left lower cellulitis, evolved inferior STEMI, and acute kidney injury.\n",
      "\n",
      "**Background:**\n",
      "- Patient has multiple medical conditions requiring various medications.\n",
      "- Recent surgical history includes L TKR.\n",
      "- Patient is allergic to Benzylpenicillin.\n",
      "\n",
      "**Assessment:**\n",
      "1. **Potential drug-drug interactions:**\n",
      "   - Enoxaparin and Aspirin/Ticagrelor: Increased risk of bleeding.\n",
      "   - Clarithromycin and Atorvastatin: Increased risk of myopathy/rhabdomyolysis.\n",
      "   - Ticagrelor and Atorvastatin: Increased risk of systemic effects of Atorvastatin.\n",
      "   - Sildenafil and Isosorbide Mononitrate: Contraindicated due to risk of severe hypotension.\n",
      "   - Omeprazole and Ticagrelor: Potential interaction, monitor for increased risk of bleeding.\n",
      "\n",
      "2. **Potential adverse drug reactions:**\n",
      "   - Enoxaparin: Increased risk of bleeding.\n",
      "   - Clarithromycin: QT prolongation, potential arrhythmias.\n",
      "   - Aspirin/Ticagrelor: Increased risk of bleeding.\n",
      "   - Sildenafil: Potential hypotension, especially with concurrent nitrates.\n",
      "   - Atorvastatin: Hepatotoxicity, increased serum transaminases.\n",
      "   - Bisoprolol: Potential masking of hypoglycemic symptoms.\n",
      "\n",
      "3. **Omission of therapy:**\n",
      "   - Lisinopril: Suspended due to AKI, appropriate.\n",
      "   - Metformin: Suspended for Cath, appropriate.\n",
      "   - Nifedipine: Suspended, reason not specified.\n",
      "\n",
      "**Recommendations:**\n",
      "1. **Medication management:**\n",
      "   - Closely monitor for signs and symptoms of bleeding due to concurrent use of Enoxaparin, Aspirin, and Ticagrelor.\n",
      "   - Consider dose adjustment or temporary discontinuation of Clarithromycin and Atorvastatin due to potential drug interaction.\n",
      "   - Monitor for adverse effects of Sildenafil, especially hypotension, and consider dose adjustment if necessary.\n",
      "   - Monitor liver function tests while on Atorvastatin due to potential hepatotoxicity.\n",
      "   - Advise patient to monitor blood glucose levels closely while on Bisoprolol and report any symptoms of hypoglycemia.\n",
      "\n",
      "2. **Consultations:**\n",
      "   - Consider consulting a pharmacist for comprehensive medication review and recommendations.\n",
      "   - Consult with the patient's healthcare team (e.g., cardiologist, nephrologist, primary care physician) for further guidance on managing the patient's complex medical conditions and medication regimen.\n",
      "\n",
      "3. **Patient education:**\n",
      "   - Educate the patient about potential drug interactions, adverse effects, and the importance of medication adherence.\n",
      "   - Reinforce the importance of reporting any new or worsening symptoms promptly.\n",
      "   - Provide information on lifestyle modifications and self-management strategies to support the patient's overall health and well-being.\n",
      "iteration # 3\n",
      "response\n",
      "response\n",
      "response\n",
      "Response from Model:  Situation: The patient is a 75-year-old male with a history of hypertension (HTN), hyperlipidemia (HLD), benign prostatic hyperplasia (BPH), and right occipital parasagittal meningioma. He is currently experiencing left-sided chest pain.\n",
      "\n",
      "Background: The patient's medication list includes Bisoprolol Fumarate, Clopidogrel, Finasteride, Omeprazole, Terazosin, and Atorvastatin.\n",
      "\n",
      "Assessment:\n",
      "\n",
      "1. Potential drug interactions:\n",
      "   a. Bisoprolol and Omeprazole: Potential interaction due to CYP3A4 metabolism, monitor blood pressure and heart rate.\n",
      "   b. Clopidogrel and Omeprazole: Potential reduction in Clopidogrel's effectiveness, consider alternative PPI or H2 receptor antagonist.\n",
      "   c. Atorvastatin and Omeprazole: Potential interaction due to CYP3A4 metabolism, monitor lipid levels.\n",
      "\n",
      "2. Potential drug-related problems:\n",
      "   a. Therapeutic duplication: Overlapping effects of Omeprazole and Atorvastatin on glucose metabolism, risk of hypoglycemia.\n",
      "   b. Omission of therapy: Lack of antihypertensive or lipid-lowering therapy despite history of HTN and HLD.\n",
      "   c. Suboptimal LDL control: Patient's LDL level is above the optimal level, consider dose adjustment or additional therapy for HLD.\n",
      "   d. Untreated macrocytic anemia: No treatment listed for macrocytic anemia.\n",
      "   e. Unnecessary medications:\n",
      "     i. Clopidogrel: Indication for antiplatelet therapy should be reviewed.\n",
      "     ii. Terazosin and Finasteride: Need for these medications should be assessed if urinary symptoms are absent.\n",
      "     iii. High-dose Omeprazole: Indication for long-term, high-dose PPI should be reviewed.\n",
      "\n",
      "Recommendation:\n",
      "\n",
      "1. Discuss potential drug interactions and drug-related problems with the patient and their healthcare provider.\n",
      "2. Adjust medication regimen as appropriate, considering potential interactions and the patient's clinical condition.\n",
      "3. Monitor for adverse effects and therapeutic response.\n",
      "4. Provide patient education on medication safety, adherence, and lifestyle modifications to manage HTN and HLD.\n",
      "Response from Model:  **Situation:**\n",
      "\n",
      "A 75-year-old male patient with a history of hypertension (HTN), hyperlipidemia (HLD), benign prostatic hyperplasia (BPH), and ischemic cardiomyopathy (CMP) presents with left-sided chest pain. His current medications include Bisoprolol, Clopidogrel, Finasteride, Omeprazole, Terazosin, and Atorvastatin.\n",
      "\n",
      "**Background:**\n",
      "\n",
      "The patient's medical history indicates a high cardiovascular risk profile, including a history of CMP and recent atypical chest pain. His medication regimen is intended to manage HTN, HLD, BPH, and prevent cardiovascular events.\n",
      "\n",
      "**Assessment:**\n",
      "\n",
      "1. **Potential Drug-Related Problems (DRPs):**\n",
      "   a. Clopidogrel and Omeprazole: This combination can potentially reduce the effectiveness of Clopidogrel due to reduced conversion to its active form.\n",
      "   b. Atorvastatin and Omeprazole: Co-administration may affect the metabolism of Atorvastatin, although the clinical significance is not well established.\n",
      "   c. Bisoprolol and Terazosin: Concurrent use of these medications may enhance the hypotensive effect, increasing the risk of hypotension.\n",
      "\n",
      "2. **Omission of Therapy:**\n",
      "   - There appears to be no anti-anginal medication prescribed for the patient's chest pain.\n",
      "\n",
      "3. **Therapeutic Duplication:**\n",
      "   - Omeprazole and Atorvastatin share similar mechanisms in decreasing hepatic glucose production and intestinal glucose absorption.\n",
      "\n",
      "4. **Suboptimal Therapy:**\n",
      "   - The patient's LDL level is above the optimal level, suggesting insufficient control of HLD with the current dose of Atorvastatin.\n",
      "\n",
      "5. **Potential Drug-Disease Interaction:**\n",
      "   - Terazosin may worsen the symptoms of BPH in some patients.\n",
      "\n",
      "6. **Potential Adverse Drug Reaction (ADR):**\n",
      "   - The patient's low Hb level may be associated with Clopidogrel use.\n",
      "\n",
      "**Recommendation:**\n",
      "\n",
      "1. **Review Clopidogrel and Omeprazole Interaction:**\n",
      "   - Assess the patient's platelet function and consider alternative medications to avoid the potential interaction. Pantoprazole, for example, does not significantly inhibit CYP2C19.\n",
      "\n",
      "2. **Optimize Atorvastatin Therapy:**\n",
      "   - Consider increasing the Atorvastatin dose or assess compliance to improve LDL control.\n",
      "\n",
      "3. **Evaluate the Need for Anti-Anginal Medication:**\n",
      "   - Given the patient's cardiac history and chest pain, consider adding an appropriate anti-anginal medication.\n",
      "\n",
      "4. **Address Therapeutic Duplication:**\n",
      "   - Review the necessity of both Omeprazole and Atorvastatin. Consider alternative strategies for gastric protection.\n",
      "\n",
      "5. **Monitor for ADRs:**\n",
      "   - Monitor the patient's Hb levels regularly to detect any persistent anemia potentially caused by Clopidogrel.\n",
      "\n",
      "6. **Reassess Terazosin Use:**\n",
      "   - Evaluate the patient's BPH symptoms and consider alternative medications if Terazosin is exacerbating the condition.\n",
      "\n",
      "7. **Educate the Patient:**\n",
      "   - Provide comprehensive education about the potential DRPs, ADRs, and appropriate medication usage to enhance adherence and safety.\n",
      "\n",
      "8. **Regular Follow-Up:**\n",
      "   - Schedule regular follow-ups to monitor the patient's progress, assess medication effectiveness, and address any new or ongoing concerns.\n",
      "\n",
      "By implementing these recommendations, the patient's medication regimen can be optimized to minimize the risk of DRPs, ensure therapeutic efficacy, and improve overall patient outcomes.\n",
      "Response from Model:  Situation: The patient is a 75-year-old male with a history of HTN, HLD, BPH, and right occipital parasagittal meningioma. He is currently experiencing left-sided chest pain. His medication list includes Bisoprolol, Clopidogrel, Finasteride, Omeprazole, Terazosin, and Atorvastatin.\n",
      "\n",
      "Background: The patient's medications are appropriate for his medical conditions. However, there are potential drug-related problems, drug-drug interactions, and omission of therapy that should be addressed.\n",
      "\n",
      "Assessment:\n",
      "1. Potential Drug-Related Problems:\n",
      "   a. Bisoprolol: Monitor for signs of bronchospasm, especially if he has undiagnosed moderate to severe asthma or COPD. Monitor renal function as clearance is decreased in severe kidney dysfunction.\n",
      "   b. Clopidogrel: Monitor for signs of bleeding, especially if he is concurrently using other agents that alter hemostasis. Monitor renal function as it should be used with caution in kidney impairment.\n",
      "   c. Finasteride: Counsel the patient about the risk of sexual dysfunction and higher-grade prostate cancer. Monitor for these adverse reactions.\n",
      "   d. Omeprazole: Monitor for signs of cutaneous and systemic lupus erythematosus, gastrointestinal effects, lactic acidosis, vitamin B12 deficiency, and gastric carcinoid tumors with long-term use.\n",
      "   e. Terazosin: Caution the patient about CNS depression that can impair physical or mental abilities.\n",
      "   f. Atorvastatin: Monitor for increased serum transaminases and hepatotoxicity. Monitor for increases in HbA1c and fasting blood glucose.\n",
      "\n",
      "2. Potential Drug-Drug Interactions:\n",
      "   a. Bisoprolol and Omeprazole: Monitor the patient's response to therapy as Omeprazole may affect the metabolism of Bisoprolol.\n",
      "   b. Clopidogrel and Omeprazole: Consider avoiding concurrent use due to potential reduced formation of the active metabolite of Clopidogrel. Monitor the patient's response to therapy if co-administration is necessary.\n",
      "   c. Atorvastatin and Omeprazole: Monitor the patient's response to therapy as Omeprazole may affect the metabolism of Atorvastatin.\n",
      "\n",
      "3. Omission of Therapy:\n",
      "   a. The patient has a history of ischemic CMP and has had CABG surgery. Consider adding an ACE inhibitor or ARB for heart failure prevention.\n",
      "   b. The patient's LDL level is above the optimal level. Consider adjusting the dose of Atorvastatin or adding another lipid-lowering agent.\n",
      "   c. The patient has anemia. Investigate the cause and initiate appropriate treatment.\n",
      "\n",
      "Recommendations:\n",
      "1. Monitor the patient for potential drug-related problems, drug-drug interactions, and adverse reactions.\n",
      "2. Adjust medication doses or add additional medications as needed to optimize the patient's therapy.\n",
      "3. Provide patient education and counseling about their medications, including potential side effects and precautions.\n",
      "4. Follow up with the patient regularly to assess their progress and make any necessary adjustments to their medication regimen.\n",
      "iteration # 4\n",
      "response\n",
      "response\n",
      "response\n",
      "Response from Model:  **Situation:** 58-year-old male patient with a history of hypertension, diabetes, and dyslipidemia, presenting with acute pulmonary edema and NSTEMI.\n",
      "\n",
      "**Background:**\n",
      "- Patient has a history of left ataxic hemiparesis and is on aspirin and dipyridamole since 2011.\n",
      "- HbA1c is elevated at 10.6% in August 2024.\n",
      "- Currently experiencing orthopnea, peripheral edema, and shortness of breath.\n",
      "- Bedside echo showed LVEF of 25-30% with inferoseptal wall motion abnormalities.\n",
      "\n",
      "**Assessment:**\n",
      "1. **Therapeutic Duplication**: The patient is taking two different doses of bisoprolol (5mg and 2.5mg), which may lead to an overdose.\n",
      "2. **Omission of Therapy**: Despite having a history of hypertension and acute pulmonary edema, there is no antihypertensive medication (ACE inhibitors or ARBs) in the medication list.\n",
      "3. **Electrolyte Imbalance**: The patient's potassium level is low (2.5 mmol/L), likely due to furosemide use, but there is no potassium supplement prescribed.\n",
      "4. **Poor Glycemic Control**: The patient's blood glucose is elevated (19.7 mmol/L), indicating inadequate diabetes management. The current insulin regimen (Actrapid and Insulatard) may need adjustment.\n",
      "5. **Increased Risk of Bleeding**: The patient is on ticagrelor and aspirin, both antiplatelet medications, which can increase the risk of bleeding.\n",
      "6. **Potential Renal Impairment**: The patient's creatinine level is slightly elevated (118 umol/L), although it is unclear if this is due to acute or chronic kidney disease. The dosing of furosemide, insulatard, losartan, and enoxaparin should be reviewed based on renal function.\n",
      "7. **Drug-Drug Interactions**:\n",
      " - Furosemide and aspirin: Potential for increased salicylate toxicity.\n",
      " - Enoxaparin and aspirin/ticagrelor: Increased risk of bleeding due to enhanced anticoagulant effect.\n",
      " - Ticagrelor and aspirin: Potential for increased bleeding risk.\n",
      " - Omeprazole and aspirin: May increase aspirin toxicity.\n",
      " - Omega-3 fish oil and aspirin: Potential for increased bleeding risk.\n",
      "\n",
      "**Recommendations:**\n",
      "1. **Review and Adjust Medications**:\n",
      " - Discontinue one of the bisoprolol doses to avoid duplication.\n",
      " - Consider adding an antihypertensive medication (e.g., ACE inhibitor or ARB) for blood pressure control.\n",
      " - Prescribe a potassium supplement to correct the low potassium level.\n",
      " - Adjust the insulin regimen to achieve better glycemic control.\n",
      " - Monitor for signs of bleeding due to the combination of ticagrelor, aspirin, and enoxaparin.\n",
      "2. **Assess Renal Function**:\n",
      " - Obtain additional renal function tests to determine the extent of renal impairment.\n",
      " - Adjust the dosing of furosemide, insulatard, losartan, and enoxaparin accordingly.\n",
      "3. **Monitor for Drug-Drug Interactions**:\n",
      " - Closely monitor for signs and symptoms of potential drug-drug interactions, especially those involving increased bleeding risk.\n",
      "4. **Patient Education**:\n",
      " - Provide instructions on proper blood glucose monitoring and medication administration.\n",
      " - Emphasize the importance of reporting any signs of bleeding or other adverse effects.\n",
      "Response from Model:  **Situation:**\n",
      "A 58-year-old male patient with a history of hypertension, diabetes, and left ataxic hemiparesis is admitted to the CCU with acute pulmonary edema. He is currently on multiple medications, including insulin, oral hypoglycemic agents, antiplatelet agents, anticoagulants, diuretics, and antihypertensives.\n",
      "\n",
      "**Background:**\n",
      "The patient's current medication regimen includes:\n",
      "\n",
      "- Insulin (Actrapid and Insulatard) for diabetes management\n",
      "- Gliclazide and Sitagliptin for additional glycemic control\n",
      "- Aspirin and Ticagrelor as antiplatelet agents\n",
      "- Enoxaparin Sodium as an anticoagulant\n",
      "- Furosemide as a diuretic\n",
      "- Losartan for hypertension\n",
      "- Bisoprolol and Bisoprolol Fumarate as beta-blockers\n",
      "- Omeprazole for gastrointestinal protection\n",
      "- Omega-3 Fish Oil as a dietary supplement\n",
      "\n",
      "**Assessment:**\n",
      "\n",
      "1. **Potential drug-related problems:**\n",
      "   - Therapeutic duplication: The patient is prescribed two different doses of Bisoprolol (5mg and 2.5mg), which could lead to potential overdose and increased risk of bradycardia, hypotension, and heart failure.\n",
      "   - Omission of therapy: There is no diuretic therapy listed for the patient's hypertension and acute pulmonary edema, despite the current fluid overload.\n",
      "   - Electrolyte imbalance: The patient's potassium level is low (2.5 mmol/L), likely due to Furosemide use, and there is no potassium supplement prescribed.\n",
      "   - Inadequate glycemic control: The patient's glucose level is high (19.7 mmol/L), indicating poor glycemic control despite multiple diabetic medications.\n",
      "   - Increased risk of bleeding: The combination of Ticagrelor, Aspirin, and Enoxaparin Sodium increases the risk of bleeding.\n",
      "   - Potential renal impairment: The patient's creatinine level is slightly elevated (118 umol/L), suggesting possible kidney dysfunction. Dosing adjustments may be necessary for medications affected by renal function.\n",
      "\n",
      "2. **Potential drug-drug interactions:**\n",
      "   - Furosemide and Aspirin: Loop diuretics can increase the serum concentration of salicylates, potentially leading to increased risk of salicylate toxicity.\n",
      "   - Enoxaparin and Antiplatelet Agents: Enoxaparin may enhance the anticoagulant effect of Aspirin and Ticagrelor, increasing the risk of bleeding.\n",
      "   - Ticagrelor and Aspirin: Concomitant use may enhance the anticoagulant effect of each other, increasing the risk of bleeding.\n",
      "   - Ticagrelor and Omeprazole: Omeprazole may decrease the effectiveness of Ticagrelor, potentially reducing its antiplatelet effect.\n",
      "   - Omega-3 Fish Oil and Aspirin: Omega-3 fatty acids may enhance the antiplatelet effect of Aspirin, increasing the risk of bleeding.\n",
      "\n",
      "**Recommendation:**\n",
      "\n",
      "1. **Medication regimen review and adjustment:**\n",
      "   - Discontinue one of the Bisoprolol medications (either the 5mg tablet or the 2.5mg tablet) to eliminate therapeutic duplication and reduce the risk of adverse effects.\n",
      "   - Initiate a suitable diuretic (e.g., Furosemide) with appropriate dosing for the patient's condition and monitor response.\n",
      "   - Prescribe a potassium supplement to correct the low potassium level and prevent further complications.\n",
      "   - Review and adjust the patient's diabetic medications (insulin, Gliclazide, and Sitagliptin) in consultation with an endocrinologist to achieve better glycemic control.\n",
      "   - Consider alternative medications or strategies to mitigate the increased risk of bleeding associated with the combination of Ticagrelor, Aspirin, and Enoxaparin Sodium.\n",
      "   - Monitor the patient's renal function closely and adjust the dosages of medications affected by renal function (e.g., Furosemide, Enoxaparin Sodium, Insulatard) as necessary.\n",
      "\n",
      "2. **Drug-drug interaction management:**\n",
      "   - Monitor for signs and symptoms of salicylate toxicity due to the potential interaction between Furosemide and Aspirin.\n",
      "   - Consider discontinuing Aspirin or using an alternative antiplatelet agent to minimize the risk of bleeding associated with the combination of Enoxaparin, Ticagrelor, and Aspirin.\n",
      "   - Monitor for reduced effectiveness of Ticagrelor due to the potential interaction with Omeprazole and consider alternative acid-suppressive medications if necessary.\n",
      "   - Monitor for increased risk of bleeding due to the potential interaction between Omega-3 Fish Oil and Aspirin.\n",
      "Response from Model:  Situation: A 58-year-old male patient is admitted to the CCU with acute pulmonary edema. His medication list includes multiple medications with potential drug-related problems.\n",
      "\n",
      "Background: The patient has a history of left ataxic hemiparesis, diabetes mellitus (HbA1c 10.6%), hypertension, and is currently experiencing acute pulmonary edema. His current medication regimen includes antiplatelet agents (aspirin and ticagrelor), insulin and oral hypoglycemic agents for diabetes management, antihypertensive medications, diuretics, anticoagulants, and medications for gastrointestinal prophylaxis.\n",
      "\n",
      "Assessment:\n",
      "1. Therapeutic Duplication: The patient is receiving two different doses of bisoprolol (5 mg and 2.5 mg). This may lead to an increased risk of bradycardia, hypotension, and heart failure exacerbation.\n",
      "2. Omission of Therapy: There is no diuretic therapy in the medication list despite the patient's history of hypertension and current acute pulmonary edema.\n",
      "3. Electrolyte Imbalance: The patient's potassium level is low (2.5 mmol/L), indicating hypokalemia, but there is no potassium supplement prescribed.\n",
      "4. Poor Glycemic Control: The patient's glucose level is high (19.7 mmol/L), suggesting inadequate control of diabetes. The current insulin regimen may need adjustment.\n",
      "5. Increased Risk of Bleeding: Concomitant use of ticagrelor, aspirin, and furosemide increases the risk of bleeding.\n",
      "6. Potential Renal Impairment: The patient's creatinine level is slightly elevated (118 umol/L), indicating possible kidney impairment. Medication doses may need to be adjusted accordingly.\n",
      "\n",
      "Recommendation:\n",
      "1. Bisoprolol Duplication: Review the necessity of two different bisoprolol doses. Consider discontinuing one to avoid potential adverse effects.\n",
      "2. Diuretic Therapy: Initiate appropriate diuretic therapy to manage fluid overload and improve symptoms of acute pulmonary edema.\n",
      "3. Potassium Supplementation: Prescribe potassium supplements to correct hypokalemia and prevent further complications. Monitor potassium levels closely.\n",
      "4. Diabetes Management: Optimize the patient's insulin regimen and/or add additional antidiabetic medications to achieve better glycemic control.\n",
      "5. Bleeding Risk Mitigation: Assess the patient's bleeding risk and consider alternative medications or dose adjustments to minimize the risk of bleeding.\n",
      "6. Renal Function Monitoring: Monitor the patient's renal function closely and adjust medication doses as needed based on creatinine clearance calculations.\n",
      "\n",
      "It is crucial to review the patient's medication regimen, address any drug-related problems, and make necessary adjustments in collaboration with the healthcare team to ensure optimal patient care and safety.\n",
      "iteration # 5\n",
      "response\n",
      "response\n",
      "response\n",
      "Response from Model:  **Situation:**\n",
      "\n",
      "The patient is a 58-year-old male with a history of hypertension who presents with dizziness, unsteady gait, and difficulty balancing. He has been diagnosed with possible posterior circulation stroke, hyponatremia, acute kidney injury, and a urinary tract infection (UTI). The patient's current medication regimen includes Sodium Chloride 0.9% Infusion, Lisinopril (which has been suspended due to stroke suspicion), Aspirin, Potassium Chloride, Simvastatin, Atorvastatin, and Co-amoxiclav.\n",
      "\n",
      "**Background:**\n",
      "\n",
      "- The patient has a history of hypertension and is currently experiencing possible posterior circulation stroke. \n",
      "- The patient's laboratory findings reveal hyponatremia and acute kidney injury. \n",
      "- The patient has a documented allergy to Amoxicillin. \n",
      "- The patient is currently prescribed multiple medications, including two statins (Simvastatin and Atorvastatin), which may increase the risk of adverse effects. \n",
      "\n",
      "**Assessment:**\n",
      "\n",
      "1. **Therapeutic duplication:** The patient is prescribed two statins (Simvastatin and Atorvastatin), which increases the risk of muscle pain, damage, and liver damage. \n",
      "\n",
      "2. **Omission of therapy:** Lisinopril, an ACE inhibitor used for managing hypertension, has been suspended due to stroke suspicion. This could potentially worsen the patient's hypertension. \n",
      "\n",
      "3. **Potential drug-allergy interaction:** The patient has a documented allergy to Amoxicillin but is currently prescribed Co-amoxiclav, which contains Amoxicillin. This could potentially cause an allergic reaction. \n",
      "\n",
      "4. **Potential drug-disease interaction:** The patient has hyponatremia and is receiving Sodium Chloride 0.9% infusion. Lisinopril, which can cause hyperkalemia, is also prescribed. This combination can worsen hyponatremia. \n",
      "\n",
      "5. **Acute kidney injury:** The patient has acute kidney injury and is prescribed medications (Lisinopril, Atorvastatin, and Co-amoxiclav) that are metabolized or excreted by the kidneys. This could lead to drug accumulation and toxicity. \n",
      "\n",
      "**Recommendation:**\n",
      "\n",
      "1. **Discontinue either Simvastatin or Atorvastatin:** To avoid therapeutic duplication and reduce the risk of adverse effects, one of the two statins should be discontinued. \n",
      "\n",
      "2. **Reevaluate Lisinopril suspension:** Considering the patient's history of hypertension and current condition, the decision to suspend Lisinopril should be reevaluated. Blood pressure should be closely monitored. \n",
      "\n",
      "3. **Consider alternative antibiotic:** Due to the patient's allergy to Amoxicillin, an alternative antibiotic that does not contain Amoxicillin should be considered for the treatment of the UTI. \n",
      "\n",
      "4. **Monitor electrolytes closely:** The patient's sodium and potassium levels should be closely monitored due to the potential interaction between Lisinopril and Sodium Chloride 0.9% infusion and the risk of worsening hyponatremia. \n",
      "\n",
      "5. **Adjust medication doses or consider alternatives:** The doses of Lisinopril, Atorvastatin, and Co-amoxiclav should be adjusted based on the patient's acute kidney injury. Alternatively, medications that are not primarily metabolized or excreted by the kidneys should be considered.\n",
      "Response from Model:  **Situation:**\n",
      "The patient is a 58-year-old male with a history of hypertension who presented to the emergency department with dizziness. He is currently experiencing possible posterior circulation stroke, hyponatremia, acute kidney injury, and a urinary tract infection (UTI). His medication list includes Sodium Chloride 0.9% Infusion, Lisinopril (suspended), Aspirin, Potassium Chloride, Simvastatin, Atorvastatin, and Co-amoxiclav.\n",
      "\n",
      "**Background:**\n",
      "The patient has been diagnosed with hyponatremia and is receiving Sodium Chloride 0.9% infusion. He has a history of hypertension and is currently on Lisinopril, which has been suspended due to suspicion of stroke. The patient is also on Aspirin for possible posterior circulation stroke. He has an allergy to Amoxicillin, which is a component of Co-amoxiclav.\n",
      "\n",
      "**Assessment:**\n",
      "1. **Potential drug-related problem:** The patient is receiving both Simvastatin and Atorvastatin, which are both statins. This may increase the risk of adverse effects such as muscle pain and damage.\n",
      "2. **Potential drug-allergy interaction:** The patient has an allergy to Amoxicillin and is currently prescribed Co-amoxiclav, which contains Amoxicillin. This could potentially cause an allergic reaction.\n",
      "3. **Potential drug-disease interaction:** The patient has acute kidney injury and is on several medications that can affect kidney function, including Lisinopril, Simvastatin, and Atorvastatin. This could potentially worsen his kidney injury.\n",
      "\n",
      "**Recommendation:**\n",
      "1. **Discontinue either Simvastatin or Atorvastatin:** The patient should discontinue one of the two statins to reduce the risk of adverse effects.\n",
      "2. **Consider an alternative antibiotic for the UTI:** The patient's allergy to Amoxicillin should be taken into consideration when choosing an antibiotic for his UTI.\n",
      "3. **Monitor renal function:** The patient's renal function should be closely monitored, and medication dosages adjusted as necessary to avoid worsening his kidney injury.\n",
      "4. **Monitor sodium levels:** The patient's sodium levels should be closely monitored to ensure they do not increase too rapidly, which could lead to osmotic demyelination syndrome.\n",
      "Response from Model:  **Situation:** The patient is a 58-year-old male with a history of hypertension who presents with dizziness, difficulty balancing, and unsteady gait. He has been diagnosed with possible posterior circulation stroke, hyponatremia, acute kidney injury, and a urinary tract infection (UTI). \n",
      "\n",
      "**Background:** The patient has a history of hypertension and is currently taking medications including Sodium Chloride 0.9% Infusion, Lisinopril (which has been suspended due to suspicion of stroke), Aspirin, Potassium Chloride, Simvastatin, Atorvastatin, and Co-amoxiclav.\n",
      "\n",
      "**Assessment:**\n",
      "\n",
      "1. **Drug-related problem (therapeutic duplication):** The patient is taking two statins, Simvastatin and Atorvastatin, which can increase the risk of side effects such as muscle pain and damage. \n",
      "\n",
      "2. **Drug-related problem (omission of therapy):** The patient has a history of hypertension and is currently experiencing possible posterior circulation stroke. Lisinopril, an antihypertensive medication, was suspended due to suspicion of stroke, but no alternative antihypertensive medication has been started. \n",
      "\n",
      "3. **Potential drug-allergy interaction:** The patient has a documented allergy to Amoxicillin and is currently prescribed Co-amoxiclav, which contains Amoxicillin. \n",
      "\n",
      "4. **Potential drug-disease interaction:** The patient has hyponatremia and is receiving Sodium Chloride 0.9% infusion. However, Lisinopril, which is currently suspended, can potentially worsen hyponatremia.\n",
      "\n",
      "5. **Potential drug-disease interaction:** The patient has acute kidney injury. Some of the current medications, such as Lisinopril and Co-amoxiclav, can potentially worsen kidney function. \n",
      "\n",
      "6. **Medication dosing:** The dose of Atorvastatin (40mg twice daily) seems higher than usual and should be reviewed. \n",
      "\n",
      "**Recommendation:**\n",
      "\n",
      "1. **Discontinue one of the statins:** Either Simvastatin or Atorvastatin should be discontinued to avoid therapeutic duplication and reduce the risk of side effects. \n",
      "\n",
      "2. **Re-evaluate the suspension of Lisinopril:** If the suspicion of stroke is ruled out, Lisinopril should be reintroduced to manage the patient's hypertension. Close monitoring of blood pressure is necessary due to the \"allow permissive hypertension up to 200/110\" instruction. \n",
      "\n",
      "3. **Consider an alternative antibiotic for the UTI:** Due to the patient's allergy to Amoxicillin, an alternative antibiotic that does not contain Amoxicillin should be prescribed for the UTI. \n",
      "\n",
      "4. **Monitor sodium levels closely:** The rate of Sodium Chloride 0.9% infusion should be adjusted to ensure that sodium correction does not exceed 6-8mmol per 24 hours to avoid osmotic demyelination syndrome. Monitor sodium levels closely.\n",
      "\n",
      "5. **Monitor kidney function:** Closely monitor the patient's kidney function, especially if Lisinopril is reintroduced or if Co-amoxiclav is continued. Consider dose adjustments or alternative medications for medications that can worsen kidney function. \n",
      "\n",
      "6. **Review Atorvastatin dose:** The dosing frequency and dose of Atorvastatin should be reviewed to ensure appropriate dosing based on the patient's condition and potential drug interactions.\n",
      "iteration # 6\n",
      "response\n",
      "response\n",
      "response\n",
      "Response from Model:  **Situation:** A 65-year-old female patient with a history of type 2 diabetes mellitus (T2DM), hypertension (HTN), hyperlipidemia (HLD), osteoarthritis (OA), and a left distal radius fracture status post open reduction internal fixation (ORIF) presented to the emergency department (ED) with symptomatic hypoglycemia.\n",
      "\n",
      "**Background:** The patient was recently hospitalized for Group B streptococcus bacteremia likely secondary to pneumonia, complicated by septic shock (resolved) and elevated troponin likely indicating a troponin T2 myocardial infarction (T2MI). She also experienced deconditioning secondary to sepsis and prolonged hospital stay. The patient lives with her daughter and takes her own medications, including oral hypoglycemic agents (OHGAs) but not insulin for T2DM.\n",
      "\n",
      "**Assessment:**\n",
      "\n",
      "1. **Symptomatic Hypoglycemia:** The patient presented with symptomatic hypoglycemia, with a blood glucose level of 3.2 [3.9-11.0 MMOL/L] below the normal range. Gliclazide, an oral hypoglycemic agent, is known to lower blood glucose levels and may have contributed to the hypoglycemia.\n",
      "\n",
      "2. **Acute Kidney Injury (AKI):** The patient's serum creatinine (SCr) level was elevated at 124 [37 – 75 UMOL/L], indicating kidney injury. Enalapril, an ACE inhibitor, can cause acute kidney injury, and the patient's Metformin dose has been appropriately suspended due to AKI.\n",
      "\n",
      "3. **Potential Adverse Drug Reaction:** Diclofenac, a non-steroidal anti-inflammatory drug (NSAID), can cause serious gastrointestinal adverse events, although the patient's history does not indicate any gastrointestinal disease.\n",
      "\n",
      "4. **Potential Drug-Disease Interactions:**\n",
      "   - Enalapril can worsen kidney function in patients with AKI.\n",
      "   - Simvastatin can increase the risk of myopathy or rhabdomyolysis, especially in older adults.\n",
      "   - Furosemide can worsen kidney function in patients with AKI.\n",
      "   - Diclofenac can worsen kidney function in patients with AKI.\n",
      "\n",
      "5. **Therapeutic Duplication:** The patient is on two different types of pain medications, Gabapentin and Diclofenac, which may not be necessary if her pain is well-controlled.\n",
      "\n",
      "6. **Omission of Therapy:** Metformin, a first-line therapy for T2DM, has been suspended due to AKI. Once the AKI resolves, it would be beneficial to restart Metformin to better manage her T2DM.\n",
      "\n",
      "**Recommendation:**\n",
      "\n",
      "1. **Gliclazide Dose Adjustment:** The dose of Gliclazide should be reviewed and adjusted if necessary to prevent further episodes of hypoglycemia.\n",
      "\n",
      "2. **Close Monitoring of Kidney Function:** The patient's kidney function should be closely monitored, and medication doses adjusted accordingly.\n",
      "\n",
      "3. **Review of Pain Management:** The necessity of dual pain medications should be assessed, and the most appropriate medication should be selected.\n",
      "\n",
      "4. **Consideration of Alternative Antihypertensive Therapy:** If the patient's kidney function does not improve, alternative antihypertensive therapy should be considered.\n",
      "\n",
      "5. **Monitoring for Adverse Drug Reactions:** The patient should be monitored for adverse drug reactions, particularly gastrointestinal events with Diclofenac and muscle symptoms with Simvastatin.\n",
      "\n",
      "6. **Restart Metformin:** Once the AKI resolves, Metformin should be restarted to optimize the management of her T2DM.\n",
      "\n",
      "7. **Patient Education:** The patient should be educated about the importance of regular blood glucose monitoring, recognizing symptoms of hypoglycemia, and proper medication management.\n",
      "Response from Model:  **Situation:** A 65-year-old female patient with a history of type 2 diabetes mellitus (T2DM), hypertension (HTN), hyperlipidemia (HLD), osteoarthritis (OA), and a left distal radius fracture status post open reduction internal fixation (ORIF) was admitted to the hospital for symptomatic hypoglycemia. Her current medication list includes:\n",
      "\n",
      "- Enalapril 5 mg by mouth (PO) twice daily (BD)\n",
      "- Gabapentin 300 mg PO once at night (ON)\n",
      "- Gliclazide 5 mg PO before breakfast\n",
      "- Metformin 500 mg PO BD (currently suspended due to acute kidney injury)\n",
      "- Simvastatin 20 mg PO ON\n",
      "- Ketoprofen 30 mg transdermal patch applied to the right knee twice daily (PRN) for pain or swelling\n",
      "- Furosemide 20 mg PO once a day in the morning (OM) PRN for pedal edema (currently suspended)\n",
      "- Calcium carbonate 450 mg and vitamin D 200 units tablet, 2 tablets PO OM\n",
      "- Diclofenac 50 mg PO three times daily (TDS) PRN for pain\n",
      "\n",
      "**Background:** The patient has a history of Group B streptococcus bacteremia likely due to pneumonia, complicated by septic shock (resolved) and elevated troponin T likely due to a type 2 myocardial infarction (T2MI). She was also deconditioned due to sepsis and prolonged hospital stay. She is currently living with her daughter and takes her own medications.\n",
      "\n",
      "**Assessment:**\n",
      "\n",
      "1. **Potential Drug-Related Problem:** Symptomatic hypoglycemia\n",
      "\n",
      "- Gliclazide can cause hypoglycemia, especially in patients with T2DM who are not on insulin. The patient's blood glucose level was 3.2 mmol/L, which is below the normal range.\n",
      "\n",
      "2. **Potential Drug-Related Problem:** Acute kidney injury (AKI)\n",
      "\n",
      "- Enalapril, furosemide, and metformin can all potentially cause AKI. The patient's serum creatinine level is 124 umol/L, which is above the normal range.\n",
      "\n",
      "3. **Potential Drug-Interaction:** Gabapentin and Simvastatin\n",
      "\n",
      "- Co-administration of gabapentin and simvastatin may increase the risk of myopathy or rhabdomyolysis.\n",
      "\n",
      "4. **Potential Adverse Drug Reaction:** Diclofenac\n",
      "\n",
      "- Diclofenac can cause serious gastrointestinal adverse events, such as bleeding, ulceration, and perforation of the stomach or intestines. The patient's history does not indicate any gastrointestinal disease, but caution should be exercised.\n",
      "\n",
      "**Recommendation:**\n",
      "\n",
      "1. **Recommendation for Symptomatic Hypoglycemia:**\n",
      "\n",
      "- Monitor the patient's blood glucose levels closely and adjust the dose of gliclazide as needed to prevent further episodes of hypoglycemia.\n",
      "\n",
      "2. **Recommendation for Acute Kidney Injury:**\n",
      "\n",
      "- Metformin is currently suspended due to AKI, which is appropriate.\n",
      "- Monitor the patient's kidney function closely while on enalapril and furosemide.\n",
      "- Consider alternative antihypertensive and diuretic medications if the patient's kidney function does not improve.\n",
      "\n",
      "3. **Recommendation for Potential Drug Interaction:**\n",
      "\n",
      "- Monitor the patient for signs and symptoms of muscle pain or weakness.\n",
      "- Consider alternative pain medications if the patient develops myopathy or rhabdomyolysis.\n",
      "\n",
      "4. **Recommendation for Potential Adverse Drug Reaction:**\n",
      "\n",
      "- Caution should be exercised when prescribing diclofenac to the patient due to the risk of gastrointestinal adverse events.\n",
      "- Monitor the patient for any gastrointestinal symptoms and discontinue the medication if any serious adverse events occur.\n",
      "Response from Model:  **Situation**:\n",
      "\n",
      "The patient is a 65-year-old female with a history of T2DM, HLD, HTN, OA, and a recent hospitalization for Group B streptococcus bacteremia with complications. She is currently experiencing symptomatic hypoglycemia and has been found to have AKI. Her medication regimen includes Enalapril, Gabapentin, Gliclazide, Simvastatin, Furosemide, Diclofenac, Ketoprofen plaster, and Calcium Carbonate with Vitamin D.\n",
      "\n",
      "**Background**:\n",
      "\n",
      "- **Enalapril**: This medication is used to treat hypertension and is known to cause hypotension and AKI.\n",
      "- **Gabapentin**: This medication is commonly used for pain and neuropathic pain but has not been indicated for this patient's OA.\n",
      "- **Gliclazide**: This medication is used to treat T2DM and can cause hypoglycemia.\n",
      "- **Metformin**: This medication is also used to treat T2DM and has been appropriately suspended due to AKI.\n",
      "- **Simvastatin**: This medication is used to treat HLD and is associated with potential hepatotoxicity.\n",
      "- **Furosemide**: This medication is used to treat edema and has been suspended due to AKI.\n",
      "- **Diclofenac**: This medication is used for pain relief and has gastrointestinal and renal side effects.\n",
      "- **Ketoprofen plaster**: This medication is used for localized pain relief.\n",
      "- **Calcium Carbonate with Vitamin D**: This medication is used for bone health and has no apparent indication in this patient's current condition.\n",
      "\n",
      "**Assessment**:\n",
      "\n",
      "- **Potential adverse drug reaction**: Symptomatic hypoglycemia may be related to Gliclazide.\n",
      "- **Potential drug-disease interactions**: Enalapril may have contributed to AKI, and both Enalapril and Diclofenac may further impair renal function.\n",
      "- **Potential drug-drug interactions**: Enalapril and Furosemide, as well as Simvastatin and Diclofenac, may increase the risk of renal impairment. Gliclazide and Metformin can both cause hypoglycemia, increasing the risk of this adverse effect. Diclofenac and Ketoprofen plaster may have additive gastrointestinal side effects.\n",
      "- **Omission of therapy**: Metformin, a first-line therapy for T2DM, has been suspended due to AKI.\n",
      "- **Therapeutic duplication**: Gabapentin and Diclofenac are both used for pain relief and may be redundant.\n",
      "\n",
      "**Recommendation**:\n",
      "\n",
      "- **Review and adjust medication doses**: The doses of Enalapril, Gabapentin, and Diclofenac should be reviewed and adjusted based on the patient's renal function.\n",
      "- **Consider alternative medications**: Gabapentin may not be necessary for OA pain, and alternative analgesics with a lower risk of renal impairment can be explored.\n",
      "- **Monitor for adverse effects**: Closely monitor the patient for signs and symptoms of hypoglycemia, renal impairment, hepatotoxicity, and gastrointestinal side effects.\n",
      "- **Optimize management of T2DM**: Once the AKI is resolved, Metformin should be restarted to optimize glycemic control.\n",
      "- **Rationalize medication regimen**: Assess the necessity of continuing Calcium Carbonate with Vitamin D and consider discontinuing it if there is no clear indication.\n",
      "iteration # 7\n",
      "response\n",
      "response\n",
      "response\n",
      "Response from Model:  Situation: A 68-year-old female patient with a history of hypertension, osteoarthritis of the knee, and multiple recent hospitalizations for various conditions is currently admitted for severe hypercalcemia. Her medication list includes Calcitonin, Sodium Chloride 0.9% Infusion, Metoclopramide, Losartan, Paracetamol, Cinnarizine, Lactulose, Sennosides, Colecalciferol, and Nifedipine.\n",
      "\n",
      "Background: The patient's medical history and current medications suggest several potential drug-related problems.\n",
      "\n",
      "Assessment:\n",
      "1. Therapeutic Duplication: The patient is prescribed two medications for hypertension, Losartan and Nifedipine. Both drugs can lower blood pressure, increasing the risk of excessive hypotension. This potential drug interaction needs to be assessed, and the necessity of both medications should be reviewed.\n",
      "\n",
      "2. Potential Adverse Drug Reactions and Contraindications:\n",
      "   - Calcitonin: Long-term use may increase the risk of malignancies. Considering the patient's age, this potential adverse effect requires monitoring.\n",
      "   - Metoclopramide: May elevate blood pressure, potentially worsening the patient's hypertension. Additionally, it can cause abdominal pain and nausea, which could exacerbate the patient's gastrointestinal symptoms.\n",
      "   - Cinnarizine: May cause abdominal pain and nausea, which could worsen the patient's gastrointestinal symptoms.\n",
      "   - Nifedipine: May cause a decrease in blood pressure and an increase in heart rate, potentially leading to rapid fluctuations in blood pressure. Given the patient's history of hypertensive urgency, this effect needs to be closely monitored.\n",
      "\n",
      "3. Ineffective Treatment: Lactulose is prescribed for constipation, but the patient reports minimal relief despite taking laxatives. The effectiveness of Lactulose should be reevaluated.\n",
      "\n",
      "4. Omission of Therapy: The patient has a history of hypertension but is not documented as taking any medications for it in the clinical document. This discrepancy needs to be clarified.\n",
      "\n",
      "Recommendation:\n",
      "1. Review the necessity of dual therapy with Losartan and Nifedipine for hypertension. Consider dose adjustment or discontinuation of one medication to minimize the risk of excessive hypotension and potential drug interactions.\n",
      "\n",
      "2. Monitor the patient for potential adverse effects of Calcitonin, Metoclopramide, Cinnarizine, and Nifedipine, particularly given her medical history and current symptoms. Adjust medication doses or consider alternatives as appropriate.\n",
      "\n",
      "3. Reassess the effectiveness of Lactulose for constipation. If it is not providing adequate relief, alternative laxatives or treatment options should be explored.\n",
      "\n",
      "4. Clarify the discrepancy regarding the patient's history of hypertension and current antihypertensive medications. Ensure accurate medication documentation and management.\n",
      "\n",
      "5. Provide patient education regarding proper medication adherence, potential side effects, and the importance of regular follow-up appointments.\n",
      "Response from Model:  **Situation**:\n",
      "A 68-year-old Chinese female with a history of hypertension, osteoarthritis of the knee, and several recent hospital admissions for severe hypercalcemia, AKI, nosocomial fever with UTI, hypertensive urgency, normocytic normochromic anemia, and bilateral lower limb weakness and numbness due to cervical myelopathy, is currently being reviewed for her medication regimen.\n",
      "\n",
      "**Background**:\n",
      "The patient is currently experiencing hypercalcemia (cCa 3.68 mmol/L) and has a history of AKI with an elevated creatinine level (192 umol/L compared to a baseline of 120 umol/L). She is taking multiple medications, including:\n",
      "\n",
      "1. Calcitonin Sub-Cutaneous 6 units Q8H\n",
      "2. Sodium Chloride 0.9% Infusion IV continuous 2L/day\n",
      "3. Metoclopramide HCl Injection IV bolus 10 mg once\n",
      "4. Losartan Potassium Tablet PO 25 mg once a day\n",
      "5. Paracetamol Tablet PO 1 g QDS PRN for pain or fever\n",
      "6. Cinnarizine Tablet PO 12.5 mg once a day\n",
      "7. Lactulose Syrup PO 15 mL TDS PRN for constipation\n",
      "8. Sennosides 7.5mg Tablet PO 2 tablets on PRN for constipation\n",
      "9. Colecalciferol (Vitamin D3) Capsule/Tablet PO 1,000 units once a day\n",
      "10. Nifedipine LA Capsule/Tablet PO 60 mg twice a day\n",
      "\n",
      "**Assessment**:\n",
      "\n",
      "1. **Therapeutic Duplication**: The patient is taking two antihypertensive medications, Losartan and Nifedipine. This may increase the risk of hypotension and other side effects.\n",
      "\n",
      "2. **Potential Drug-Disease Interactions**:\n",
      "   - The patient has a history of nausea with previous use of Cinacalcet, which is included in her current medication list. This may worsen her nausea.\n",
      "   - The patient is taking Calcium and Vitamin D supplements, which can potentially worsen constipation.\n",
      "   - The patient is taking Sodium Chloride 0.9% infusion, which can potentially worsen kidney function in high doses.\n",
      "   - The patient is taking Metoclopramide, which can cause extrapyramidal symptoms, especially in elderly patients.\n",
      "   - The patient is taking Paracetamol without any mention of pain or fever in the clinical document.\n",
      "\n",
      "**Recommendation**:\n",
      "\n",
      "1. **Review the necessity of dual antihypertensive therapy**: Assess the patient's blood pressure control and consider whether one antihypertensive medication may be discontinued to minimize the risk of side effects.\n",
      "\n",
      "2. **Evaluate and address potential drug-disease interactions**:\n",
      "   - Monitor for and manage nausea if Cinacalcet is continued.\n",
      "   - Monitor bowel movements and adjust laxative regimen as needed to prevent worsening constipation.\n",
      "   - Monitor renal function and adjust Sodium Chloride infusion rate if necessary.\n",
      "   - Monitor for extrapyramidal symptoms and consider alternative medications if they develop.\n",
      "   - Clarify the indication for Paracetamol and discontinue if not necessary.\n",
      "\n",
      "3. **Optimize medication management**:\n",
      "   - Ensure appropriate dosing and monitoring of medications based on the patient's current clinical status and laboratory values.\n",
      "   - Review the patient's overall medication regimen for any other potential drug interactions, adverse effects, or omissions.\n",
      "\n",
      "4. **Patient Education**: Provide clear instructions and education to the patient regarding her medications, including their purpose, dosing schedules, potential side effects, and any precautions or lifestyle modifications that may be necessary.\n",
      "Response from Model:  Situation: The patient is a 68-year-old Chinese female with a history of hypertension (HTN), osteoarthritis (OA) of the knee, and hypercalcemia. She is currently hospitalized for severe hypercalcemia, acute kidney injury (AKI), and constipation.\n",
      "\n",
      "Background: The patient's current medication regimen includes:\n",
      "- Calcitonin injection for hypercalcemia\n",
      "- Sodium Chloride 0.9% infusion\n",
      "- Metoclopramide HCl injection\n",
      "- Gaviscon Liquid for gastric discomfort\n",
      "- Losartan Potassium for HTN\n",
      "- Paracetamol for pain or fever\n",
      "- Cinnarizine for an unknown indication\n",
      "- Lactulose Syrup and Sennosides for constipation\n",
      "- Colecalciferol (Vitamin D3)\n",
      "- Nifedipine LA for HTN\n",
      "\n",
      "Assessment:\n",
      "1. Potential drug-drug interactions:\n",
      " - Metoclopramide may increase the serum concentration of Losartan, increasing the risk of side effects like hypotension and hyperkalemia.\n",
      " - Metoclopramide may increase the absorption of Paracetamol, potentially leading to increased Paracetamol levels and toxicity.\n",
      " - Nifedipine and Metoclopramide may increase the risk of hypotension.\n",
      " - Nifedipine and Losartan may both lower blood pressure, increasing the risk of excessive hypotension.\n",
      " - Calcitonin and Colecalciferol can both increase serum calcium levels, increasing the risk of hypercalcemia.\n",
      "\n",
      "2. Potential adverse drug reactions:\n",
      " - Metoclopramide can cause nausea and vomiting.\n",
      " - Cinnarizine can cause abdominal pain and nausea.\n",
      " - Lactulose and Sennosides may cause diarrhea and electrolyte imbalance.\n",
      " - Paracetamol can cause gastrointestinal effects such as diarrhea, lactic acidosis, and vitamin B12 deficiency.\n",
      "\n",
      "3. Therapeutic duplication: The patient is taking two medications for HTN (Losartan and Nifedipine). It should be determined if both medications are necessary or if one can be discontinued to avoid potential side effects and drug interactions.\n",
      "\n",
      "4. Omission of therapy: The patient's history mentions HTN, but the clinical document states she is not on any medications for it. This discrepancy needs clarification.\n",
      "\n",
      "5. Medication appropriateness:\n",
      " - Cinnarizine is not typically used for the patient's current conditions and may be discontinued.\n",
      " - Metoclopramide is typically used for nausea and vomiting, which the patient does not currently have. Its continued use should be evaluated.\n",
      "\n",
      "Recommendation:\n",
      "1. The healthcare team should closely monitor the patient for potential drug-drug interactions and adverse drug reactions.\n",
      "2. The necessity of continuing both Losartan and Nifedipine for HTN should be reviewed.\n",
      "3. The discrepancy regarding the patient's HTN medications should be clarified.\n",
      "4. The appropriateness of Cinnarizine and Metoclopramide should be reevaluated.\n",
      "5. The patient's response to treatment should be closely monitored, and medication adjustments should be made as necessary.\n",
      "iteration # 8\n",
      "response\n",
      "response\n",
      "response\n",
      "Response from Model:  **Situation:**\n",
      "The patient is a 71-year-old male with a history of poorly controlled type 2 diabetes mellitus (T2DM), ischemic heart disease (IHD), chronic kidney disease (CKD) stage 4, peripheral vascular disease (PVD), and moderate-severe dementia. He is currently admitted to the hospital for fluid overload.\n",
      "\n",
      "**Background:**\n",
      "The patient has been experiencing multiple admissions for fluid overload this year. His current medications include NovoRAPID Flexpen (insulin aspart), Furosemide (frusemide) Injection, ACTRAPID (insulin soluble) Injection, Simvastatin, Aspirin, Famotidine, Calcium Carb 450mg, Vitamin D 200 unit Tablet, and Bisacodyl Suppository.\n",
      "\n",
      "**Assessment:**\n",
      "- Therapeutic duplication: The patient is prescribed two types of insulin, NovoRAPID Flexpen and ACTRAPID, which are both rapid-acting insulins and may increase the risk of hypoglycemia.\n",
      "- Omission of therapy: The patient's Metformin HCl, a first-line treatment for T2DM, is currently suspended, which could lead to poor glycemic control.\n",
      "- Potential drug-drug interactions:\n",
      "   - Furosemide may increase the serum concentration of salicylates like aspirin, increasing the risk of aspirin-related side effects.\n",
      "   - Furosemide may decrease the serum concentration of metformin, reducing its effectiveness.\n",
      "- Potential adverse drug reactions:\n",
      "   - Simvastatin may cause hepatotoxicity and increase serum transaminases.\n",
      "   - Aspirin may cause gastrointestinal ulcers and bleeding.\n",
      "   - Famotidine may cause central nervous system (CNS) effects such as agitation, confusion, and delirium.\n",
      "\n",
      "**Recommendation:**\n",
      "- Discontinue ACTRAPID insulin to avoid therapeutic duplication and potential hypoglycemia.\n",
      "- Reinstate Metformin HCl to improve glycemic control, considering the patient's renal function and monitoring for adverse effects.\n",
      "- Monitor for signs of salicylate toxicity due to the potential interaction between Furosemide and Aspirin.\n",
      "- Monitor liver function tests while the patient is taking Simvastatin.\n",
      "- Monitor for gastrointestinal bleeding in the patient, especially considering his age and multiple comorbidities, due to Aspirin use.\n",
      "- Observe the patient for CNS effects of Famotidine, especially given his history of moderate-severe dementia.\n",
      "- Review the patient's fluid restriction and adjust it based on his fluid balance and clinical status to avoid dehydration.\n",
      "- Consider medication or therapy for weight management, as the patient's BMI indicates obesity, which can worsen his T2DM and other comorbidities.\n",
      "- Initiate appropriate therapy for the patient's dementia to manage his cognitive impairment.\n",
      "- Review the patient's medications for any potential drug-drug interactions or contraindications based on his medical conditions.\n",
      "Response from Model:  Situation: The patient has poorly controlled Type 2 Diabetes Mellitus (T2DM) and is on multiple medications to manage his condition, including insulin (NovoRAPID and ACTRAPID), diuretics (Furosemide), and other supportive medications (Simvastatin, Aspirin, Famotidine, and Bisacodyl).\n",
      "\n",
      "Background: The patient has several co-morbidities, including Chronic Kidney Disease (CKD) stage 4, Ischemic Heart Disease (IHD), Peripheral Vascular Disease (PVD), and Moderate-Severe Dementia. He has a history of fluid overload and is currently admitted for the same issue.\n",
      "\n",
      "Assessment: \n",
      "1. Potential drug-related problems:\n",
      "- Multiple insulin use (NovoRAPID and ACTRAPID) may increase the risk of hypoglycemia, especially with fluctuating blood glucose levels. \n",
      "- Furosemide use in CKD stage 4 may worsen kidney function and requires close monitoring of renal parameters. \n",
      "- Simvastatin and Aspirin both have the potential to cause gastrointestinal bleeding, which should be monitored given the patient's age and medical history. \n",
      "- Famotidine may cause CNS effects such as agitation and confusion, which could exacerbate the patient's dementia. \n",
      "- Metformin is currently suspended, which may impact glycemic control.\n",
      "\n",
      "2. Omission of therapy: Metformin, an oral antidiabetic agent, is currently suspended, leaving a gap in the patient's diabetes management regimen.\n",
      "\n",
      "3. Suboptimal fluid management: The patient has fluid overload but also a negative fluid balance, indicating potential dehydration. Fluid intake and output should be closely monitored and managed.\n",
      "\n",
      "Recommendation:\n",
      "1. Review and rationalize insulin therapy: Consider optimizing the insulin regimen to achieve better blood glucose control and minimize hypoglycemia risk. Discuss with the healthcare team whether continuing both NovoRAPID and ACTRAPID is necessary or if one can be discontinued.\n",
      "\n",
      "2. Monitor renal function closely: Regularly monitor creatinine levels and adjust Furosemide dosage as needed to avoid further decline in kidney function. Assess fluid status and ensure adequate hydration to prevent dehydration.\n",
      "\n",
      "3. Monitor for gastrointestinal issues: Keep a close watch for signs of gastrointestinal bleeding or ulcers due to Aspirin and Simvastatin use. Encourage the patient to report any abdominal pain, nausea, or changes in bowel movements.\n",
      "\n",
      "4. Review the need for Famotidine: Evaluate if Famotidine is still necessary considering the patient's dementia and potential for CNS side effects. Discuss alternative options for managing gastric issues.\n",
      "\n",
      "5. Consider reintroducing Metformin: If appropriate, based on renal function and clinical status, consider reintroducing Metformin to optimize diabetes management.\n",
      "\n",
      "6. Address fluid management: Work with the healthcare team to ensure accurate fluid intake and output monitoring and management to avoid both fluid overload and dehydration.\n",
      "\n",
      "7. Patient education: Provide clear instructions to the patient and caregivers regarding medication administration, dietary restrictions, fluid intake, and monitoring for adverse effects. Encourage regular communication about any concerns or changes in the patient's condition.\n",
      "\n",
      "By implementing these recommendations, potential drug-related problems can be addressed, appropriate therapy can be resumed, and the patient's overall health outcomes can be improved.\n",
      "Response from Model:  Situation: The patient is a 71-year-old male with a history of poorly controlled Type 2 Diabetes Mellitus (T2DM), Chronic Kidney Disease (CKD) stage 4, Ischemic Heart Disease (IHD) with reduced Left Ventricular Ejection Fraction (LVEF) of 46%, and moderate-severe dementia. He is currently admitted for fluid overload.\n",
      "\n",
      "Background: The patient has been experiencing multiple admissions for fluid overload this year. His current medications include NovoRAPID Flexpen [Insulin Aspart] and ACTRAPID [Insulin Soluble] for T2DM, Furosemide [Frusemide] for fluid overload, MetFORMIN HCl for T2DM (currently suspended), Simvastatin for IHD, Aspirin for IHD, Famotidine for unknown indication, Bisacodyl for constipation, and Calcium Carb 450mg, Vitamin D 200 unit Tablet for bone health.\n",
      "\n",
      "Assessment:\n",
      "1.\tPotential for suboptimal diabetes control: The patient's poorly controlled T2DM is evident from his elevated HbA1c of 8.5% and fluctuating capillary blood glucose levels. The current insulin regimen may not be adequately controlling his blood glucose levels, increasing the risk of hypoglycemia or hyperglycemia.\n",
      "\n",
      "2.\tPotential for worsening kidney function: The patient has CKD stage 4 with significantly elevated creatinine levels, indicating impaired kidney function. Furosemide, a diuretic, can further compromise kidney function, especially in patients with pre-existing kidney disease.\n",
      "\n",
      "3.\tPotential for gastrointestinal adverse effects: Aspirin can increase the risk of gastrointestinal ulcers and bleeding, which may be of particular concern given the patient's age and multiple comorbidities.\n",
      "\n",
      "4.\tPotential for drug-related cognitive impairment: Famotidine can cause CNS effects such as agitation, confusion, and delirium, which could potentially exacerbate the patient's moderate-severe dementia.\n",
      "\n",
      "5.\tOmission of therapy: Metformin, a first-line treatment for T2DM, is currently suspended without a clear reason, which may contribute to the patient's poorly controlled diabetes.\n",
      "\n",
      "6.\tTherapeutic duplication: The patient is prescribed two types of insulin - NovoRAPID Flexpen [Insulin Aspart] and ACTRAPID [Insulin Soluble], both rapid-acting insulins, which may increase the risk of hypoglycemia.\n",
      "\n",
      "7.\tPotential for electrolyte imbalance: Bisacodyl and Furosemide can both cause electrolyte disturbances, which could be particularly problematic in a patient with CKD stage 4.\n",
      "\n",
      "8.\tPotential for drug-disease interactions: Several medications, including Furosemide, Simvastatin, Metformin, and Aspirin, have potential interactions or adverse effects that may impact the patient's conditions, such as CKD, diabetes, and cardiovascular status.\n",
      "\n",
      "Recommendation:\n",
      "1.\tDiabetes management: Collaborate with the diabetes team to review and optimize the patient's insulin regimen. Consider adjusting insulin doses or adding other glucose-lowering medications as appropriate. Monitor capillary blood glucose levels closely to ensure adequate glycemic control.\n",
      "\n",
      "2.\tRenal function monitoring: Monitor the patient's renal function closely, including regular creatinine and electrolyte checks. Adjust the doses of Furosemide and other medications as needed based on the patient's kidney function.\n",
      "\n",
      "3.\tGastrointestinal risk assessment: Evaluate the patient's risk of gastrointestinal ulcers and bleeding, considering his age, comorbidities, and medication history. Consider alternatives to Aspirin or implement measures to mitigate the risk, such as using proton pump inhibitors.\n",
      "\n",
      "4.\tCognitive function monitoring: Monitor the patient for signs of cognitive impairment or changes in mental status. Consider deprescribing Famotidine if it is not essential and closely observe the patient's response.\n",
      "\n",
      "5.\tMedication review: Conduct a comprehensive medication review to assess the necessity and appropriateness of all medications. Discontinue or adjust medications as needed, taking into account the patient's clinical condition, renal function, and potential drug interactions.\n",
      "\n",
      "6.\tPatient education: Provide education to the patient and their caregivers regarding medication administration, blood glucose monitoring, diet, fluid restriction, and other self-management strategies to optimize their health and prevent complications.\n",
      "\n",
      "Regular interdisciplinary team discussions involving the primary care physician, specialists, pharmacists, nurses, and dietitians are recommended to ensure a comprehensive and coordinated approach to the patient's care.\n",
      "iteration # 9\n",
      "response\n",
      "response\n",
      "response\n",
      "Response from Model:  **Situation**\n",
      "\n",
      "The patient is a person with a history of diabetes, hypertension, dyslipidemia, and right phacomorphic glaucoma. They are currently taking multiple medications, including Acetazolamide, Potassium Chloride, Atorvastatin, Brimonidine Tartrate, Brinzolamide, Enalapril, Gliclazide, Hydroxyzine, Latanoprost, Dapagliflozin, and Metformin. \n",
      "\n",
      "**Background**\n",
      "\n",
      "- The patient's current medication regimen appears to be appropriate for their diagnosed conditions. \n",
      "- There are a few potential drug-related problems that have been identified, including: \n",
      "  1. Therapeutic duplication with two medications containing Latanoprost \n",
      "  2. Potential omission of beta-blockers for the management of glaucoma and hypertension\n",
      "  3. Potential drug-drug interactions between Acetazolamide and Potassium Chloride, Atorvastatin and Enalapril, Brimonidine and Hydroxyzine, Metformin and Gliclazide, Spironolactone and Potassium Chloride, Dapagliflozin and Metformin, and Brinzolamide and Acetazolamide \n",
      "  4. Potential side effects of Brimonidine Tartrate and Brinzolamide, including ocular hyperemia\n",
      "  5. Monitoring requirements for Metformin, including regular monitoring of renal function\n",
      "  6. Potential dose optimization of Spironolactone\n",
      "  7. Patient education regarding proper usage of multiple eye drops for glaucoma\n",
      "\n",
      "**Assessment**\n",
      "\n",
      "The identified potential drug-related problems may lead to adverse drug reactions, medication inefficacy, or suboptimal management of the patient's conditions. \n",
      "\n",
      "**Recommendation** \n",
      "\n",
      "It is recommended that the healthcare provider reviews the patient's medication regimen and addresses the identified drug-related problems. This may involve:\n",
      "\n",
      "1. Discontinuing one of the medications containing Latanoprost (either Latanoprost 0.005% Eye Drop or XalaCOM Eye Drop) to avoid therapeutic duplication.\n",
      "2. Considering the addition of a beta-blocker for the management of glaucoma and hypertension, taking into account any potential contraindications or adverse effects. \n",
      "3. Monitoring for and managing potential drug-drug interactions, including adjusting dosages or considering alternative medications if necessary.\n",
      "4. Providing patient education and counseling on the proper usage of multiple eye drops for glaucoma, including techniques to ensure accurate instillation and avoiding contamination.\n",
      "5. Regularly monitoring renal function in the context of Metformin therapy.\n",
      "6. Reintroducing Spironolactone at a lower dose if appropriate, considering its potential benefits in hypertension and heart failure management.\n",
      "7. Optimizing the doses of other medications as needed based on the patient's clinical status and response to therapy.\n",
      "Response from Model:  **Situation:**\n",
      "\n",
      "A patient with multiple chronic conditions and medications has been identified for medication review.\n",
      "\n",
      "**Background:**\n",
      "\n",
      "The patient has a history of right phacomorphic glaucoma, diabetes mellitus, hypertension, and dyslipidemia, among other conditions. \n",
      "\n",
      "Their current medication list includes:\n",
      "\n",
      "- Acetazolamide\n",
      "- Potassium Chloride\n",
      "- Atorvastatin\n",
      "- Enalapril\n",
      "- Gliclazide\n",
      "- Hydroxyzine\n",
      "- Latanoprost \n",
      "- XalaCOM Eye Drop [Latanoprost 0.005%, Timolol 0.5%]\n",
      "- Brinzolamide \n",
      "- Brimonidine \n",
      "- Dapagliflozin\n",
      "- Metformin \n",
      "- Spironolactone (currently suspended)\n",
      "\n",
      "**Assessment:**\n",
      "\n",
      "1. **Potential Drug-Drug Interactions:** \n",
      "\n",
      " - **Acetazolamide and Potassium Chloride:** Concomitant use may increase the risk of hyperkalemia. \n",
      " - **Atorvastatin and Enalapril:** Both can potentially affect kidney function, increasing the risk of renal impairment. \n",
      " - **Brimonidine and Enalapril:** Both can lower blood pressure, potentially leading to an additive hypotensive effect. \n",
      " - **Gliclazide and Metformin:** Both can cause hypoglycemia, increasing the risk when used together. \n",
      " - **Spironolactone and Potassium Chloride:** Spironolactone can increase potassium levels, potentially leading to hyperkalemia when combined with Potassium Chloride. \n",
      "\n",
      "2. **Medication Appropriateness:** \n",
      "\n",
      " - **Acetazolamide:** Off-label use for prevention of acute mountain sickness/high-altitude cerebral edema without a clear indication in the clinical document. \n",
      " - **Hydroxyzine:** Should be avoided in older adults due to potential CNS depression. Patient's age is not mentioned.\n",
      "\n",
      "3. **Therapeutic Duplication:**\n",
      "\n",
      " - **Latanoprost 0.005% Eye Drop and XalaCOM Eye Drop [Latanoprost 0.005%, Timolol 0.5%]: Both contain Latanoprost, increasing the risk of overdose.\n",
      "\n",
      "4. **Omission of Therapy:** \n",
      " \n",
      " - No antihypertensive or lipid-lowering medications are listed despite history of hypertension and dyslipidemia.\n",
      "\n",
      "5. **Potential Adverse Effects:**\n",
      "\n",
      " - Multiple eye drops for glaucoma (Brimonidine, Brinzolamide, Latanoprost) can cause ocular side effects like blurred vision, eye discomfort, and dry eyes. \n",
      "\n",
      "6. **Monitoring Considerations:** \n",
      "\n",
      " - Renal function: Atorvastatin, Enalapril, Dapagliflozin, Metformin, and Spironolactone may require dosage adjustments in renal impairment. \n",
      " - Blood glucose levels: Gliclazide, Dapagliflozin, and Metformin can cause hypoglycemia. \n",
      " - Blood pressure: Enalapril can cause hypotension.\n",
      " - Electrolytes: Acetazolamide and Spironolactone can affect electrolyte levels. \n",
      "\n",
      "**Recommendation:**\n",
      "\n",
      "1. **Discontinue:**\n",
      " \n",
      " - **Acetazolamide** due to lack of clear indication and potential drug interactions.\n",
      " - **Hydroxyzine** due to potential CNS depression, especially if the patient is an older adult.\n",
      "\n",
      "2. **Dose Adjustment:**\n",
      "\n",
      " - Adjust dosages of **Atorvastatin, Enalapril, Dapagliflozin, Metformin, and Spironolactone** based on renal function monitoring. \n",
      "\n",
      "3. **Prescribe:**\n",
      " \n",
      " - Initiate appropriate **antihypertensive and lipid-lowering therapy** based on patient's blood pressure and lipid levels.\n",
      "\n",
      "4. **Change Medication:** \n",
      "\n",
      " - Consider switching to a **single Latanoprost-containing eye drop** to avoid duplication and overdose. \n",
      "\n",
      "5. **Monitor:**\n",
      "\n",
      " - **Renal function, blood glucose levels, blood pressure, and electrolyte levels** as indicated.\n",
      " - Monitor for potential **adverse effects** of glaucoma eye drops and adjust treatment accordingly.\n",
      "\n",
      "6. **Educate the patient:**\n",
      "\n",
      " - Provide comprehensive education on their medications, potential side effects, and importance of medication adherence. \n",
      " - Emphasize the importance of regular follow-up and monitoring to optimize their health outcomes.\n",
      "Response from Model:  **Situation:**\n",
      "The patient is on multiple medications to manage their various health conditions, including glaucoma, diabetes, hypertension, and dyslipidemia.\n",
      "\n",
      "**Background:**\n",
      "- Right Phacomorphic glaucoma\n",
      "- Diabetes mellitus\n",
      "- Hypertension\n",
      "- Dyslipidemia\n",
      "- Dermatitis\n",
      "\n",
      "**Assessment:**\n",
      "There are a few potential drug-related problems that should be addressed:\n",
      "\n",
      "1. **Therapeutic Duplication:** The patient is on Latanoprost 0.005% Eye Drop and XalaCOM Eye Drop [Latanoprost 0.005%, Timolol 0.5%]. This could lead to an overdose of Latanoprost.\n",
      "2. **Potential Drug-Drug Interaction:** The patient is on Acetazolamide and Potassium Chloride. Acetazolamide can cause metabolic acidosis, which can lead to increased potassium levels in the body. This could potentially lead to hyperkalemia when used in combination with potassium chloride.\n",
      "3. **Omission of Therapy:** The patient is on Enalapril for hypertension, but their Spironolactone is suspended. Spironolactone can be beneficial in managing hypertension, especially in patients with heart failure.\n",
      "4. **Potential Side Effect:** The patient is on Hydroxyzine for itch, but this medication can cause drowsiness and may enhance the CNS depressant effect of other CNS depressants.\n",
      "5. **Monitoring Parameters:** Given the patient's multiple medical conditions and medications, it is crucial to closely monitor various parameters, including blood pressure, blood glucose levels, electrolytes, liver function, and kidney function.\n",
      "\n",
      "**Recommendation:**\n",
      "1. **Discontinue one Latanoprost product:** To avoid the risk of overdose, either Latanoprost 0.005% Eye Drop or XalaCOM Eye Drop should be discontinued.\n",
      "2. **Monitor potassium levels:** The patient should be monitored regularly for any signs of hyperkalemia, especially if they experience muscle weakness, numbness, or tingling sensations.\n",
      "3. **Consider reintroducing Spironolactone:** If the patient's condition allows, reintroducing Spironolactone may be beneficial in managing their hypertension. The dosage should be adjusted accordingly and their potassium levels monitored closely.\n",
      "4. **Educate the patient:** The patient should be counseled about the potential side effects of Hydroxyzine, particularly the risk of drowsiness. They should be advised to use caution when operating machinery or driving.\n",
      "5. **Regular monitoring:** The patient should undergo regular check-ups and monitoring of their blood pressure, blood glucose levels, electrolytes, liver function, and kidney function. This will allow for early identification and management of any adverse effects.\n",
      "\n",
      "By implementing these recommendations, the patient's drug-related problems can be addressed, and their overall health outcomes can be optimized.\n",
      "iteration # 10\n",
      "response\n",
      "response\n",
      "response\n",
      "Response from Model:  Situation: \n",
      "The patient is a 65-year-old female with a history of Graves' disease, thyroid nodules, and total thyroidectomy. She is currently being treated for bilateral active thyroid eye disease (TED) and has undergone bilateral orbital decompression surgery. Her current medication regimen includes Co-amoxiclav, Methylprednisolone, Paracetamol, Atorvastatin, Etoricoxib, Levofloxacin eye drop, Levothyroxine, Omega-3 fish oil, Omeprazole, and Prednisolone.\n",
      "\n",
      "Background:\n",
      "The patient has a history of Graves' disease and underwent total thyroidectomy. She is currently on levothyroxine replacement therapy. She is also taking Atorvastatin, which may affect thyroid function. The patient is at risk for potential drug-related problems due to multiple medications and underlying medical conditions.\n",
      "\n",
      "Assessment:\n",
      "1. Potential Drug-Drug Interaction: Concomitant use of Atorvastatin and Omeprazole may increase the risk of myopathy and rhabdomyolysis. Omeprazole is a CYP2C19 inhibitor and can increase the serum concentration of Atorvastatin. \n",
      "\n",
      "2. Potential Drug-Disease Interaction: Atorvastatin may affect thyroid function. The patient has a history of Graves' disease and has undergone total thyroidectomy, which makes her more susceptible to this interaction. \n",
      "\n",
      "3. Potential Drug-Disease Interaction: Omega-3 fish oil may affect thyroid function. The patient's thyroid function should be closely monitored while taking this supplement.\n",
      "\n",
      "4. Therapeutic Duplication: The patient is receiving both Methylprednisolone and Prednisolone, which are both corticosteroids. This may increase the risk of side effects such as weight gain, mood changes, and increased risk of infections.\n",
      "\n",
      "5. Omission of Therapy: The patient's thyroid function should be regularly monitored to ensure the dose of levothyroxine is appropriate.\n",
      "\n",
      "Recommendation:\n",
      "1. Close monitoring for signs and symptoms of myopathy and rhabdomyolysis, such as muscle pain, weakness, and dark urine. Consider dose adjustment or alternative medications if necessary.\n",
      "\n",
      "2. Monitor thyroid function tests regularly to assess the impact of Atorvastatin and Omega-3 fish oil on the patient's thyroid status. Adjust medications as needed.\n",
      "\n",
      "3. Consider tapering or discontinuing one of the corticosteroids (Methylprednisolone or Prednisolone) to minimize the risk of therapeutic duplication. \n",
      "\n",
      "4. Ensure regular monitoring of thyroid function to optimize levothyroxine therapy and promptly address any changes in thyroid status.\n",
      "Response from Model:  Situation:\n",
      "The patient is a 65-year-old female who has undergone bilateral orbital decompression surgery. She has a history of Graves' disease and has undergone total thyroidectomy. Her current medications include Co-amoxiclav, Methylprednisolone, Paracetamol, Atorvastatin, Etoricoxib, Levofloxacin eye drop, Levothyroxine, Omega-3 Fish Oil, Omeprazole, Prednisolone, and Tobramycin eye ointment.\n",
      "\n",
      "Background:\n",
      "The patient has a history of Graves' disease and has undergone total thyroidectomy. She is currently being treated for bilateral active thyroid eye disease.\n",
      "\n",
      "Assessment:\n",
      "1. Potential drug-drug interaction: The patient is taking Atorvastatin and Omeprazole. Atorvastatin is metabolized by CYP3A4, and Omeprazole is a CYP3A4 inhibitor. This interaction can lead to increased serum levels of Atorvastatin and an increased risk of muscle toxicity.\n",
      "2. Potential drug-disease interaction: The patient is taking Atorvastatin, which can worsen thyroid eye disease. Statins have been associated with an increased risk of developing Graves' ophthalmopathy.\n",
      "3. Potential adverse drug reactions: The patient is taking multiple medications, including corticosteroids, NSAIDs, and antibiotics, which can all cause a variety of adverse effects, including gastrointestinal upset, bleeding, and kidney damage.\n",
      "\n",
      "Recommendation:\n",
      "1. The prescriber should be consulted to consider an alternative to Omeprazole to avoid the potential drug-drug interaction with Atorvastatin.\n",
      "2. The patient should be monitored closely for signs and symptoms of thyroid eye disease worsening and Atorvastatin-related adverse effects.\n",
      "3. The patient should be educated about the potential adverse effects of the medications she is taking and should be advised to report any unusual symptoms to her healthcare provider.\n",
      "Response from Model:  **Situation:** A 65-year-old female patient with a history of Graves' disease, thyroid eye disease (TED), and total thyroidectomy is currently admitted post-op following bilateral orbital decompression surgery. Her current medication regimen includes Co-amoxiclav Injection, Methylprednisolone Injection, Paracetamol Injection, Atorvastatin Tablet, Calcium Carb and Vitamin D Tablet, Carbomer Eye Gel, Colecalciferol Capsule, Etoricoxib Tablet, LevoFLOXacin Eye Drop, Levothyroxine Sodium Tablet, Omega-3 Fish Oil Capsule, Omeprazole Capsule, Paracetamol Tablet, Prednisolone Tablet, and Tobramycin Eye Ointment.\n",
      "\n",
      "**Background:**\n",
      "- The patient underwent bilateral orbital decompression surgery and is at risk of post-operative infections.\n",
      "- She has a history of Graves' disease and TED, which are inflammatory conditions.\n",
      "- The patient has undergone total thyroidectomy and is currently on levothyroxine replacement therapy.\n",
      "- Her current medication regimen includes various medications with different indications and potential adverse effects.\n",
      "\n",
      "**Assessment:**\n",
      "1. **Potential Drug-Related Problems:**\n",
      "   - Therapeutic Duplication: Methylprednisolone Injection and Prednisolone Tablet are both corticosteroids and their concurrent use may increase the risk of side effects.\n",
      "   - Omission of Therapy: The patient is at risk of suboptimal thyroid hormone replacement due to potential interference between Etoricoxib and Levothyroxine absorption.\n",
      "   - Potential Overuse: Overlapping use of IV Paracetamol and oral Paracetamol should be monitored to avoid exceeding the recommended daily limit.\n",
      "   - Potential Drug-Drug Interaction: Concomitant use of Atorvastatin and Etoricoxib may increase the risk of myopathy or rhabdomyolysis.\n",
      "   - Potential Drug-Disease Interaction: Prednisolone use in patients with a history of Graves' disease may potentially exacerbate the condition.\n",
      "   - Potential Drug-Disease Interaction: Omega-3 Fish Oil Capsule may worsen dry eye symptoms in some patients with thyroid eye disease.\n",
      "\n",
      "2. **Incomplete Medication Information:**\n",
      "   - The indications for Atorvastatin Tablet and Omega-3 Fish Oil Capsule are not clearly specified in the provided clinical document.\n",
      "\n",
      "**Recommendations:**\n",
      "1. **Consult with the Prescriber:**\n",
      "   - Discuss the potential drug-related problems, particularly therapeutic duplication (Methylprednisolone Injection and Prednisolone Tablet), omission of therapy (potential interference between Etoricoxib and Levothyroxine), and potential drug-drug interaction (Atorvastatin and Etoricoxib).\n",
      "2. **Monitor Thyroid Function:**\n",
      "   - Closely monitor the patient's thyroid function due to the potential interference between Etoricoxib and Levothyroxine absorption.\n",
      "3. **Avoid Overuse of Paracetamol:**\n",
      "   - Ensure that the total daily dose of Paracetamol does not exceed the recommended limit once oral Paracetamol is resumed.\n",
      "4. **Monitor for Signs of Muscle Pain or Weakness:**\n",
      "   - Closely monitor the patient for signs and symptoms of muscle pain or weakness due to the potential interaction between Atorvastatin and Etoricoxib.\n",
      "5. **Monitor Thyroid Function and Eye Symptoms:**\n",
      "   - Monitor the patient's thyroid function and eye symptoms while using Prednisolone and Omega-3 Fish Oil Capsule, respectively.\n",
      "6. **Clarify Indications for Atorvastatin and Omega-3 Fish Oil:**\n",
      "   - Obtain more information about the indications for Atorvastatin Tablet and Omega-3 Fish Oil Capsule to ensure appropriate use.\n",
      "\n",
      "**Note:** The recommendations provided are based on the available information and may require further adjustments based on the patient's progress and response to treatment. Regular monitoring and collaboration with the healthcare team are crucial to ensure optimal medication management and patient safety.\n",
      "iteration # 11\n",
      "response\n",
      "response\n",
      "response\n",
      "Response from Model:  **Situation:**\n",
      "The patient is a 45-year-old male with a history of valvular cardiomyopathy and left carotid stenosis who is currently being treated for right acute endophthalmitis and both pseudophakia. He is on a complex medication regimen that includes Tienam (Imipenem, Cilastatin), Azithromycin, Ciprofloxacin, Dexamethasone 0.1% Eye Ointment, Linezolid, Paracetamol, Prednisolone Acetate [Pred Forte] 1% Eye Drop, Tramadol HCl, and Atropine Sulfate 1% Eye Drop.\n",
      "\n",
      "**Background:**\n",
      "The patient's current medications are prescribed for the following conditions:\n",
      "\n",
      "* Tienam (Imipenem, Cilastatin): Presumed mycobacterium abscess.\n",
      "* Azithromycin: Presumed mycobacterium abscess.\n",
      "* Ciprofloxacin: Right eye endophthalmitis.\n",
      "* Dexamethasone 0.1% Eye Ointment: Right eye endophthalmitis.\n",
      "* Linezolid: Presumed mycobacterium abscess.\n",
      "* Paracetamol: Pain or fever.\n",
      "* Prednisolone Acetate [Pred Forte] 1% Eye Drop: Left eye endophthalmitis.\n",
      "* Tramadol HCl: Back pain.\n",
      "* Atropine Sulfate 1% Eye Drop: Right eye endophthalmitis.\n",
      "\n",
      "**Assessment:**\n",
      "\n",
      "1. **Therapeutic Duplication**: The patient is prescribed two topical corticosteroids, Dexamethasone 0.1% Eye Ointment and Prednisolone Acetate [Pred Forte] 1% Eye Drop, for different eyes. This may increase the risk of side effects and may not be necessary.\n",
      "\n",
      "2. **Omission of Therapy**: The patient has a history of valvular cardiomyopathy and left carotid stenosis but is not on any antiplatelet or anticoagulant therapy. This omission increases the risk of thromboembolic events.\n",
      "\n",
      "3. **Potential Drug-Drug Interaction**: Tramadol and Linezolid can both increase serotonin levels and may lead to serotonin syndrome, a potentially life-threatening condition.\n",
      "\n",
      "4. **Potential Adverse Drug Reactions**:\n",
      "    * Azithromycin: QT prolongation, leading to torsades de pointes.\n",
      "    * Ciprofloxacin: Tendon rupture, especially in elderly patients.\n",
      "    * Alprazolam: Dependence and withdrawal symptoms if stopped abruptly.\n",
      "    * Imipenem: Seizures, especially in patients with a history of seizure disorders.\n",
      "\n",
      "**Recommendation:**\n",
      "\n",
      "1. **Therapeutic Duplication**: Discuss the necessity of continuing both Dexamethasone 0.1% Eye Ointment and Prednisolone Acetate [Pred Forte] 1% Eye Drop with the healthcare team. Consider discontinuing one of the medications based on the patient's response and the potential for adverse effects.\n",
      "\n",
      "2. **Omission of Therapy**: Consult with the healthcare team to consider starting an appropriate antiplatelet or anticoagulant therapy, taking into account any potential contraindications, to reduce the risk of thromboembolic events.\n",
      "\n",
      "3. **Potential Drug-Drug Interaction**: Monitor the patient for symptoms of serotonin syndrome, including agitation, hallucinations, rapid heartbeat, fever, overactive reflexes, nausea, vomiting, diarrhea, and loss of coordination. Consider discontinuing or adjusting the doses of Tramadol and/or Linezolid if serotonin syndrome is suspected.\n",
      "\n",
      "4. **Potential Adverse Drug Reactions**:\n",
      "    * Advise the patient to report any signs of tendon inflammation or rupture, such as pain, swelling, or inflammation, especially in the lower extremities. Emphasize the importance of avoiding exercise and using the affected area at the first sign of tendon-related symptoms.\n",
      "    * Monitor the patient's ECG for signs of QT prolongation. Consider alternative antibiotics if QT prolongation occurs.\n",
      "    * Monitor the patient for signs of dependence or withdrawal symptoms if Alprazolam is discontinued. Taper the dose gradually if discontinuation is necessary.\n",
      "    * Monitor the patient for signs of seizures, especially if the patient has a history of seizure disorders.\n",
      "\n",
      "5. **Follow-up and Monitoring**: Regularly review the patient's medication regimen, monitor for the effectiveness and tolerability of the prescribed medications, and promptly address any adverse effects or new developments.\n",
      "Response from Model:  Situation: \n",
      "A 45-year-old male patient with a history of valvular cardiomyopathy, bilateral pseudophakia, and left carotid stenosis is currently hospitalized and being treated for right acute endophthalmitis caused by mycobacterium spp. The patient's current medication regimen includes multiple antibiotics, corticosteroids, and other medications for pain and insomnia.\n",
      "\n",
      "Background: \n",
      "The patient's history includes valvular cardiomyopathy, bilateral pseudophakia, and left carotid stenosis. He is not currently on any antiplatelet or anticoagulant therapy for his carotid stenosis. Recent ophthalmological procedures include right cataract surgery with subsequent development of endophthalmitis. Infectious workup revealed mycobacterium spp. in vitreous culture, leading to the initiation of empiric antibiotic therapy with Tienam (Imipenem, Cilastatin), Linezolid, and Azithromycin.\n",
      "\n",
      "Assessment: \n",
      "1. Potential for Drug-Related Problems: \n",
      "- Therapeutic Duplication: Concomitant use of Prednisolone Acetate [Pred Forte] 1% Eye Drop and Dexamethasone 0.1% Eye Ointment increases the risk of side effects such as elevated intraocular pressure, glaucoma, and cataract formation. \n",
      "- Omission of Therapy: Patient has history of valvular cardiomyopathy and left carotid stenosis, but no antiplatelet or anticoagulant is prescribed, increasing the risk of thromboembolic events.\n",
      "- Potential Drug-Drug Interactions: \n",
      " - Linezolid and Tramadol: Both can increase serotonin levels, leading to serotonin syndrome.\n",
      " - Ciprofloxacin and Azithromycin: Potential for increased risk of overgrowth of non-susceptible organisms.\n",
      " - Tienam and Azithromycin: Potential for increased risk of overgrowth of non-susceptible organisms.\n",
      " - Tienam and Ciprofloxacin: Potential for increased risk of overgrowth of non-susceptible organisms.\n",
      "- Potential Side Effects: \n",
      " - Atropine Sulfate 1% Eye Drop may cause dry eyes, which could be exacerbated by concurrent use of Tears Naturale Free Eye Drop. \n",
      " - Alprazolam may worsen valvular cardiomyopathy by causing decreased blood pressure and heart rate.\n",
      "- Potential Drug-Disease Interactions: \n",
      " - Prednisolone Acetate [Pred Forte] 1% Eye Drop and Dexamethasone 0.1% Eye Ointment may increase the risk of immunosuppression and secondary ocular infections in the context of endophthalmitis.\n",
      "\n",
      "2. Medication Dosing and Duration: \n",
      "- Review the duration of Ciprofloxacin therapy, as it may need to be extended beyond 7 days based on the diagnosis of mycobacterium abscess. \n",
      "\n",
      "3. Patient Education: \n",
      "- Reinforce the importance of medication adherence and regular follow-up appointments to monitor the effectiveness of treatment and detect any adverse effects.\n",
      "\n",
      "Recommendations: \n",
      "1. Therapeutic Duplication: \n",
      "- Consider tapering or discontinuing one of the two topical corticosteroids (Prednisolone Acetate [Pred Forte] 1% Eye Drop or Dexamethasone 0.1% Eye Ointment) to minimize the risk of adverse effects.\n",
      "\n",
      "2. Omission of Therapy: \n",
      "- Consult with the healthcare team to consider initiating appropriate antiplatelet or anticoagulant therapy for the patient's carotid stenosis.\n",
      "\n",
      "3. Potential Drug-Drug Interactions: \n",
      "- Monitor the patient closely for signs and symptoms of serotonin syndrome, particularly when Tramadol and Linezolid are co-administered.\n",
      "- Review other concomitant medications for potential interactions and adjust as necessary.\n",
      "\n",
      "4. Potential Side Effects: \n",
      "- Monitor the patient's response to Atropine Sulfate 1% Eye Drop and Tears Naturale Free Eye Drop, adjusting the dosing or considering alternative options if dry eyes persist. \n",
      "- Monitor cardiac function while the patient is taking Alprazolam.\n",
      "\n",
      "5. Potential Drug-Disease Interactions: \n",
      "- Monitor for signs of immunosuppression and secondary ocular infections, especially with prolonged use of topical corticosteroids.\n",
      "\n",
      "6. Medication Dosing and Duration: \n",
      "- Work with the infectious disease team to determine the optimal duration of Ciprofloxacin therapy based on the patient's clinical progress and response to treatment.\n",
      "\n",
      "7. Patient Education: \n",
      "- Provide comprehensive counseling on the patient's current medications, including their purpose, dosing instructions, potential side effects, and the importance of adherence and follow-up care.\n",
      "Response from Model:  Situation: The patient is a 45-year-old male with a history of valvular cardiomyopathy, left carotid stenosis, and bilateral pseudophakia. He is currently hospitalized for right acute endophthalmitis and presumed mycobacterium abscess. The patient is on a complex medication regimen, including Tienam (Imipenem, Cilastatin), Atropine Sulfate 1% Eye Drop, Azithromycin, Ciprofloxacin, Dexamethasone 0.1% Eye Ointment, Linezolid, Paracetamol, Prednisolone Acetate [Pred Forte] 1% Eye Drop, Tramadol HCl, and Alprazolam.\n",
      "\n",
      "Background: The patient's current medications are prescribed for the treatment of his endophthalmitis, mycobacterium abscess, and associated symptoms. However, there are potential drug-related problems, including therapeutic duplication, omission of therapy, potential drug-drug interactions, potential adverse drug reactions, potential drug-disease interactions, and potential overuse of medication.\n",
      "\n",
      "Assessment:\n",
      "1. Therapeutic Duplication: The patient is receiving Dexamethasone 0.1% Eye Ointment and Prednisolone Acetate [Pred Forte] 1% Eye Drop, which are both steroids. This duplication may increase the risk of side effects.\n",
      "\n",
      "2. Omission of Therapy: The patient has a history of valvular cardiomyopathy and left carotid stenosis but is not on antiplatelet or anticoagulant therapy. This omission increases the risk of thromboembolic events.\n",
      "\n",
      "3. Potential Drug-Drug Interaction: Tramadol has a potential interaction with Linezolid, both of which increase serotonin levels and may lead to serotonin syndrome.\n",
      "\n",
      "4. Potential Adverse Drug Reaction: Ciprofloxacin can cause QT prolongation and may lead to a serious irregular heart rhythm. This is a concern given the patient's history of valvular cardiomyopathy.\n",
      "\n",
      "5. Potential Drug-Disease Interaction: Alprazolam can worsen cardiomyopathy due to its negative inotropic effects.\n",
      "\n",
      "6. Potential Overuse of Medication: The patient is taking Paracetamol for pain or fever without a clear indication in the clinical document.\n",
      "\n",
      "Recommendation:\n",
      "1. Review the necessity of both Dexamethasone 0.1% Eye Ointment and Prednisolone Acetate [Pred Forte] 1% Eye Drop. Consider discontinuing one of these medications to reduce the risk of side effects.\n",
      "\n",
      "2. Consult the patient's healthcare team about starting antiplatelet or anticoagulant therapy to reduce the risk of thromboembolic events, considering the patient's history of valvular cardiomyopathy and left carotid stenosis.\n",
      "\n",
      "3. Monitor the patient for symptoms of serotonin syndrome, such as agitation, hallucinations, rapid heartbeat, fever, overactive reflexes, nausea, vomiting, and diarrhea, due to the potential interaction between Tramadol and Linezolid.\n",
      "\n",
      "4. Monitor the patient's ECG for QT prolongation while taking Ciprofloxacin. Consider an alternative antibiotic if QT prolongation is observed.\n",
      "\n",
      "5. Consider an alternative medication for insomnia, as Alprazolam can worsen cardiomyopathy.\n",
      "\n",
      "6. Review the necessity of Paracetamol and discontinue if there is no clear indication for its use.\n",
      "\n",
      "These recommendations should be discussed with the patient's healthcare team to ensure optimal medication management and patient safety.\n",
      "iteration # 12\n",
      "response\n",
      "response\n",
      "response\n",
      "Response from Model:  Situation: \n",
      "The patient is a 20-year-old female with a history of primary sclerosing cholangitis with Child's Pugh A cirrhosis, chronic ulcerative pancolitis, and gout. She is currently being treated with multiple medications, including Azathioprine, Ursodeoxycholic Acid, Omeprazole, Mesalazine, Carvedilol, Ciprofloxacin, Allopurinol, Metronidazole, and Aztreonam.\n",
      "\n",
      "Background: \n",
      "The patient has a history of several medical conditions and is taking multiple medications to manage them. It is important to review the patient's medication list for potential drug interactions, adverse effects, and appropriateness of therapy.\n",
      "\n",
      "Assessment: \n",
      "1. Potential Drug-Drug Interactions: \n",
      "   - Azathioprine and Allopurinol: Allopurinol can increase the levels of Azathioprine in the body, potentially leading to increased side effects.\n",
      "   - Omeprazole and Azathioprine: Omeprazole can potentially increase the levels of Azathioprine in the body, also leading to increased side effects.\n",
      "   - Omeprazole and Metronidazole: Omeprazole can potentially increase the absorption of Metronidazole, leading to increased side effects.\n",
      "\n",
      "2. Potential Adverse Drug Reactions: \n",
      "   - Azathioprine and Mesalazine: Both drugs can cause myelosuppression, increasing the risk of blood disorders.\n",
      "   - Omeprazole can cause vitamin B12 deficiency, potentially worsening the patient's anemia.\n",
      "   - Ciprofloxacin can cause peripheral neuropathy, tendon rupture, and aortic aneurysm.\n",
      "\n",
      "3. Potential Omission of Therapy: \n",
      "   - The patient has a history of anemia, but there is no iron supplement or other treatment for anemia listed in the medication list.\n",
      "\n",
      "4. Potential Inappropriate Use: \n",
      "   - Ciprofloxacin for cholelithiasis is an off-label use of the medication.\n",
      "\n",
      "Recommendation: \n",
      "1. Monitor the patient closely for signs of drug interactions, adverse drug reactions, and therapeutic effectiveness. \n",
      "2. Consider dose adjustment or alternative medications for Azathioprine, Omeprazole, and Ciprofloxacin to minimize potential interactions and adverse effects.\n",
      "3. Prescribe iron supplements or other appropriate treatments to address the patient's anemia.\n",
      "4. Reevaluate the need for Ciprofloxacin and consider alternative treatments for cholelithiasis.\n",
      "5. Educate the patient about the potential risks and benefits of their medications and encourage them to report any new or worsening symptoms.\n",
      "Response from Model:  **Situation:** A 20-year-old female patient with a history of primary sclerosing cholangitis, Child's Pugh A cirrhosis, chronic ulcerative pancolitis (UC), and gout is currently being treated with multiple medications.\n",
      "\n",
      "**Background:**\n",
      "\n",
      "- The patient has a history of ascending cholangitis and underwent esophageal variceal banding.\n",
      "- She experiences recurrent flares of UC due to non-compliance with medication.\n",
      "- She was recently admitted for cholelithiasis and underwent ERCP, which did not reveal any stones.\n",
      "- She is currently experiencing left knee pain and fever.\n",
      "\n",
      "**Assessment:**\n",
      "\n",
      "1. **Potential Drug-Drug Interactions:**\n",
      "   - Azathioprine and Allopurinol: Allopurinol can increase the levels of azathioprine in the body, leading to increased risk of toxicity.\n",
      "   - Azathioprine and Metronidazole: Concomitant use may increase the risk of myelosuppression.\n",
      "   - Omeprazole and Azathioprine: Omeprazole can increase the levels of azathioprine in the body, potentially leading to toxicity.\n",
      "   - Omeprazole and Carvedilol: Omeprazole may increase the serum concentration of carvedilol, increasing the risk of side effects such as bradycardia and hypotension.\n",
      "   - Omeprazole and Ciprofloxacin: Omeprazole may decrease the absorption of ciprofloxacin, reducing its effectiveness.\n",
      "   - Ciprofloxacin and Azathioprine: Ciprofloxacin may increase the levels of azathioprine in the body, leading to potential toxicity.\n",
      "   - Ciprofloxacin and Metronidazole: Concurrent use may increase the risk of seizures due to additive CNS effects.\n",
      "   - Allopurinol and Azathioprine: Allopurinol can inhibit the metabolism of azathioprine, leading to increased azathioprine levels and potential toxicity.\n",
      "   - Allopurinol and Omeprazole: Allopurinol may increase the serum concentration of omeprazole, potentially leading to an increased risk of omeprazole side effects.\n",
      "\n",
      "2. **Potential Adverse Drug Reactions:**\n",
      "   - Azathioprine: Gastrointestinal intolerance, myelosuppression, hepatotoxicity.\n",
      "   - Allopurinol: Skin rash, nausea, drowsiness.\n",
      "   - Carvedilol: Hypotension, syncope.\n",
      "   - Ciprofloxacin: Aortic aneurysm and aortic dissection, tendinopathy and tendon rupture, peripheral neuropathy, CNS effects.\n",
      "   - Metronidazole: Peripheral neuropathy, blood disorders.\n",
      "   - Aztreonam: Peripheral neuropathy.\n",
      "\n",
      "3. **Contraindications and Cautions:**\n",
      "   - Azathioprine: Use with caution in patients with liver impairment (Child's Pugh A cirrhosis).\n",
      "   - Allopurinol: Caution in patients with history of rash.\n",
      "   - Carvedilol: Use with caution in patients with low blood pressure.\n",
      "   - Ciprofloxacin: Use with caution in patients with kidney impairment.\n",
      "\n",
      "4. **Therapeutic Duplication:**\n",
      "   - IV Metronidazole and IV Aztreonam are both antibiotics. It is important to ensure that this is necessary and not a duplication of therapy.\n",
      "\n",
      "5. **Omission of Therapy:**\n",
      "   - The patient has a history of gout and is currently experiencing a gout flare. However, there is no medication for acute gout flare management in the medication list.\n",
      "\n",
      "6. **Potential Drug-Disease Interactions:**\n",
      "   - Azathioprine: Potential hepatotoxicity. Monitor liver function closely.\n",
      "   - Mesalazine: May exacerbate ulcerative colitis symptoms. Monitor for worsening of UC symptoms.\n",
      "   - Carvedilol: May exacerbate respiratory symptoms. Monitor for worsening of respiratory symptoms.\n",
      "\n",
      "7. **Drug Allergy:**\n",
      "   - The patient has a known allergy to Co-amoxiclav (Augmentin). Ensure that the patient is not prescribed any medications that may cross-react, such as other penicillins or cephalosporins.\n",
      "\n",
      "**Recommendations:**\n",
      "\n",
      "1. **Discontinue:**\n",
      "   - IV Metronidazole and IV Aztreonam if they are not indicated for specific infections.\n",
      "   - Ciprofloxacin due to its potential for serious adverse effects and drug interactions.\n",
      "\n",
      "2. **Dose Adjustments:**\n",
      "   - Consider increasing the dose or frequency of Omeprazole to 20 mg twice daily for better management of gastrointestinal symptoms.\n",
      "\n",
      "3. **Add Medications:**\n",
      "   - Initiate medication for acute gout flare management, such as colchicine or NSAIDs (if not contraindicated due to UC).\n",
      "\n",
      "4. **Monitor Closely:**\n",
      "   - Monitor liver function tests regularly to assess for potential hepatotoxicity from Azathioprine.\n",
      "   - Monitor for worsening of UC symptoms and adjust Mesalazine dose or consider alternative therapies if\n",
      "Response from Model:  **Situation:** A 20-year-old female patient with a history of primary sclerosing cholangitis with Child's Pugh A cirrhosis, chronic ulcerative pancolitis, gout, and a documented allergy to co-amoxiclav is currently admitted with left knee pain. She is currently receiving IV metronidazole, IV aztreonam, azathioprine, ursodeoxycholic acid, omeprazole, mesalazine, carvedilol, lactulose, and allopurinol.\n",
      "\n",
      "**Background:**\n",
      "- The patient has a history of primary sclerosing cholangitis with Child's Pugh A cirrhosis and is on azathioprine, an immunosuppressant, which can cause myelosuppression and hepatotoxicity.\n",
      "- She also has chronic ulcerative pancolitis and is on mesalazine, which can cause gastrointestinal side effects such as diarrhea.\n",
      "- The patient has gout and is on allopurinol, which can cause rash and bone marrow suppression.\n",
      "- She is allergic to co-amoxiclav, which limits the choice of antibiotics available to treat infections.\n",
      "\n",
      "**Assessment:**\n",
      "1. Potential Drug-Drug Interactions:\n",
      "   - Azathioprine and Allopurinol: Allopurinol can increase the levels of azathioprine, increasing the risk of myelosuppression and hepatotoxicity. The patient should be closely monitored for signs of toxicity.\n",
      "   - Azathioprine and Metronidazole: Both drugs can cause myelosuppression and should be used cautiously together. Regular monitoring of blood counts is recommended.\n",
      "\n",
      "2. Potential Adverse Drug Reactions:\n",
      "   - Azathioprine: Myelosuppression, hepatotoxicity, and gastrointestinal side effects.\n",
      "   - Metronidazole: Nausea, vomiting, diarrhea, peripheral neuropathy.\n",
      "   - Allopurinol: Rash, bone marrow suppression.\n",
      "   - Ursodeoxycholic Acid: Diarrhea, abdominal pain.\n",
      "   - Carvedilol: Hypotension, bradycardia, dizziness.\n",
      "\n",
      "3. Drug Allergy:\n",
      "   - The patient has a documented allergy to co-amoxiclav, which should be considered when prescribing antibiotics.\n",
      "\n",
      "**Recommendations:**\n",
      "1. Closely monitor the patient for signs of myelosuppression, hepatotoxicity, and gastrointestinal side effects, especially with the combination of azathioprine, allopurinol, and metronidazole. Regular laboratory tests, including complete blood counts and liver function tests, should be performed.\n",
      "2. Monitor blood pressure and heart rate closely while the patient is taking carvedilol.\n",
      "3. Avoid prescribing co-amoxiclav or any other medications containing amoxicillin or clavulanic acid due to the patient's allergy.\n",
      "4. Educate the patient about the potential side effects of her medications and the importance of reporting any adverse reactions promptly.\n",
      "iteration # 13\n",
      "response\n",
      "response\n",
      "response\n",
      "Response from Model:  Situation: The patient is a 45-year-old male with a history of Hepatitis C genotype 3A and Child's B cirrhosis, who is currently being treated for deranged liver function and possible acute cholecystitis. His current medication regimen includes Neurobion, Furosemide, Omeprazole, Spironolactone, Sodium Phosphate, Epclusa, and Paracetamol.\n",
      "\n",
      "Background: The patient has been experiencing scleral icterus, mild abdominal distension, and pedal edema. His laboratory findings show slightly low sodium and hemoglobin levels, as well as a low platelet count. He has a history of hypertension but is not on any antihypertensive medications. Additionally, he drinks three large cans of beer daily, which could potentially worsen his liver disease and hypertension.\n",
      "\n",
      "Assessment:\n",
      "\n",
      "1. Omission of Therapy: The patient has uncontrolled hypertension with a blood pressure of 162/94 mmHg, but he is not on any antihypertensive medication. This could lead to further complications and worsen his liver disease.\n",
      "2. Therapeutic Duplication: The patient is prescribed two diuretics, Furosemide and Spironolactone, which may increase the risk of fluid and electrolyte imbalances.\n",
      "3. Potential Drug-Disease Interactions:\n",
      "   - Omeprazole may increase the risk of hepatic encephalopathy in patients with liver disease.\n",
      "   - Paracetamol should be used cautiously in patients with liver disease due to the risk of hepatotoxicity.\n",
      "   - Spironolactone may worsen hyperkalemia in patients with liver disease.\n",
      "4. Potential Drug-Drug Interactions:\n",
      "   - Furosemide and Spironolactone may increase the risk of hyperkalemia.\n",
      "   - Omeprazole may decrease the absorption of Velpatasvir, a component of Epclusa, reducing its effectiveness.\n",
      "5. Alcohol Consumption: The patient's significant alcohol intake can worsen his liver disease and interact with several medications.\n",
      "\n",
      "Recommendation:\n",
      "1. Initiate appropriate antihypertensive therapy to control blood pressure.\n",
      "2. Monitor the patient's fluid and electrolyte balance closely due to the use of two diuretics.\n",
      "3. Consider alternative medications or dose adjustments to minimize potential drug-disease interactions, such as using H2 receptor antagonists instead of Omeprazole.\n",
      "4. Advise the patient to reduce or avoid alcohol consumption to prevent further liver damage and medication interactions.\n",
      "5. Closely monitor the patient's liver function tests, electrolyte levels, and overall response to treatment.\n",
      "Response from Model:  **Situation:** The patient is a 45-year-old male with a history of Hepatitis C genotype 3A and Child's B cirrhosis, who is currently hospitalized for deranged liver function tests and jaundice. His medication regimen includes Neurobion, Furosemide, Omeprazole, Spironolactone, Sodium Phosphate, Epclusa, and Paracetamol.\n",
      "\n",
      "**Background:** The patient's medical history includes hypertension (HTN), for which he is not currently taking any medications. He also has a history of possible acute cholecystitis, for which he received antibiotics. The patient drinks 3 large cans of beer a day.\n",
      "\n",
      "**Assessment:**\n",
      "\n",
      "1. **Potential Drug-Related Problems:**\n",
      "   - Omission of Therapy: The patient has HTN but is not on any antihypertensive medications.\n",
      "   - Therapeutic Duplication: The patient is taking two diuretics (Furosemide and Spironolactone), which may increase the risk of dehydration and electrolyte imbalances.\n",
      "   - Potential Drug-Disease Interaction: Omeprazole may worsen liver function in patients with liver disease.\n",
      "   - Potential Drug-Disease Interaction: Paracetamol can cause drug-induced liver injury.\n",
      "   - Potential Drug-Disease Interaction: Epclusa should be monitored closely in patients with liver disease.\n",
      "\n",
      "2. **Drug-Drug Interactions:**\n",
      "   - Furosemide and Spironolactone: Increased risk of hyperkalemia.\n",
      "   - Omeprazole and Epclusa: Omeprazole may decrease the absorption of Epclusa.\n",
      "   - Furosemide and Paracetamol: Increased risk of renal adverse effects.\n",
      "   - Spironolactone and Paracetamol: Increased risk of Paracetamol toxicity.\n",
      "\n",
      "**Recommendations:**\n",
      "\n",
      "1. **Address Omission of Therapy:** Consider starting the patient on an antihypertensive medication to manage his HTN.\n",
      "2. **Assess Therapeutic Duplication:** Re-evaluate the need for dual diuretic therapy. Monitor electrolyte levels closely if both diuretics are continued.\n",
      "3. **Consider Alternative Medications:** Consider an alternative to Omeprazole, such as an H2 blocker, to reduce the risk of liver toxicity.\n",
      "4. **Monitor for Drug-Induced Liver Injury:** Monitor liver function tests closely while the patient is on Paracetamol and Epclusa.\n",
      "5. **Monitor Fluid Balance:** Monitor the patient's fluid balance closely to prevent dehydration.\n",
      "6. **Counsel on Alcohol Intake:** Counsel the patient on the risks of alcohol consumption, particularly in relation to his liver disease and medication regimen.\n",
      "7. **Discontinue Neurobion:** Since the clinical notes do not mention any conditions that require Neurobion, its necessity should be reviewed and discontinued if not essential.\n",
      "8. **Discontinue Sodium Phosphate:** The patient's lab values do not show a deficiency in phosphate, so Sodium Phosphate may not be necessary and should be discontinued.\n",
      "Response from Model:  Situation: The patient has a history of hypertension (HTN) but is not on any antihypertensive medication despite having elevated blood pressure readings.\n",
      "\n",
      "Background: Uncontrolled HTN can lead to serious health consequences, including increased risk of cardiovascular disease, stroke, and kidney damage.\n",
      "\n",
      "Assessment: The omission of antihypertensive therapy in a patient with HTN is a significant drug-related problem.\n",
      "\n",
      "Recommendation: Initiate appropriate antihypertensive medication and monitor blood pressure regularly to achieve and maintain blood pressure control. \n",
      "\n",
      "Situation: The patient is currently prescribed both Furosemide and Spironolactone, which are both diuretics.\n",
      "\n",
      "Background: While these medications can be used together in certain situations, they can also lead to excessive diuresis, dehydration, and electrolyte imbalances.\n",
      "\n",
      "Assessment: The concurrent use of two diuretics without close monitoring increases the risk of adverse effects.\n",
      "\n",
      "Recommendation: Re-evaluate the need for dual diuretic therapy. If both are deemed necessary, monitor the patient's fluid and electrolyte status closely to prevent complications.\n",
      "\n",
      "Situation: The patient has liver cirrhosis and is prescribed Omeprazole.\n",
      "\n",
      "Background: Omeprazole is a proton pump inhibitor that can be metabolized in the liver. In patients with liver impairment, the bioavailability of Omeprazole may be increased, leading to potential adverse effects.\n",
      "\n",
      "Assessment: The use of Omeprazole in a patient with liver cirrhosis warrants caution and close monitoring.\n",
      "\n",
      "Recommendation: Consider alternative medications or dose adjustments of Omeprazole based on the patient's liver function to minimize the risk of adverse reactions.\n",
      "\n",
      "Situation: The patient is on Spironolactone, a potassium-sparing diuretic, and has liver disease.\n",
      "\n",
      "Background: Liver disease can impair the body's ability to excrete potassium, increasing the risk of hyperkalemia. Spironolactone can further elevate potassium levels.\n",
      "\n",
      "Assessment: The combination of Spironolactone and liver disease increases the risk of hyperkalemia.\n",
      "\n",
      "Recommendation: Closely monitor the patient's potassium levels while on Spironolactone and consider dose adjustments or alternative medications if hyperkalemia develops.\n",
      "iteration # 14\n",
      "response\n",
      "response\n",
      "response\n",
      "Response from Model:  **Situation:**\n",
      "A 64-year-old Indian male with a history of Child's B8 cirrhosis, diabetes mellitus, hypertension, ischemic heart disease with heart failure with reduced ejection fraction, atrial fibrillation, chronic kidney disease, and hypothyroidism is currently hospitalized for recurrent ascites and acute on chronic kidney disease. His medication regimen includes Isosorbide Mononitrate, Linagliptin, Allopurinol, Omeprazole, Aspirin, Carvedilol, Ciprofloxacin, Digoxin, Sodium Bicarbonate, Levothyroxine, Neurobion, Renal Vitamin, Lactulose Syrup, and Sennosides 7.5mg Tablet.\n",
      "\n",
      "**Background:**\n",
      "The patient has a complex medical history with multiple chronic conditions and is currently experiencing complications related to his liver disease and kidney function. He has been hospitalized for recurrent ascites and is also being treated for a urinary tract infection. His medication regimen is extensive and includes medications for various indications, including angina, diabetes, gout, gastrointestinal prophylaxis, cardiovascular management, atrial fibrillation, hypothyroidism, vitamin deficiencies, constipation, and renal support.\n",
      "\n",
      "**Assessment:**\n",
      "\n",
      "1. **Potential for Drug-Related Problems:**\n",
      "- Therapeutic Duplication: The patient is taking both Lactulose Syrup and Sennosides 7.5mg Tablet for constipation. Both medications are laxatives and using them together may increase the risk of diarrhea and electrolyte imbalance.\n",
      "- Omission of Therapy: The patient has a history of atrial fibrillation and is not currently on any anticoagulation therapy. Although he was previously on Apixaban, it was stopped due to high falls and bleeding risk. However, the patient's CHADSVasc score is 5, indicating a high risk of stroke. The benefits and risks of anticoagulation therapy should be reassessed.\n",
      "- Potential Drug-Disease Interaction: The patient has a history of chronic kidney disease (CKD) and is taking Allopurinol, which may worsen renal function. The dose of Allopurinol should be adjusted according to the patient's renal function.\n",
      "- Potential Drug-Disease Interaction: The patient has a history of heart failure and is taking Isosorbide Mononitrate. This medication can cause hypotension, which may exacerbate heart failure symptoms. The patient's blood pressure and heart failure symptoms should be closely monitored.\n",
      "- Omission of Therapy: The patient has a history of hypothyroidism and is taking Levothyroxine. However, the patient's latest lab results show a low hemoglobin level, which may indicate anemia. Anemia is a common condition in patients with hypothyroidism. The patient's hemoglobin level should be monitored and treatment for anemia should be considered if necessary.\n",
      "- Potential Drug-Disease Interaction: The patient has a history of liver disease and is taking Omeprazole, which is metabolized in the liver. The use of Omeprazole in patients with liver disease may increase the risk of hepatic encephalopathy. The patient's liver function should be closely monitored and the dose of Omeprazole should be adjusted if necessary.\n",
      "- Potential Drug-Disease Interaction: The patient has a history of liver disease and is taking Aspirin. Aspirin can potentially cause or worsen liver damage. The patient's liver function should be closely monitored.\n",
      "- Potential Drug-Disease Interaction: The patient has a history of liver disease and is taking Digoxin. Digoxin can potentially cause or worsen liver damage. The patient's liver function should be closely monitored.\n",
      "- Potential Drug-Disease Interaction: The patient has a history of liver disease and is taking Carvedilol. Carvedilol can potentially cause or worsen liver damage. The patient's liver function should be closely monitored.\n",
      "- Potential Drug-Disease Interaction: The patient has a history of liver disease and is taking Ciprofloxacin. Ciprofloxacin can potentially cause or worsen liver damage. The patient's liver function should be closely monitored.\n",
      "\n",
      "2. **Medication Dosing and Monitoring:**\n",
      "The patient's medication doses do not appear to be adjusted for his kidney and liver impairment. While some medications have specific dosing recommendations for renal or hepatic impairment, the provided information does not include specific dose adjustments for this patient. It is important to consult with a pharmacist or physician to review the patient's medication doses and make necessary adjustments based on his organ function.\n",
      "\n",
      "3. **Potential Drug-Drug Interactions:**\n",
      "There are several potential drug interactions to consider based on the patient's medication list:\n",
      "- Allopurinol and Omeprazole: Both drugs can interact with amoxicillin, potentially altering its serum concentration. If the patient is prescribed amoxicillin in the future, this interaction should be considered.\n",
      "- Carvedilol and Digoxin: Both drugs can have their serum concentrations affected by certain enzyme inhibitors. If the patient is prescribed any CYP2D6, CYP2C9 inhibitors (for Carvedilol) or drugs like vibegron, vilazodone,\n",
      "Response from Model:  **Situation:**\n",
      "\n",
      "A 64-year-old male patient with a history of Child's B8 Cirrhosis, Diabetes Mellitus (DM), Hypertension (HTN), Hyperlipidemia (HLD), Ischemic Heart Disease (IHD) with Heart Failure with Reduced Ejection Fraction (HFrEF), Atrial Fibrillation (AF), Stage 3 Chronic Kidney Disease (CKD), and Hypothyroidism is currently admitted for recurrent ascites and acute on chronic kidney disease (AoCKD), likely secondary to a male urinary tract infection (UTI). The patient's medication list includes medications for various conditions, including isosorbide mononitrate, linagliptin, allopurinol, omeprazole, aspirin, carvedilol, ciprofloxacin (currently suspended), digoxin, sodium bicarbonate, levothyroxine, neurobion, renal vitamins, lactulose, and sennoside.\n",
      "\n",
      "**Background:**\n",
      "\n",
      "The patient has a complex medical history with multiple chronic conditions. His liver cirrhosis is at Child's B8 stage, indicating advanced liver disease. He has a history of spontaneous bacterial peritonitis and is on lifelong ciprofloxacin prophylaxis. The patient also has DM, HTN, HLD, and IHD with HFrEF. He underwent coronary artery bypass graft (CABG) x4 and has a reduced left ventricular ejection fraction (LVEF) of 17%. The patient has AF with a CHADSVasc score of 5, indicating a high risk of stroke, but he is not currently on anticoagulation due to a history of high falls and bleeding risk. Additionally, he has stage 3 CKD and hypothyroidism, for which he is taking levothyroxine.\n",
      "\n",
      "**Assessment:**\n",
      "\n",
      "1. **Potential for drug-related problems:** There are several potential drug-related problems based on the patient's medication list and clinical condition. These include:\n",
      "    * Therapeutic duplication: The patient is taking both omeprazole and sodium bicarbonate, which are both used to reduce stomach acid. This may increase the risk of side effects and potential interactions.\n",
      "    * Omission of therapy: The patient has a history of AF and is currently not on anticoagulation therapy. This increases his risk of stroke. Alternative anticoagulation options or other stroke prevention strategies should be considered.\n",
      "    * Potential drug-disease interaction: The patient has stage 3 CKD and is taking allopurinol, which can worsen renal function. His renal function should be closely monitored, and the dose of allopurinol may need to be adjusted.\n",
      "    * Potential drug-disease interaction: The patient has liver cirrhosis and is taking several medications that are metabolized in the liver, including omeprazole, carvedilol, and levothyroxine. This can increase the risk of drug accumulation and potential side effects. Liver function should be closely monitored, and dose adjustments or alternative medications may be necessary.\n",
      "    * Omission of therapy: The patient has hypothyroidism and is taking levothyroxine, but his TSH level is not mentioned in the clinical document. Thyroid function should be monitored regularly to ensure adequate replacement therapy.\n",
      "    * Potential drug-disease interaction: The patient has HFrEF and is taking digoxin. Digoxin levels should be monitored closely to avoid toxicity, which can worsen heart failure.\n",
      "    * Omission of therapy: The patient has DM and is only taking linagliptin. His blood glucose levels should be reviewed, and additional antidiabetic therapy may be needed.\n",
      "    * Potential drug-disease interaction: The patient has ascites and is fluid restricted. However, he is taking isosorbide mononitrate, which can cause hypotension and worsen ascites. Blood pressure and fluid status should be closely monitored.\n",
      "\n",
      "2. **Dosing and monitoring considerations:** The dosages of the patient's medications appear to be within the usual range for their respective indications. However, given the patient's impaired kidney and liver function, close monitoring is necessary. Dose adjustments may be needed based on the patient's condition and response to treatment.\n",
      "\n",
      "**Recommendation:**\n",
      "\n",
      "1. **Review medications:** The patient's medication regimen should be reviewed by a healthcare professional to address the potential drug-related problems identified. This may involve discontinuing unnecessary medications, adjusting doses, or adding additional therapies.\n",
      "\n",
      "2. **Monitor renal and liver function:** The patient's renal and liver function should be closely monitored due to the presence of CKD and liver cirrhosis. This may involve regular laboratory tests, monitoring of vital signs, and assessment for signs and symptoms of organ dysfunction.\n",
      "\n",
      "3. **Educate the patient:** The patient should be educated about his medications, including their purpose, potential side effects, and interactions. He should also be advised to adhere to the prescribed dosing schedule and fluid restrictions.\n",
      "\n",
      "4. **Follow-up care:** The patient should have regular follow-up appointments with his healthcare provider to monitor his condition and make any necessary adjustments to his treatment plan.\n",
      "Response from Model:  **Situation:**\n",
      "A 64-year-old male patient with a history of Child's B8 Cirrhosis, Diabetes Mellitus (DM), Hypertension (HTN), Ischemic Heart Disease (IHD) with Heart Failure with Reduced Ejection Fraction (HFrEF), Atrial Fibrillation (AF), Stage 3 Chronic Kidney Disease (CKD), and Hypothyroidism is currently admitted for recurrent ascites. His medication regimen includes Isosorbide Mononitrate, Linagliptin, Allopurinol, Omeprazole, Aspirin, Carvedilol, Ciprofloxacin (currently suspended due to urinary tract infection [UTI] and replaced with Augmentin), Digoxin, Sodium Bicarbonate, Levothyroxine, Neurobion, Renal Vitamin, Lactulose Syrup, and Sennosides 7.5mg Tablet.\n",
      "\n",
      "**Background:**\n",
      "The patient has several medical conditions and is taking numerous medications, some of which may interact or have dose adjustments due to his kidney and liver impairment. It is crucial to review his medication regimen for potential drug-related problems, including indications, dosages, adverse reactions, contraindications, drug interactions, and omission of therapy or therapeutic duplication.\n",
      "\n",
      "**Assessment:**\n",
      "1. **Indication:** Most of the medications appear to be prescribed for appropriate indications based on the patient's medical conditions. \n",
      "\n",
      "2. **Dosing:**\n",
      "   - The medication list does not provide information about dosages for several medications. It is essential to review the dosages and ensure they are appropriate considering the patient's weight, renal function, and liver function. Some medications, such as Isosorbide Mononitrate, Linagliptin, Allopurinol, Omeprazole, Carvedilol, Ciprofloxacin, Digoxin, and Levothyroxine, may require dosage adjustments in patients with kidney or liver impairment.\n",
      "\n",
      "3. **Potential Adverse Reactions:**\n",
      "   - Aspirin: Increased risk of bleeding, especially in patients with liver disease.\n",
      "   - Carvedilol: May increase the serum concentration of Digoxin, which should be monitored.\n",
      "   - Ciprofloxacin: Potential adverse reactions include aortic aneurysm and dissection, tendinopathy and tendon rupture, peripheral neuropathy, and CNS effects. Renal function should be closely monitored due to the risk of crystalluria.\n",
      "   - Digoxin: Periodic monitoring of serum digoxin concentrations is recommended, especially in the presence of kidney impairment.\n",
      "   - Levothyroxine: Adverse reactions are primarily those of hyperthyroidism due to therapeutic overdosage.\n",
      "   - Omeprazole: Potential adverse reactions include cutaneous and systemic lupus erythematosus, gastrointestinal effects, lactic acidosis, and vitamin B12 deficiency.\n",
      "   - Allopurinol: May cause skin rash, nausea, vomiting, and gout.\n",
      "\n",
      "4. **Contraindications:** No apparent contraindications based on the provided information.\n",
      "\n",
      "5. **Drug Interactions:**\n",
      "   - Linagliptin and Omeprazole: Omeprazole is a CYP3A4 inhibitor and may increase the serum concentration of Linagliptin, potentially requiring dose adjustment.\n",
      "   - Allopurinol and Aspirin: May interact, leading to changes in serum concentrations or an increased risk of allergic or hypersensitivity reactions.\n",
      "   - Carvedilol and Digoxin: Both drugs can slow heart rate and decrease blood pressure, increasing the risk of bradycardia, hypotension, heart failure, and other side effects.\n",
      "   - Ciprofloxacin and Omeprazole: Omeprazole may decrease the absorption of Ciprofloxacin, reducing its effectiveness.\n",
      "   - Levothyroxine and Omeprazole: Omeprazole may decrease the absorption of Levothyroxine, reducing its effectiveness.\n",
      "\n",
      "6. **Omission of Therapy:** The patient has a history of AF and is at high risk of stroke (CHADSVasc score of 5), but he is not currently receiving anticoagulation therapy due to high falls and bleeding risk. This omission of therapy should be addressed to prevent potential stroke.\n",
      "\n",
      "7. **Therapeutic Duplication:** The patient is taking both Lactulose Syrup and Sennosides 7.5mg Tablet for constipation, which may increase the risk of diarrhea and electrolyte imbalance.\n",
      "\n",
      "**Recommendation:**\n",
      "1. **Medication Review:** A comprehensive medication review should be performed by a pharmacist or healthcare provider to assess the appropriateness of indications, dosages, and potential drug interactions. This review should consider the patient's renal and hepatic function.\n",
      "\n",
      "2. **Omission of Anticoagulation Therapy:** The healthcare team should reassess the patient's risk of stroke and consider alternative anticoagulation strategies that may be safer for him, such as a lower dose of a direct oral anticoagulant or a non-vitamin K antagonist oral anticoagulant.\n",
      "\n",
      "3. **Therapeutic Duplication:** The necessity of both Lactulose Syrup and Sennosides 7.5mg Tablet should be evaluated, and one of the\n",
      "iteration # 15\n",
      "response\n",
      "response\n",
      "response\n",
      "Response from Model:  **Situation:**\n",
      "The patient is a 77-year-old female with a history of decompensated Child's C 10 cryptogenic liver cirrhosis, H Pylori infection, osteoporosis, asthma, and likely anemia of chronic disease. She is currently on multiple medications, including Rifaximin, Metronidazole, Omeprazole, Tetracycline, Lactulose, Ciprofloxacin, Amlodipine, and Furosemide.\n",
      "\n",
      "**Background:**\n",
      "- The patient has a history of multiple medical conditions and is on a complex medication regimen.\n",
      "- Her liver cirrhosis is complicated by diuretic-intolerant ascites, portal hypertension, varices, recurrent hepatic encephalopathy, hepatorenal syndrome type 2, and hyponatremia.\n",
      "- She also has a history of H Pylori infection, osteoporosis, asthma, and anemia of chronic disease.\n",
      "\n",
      "**Assessment:**\n",
      "- There are several potential drug-related problems and omissions of therapy that need to be addressed.\n",
      "\n",
      "**Recommendations:**\n",
      "\n",
      "1. **Drug-related problems:**\n",
      "    - **Potential therapeutic duplication:** The patient is on two antibiotics, Rifaximin and Metronidazole, for hepatic encephalopathy prophylaxis. While both drugs are commonly used for this purpose, their concurrent use may increase the risk of antibiotic-associated diarrhea and antibiotic resistance. The need for dual antibiotic therapy should be reassessed.\n",
      "\n",
      "    - **Omission of therapy:**\n",
      "        - The patient has a history of H Pylori infection, but she is not currently on any treatment for this condition. She should be started on a standard triple or quadruple therapy regimen to eradicate H Pylori.\n",
      "        - The patient has osteoporosis but is not taking any medication for this condition. She should be assessed for her bone mineral density and started on an appropriate osteoporosis medication, such as a bisphosphonate.\n",
      "        - The patient has a history of asthma, but she does not have a rescue inhaler. She should be provided with a short-acting beta-agonist inhaler for acute asthma attacks.\n",
      "        - The patient has anemia of chronic disease, but she is not taking any iron supplementation or erythropoiesis-stimulating agents. Her iron studies should be checked, and she should be started on iron therapy if she is iron-deficient.\n",
      "\n",
      "2. **Medication changes:**\n",
      "    - **Amlodipine:** The patient's blood pressure is within the normal range, and there is no indication that she needs to be on Amlodipine. This medication can cause peripheral edema, which may worsen her ascites. It is recommended to discontinue Amlodipine.\n",
      "\n",
      "    - **Furosemide:** The patient's Furosemide is currently suspended due to her diuretic-intolerant ascites. However, given her history of recurrent ascites, the use of diuretics should be carefully considered. If diuretics are deemed necessary, they should be used cautiously and monitored closely for their effectiveness and side effects.\n",
      "\n",
      "3. **Other recommendations:**\n",
      "    - The patient should be monitored closely for any signs and symptoms of infection, including fever, chills, and abdominal pain.\n",
      "    - She should also be monitored for any adverse effects of her medications, such as gastrointestinal upset, rash, or peripheral neuropathy.\n",
      "    - The patient should follow a low-sodium diet and fluid restriction as prescribed to manage her ascites.\n",
      "    - She should also be encouraged to exercise regularly and maintain a healthy weight to prevent further complications of her liver cirrhosis.\n",
      "\n",
      "It is important to note that these recommendations are based on the information provided in the clinical document and medication list. A comprehensive medication review and assessment by a healthcare professional are necessary to confirm these recommendations and make any necessary adjustments to the patient's medication regimen.\n",
      "Response from Model:  Situation:\n",
      "A 77-year-old female patient with a complex medical history including liver cirrhosis, H. pylori infection, osteoporosis, asthma, and likely anemia of chronic disease is currently on multiple medications for various conditions. \n",
      "\n",
      "Background:\n",
      "The patient's medication list includes Rifaximin, Metronidazole, Omeprazole, Tetracycline, Lactulose, Ciprofloxacin, Amlodipine, and Calcium Carb 450mg, Vitamin D 200-unit Tablet. \n",
      "\n",
      "Assessment:\n",
      "1. Potential Drug-Related Problems:\n",
      "   - Unclear indication for Metronidazole.\n",
      "   - Omission of therapy for H. pylori infection.\n",
      "   - Potential for antibiotic-associated diarrhea with Rifaximin and Metronidazole co-administration.\n",
      "   - Increased risk of CNS toxicity with Ciprofloxacin and Metronidazole combination.\n",
      "   - Potential for peripheral edema exacerbation with Amlodipine.\n",
      "   - Potential for drug interactions and altered drug metabolism due to hepatic and renal impairment.\n",
      "\n",
      "2. Omission of Therapy:\n",
      "   - Osteoporosis medication.\n",
      "   - Asthma medication.\n",
      "   - Anemia of chronic disease management.\n",
      "   - Hyponatremia treatment.\n",
      "   - Portal vein thrombosis therapy.\n",
      "   - HRS Type 2 management.\n",
      "   - BD-IPMN treatment.\n",
      "   - Liver cirrhosis-specific therapy.\n",
      "   - Ascites-specific medication.\n",
      "\n",
      "Recommendation:\n",
      "1. Review the necessity and appropriateness of Metronidazole therapy.\n",
      "2. Initiate appropriate treatment for H. pylori infection, considering alternatives due to cloxacillin allergy.\n",
      "3. Monitor for and manage potential adverse effects of drug combinations, such as antibiotic-associated diarrhea and CNS toxicity.\n",
      "4. Address omitted therapies for osteoporosis, asthma, anemia, hyponatremia, portal vein thrombosis, HRS Type 2, BD-IPMN, liver cirrhosis, and ascites.\n",
      "5. Adjust medication dosages or consider alternative agents as needed based on the patient's hepatic and renal function.\n",
      "6. Provide patient education and counseling regarding medication adherence, potential side effects, and lifestyle modifications.\n",
      "7. Monitor the patient's overall clinical status, response to therapies, and any changes in laboratory values or vital signs.\n",
      "Response from Model:  **Situation:** A 77-year-old female patient with a history of decompensated Child's C 10 cryptogenic liver cirrhosis, H Pylori infection, osteoporosis, asthma, and likely anemia of chronic disease is on multiple medications, including Rifaximin, Metronidazole, Omeprazole, Tetracycline, Lactulose, Ciprofloxacin, Amlodipine, and others.\n",
      "\n",
      "**Background:** The patient's complex medical history and extensive medication regimen warrant a thorough review to identify and address potential drug-related problems.\n",
      "\n",
      "**Assessment:** \n",
      "\n",
      "1. **Therapeutic Duplication:** The patient is prescribed two antibiotics, Rifaximin and Metronidazole, which increases the risk of antibiotic-associated diarrhea and antibiotic resistance. \n",
      "\n",
      "2. **Omission of Therapy:** Despite a history of H Pylori infection, treatment has not been initiated, leaving the infection untreated.\n",
      "\n",
      "3. **Potential Drug-Drug Interactions:** \n",
      "   - Rifaximin and Metronidazole: Concomitant use can increase the risk of antibiotic-associated diarrhea.\n",
      "   - Omeprazole and Ciprofloxacin: Omeprazole may decrease Ciprofloxacin absorption, reducing its effectiveness.\n",
      "   - Omeprazole and Metronidazole: Omeprazole may increase Metronidazole serum concentration, potentially enhancing adverse effects.\n",
      "   - Omeprazole and Tetracycline: Omeprazole may decrease Tetracycline absorption, reducing its effectiveness.\n",
      "   - Amlodipine and Furosemide: Concomitant use may increase the risk of hypotension.\n",
      "\n",
      "4. **Potential Drug-Disease Interactions:**\n",
      "   - Omeprazole and osteoporosis: Omeprazole may decrease calcium absorption, potentially worsening osteoporosis.\n",
      "   - Amlodipine and liver cirrhosis: Amlodipine may worsen liver function.\n",
      "   - Ciprofloxacin and liver cirrhosis: Ciprofloxacin may worsen liver function.\n",
      "   - Tetracycline and liver cirrhosis: Tetracycline may worsen liver function.\n",
      "   - Metronidazole and liver cirrhosis: Metronidazole may worsen liver function.\n",
      "   - Rifaximin and liver cirrhosis: Rifaximin may worsen liver function.\n",
      "\n",
      "**Recommendation:** \n",
      "\n",
      "1. **Discontinuation of Metronidazole:** Given the potential for therapeutic duplication and drug-drug interactions, Metronidazole should be discontinued, and the patient should be closely monitored for any signs of worsening H Pylori infection.\n",
      "\n",
      "2. **Initiation of H Pylori Treatment:** Quadruple therapy should be initiated to eradicate H Pylori and prevent further complications. The patient's cloxacillin allergy should be considered when selecting antibiotics for the regimen.\n",
      "\n",
      "3. **Dose Adjustments or Alternative Medications:** The potential drug-drug and drug-disease interactions should be addressed by adjusting doses, choosing alternative medications, or implementing additional monitoring measures. \n",
      "\n",
      "4. **Regular Monitoring:** The patient's liver function, renal function, blood pressure, and any other relevant parameters should be closely monitored to detect and manage any adverse effects or complications.\n",
      "\n",
      "5. **Patient Education:** Provide comprehensive counseling to the patient regarding their medications, including proper administration, potential side effects, and the importance of medication adherence. \n",
      "\n",
      "By implementing these recommendations, we aim to optimize the patient's medication regimen, minimize drug-related problems, and ensure safe and effective management of their medical conditions.\n",
      "iteration # 16\n",
      "response\n",
      "response\n",
      "response\n",
      "Response from Model:  **Situation:**\n",
      "The patient is a 55-year-old male with a history of perforated duodenal ulcer, metastatic relapse of salivary gland-epithelial myoepithelial carcinoma with liver visceral crisis, neutropenia sepsis, and Hepatitis B. He has elevated glucose levels and is currently on multiple medications, including insulin, antibiotics, antifungals, proton pump inhibitors, and pain relievers.\n",
      "\n",
      "**Background:**\n",
      "The patient's current medications include:\n",
      "\n",
      "- ACTRAPID [Insulin Soluble] Injection\n",
      "- Anidulafungin Injection\n",
      "- Filgrastim Injection\n",
      "- INSULAtard [Insulin Isophane] Injection\n",
      "- OMEprazole Injection\n",
      "- Paracetamol Injection\n",
      "- Tazocin Injection [Piperacillin, Tazobactam]\n",
      "- Thiamine HCl [Vitamin B1] Injection\n",
      "- TPN (With Electrolytes) [SMOFKABIVEN] Infusion\n",
      "- Tramadol HCl Injection\n",
      "- Vancomycin Injection\n",
      "- Entecavir Tablet\n",
      "- GliPIzide Tablet (suspended)\n",
      "- MetFORMIN HCl Tablet (suspended)\n",
      "\n",
      "**Assessment:**\n",
      "\n",
      "1. **Hyperglycemia:** The patient's glucose levels are consistently elevated, indicating poor glycemic control. The suspension of oral antidiabetic medications (GliPIzide and MetFORMIN) and TPN may be contributing factors.\n",
      "\n",
      "2. **Potential drug-drug interactions:** There are several potential drug-drug interactions, including:\n",
      "    - Filgrastim and chemotherapy: increased risk of myelodysplastic syndrome (MDS) and acute myeloid leukemia (AML).\n",
      "    - Omeprazole and other drugs: inhibition of CYP2C19, affecting the metabolism of certain drugs.\n",
      "    - Tazocin and CYP3A4 inhibitors: increased serum concentration of Tazocin.\n",
      "    - Tramadol and other drugs: increased serum concentration due to CYP2D6 and CYP3A4 inhibition.\n",
      "    - Vancomycin and other drugs: enhanced nephrotoxic and neurotoxic effects.\n",
      "\n",
      "3. **Potential drug-disease interactions:**\n",
      "    - Tazocin and Vancomycin: potential nephrotoxicity, especially in the presence of impaired kidney function.\n",
      "    - Entecavir and liver disease: potential for altered drug metabolism and increased risk of adverse effects.\n",
      "\n",
      "4. **Omission of therapy:** The patient's oral antidiabetic medications (GliPIzide and MetFORMIN) have been suspended, which could lead to poor glycemic control.\n",
      "\n",
      "5. **Therapeutic duplication:** The patient is on two types of insulin (ACTRAPID and INSULAtard), which may increase the risk of hypoglycemia.\n",
      "\n",
      "6. **Underuse of medication:** The patient's neutropenia may indicate that the current dose of Filgrastim is insufficient.\n",
      "\n",
      "**Recommendations:**\n",
      "1. **Optimize glycemic control:**\n",
      "    - Consult with an endocrinologist or diabetes specialist to review the patient's insulin regimen, including the potential need to adjust doses or resume oral antidiabetic medications.\n",
      "\n",
      "2. **Review medication interactions:**\n",
      "    - Evaluate the patient's medications for potential drug-drug interactions and adjust doses or medications as needed.\n",
      "\n",
      "3. **Monitor for adverse effects:**\n",
      "    - Closely monitor the patient for signs of adverse drug reactions, especially those related to potential drug-drug and drug-disease interactions.\n",
      "\n",
      "4. **Optimize supportive care:**\n",
      "    - Ensure adequate hydration and nutrition to support the patient's overall health and recovery.\n",
      "    - Provide pain management as needed, considering the potential for drug interactions with Tramadol.\n",
      "\n",
      "5. **Educate the patient:**\n",
      "    - Provide education to the patient and their caregivers about their medications, potential side effects, and the importance of adhering to the prescribed treatment plan.\n",
      "Response from Model:  Situation: A 55-year-old male patient with a history of perforated duodenal ulcer, metastatic relapse of salivary gland-epithelial myoepithelial carcinoma with liver visceral crisis, neutropenia sepsis, and Hepatitis B is currently being managed with multiple medications.\n",
      "\n",
      "Background: The patient's current medication regimen includes Actrapid and Insulatard for glucose control, Anidulafungin and Tazocin for neutropenia sepsis, Filgrastim for neutropenia, Omeprazole for perforated duodenal ulcer, Paracetamol for pain, Tramadol for pain, Vancomycin for MRSA colonization, and Entecavir for Hepatitis B. His laboratory values show potential kidney impairment (creatinine 40 umol/L) and a history of Hepatitis B.\n",
      "\n",
      "Assessment:\n",
      "\n",
      "1. Potential Omission of Therapy: The patient's glucose levels are consistently elevated, suggesting that the current insulin regimen may be inadequate. The recent glucose results indicate persistent hyperglycemia.\n",
      "\n",
      "2. Potential Drug-Drug Interaction: The combination of Filgrastim and Tazocin may increase the risk of pulmonary toxicity.\n",
      "\n",
      "3. Potential Drug-Disease Interaction: Omeprazole's effect on CYP2C19 activity may influence the metabolism of other co-administered medications, potentially leading to altered drug effects.\n",
      "\n",
      "4. Potential Adverse Drug Reaction: Anidulafungin should not be infused concurrently with other medications or electrolytes to avoid compatibility issues.\n",
      "\n",
      "5. Potential Therapeutic Duplication: The patient is prescribed both Insulatard and Actrapid insulin, which are both used for glucose control. It is crucial to ensure appropriate dosing and assess the effectiveness of the current regimen.\n",
      "\n",
      "Recommendation:\n",
      "\n",
      "1. Review and optimize the patient's insulin regimen:\n",
      "- Consult with an endocrinologist or diabetes specialist to assess the patient's glucose control and adjust insulin doses accordingly.\n",
      "- Consider reintroducing GliPIzide and MetFORMIN if appropriate, taking into account the patient's current condition and tolerability.\n",
      "\n",
      "2. Monitor for potential drug-drug interactions:\n",
      "- Closely observe the patient for signs of pulmonary toxicity, especially respiratory symptoms, and adjust therapy if necessary.\n",
      "\n",
      "3. Assess and manage potential drug-disease interactions:\n",
      "- Monitor for any alterations in drug response or adverse effects related to the interaction between Omeprazole and other medications.\n",
      "\n",
      "4. Ensure proper administration of Anidulafungin:\n",
      "- Verify the compatibility of Anidulafungin with other medications or electrolytes before infusion.\n",
      "\n",
      "5. Review the necessity of therapeutic duplication:\n",
      "- Evaluate the rationale for prescribing both Insulatard and Actrapid insulin. Consider simplifying the regimen if appropriate.\n",
      "\n",
      "6. Monitor for adverse drug reactions:\n",
      "- Observe the patient for any signs of hypersensitivity or infusion-related reactions, especially with Anidulafungin.\n",
      "\n",
      "7. Address potential kidney impairment:\n",
      "- Assess the patient's renal function regularly and adjust medication doses as necessary based on creatinine clearance.\n",
      "\n",
      "8. Continue monitoring for signs of infection and neutropenia:\n",
      "- Monitor the patient's response to the current antibiotic regimen and Filgrastim therapy. Adjust treatment as needed based on culture results and clinical progress.\n",
      "\n",
      "9. Monitor for potential adverse effects of Vancomycin:\n",
      "- Observe the patient for signs of immune-mediated anaphylaxis, especially considering the patient's history of neutropenia.\n",
      "\n",
      "10. Provide patient education:\n",
      "- Educate the patient about their medications, including proper administration techniques, potential side effects, and the importance of adherence to the prescribed regimen.\n",
      "\n",
      "11. Regularly review and optimize the medication regimen:\n",
      "- Conduct periodic medication reviews to ensure the continued appropriateness, effectiveness, and safety of the patient's medication therapy.\n",
      "Response from Model:  **Situation:** The patient has high glucose levels and is currently on sliding scale insulin regimen with Actrapid and Insulatard, but their blood glucose levels remain uncontrolled. \n",
      "\n",
      "**Background:** The patient has a history of perforated duodenal ulcer, metastatic relapse of salivary gland-epithelial myoepithelial carcinoma with liver visceral crisis, neutropenia sepsis, and hepatitis B. They are currently receiving various medications including antibiotics, antifungals, chemotherapy, proton pump inhibitors, and pain relievers. \n",
      "\n",
      "**Assessment:** \n",
      "1. Omission of therapy: The patient's oral antidiabetic medications, GliPIzide and Metformin, have been suspended, which could be contributing to poor glycemic control. \n",
      "\n",
      "2. Therapeutic duplication: The patient is prescribed two types of insulin, Actrapid and Insulatard, without clear justification or indication for combination therapy. \n",
      "\n",
      "**Recommendation:** \n",
      "1. Consider restarting the patient's oral antidiabetic medications, GliPIzide and Metformin, as appropriate, and closely monitor their blood glucose levels. Adjust insulin doses if needed. \n",
      "\n",
      "2. Review the necessity of dual insulin therapy. Consider optimizing the dosing or regimen of one long-acting insulin instead of using both Actrapid and Insulatard. \n",
      "\n",
      "**Situation**: The patient is on multiple medications that can potentially interact with each other, increasing the risk of adverse drug reactions. \n",
      "\n",
      "**Background**: The patient is receiving Tazocin (piperacillin/tazobactam), Vancomycin, Anidulafungin, Tramadol, Omeprazole, and Entecavir, among others. \n",
      "\n",
      "**Assessment**: \n",
      "1. Potential drug-drug interactions: \n",
      "   - Tazocin and Vancomycin: both antibiotics, can have additive nephrotoxic effects. \n",
      "   - Filgrastim and Pac/Carbo (chemotherapy): Filgrastim may increase the risk of MDS and AML when used with chemotherapy. \n",
      "   - Omeprazole and other drugs: Omeprazole can inhibit the activity of CYP2C19, affecting the metabolism of certain medications. \n",
      "   - Tramadol and CYP2D6/CYP3A4 inhibitors: Tramadol serum concentration may increase if co-administered with these inhibitors. \n",
      "\n",
      "2. Potential drug-disease interactions:\n",
      "   - Vancomycin and neutropenia: Vancomycin can cause neutropenia, which may worsen the patient's existing neutropenia. \n",
      "   - Entecavir and liver disease: Entecavir should be used with caution in patients with liver impairment as it is primarily metabolized by the liver. \n",
      "\n",
      "**Recommendation**: \n",
      "1. Carefully review the patient's medication list for potential drug-drug and drug-disease interactions. \n",
      "2. Monitor for signs of adverse drug reactions and adjust medications as necessary. Consider alternative medications or dose modifications to minimize the risk of interactions. \n",
      "\n",
      "**Situation**: The patient's lab values indicate potential kidney impairment, as evidenced by a low creatinine level (Cr 40 uMOL/L). \n",
      "\n",
      "**Background**: The patient is on several medications that require dose adjustments or close monitoring in patients with renal impairment, including Insulatard, Tazocin, Vancomycin, and Entecavir. \n",
      "\n",
      "**Assessment**: \n",
      "1. Potential dosing issues:\n",
      "   - Insulatard: Not recommended in adults with CrCl <30 mL/min or end-stage renal disease requiring hemodialysis or peritoneal dialysis. \n",
      "   - Tazocin: No dosage adjustment necessary for patients with altered kidney function. However, caution is advised due to potential nephrotoxicity.\n",
      "   - Vancomycin: No dosage adjustment necessary for adults with normal kidney function, but dosing recommendations for impaired kidney function are not provided. \n",
      "   - Entecavir: Not recommended in adults with altered kidney function. \n",
      "\n",
      "**Recommendation**: \n",
      "1. Review the patient's current medication doses and consider adjusting them based on their renal function. \n",
      "2. Monitor renal function closely and adjust medication doses as needed to avoid potential adverse effects. Consult with a nephrologist if necessary.\n",
      "iteration # 17\n",
      "response\n",
      "response\n",
      "response\n",
      "Response from Model:  Situation:\n",
      "The patient's blood pressure is still uncontrolled (164/87 mmHg) despite being on Atenolol and Lisinopril. \n",
      "\n",
      "Background:\n",
      "- The patient has a history of hypertension and is currently on Atenolol 25 mg once daily and Lisinopril 5 mg once daily.\n",
      "- The patient's current medications include Atenolol, Lisinopril, Atorvastatin, Ezetimibe, Ciclosporin, Cinacalcet, Clopidogrel, Co-trimoxazole, Everolimus, Folic Acid, Furosemide, GliPIzide, Linagliptin, Magnesium, Mycophenolate Mofetil, Omega-3 Fish Oil, Omeprazole, and Tamsulosin.\n",
      "\n",
      "Assessment:\n",
      "- Atenolol and Lisinopril may not be adequately controlling the patient's hypertension.\n",
      "- The patient's uncontrolled hypertension may be due to non-adherence to medication, underlying kidney disease, or other factors.\n",
      "\n",
      "Recommendation:\n",
      "- The patient's blood pressure should be closely monitored.\n",
      "- The patient's medication adherence should be assessed.\n",
      "- The patient's renal function should be assessed to rule out underlying kidney disease.\n",
      "- Consider increasing the dose of Atenolol or Lisinopril, or adding another antihypertensive medication.\n",
      "Response from Model:  **Situation:**\n",
      "- 71-year-old Chinese male with a history of CKD of allograft, hypertension (HTN), dyslipidemia, type 2 diabetes mellitus (T2DM), hyperparathyroidism with hypercalcemia, and benign prostatic hyperplasia (BPH).\n",
      "- Currently hospitalized for right big toe dry gangrene.\n",
      "- Multiple medications prescribed.\n",
      "\n",
      "**Background:**\n",
      "- CKD of allograft status post deceased donor renal transplant in 2007.\n",
      "- Currently on immunosuppressive medications: ciclosporin and mycophenolate mofetil.\n",
      "- History of left radical nephrectomy for renal cell carcinoma in 2007.\n",
      "- Uncontrolled HLD despite treatment with atorvastatin and ezetimibe.\n",
      "- Suboptimal glycemic control with T2DM, last HbA1c 7.2%.\n",
      "- HTN not adequately controlled with atenolol and lisinopril.\n",
      "- History of hyperparathyroidism with hypercalcemia, currently on cinacalcet.\n",
      "- BPH treated with tamsulosin.\n",
      "- Patient has drug allergies to paracetamol, phenoxymethylpenicillin, and aspirin.\n",
      "\n",
      "**Assessment:**\n",
      "1. **Hypertension:**\n",
      "- Elevated blood pressure (164/87 mmHg).\n",
      "- Current antihypertensive regimen (atenolol and lisinopril) may be inadequate.\n",
      "\n",
      "2. **Dyslipidemia:**\n",
      "- Uncontrolled cholesterol levels despite treatment with atorvastatin and ezetimibe.\n",
      "- Recent increase in atorvastatin dose to 80 mg once daily.\n",
      "\n",
      "3. **Hyperglycemia:**\n",
      "- Blood glucose levels not mentioned in the clinical document.\n",
      "- Patient on multiple antidiabetic medications (Actrapid, GliPIzide, Linagliptin).\n",
      "\n",
      "4. **Impaired kidney function:**\n",
      "- Elevated creatinine level (170 UMOL/L).\n",
      "- May be related to CKD or medications such as ciclosporin.\n",
      "\n",
      "5. **Hyperparathyroidism:**\n",
      "- Calcium level not provided.\n",
      "- Patient on cinacalcet for hyperparathyroidism with hypercalcemia.\n",
      "\n",
      "6. **Potential drug-drug interactions:**\n",
      "- Atorvastatin and ciclosporin: increased risk of myopathy and rhabdomyolysis.\n",
      "- Ciclosporin and mycophenolate mofetil: increased risk of infection and malignancy.\n",
      "- Clopidogrel and omeprazole: decreased effectiveness of clopidogrel.\n",
      "- Furosemide and lisinopril: increased risk of renal dysfunction and hyperkalemia.\n",
      "\n",
      "7. **Omission of therapy:**\n",
      "- Calcium level not monitored despite history of hyperparathyroidism and treatment with cinacalcet.\n",
      "\n",
      "**Recommendation:**\n",
      "1. **Hypertension:**\n",
      "- Consider dose adjustment or addition of another antihypertensive medication to achieve blood pressure control.\n",
      "- Monitor blood pressure regularly.\n",
      "\n",
      "2. **Dyslipidemia:**\n",
      "- Closely monitor lipid levels, including total cholesterol, HDL-C, LDL-C, and triglycerides.\n",
      "- Consider further medication adjustment or lifestyle modifications if lipid goals are not met.\n",
      "\n",
      "3. **Hyperglycemia:**\n",
      "- Monitor blood glucose levels regularly to assess glycemic control.\n",
      "- Adjust antidiabetic medications as needed to achieve target blood glucose levels.\n",
      "\n",
      "4. **Impaired kidney function:**\n",
      "- Monitor creatinine levels regularly to assess kidney function.\n",
      "- Adjust medication doses as needed based on kidney function.\n",
      "\n",
      "5. **Hyperparathyroidism:**\n",
      "- Monitor calcium levels regularly to assess the effectiveness of cinacalcet.\n",
      "- Adjust cinacalcet dose or consider additional measures if calcium levels remain elevated.\n",
      "\n",
      "6. **Potential drug-drug interactions:**\n",
      "- Review medications for potential interactions and make necessary dose adjustments or changes.\n",
      "\n",
      "7. **Omission of therapy:**\n",
      "- Monitor calcium levels and consider restarting cinacalcet if necessary.\n",
      "Response from Model:  **Situation:** 71-year-old Chinese male with a history of CKD of allograft, hypertension (HTN), type 2 diabetes mellitus (T2DM), and BPH. He is currently experiencing right big toe pain and duskiness. His recent blood pressure reading was 164/87 mmHg, and his latest HbA1c is 7.2%. He is on multiple medications, including antihypertensives, lipid-lowering agents, antidiabetics, immunosuppressants, and analgesics.\n",
      "\n",
      "**Background:**\n",
      "- CKD of allograft: The patient has a history of end-stage kidney disease (ESKD) due to HTN nephrosclerosis and underwent a deceased donor renal transplant (DDRT) on 15/08/2007. He is currently on ciclosporin and mycophenolate mofetil to prevent rejection.\n",
      "- HTN: The patient has a history of HTN, which is currently uncontrolled with blood pressure readings above the target range. He is taking atenolol and lisinopril for blood pressure control.\n",
      "- T2DM: The patient has a history of T2DM with a recent HbA1c of 7.2%, indicating poor glycemic control. He is on insulin (Actrapid), gliclazide, and linagliptin for blood glucose management.\n",
      "- BPH: The patient has BPH and is taking tamsulosin for symptom relief.\n",
      "\n",
      "**Assessment:**\n",
      "- Uncontrolled HTN: Despite being on antihypertensive medications (atenolol and lisinopril), the patient's blood pressure remains elevated, indicating inadequate control.\n",
      "- Dyslipidemia: The patient's lipid levels are above the optimal levels despite treatment with atorvastatin and ezetimibe. This suggests the need for medication dose adjustment or additional lipid-lowering therapy.\n",
      "- Suboptimal glycemic control: The patient's recent HbA1c indicates suboptimal glycemic control. His insulin regimen may need to be optimized or additional antidiabetic medications may be required.\n",
      "- Potential drug-related problems:\n",
      "  - Drug-drug interactions: There are several potential drug-drug interactions involving the patient's medications, including interactions between ciclosporin and mycophenolate mofetil (increased risk of infection and lymphoma), between ciclosporin and omeprazole (increased ciclosporin levels and toxicity), and between clopidogrel and omeprazole (reduced effectiveness of clopidogrel).\n",
      "  - Drug-disease interactions: Furosemide can worsen CKD, and omeprazole can potentially worsen osteoporosis.\n",
      "\n",
      "**Recommendation:**\n",
      "1. **Optimize blood pressure control**: \n",
      " - Consider increasing the doses of atenolol and/or lisinopril or adding another antihypertensive medication to achieve blood pressure targets.\n",
      " - Monitor blood pressure regularly and adjust medication as needed.\n",
      "\n",
      "2. **Optimize lipid management**:\n",
      " - Consider increasing the dose of atorvastatin or adding another lipid-lowering medication to achieve optimal lipid levels.\n",
      " - Monitor lipid levels regularly and adjust medication as needed.\n",
      "\n",
      "3. **Optimize glycemic control**:\n",
      " - Review the patient's insulin regimen and consider dose adjustments or additional antidiabetic medications to achieve target HbA1c levels.\n",
      " - Monitor blood glucose levels regularly and adjust insulin doses as needed.\n",
      "\n",
      "4. **Address potential drug-related problems**:\n",
      " - Review the patient's medications for potential drug-drug and drug-disease interactions.\n",
      " - Consider alternative medications or dose adjustments as necessary to minimize the risk of interactions.\n",
      "\n",
      "5. **Monitor renal function**:\n",
      " - Regularly monitor the patient's creatinine levels and adjust medication doses as needed to prevent further deterioration of kidney function.\n",
      "iteration # 18\n",
      "response\n",
      "response\n",
      "response\n",
      "Response from Model:  Situation: A 60-year-old male patient with a history of diabetes mellitus (DM), hypertension (HTN), hyperlipidemia (HLD), polycythemia rubra vera, end-stage renal failure (ESRF) secondary to DM nephropathy, diverticular disease, perforated jejunal diverticulum with abscess, bilateral lower limb recurrent cutaneous vasculitis, and bilateral lower limb pain likely due to neuropathy/ischemia is currently admitted for lower abdominal pain and constipation, as well as left knee pain. \n",
      "\n",
      "Background: The patient's current medication regimen includes lactulose, sennosides, bisacodyl, lidocaine, tramadol, atorvastatin, gabapentin, linagliptin, glipizide, metoclopramide, cinacalcet, pentoxifylline, sevelamer, glyceryl trinitrate, neurobion, and ciprofloxacin. He has a known allergy to piperacillin-tazobactam.\n",
      "\n",
      "Assessment:\n",
      "\n",
      "1. Potential drug-related problems:\n",
      "   a) Lactulose, sennosides, bisacodyl, lidocaine, tramadol, atorvastatin, gabapentin, linagliptin, glipizide, metoclopramide, cinacalcet, pentoxifylline, sevelamer, glyceryl trinitrate, neurobion, and ciprofloxacin are all being administered without specific dosage adjustments for severe kidney impairment.\n",
      "   b) Paracetamol is not recommended for patients with a CrCl less than 30 mL/minute, which might be the case for this patient with ESRF.\n",
      "   c) Gabapentin dosage has been increased from 100 mg BD to 300 mg BD, which could be problematic given the patient's ESRF.\n",
      "   d) Ciprofloxacin should have its dose decreased by 50% for a CrCl less than 30 mL/minute, which might be the case for this patient with ESRF.\n",
      "   e) Potential drug-drug interactions include tramadol and metoclopramide (increased risk of serotonin syndrome), atorvastatin and ciprofloxacin (increased risk of liver damage and muscle pain/weakness), sevelamer and ciprofloxacin (decreased effectiveness of ciprofloxacin), gabapentin and tramadol (increased CNS depression), metoclopramide and gabapentin (increased effects and side effects of gabapentin), and glipizide and ciprofloxacin (increased risk of hypoglycemia).\n",
      "   f) Therapeutic duplication with multiple laxatives (lactulose, sennosides, bisacodyl).\n",
      "   g) Omission of therapy with antihypertensive and antiplatelet medications for HTN and cardiovascular risk management, as well as potential omission of insulin therapy for DM considering ESRF.\n",
      "\n",
      "Recommendation:\n",
      "\n",
      "1. Consult with a pharmacist or a healthcare professional for a comprehensive review of the patient's medication regimen, including dosage adjustments, potential drug-drug interactions, and recommendations for optimizing therapy based on his renal function and overall health status.\n",
      "2. Adjust the dosages of lactulose, sennosides, bisacodyl, lidocaine, tramadol, atorvastatin, gabapentin, linagliptin, glipizide, metoclopramide, cinacalcet, pentoxifylline, sevelamer, glyceryl trinitrate, neurobion, and ciprofloxacin based on the patient's renal function.\n",
      "3. Monitor the patient closely for signs and symptoms of potential adverse reactions, drug-drug interactions, and the impact of medications on existing comorbidities.\n",
      "4. Consider reducing the number of laxatives to one or two as needed to minimize the risk of overuse and side effects.\n",
      "5. Review the patient's blood pressure control and consider adding an antihypertensive medication if necessary. Assess the need for antiplatelet therapy.\n",
      "6. Evaluate the patient's DM management and consider adding insulin therapy if appropriate based on his ESRF and current glycemic control.\n",
      "7. Clearly document the patient's allergy to piperacillin-tazobactam in the medical records and communicate this information to all healthcare providers to prevent inadvertent administration.\n",
      "Response from Model:  Situation:\n",
      "A 60-year-old male patient with a history of diabetes mellitus (DM), hypertension (HTN), hyperlipidemia (HLD), polycythaemia rubra vera, end-stage renal failure (ESRF) secondary to DM nephropathy, diverticular disease, perforated jejunal diverticulum with abscess, bilateral lower limb recurrent cutaneous vasculitis, and bilateral lower limb pain, is currently experiencing abdominal pain and constipation, as well as left knee pain.\n",
      "\n",
      "Background:\n",
      "The patient is currently on a complex medication regimen, including:\n",
      "- Lactulose, Sennosides, Bisacodyl: for constipation\n",
      "- Paracetamol, Tramadol: for pain\n",
      "- Atorvastatin: for HLD\n",
      "- Gabapentin: for neuropathic pain\n",
      "- Linagliptin, Glipizide: for DM\n",
      "- Metoclopramide: for nausea and vomiting\n",
      "- Cinacalcet, Sevelamer, and dialysis: for ESRF\n",
      "- Pentoxifylline: for vasculitis\n",
      "- Ciprofloxacin: for infection prevention\n",
      "\n",
      "Assessment:\n",
      "1. Potential for drug-related problems:\n",
      "   - Multiple medications increase the risk of drug interactions.\n",
      "   - Dosing of some medications may need adjustment due to ESRF.\n",
      "   - Patient's symptoms (abdominal pain, constipation) may be related to medication side effects or interactions.\n",
      "\n",
      "2. Omission of therapy:\n",
      "   - No antihypertensive medications noted, despite history of HTN.\n",
      "\n",
      "3. Allergy:\n",
      "   - Patient has a known allergy to Piperacillin-tazobactam, which should be strictly avoided.\n",
      "\n",
      "4. Incomplete pain management:\n",
      "   - Patient's pain may be inadequately controlled.\n",
      "\n",
      "Recommendation:\n",
      "1. Thorough review of the patient's medication regimen:\n",
      "   - Evaluate for potential drug interactions, especially considering renal impairment.\n",
      "   - Assess the need for dose adjustments based on renal function.\n",
      "   - Monitor for potential adverse effects and drug interactions.\n",
      "\n",
      "2. Consider addition of antihypertensive therapy:\n",
      "   - Initiate appropriate antihypertensive medication to manage HTN.\n",
      "\n",
      "3. Ensure strict adherence to drug allergy:\n",
      "   - Clearly document and communicate the patient's allergy to Piperacillin-tazobactam to all healthcare providers.\n",
      "\n",
      "4. Optimize pain management:\n",
      "   - Re-evaluate the patient's pain control.\n",
      "   - Consider additional or alternative pain management strategies if needed.\n",
      "\n",
      "5. Patient education and monitoring:\n",
      "   - Educate the patient about their medications, potential side effects, and importance of adherence.\n",
      "   - Encourage regular monitoring of blood pressure, blood glucose, and other relevant parameters.\n",
      "\n",
      "By addressing these issues, we can ensure the patient receives optimal medication therapy and appropriate management of their medical conditions.\n",
      "Response from Model:  **Situation:** \n",
      "\n",
      "The patient has been prescribed multiple medications to manage his various health conditions, including diabetes, hypertension, chronic kidney disease, diverticular disease, and lower limb pain. \n",
      "\n",
      "**Background:** \n",
      "\n",
      "The patient has a history of DM, HTN, HLD, polycythemia rubra vera, ESRF secondary to DM nephropathy, diverticular disease, perforated jejunal diverticulum with abscess, bilateral lower limb recurrent cutaneous vasculitis, and bilateral lower limb pain likely due to neuropathy/ischemia. He is currently experiencing lower abdominal pain and constipation and has requested a brain scan. \n",
      "\n",
      "**Assessment:** \n",
      "\n",
      "1. The patient's abdominal pain is likely secondary to constipation colic as evidenced by improvement of symptoms after Fleet enema and soft brown stool seen on DRE. \n",
      "\n",
      "2. There are several potential drug-related problems:\n",
      "    - Multiple medications may increase the risk of drug interactions.\n",
      "    - Gabapentin dose has been increased without appropriate renal dosing adjustment.\n",
      "    - Paracetamol should be used with caution given potential renal impairment.\n",
      "    - Caution is advised with the use of several medications due to potential adverse reactions in renal impairment, including lactulose, sennosides, bisacodyl, lidocaine, tramadol, linagliptin, metoclopramide, cinacalcet, pentoxifylline, sevelamer, and ciprofloxacin.\n",
      "\n",
      "3. The patient's request for a brain scan may indicate a concern about neurological symptoms, which could potentially be a side effect of some of his medications, such as gabapentin or tramadol.\n",
      "\n",
      "**Recommendation:** \n",
      "\n",
      "1. Review the patient's medication list for potential drug interactions and duplications. \n",
      "\n",
      "2. Adjust Gabapentin dosing based on renal function. \n",
      "\n",
      "3. Monitor for potential adverse reactions associated with the medications, particularly those that require renal dose adjustment. \n",
      "\n",
      "4. Discuss the patient's neurological symptoms and the need for a brain scan with the patient and consider alternative explanations for these symptoms, such as medication side effects.\n",
      "iteration # 19\n",
      "response\n",
      "response\n",
      "response\n",
      "Response from Model:  **Situation**: A 46-year-old male patient with a history of lupus nephritis, adjustment disorder, hypertensive urgency, and chest pain unlikely ACS has undergone a surgical procedure (limited right hemicolectomy) for perforated appendicitis and is currently in the post-operative phase. He is on multiple medications, including antibiotics, antihypertensives, pain relievers, proton pump inhibitors, and antiemetics.\n",
      "\n",
      "**Background**: The patient's current medication regimen appears to be appropriate for the conditions diagnosed and the post-operative care. However, there are potential drug-related problems that need to be addressed.\n",
      "\n",
      "**Assessment**:\n",
      "1. **Therapeutic Duplication**: The patient is receiving both oral and IV omeprazole, which may increase the risk of side effects and over-suppression of gastric acid.\n",
      "2. **Omission of Therapy**: The patient has a history of lupus nephritis but is not currently on immunosuppressive therapy, which could lead to a flare-up of the disease.\n",
      "3. **Overuse of Antihypertensives**: The patient is on three antihypertensive medications, which may increase the risk of hypotension, especially in a post-operative setting.\n",
      "4. **Potential Drug-Drug Interactions**: There are several potential drug-drug interactions, including between omeprazole and amlodipine, celecoxib, and metoclopramide and ondansetron.\n",
      "5. **Omission of Therapy**: The patient's hemoglobin level is slightly below the normal range, suggesting potential anemia, but there is no iron supplement or other treatment for anemia listed.\n",
      "6. **Omission of Therapy**: The patient has a history of adjustment disorder, but there is no psychotropic medication listed, which could lead to exacerbation of mental health symptoms.\n",
      "\n",
      "**Recommendation**:\n",
      "1. **Discontinue IV Omeprazole**: The IV omeprazole should be discontinued to avoid over-suppression of gastric acid and potential side effects. The patient can continue with oral omeprazole once tolerated.\n",
      "2. **Consider Immunosuppressive Therapy**: The patient's history of lupus nephritis should be reevaluated, and immunosuppressive therapy should be considered to prevent a flare-up of the disease.\n",
      "3. **Adjust Antihypertensive Medications**: The patient's antihypertensive medications should be reviewed and adjusted as needed to achieve adequate blood pressure control while minimizing the risk of hypotension.\n",
      "4. **Monitor for Drug-Drug Interactions**: The patient should be closely monitored for potential drug-drug interactions, and dosage adjustments or alternative medications should be considered if necessary.\n",
      "5. **Evaluate for Anemia**: Further investigation is needed to determine the cause of the patient's low hemoglobin level, and appropriate treatment should be initiated if anemia is confirmed.\n",
      "6. **Consider Psychotropic Medication**: The patient's mental health history should be reassessed, and psychotropic medication should be considered if appropriate to manage the adjustment disorder.\n",
      "\n",
      "Regular monitoring of the patient's vital signs, pain levels, laboratory values, and clinical status is crucial to ensure optimal care and timely management of any adverse effects or changes in the patient's condition.\n",
      "Response from Model:  Situation:\n",
      "The patient is currently experiencing mild abdominal pain post-operatively after undergoing a limited right hemicolectomy for perforated appendicitis. The patient also has a history of hypertensive urgency and is on multiple medications.\n",
      "\n",
      "Background:\n",
      "The patient's medication regimen includes antibiotics (ceftriaxone and metronidazole), proton pump inhibitors (omeprazole), antiemetics (ondansetron and metoclopramide), analgesics (paracetamol and PCA morphine), antihypertensives (amlodipine and enalapril), and laxatives (lactulose). The patient is also prescribed celecoxib and etoricoxib, both of which are non-steroidal anti-inflammatory drugs (NSAIDs).\n",
      "\n",
      "Assessment:\n",
      "1. Potential Adverse Drug Reactions:\n",
      "   - NSAID Use: Celecoxib and etoricoxib are both NSAIDs, which can increase the risk of gastrointestinal bleeding, renal impairment, and cardiovascular events.\n",
      "   - Proton Pump Inhibitors: Omeprazole may interact with clopidogrel (not listed in the medication list) and decrease its effectiveness.\n",
      "   - Serotonin Syndrome Risk: Metoclopramide and ondansetron have serotonergic properties and their combined use can increase the risk of serotonin syndrome.\n",
      "\n",
      "2. Therapeutic Duplication:\n",
      "   - NSAID Duplication: The patient is prescribed both celecoxib and etoricoxib, which serve a similar purpose and may increase the risk of side effects.\n",
      "\n",
      "3. Omission of Therapy:\n",
      "   - Anemia: The patient's hemoglobin level is slightly below normal, indicating potential anemia. Iron supplements or erythropoiesis-stimulating agents may be necessary.\n",
      "   - Hypertension Management: The patient's blood pressure is elevated despite multiple antihypertensive medications. Dosage adjustment or additional antihypertensives may be required.\n",
      "   - Lupus Nephritis: The patient has a history of lupus nephritis but is not on immunosuppressive therapy, which could lead to disease progression.\n",
      "   - Adjustment Disorder: The patient has a history of adjustment disorder and is not receiving any psychiatric treatment, which could worsen his mental health.\n",
      "   - Chest Pain Management: The patient's history of chest pain is not being addressed with appropriate medications.\n",
      "   - Kidney Protection: The patient's latest creatinine level is at the upper limit of normal and he is not on any medications to protect his kidneys.\n",
      "\n",
      "Recommendation:\n",
      "1. Review and Adjust Medications:\n",
      "   - NSAID Use: Consider discontinuing one of the two NSAIDs (celecoxib or etoricoxib) to reduce the risk of side effects.\n",
      "   - Proton Pump Inhibitor Interaction: Advise the patient to avoid clopidogrel (if applicable) while taking omeprazole to prevent reduced effectiveness.\n",
      "   - Serotonin Syndrome Risk: Monitor for symptoms of serotonin syndrome and adjust medications as needed.\n",
      "\n",
      "2. Address Therapeutic Duplication:\n",
      "   - NSAID Duplication: Discontinue one of the two NSAIDs to reduce the risk of side effects.\n",
      "\n",
      "3. Initiate Omitted Therapies:\n",
      "   - Anemia: Assess the cause of anemia and initiate appropriate treatment, such as iron supplements or erythropoiesis-stimulating agents.\n",
      "   - Hypertension Management: Adjust the dosages of current antihypertensives or consider adding another antihypertensive medication.\n",
      "   - Lupus Nephritis: Discuss the importance of immunosuppressive therapy with the patient and consider initiating treatment.\n",
      "   - Adjustment Disorder: Refer the patient to a psychiatrist for evaluation and appropriate treatment.\n",
      "   - Chest Pain Management: Investigate the cause of chest pain and initiate appropriate medications.\n",
      "   - Kidney Protection: Consider adding an angiotensin II receptor blocker (ARB) or angiotensin-converting enzyme (ACE) inhibitor to protect the kidneys.\n",
      "\n",
      "4. Monitor and Educate:\n",
      "   - Monitor the patient for any signs of adverse drug reactions, disease progression, or worsening symptoms.\n",
      "   - Provide education to the patient regarding their medications, potential side effects, and the importance of medication adherence.\n",
      "Response from Model:  **Situation**\n",
      "\n",
      "The patient is a 46-year-old male with a history of adjustment disorder, lupus nephritis (refused immunosuppression), hypertensive urgency, and chest pain unlikely ACS with underlying TRO IHD. He underwent a laparoscopic converted to open limited right hemicolectomy for perforated appendicitis and is currently in the post-operative phase. His current medication regimen includes:\n",
      "\n",
      "- Potassium Chloride (Premixed in D5) 10mmol/500ml Infusion\n",
      "- Ceftriaxone Injection 2 g IV q24h\n",
      "- Metronidazole Injection 500 mg IV q8h\n",
      "- Omeprazole Injection 40 mg IV bolus OM\n",
      "- Ondansetron Injection 4 mg IV bolus TDS PRN\n",
      "- PCA Morphine 50 mg continuous IV infusion\n",
      "- Metoclopramide HCl Injection 10 mg IV bolus q8h\n",
      "- Paracetamol Injection 1 g IV q4h\n",
      "- Bromhexine HCl Injection 4 mg IV bolus TDS\n",
      "- Amlodipine Tablet 10 mg PO OM\n",
      "- Enalapril Tablet 20 mg PO BD\n",
      "- Celecoxib Capsule 200 mg PO BD for 5 days\n",
      "- Lactulose Syrup 10 mL PO TDS PRN\n",
      "- Hydralazine HCl Tablet 25 mg PO TDS\n",
      "- Omeprazole Capsule 40 mg PO OM\n",
      "- Etoricoxib Tablet 90 mg PO OM for 5 days\n",
      "\n",
      "**Background**\n",
      "\n",
      "The patient's medical history, current medications, and post-operative status need to be considered when evaluating potential drug-related problems.\n",
      "\n",
      "**Assessment**\n",
      "\n",
      "1. **Potential Drug-Drug Interactions**:\n",
      "   - Omeprazole (CYP2C19 inhibitor) may increase the serum concentrations of amlodipine and celecoxib, potentially leading to increased risk of side effects.\n",
      "   - Metoclopramide and ondansetron both have serotonergic properties, increasing the risk of serotonin syndrome.\n",
      "   - Enalapril and celecoxib may have decreased antihypertensive effect.\n",
      "   - Hydralazine and celecoxib may have decreased antihypertensive effect.\n",
      "   - Omeprazole and etoricoxib are both metabolized by CYP enzymes, increasing the risk of side effects.\n",
      "   - Metoclopramide may decrease the absorption and effectiveness of omeprazole.\n",
      "   - Omeprazole may increase the serum concentration of paracetamol, increasing the risk of side effects.\n",
      "   - Metoclopramide may increase the absorption of paracetamol, increasing the risk of side effects.\n",
      "\n",
      "2. **Therapeutic Duplication**:\n",
      "   - Two proton pump inhibitors (omeprazole injection and omeprazole capsule) are prescribed, increasing the risk of adverse effects.\n",
      "\n",
      "3. **Omission of Therapy**:\n",
      "   - Patient has history of lupus nephritis but no immunosuppressive therapy is prescribed.\n",
      "   - Patient has history of chest pain unlikely ACS, TRO underlying IHD but no anti-anginal or antiplatelet therapy is prescribed.\n",
      "\n",
      "4. **Therapeutic Duplication**:\n",
      "   - Two NSAIDs (celecoxib capsule and etoricoxib tablet) are prescribed, increasing the risk of gastrointestinal bleeding and renal impairment.\n",
      "\n",
      "5. **Potential Drug-Disease Interaction**:\n",
      "   - Hydralazine can cause reflex tachycardia, potentially exacerbating hypertension.\n",
      "   - Opioids like morphine can exacerbate mental health conditions, which should be used with caution in patients with a history of adjustment disorder.\n",
      "\n",
      "**Recommendation**\n",
      "\n",
      "1. **Discontinuation**:\n",
      "   - Discontinue one of the two proton pump inhibitors (omeprazole injection or omeprazole capsule).\n",
      "\n",
      "2. **Add Therapy**:\n",
      "   - Initiate immunosuppressive therapy for lupus nephritis.\n",
      "   - Consider anti-anginal or antiplatelet therapy for chest pain.\n",
      "\n",
      "3. **Dose Adjustment or Alternative**:\n",
      "   - Consider alternative NSAID or stagger dosing to reduce the risk of gastrointestinal bleeding and renal impairment.\n",
      "\n",
      "4. **Monitor Closely**:\n",
      "   - Monitor blood pressure, heart rate, and mental status closely due to potential drug-disease interactions.\n",
      "\n",
      "5. **Educate Patient**:\n",
      "   - Educate the patient about potential side effects, interactions, and precautions of the prescribed medications.\n",
      "\n",
      "Regular monitoring of laboratory parameters, vital signs, and the patient's response to the medication regimen is crucial. The healthcare team should collaborate to optimize the medication plan, considering the patient's medical history, current condition, and potential drug-related problems.\n",
      "iteration # 20\n",
      "response\n",
      "response\n",
      "response\n",
      "Response from Model:  Situation:\n",
      "A 71-year-old male patient with a history of hypertension (HTN), hyperlipidemia (HLD), and benign prostatic hyperplasia (BPH) is currently hospitalized for right iliac fossa (RIF) pain secondary to cecal diverticulitis with a small diverticular abscess. His medication list includes medications for pain management, antibiotics, proton pump inhibitor, antiemetics, and medications for BPH. \n",
      "\n",
      "Background:\n",
      "The patient's current medication regimen includes: \n",
      "\n",
      "Potassium Chloride: This medication is typically used for the treatment of hypokalemia, but the patient's lab values do not indicate hypokalemia. \n",
      "Ceftriaxone and Metronidazole: These antibiotics are appropriate for the treatment of cecal diverticulitis with a diverticular abscess.\n",
      "Omeprazole: The reason for its use is not clear from the clinical document.\n",
      "Metoclopramide: This medication is appropriate for the prophylaxis of nausea and vomiting.\n",
      "Finasteride and Tamsulosin: These medications are appropriate for the treatment of BPH.\n",
      "Paracetamol and Tramadol: These medications are appropriate for pain management.\n",
      "Indapamide: This medication is appropriate for the management of mild to moderate hypertension.\n",
      "Prochlorperazine: This medication is appropriate for the management of severe nausea and vomiting.\n",
      "\n",
      "Assessment:\n",
      "1. Potassium Chloride: The patient's potassium levels are elevated (K 5.5 [3.5 – 4.5]), indicating potential hyperkalemia. The need for potassium supplementation should be reassessed, and renal function should be closely monitored.\n",
      "2. Omeprazole: The clinical document does not provide an indication for omeprazole use. Further assessment is needed to determine the appropriateness of this medication.\n",
      "3. Metoclopramide: Metoclopramide can cause CNS depression and elevate blood pressure. Given the patient's history of hypertension, blood pressure should be closely monitored while using this medication.\n",
      "4. Therapeutic Duplication: Metoclopramide and Prochlorperazine have similar antiemetic effects. This duplication increases the risk of adverse effects such as drowsiness, dizziness, and extrapyramidal symptoms.\n",
      "5. Potential Overuse or Misuse: Tramadol has the potential for addiction, and the patient is also prescribed Paracetamol for pain. Monitoring for potential overuse or misuse is crucial, particularly with Tramadol.\n",
      "6. Omission of Therapy: There is no antihypertensive or lipid-lowering medication listed for the patient despite his history of HTN and HLD. This omission could lead to uncontrolled blood pressure and lipid levels, increasing the risk of cardiovascular events.\n",
      "\n",
      "Recommendation:\n",
      "1. Potassium Chloride: The patient's renal function should be assessed, and the need for potassium supplementation should be reevaluated to avoid hyperkalemia.\n",
      "2. Omeprazole: The indication for omeprazole should be clarified. If there is no appropriate indication, it should be discontinued to avoid potential adverse effects.\n",
      "3. Metoclopramide: The patient's blood pressure should be closely monitored while using Metoclopramide, especially considering his history of hypertension.\n",
      "4. Therapeutic Duplication: Either Metoclopramide or Prochlorperazine should be discontinued to avoid unnecessary duplication and the risk of increased adverse effects.\n",
      "5. Potential Overuse or Misuse: The patient should be monitored for potential overuse or misuse of Tramadol, especially considering its addictive potential.\n",
      "6. Omission of Therapy: Appropriate antihypertensive and lipid-lowering medications should be added to the patient's regimen to manage his history of HTN and HLD.\n",
      "\n",
      "Regular monitoring of the patient's response to therapy, laboratory values, and overall clinical status is essential to ensure the safety and effectiveness of the medication regimen. Dose adjustments, medication changes, or additional interventions may be necessary based on the patient's progress and response to treatment.\n",
      "Response from Model:  **Situation:** A 71-year-old male patient with a history of hypertension (HTN), hyperlipidemia (HLD), and benign prostatic hyperplasia (BPH) is being treated for cecal diverticulitis with a small diverticular abscess. His medication list includes several medications that require careful monitoring and assessment for potential drug-related problems.\n",
      "\n",
      "**Background:** The patient is currently receiving IV fluids, antibiotics (ceftriaxone and metronidazole), IV omeprazole, metoclopramide, finasteride, tamsulosin, paracetamol, tramadol, indapamide, and prochlorperazine. His lab values show elevated potassium levels (K 5.5 [3.5 – 4.5]) and an elevated CRP level (50.5 [0.2-9.1 MG/L]), indicating ongoing inflammation.\n",
      "\n",
      "**Assessment:**\n",
      "\n",
      "1. **Potassium Chloride:** The patient's elevated potassium levels indicate a risk of hyperkalemia. Potassium Chloride should be used cautiously and monitored closely, especially considering his current IV fluids containing 0.9% NaCl.\n",
      "\n",
      "2. **Antibiotic Therapy:** The patient's CRP level suggests that the current antibiotic regimen may not be adequately controlling the infection. The duration of therapy and effectiveness of ceftriaxone and metronidazole should be reassessed.\n",
      "\n",
      "3. **Omeprazole:** The indication for IV omeprazole is not clear from the provided clinical notes. Long-term use of proton pump inhibitors (PPIs) like omeprazole can have potential side effects, so its use should be justified and regularly reviewed.\n",
      "\n",
      "4. **Metoclopramide:** Metoclopramide can cause CNS depression and elevate blood pressure. Given the patient's history of hypertension, his blood pressure should be closely monitored.\n",
      "\n",
      "5. **Therapeutic Duplication:** Metoclopramide and prochlorperazine have similar antiemetic effects and can cause additive side effects. Consider choosing one primary medication for nausea and vomiting management.\n",
      "\n",
      "6. **Omission of Therapy:** The patient's history of HLD suggests that a lipid-lowering medication should be part of his treatment plan.\n",
      "\n",
      "7. **Tramadol Dependence:** Tramadol is an opioid that can lead to dependence and withdrawal symptoms. The patient's pain management regimen should be monitored to ensure appropriate and safe use.\n",
      "\n",
      "**Recommendation:**\n",
      "\n",
      "1. **Potassium Chloride:** Monitor potassium levels closely and adjust the rate of IV fluids or Potassium Chloride infusion as needed to prevent hyperkalemia.\n",
      "\n",
      "2. **Antibiotic Therapy:** Consult with infectious disease specialists to review the patient's current antibiotic regimen and consider alternative or additional antibiotics based on the ongoing inflammation indicated by elevated CRP levels.\n",
      "\n",
      "3. **Omeprazole:** Review the patient's medical history and current symptoms to determine the appropriate indication for IV omeprazole. If there is no clear indication, consider discontinuing its use to minimize potential side effects.\n",
      "\n",
      "4. **Metoclopramide:** Monitor the patient's blood pressure regularly, especially when using metoclopramide, due to its potential to elevate blood pressure.\n",
      "\n",
      "5. **Therapeutic Duplication:** Choose either metoclopramide or prochlorperazine as the primary antiemetic medication and discontinue the other to avoid unnecessary side effects.\n",
      "\n",
      "6. **Omission of Therapy:** Prescribe an appropriate lipid-lowering medication to manage the patient's hyperlipidemia.\n",
      "\n",
      "7. **Tramadol Dependence:** Monitor the patient's use of tramadol for signs of dependence or misuse and adjust the pain management plan accordingly.\n",
      "\n",
      "8. **Patient Education:** Educate the patient about the importance of regular follow-up and medication adherence. Provide information on potential side effects and interactions of his medications.\n",
      "\n",
      "By implementing these recommendations, the patient's medication regimen can be optimized to ensure effective treatment of his diverticular abscess while minimizing the risk of drug-related problems. Regular monitoring and collaboration with specialists can help achieve the best possible outcomes for the patient.\n",
      "Response from Model:  **Situation:**\n",
      "The patient is a 71-year-old male with a history of hypertension (HTN), hyperlipidemia (HLD), and benign prostatic hyperplasia (BPH). He is currently experiencing right iliac fossa (RIF) pain due to cecal diverticulitis with a small diverticular abscess. The patient's medication list includes medications for pain management, antibiotics, antiemetics, proton pump inhibitors, diuretics, and medications for BPH.\n",
      "\n",
      "**Background:**\n",
      "The patient's lab values show a slightly elevated potassium level (K 5.5 [3.5 – 4.5]), which could potentially indicate a kidney issue. The patient's renal function is not documented in the clinical notes. Additionally, the patient has a history of hypertension and hyperlipidemia, but his current medication regimen does not include any antihypertensive or lipid-lowering medications.\n",
      "\n",
      "**Assessment:**\n",
      "1. Potential drug-drug interactions:\n",
      "   - Ceftriaxone and Metronidazole: Increased risk of antibiotic-associated diarrhea.\n",
      "   - Omeprazole and Metoclopramide: Decreased effectiveness of Metoclopramide due to increased pH of the stomach.\n",
      "   - Omeprazole and Ceftriaxone: Decreased absorption of Ceftriaxone.\n",
      "   - Metoclopramide and Prochlorperazine: Increased risk of extrapyramidal symptoms.\n",
      "   - Tamsulosin and Metoclopramide: Enhanced hypotensive effect of Metoclopramide.\n",
      "   - Tramadol and Metoclopramide: Increased risk of serotonin syndrome.\n",
      "   - Tramadol and Paracetamol: Increased risk of liver damage.\n",
      "   - Indapamide and Metoclopramide: Enhanced hypotensive effect of Metoclopramide.\n",
      "   - Prochlorperazine and Metoclopramide: Increased risk of extrapyramidal symptoms.\n",
      "\n",
      "2. Therapeutic duplication:\n",
      "   - Metoclopramide and Prochlorperazine are both antiemetics, which increases the risk of side effects.\n",
      "\n",
      "3. Omission of therapy:\n",
      "   - No antihypertensive or lipid-lowering therapy is prescribed despite the patient's history of HTN and HLD.\n",
      "\n",
      "4. Potential adverse drug reactions:\n",
      "   - Metoclopramide can cause CNS depression and elevate blood pressure.\n",
      "   - Finasteride can cause sexual dysfunction and is associated with an increased risk of higher-grade prostate cancer.\n",
      "   - Tamsulosin can cause orthostatic hypotension and is associated with intraoperative floppy iris syndrome.\n",
      "   - Tramadol can interact with other medications and cause serotonin syndrome.\n",
      "   - Indapamide can cause electrolyte disturbances and increase cholesterol concentrations.\n",
      "   - Prochlorperazine can cause drowsiness and increase the risk of seizures.\n",
      "\n",
      "**Recommendation:**\n",
      "1. Review the patient's renal function to assess the risk of hyperkalemia associated with Potassium Chloride use.\n",
      "2. Consider alternative medications or monitor for adverse effects associated with the potential drug-drug interactions.\n",
      "3. Discontinue one of the antiemetics (Metoclopramide or Prochlorperazine) to reduce the risk of side effects.\n",
      "4. Consider adding an antihypertensive and a lipid-lowering agent to manage the patient's HTN and HLD.\n",
      "5. Monitor the patient closely for signs and symptoms of serotonin syndrome.\n",
      "6. Consider reducing the dose of Paracetamol or monitoring liver function tests regularly.\n",
      "7. Reduce the dose of Omeprazole to 20-40mg daily unless a higher dose is clinically indicated.\n",
      "8. Educate the patient about the potential adverse effects of the prescribed medications and instruct them to report any concerns to the healthcare team.\n",
      "iteration # 21\n",
      "response\n",
      "response\n",
      "response\n",
      "Response from Model:  **Situation:** A 75-year-old male patient with a history of ischemic colitis, hemorrhoids, BPH, asthma (not on inhalers), hypertension, gastritis, ischemic cardiomyopathy, and recent NSTEMI is currently admitted for gross hematuria. His current medication regimen includes Potassium Chloride, Tazocin, Abiraterone Acetate, Bisoprolol, Calcium Carbonate with Vitamin D, Finasteride, Lactulose, Neurobion, Paracetamol, Tamsulosin, Diclofenac, Glyceryl Trinitrate, and Furosemide. \n",
      "\n",
      "**Background:** The patient's laboratory findings indicate low potassium (K: 3.2 [3.6-5.0 MMOL/L]) and low hemoglobin (Hb: 8.5 [14.0-18.0 G/DL]). His most recent vital signs show stability with no signs of distress. \n",
      "\n",
      "**Assessment:** \n",
      "- Potassium Chloride: The patient's low potassium level warrants continued monitoring and appropriate interventions to maintain electrolyte balance. \n",
      "\n",
      "- Tazocin: The use of Tazocin is appropriate considering the patient's suspected infection, as indicated by gross hematuria and elevated CRP levels.\n",
      "\n",
      "- Abiraterone Acetate: This medication is suitable for the patient's prostate cancer. However, close monitoring is necessary due to potential drug-drug interactions and adverse effects.\n",
      "\n",
      "- Aspirin: The suspension of Aspirin due to gross hematuria is appropriate given the increased risk of bleeding. However, the reason for its initial prescription (likely related to the patient's ischemic cardiomyopathy and recent NSTEMI) should be reviewed to determine if alternative therapies are needed.\n",
      "\n",
      "- Bisoprolol: While this medication is commonly used for hypertension, it should be assessed for potential interactions with other medications and the patient's history of asthma.\n",
      "\n",
      "- Finasteride: This medication is suitable for the patient's BPH.\n",
      "\n",
      "- Paracetamol: The patient's pain score is currently 0, indicating that the need for Paracetamol may be reevaluated to avoid unnecessary medication use.\n",
      "\n",
      "- Tamsulosin: This medication is suitable for the patient's BPH. However, the patient should be monitored for potential adverse effects, especially considering his history of ischemic cardiomyopathy and recent NSTEMI.\n",
      "\n",
      "- Diclofenac: Similar to Paracetamol, the need for Diclofenac should be reassessed given the patient's pain score of 0. Additionally, its use should be approached cautiously due to the patient's history of ischemic colitis and CABG surgery.\n",
      "\n",
      "- Furosemide: This medication is suitable for managing the patient's fluid balance. However, close monitoring of renal function and potassium levels is necessary.\n",
      "\n",
      "- Lactulose: The indication for Lactulose is unclear and should be reviewed. \n",
      "\n",
      "**Recommendations:** \n",
      "1. **Potassium Chloride:** Monitor potassium levels closely and adjust the dose or frequency of Potassium Chloride as needed to maintain normal levels.\n",
      "\n",
      "2. **Aspirin:** Re-evaluate the rationale for Aspirin suspension and consider alternative therapies for the patient's ischemic cardiomyopathy and recent NSTEMI.\n",
      "\n",
      "3. **Paracetamol and Diclofenac:** Discontinue Paracetamol and Diclofenac since the patient's pain score is 0.\n",
      "\n",
      "4. **Lactulose:** Clarify the indication for Lactulose and adjust the dosage or discontinue it if necessary.\n",
      "\n",
      "5. **Drug-Drug Interactions:** Carefully review the patient's medication regimen for potential drug-drug interactions, especially with Abiraterone Acetate, Bisoprolol, and Tamsulosin. Consult drug references and consider dose adjustments or alternative medications as needed to minimize interaction risks.\n",
      "\n",
      "6. **Laboratory Monitoring:** Regularly monitor the patient's renal function, liver enzymes, and hemoglobin levels to ensure appropriate medication dosing and identify any adverse effects.\n",
      "Response from Model:  Situation:\n",
      "The patient is a 75-year-old male with a history of ischemic colitis, haemorrhoids, BPH, asthma (not on inhalers), hypertension, gastritis, ischemic cardiomyopathy, and recent NSTEMI. He is currently admitted for gross hematuria. His medications include potassium chloride, Tazocin, abiraterone acetate, aspirin (suspended), bisoprolol, calcium carbonate with vitamin D, finasteride, lactulose, neurobion, paracetamol, tamsulosin, diclofenac, glyceryl trinitrate, furosemide, and rosuvastatin.\n",
      "\n",
      "Background:\n",
      "The patient has a history of multiple medical conditions and is taking several medications. It is important to review his medication list for potential drug-related problems, including therapeutic duplication, omission of therapy, potential adverse drug reactions, contraindications, and drug interactions.\n",
      "\n",
      "Assessment:\n",
      "1. Therapeutic duplication: The patient is taking paracetamol 1g QDS and paracetamol 1g QDS PRN pain. This could potentially lead to an overdose of paracetamol if the patient takes both doses.\n",
      "2. Omission of therapy: The patient has a history of asthma but is not currently on any inhalers. This could potentially lead to uncontrolled asthma symptoms.\n",
      "3. Potential drug-disease interaction: The patient is taking aspirin, which has been suspended. Given his history of ischemic cardiomyopathy and recent NSTEMI, it is important to ensure that the patient is on appropriate antiplatelet therapy unless contraindicated.\n",
      "4. Potential drug-disease interaction: The patient is taking bisoprolol for hypertension. However, his latest BP reading is on the lower side (91/50). This could indicate that the patient's blood pressure is being over-managed, which could lead to hypotension.\n",
      "5. Potential drug-disease interaction: The patient is taking finasteride, which is typically used for BPH. However, the patient also has a history of prostate cancer. Finasteride can mask the symptoms of prostate cancer and make it harder to diagnose and treat.\n",
      "6. Potential drug-drug interaction: Abiraterone acetate and rosuvastatin: Abiraterone acetate may enhance the myopathic effect of HMG-CoA reductase inhibitors (statins) such as rosuvastatin. This could potentially increase the risk of muscle damage in the patient.\n",
      "7. Potential drug-drug interaction: Bisoprolol and abiraterone acetate: Bisoprolol is metabolized by CYP3A4, and abiraterone acetate is a strong inhibitor of CYP3A4. This could potentially lead to increased levels of bisoprolol in the body, which could increase the risk of side effects such as bradycardia, hypotension, and heart failure.\n",
      "8. Potential drug-drug interaction: Tazocin and abiraterone acetate: Tazocin may interact with strong CYP3A4 inhibitors such as abiraterone acetate. This could potentially lead to increased levels of Tazocin in the body, which could increase the risk of side effects such as diarrhea, nausea, and rash.\n",
      "\n",
      "Recommendation:\n",
      "1. The healthcare team should review the patient's medication list to address the identified drug-related problems.\n",
      "2. The patient should be advised to take only one dose of paracetamol 1g QDS and discontinue the paracetamol 1g QDS PRN pain to avoid potential overdose.\n",
      "3. The healthcare team should consider restarting the patient's asthma inhalers to prevent uncontrolled asthma symptoms.\n",
      "4. The healthcare team should assess the appropriateness of continuing aspirin therapy and consider alternative antiplatelet therapy if necessary.\n",
      "5. The healthcare team should monitor the patient's blood pressure closely to ensure that it is not being over-managed with bisoprolol.\n",
      "6. The healthcare team should consider alternative medications for BPH management in the patient given his history of prostate cancer.\n",
      "7. The healthcare team should monitor the patient for signs of muscle damage and adjust the doses of abiraterone acetate and rosuvastatin as necessary.\n",
      "8. The healthcare team should monitor the patient for signs of increased bisoprolol or Tazocin levels and adjust the doses as necessary.\n",
      "Response from Model:  **Situation:** A 75-year-old male patient with a history of ischemic colitis, haemorrhoids, BPH, asthma, hypertension, gastritis, ischemic cardiomyopathy, and recent NSTEMI is currently admitted for gross hematuria.\n",
      "\n",
      "**Background:** The patient is on multiple medications, including Potassium Chloride, Tazocin, Abiraterone Acetate, Aspirin (currently suspended), Bisoprolol, Finasteride, Lactulose, Neurobion, Paracetamol, Tamsulosin, Diclofenac, Glyceryl Trinitrate, Furosemide, and Rosuvastatin.\n",
      "\n",
      "**Assessment:**\n",
      "- Potential drug-related problems:\n",
      " - Therapeutic duplication: Lactulose Syrup and Paracetamol tablets are prescribed both regularly and as needed, increasing the risk of overdose.\n",
      " - Omission of therapy: The patient has a history of asthma but is not on any inhalers, potentially leading to uncontrolled asthma symptoms.\n",
      " - Potassium Chloride administration frequency seems too frequent (Q1H), potentially causing hyperkalemia.\n",
      " - Abiraterone Acetate should be taken with a steroid to prevent side effects, but none is listed in the medication list.\n",
      " - Low hemoglobin level (8.5 G/DL) is not being addressed with iron supplements or erythropoiesis-stimulating agents.\n",
      " - Temporary discontinuation of Aspirin for gross hematuria may increase the risk of cardiovascular events.\n",
      " - Bisoprolol may cause hypotension, especially given the patient's low blood pressure.\n",
      " - Tamsulosin can worsen hypotension.\n",
      " - Furosemide may lead to fluid overload as the patient has a positive intake/output balance.\n",
      " - Diclofenac can exacerbate gastritis.\n",
      "\n",
      "- Potential drug-drug interactions:\n",
      " - Abiraterone Acetate may enhance the myopathic effect of Rosuvastatin, increasing the risk of muscle damage.\n",
      " - Bisoprolol and Tamsulosin may have additive hypotensive effects, potentially causing hypotension or bradycardia.\n",
      " - Tazocin may interact with Abiraterone Acetate, affecting its metabolism and efficacy.\n",
      " - Aspirin and Diclofenac increase the risk of gastrointestinal bleeding and ulcers when used together.\n",
      " - Furosemide and Potassium Chloride may interact, requiring close monitoring of serum potassium levels to avoid hyperkalemia.\n",
      "\n",
      "**Recommendation:**\n",
      "1. Review and adjust the frequency of Potassium Chloride administration to avoid hyperkalemia.\n",
      "2. Prescribe a steroid to manage potential side effects of Abiraterone Acetate.\n",
      "3. Consider iron supplements or erythropoiesis-stimulating agents to address low hemoglobin levels.\n",
      "4. Weigh the risks and benefits of restarting Aspirin for cardiovascular protection versus the risk of gross hematuria.\n",
      "5. Monitor blood pressure closely while the patient is taking Bisoprolol and Tamsulosin, and adjust doses if necessary.\n",
      "6. Monitor for signs of fluid overload and adjust Furosemide dosage accordingly.\n",
      "7. Avoid prescribing Diclofenac due to the patient's history of gastritis.\n",
      "8. Counsel the patient about the potential drug interactions and monitor for adverse effects.\n",
      "9. Address the therapeutic duplication of Lactulose Syrup and Paracetamol tablets.\n",
      "10. Consider initiating asthma inhalers to manage the patient's asthma.\n",
      "iteration # 22\n",
      "response\n",
      "response\n",
      "response\n",
      "Response from Model:  **Situation:**\n",
      "A 67-year-old male patient is admitted to the urology ward with a history of hypertension (HTN), type 2 diabetes mellitus (T2DM), and ischemic heart disease (IHD) status post percutaneous coronary intervention (PCI). He is currently experiencing persistent purulent discharge from a left loin wound post open drainage of a renal abscess. The wound culture reveals Escherichia coli resistant to ampicillin and amoxicillin-clavulanic acid (Co-amoxiclav).\n",
      "\n",
      "**Background:**\n",
      "The patient has a history of BPH and lower urinary tract symptoms. He was previously hospitalized for pyelonephritis and underwent a left percutaneous nephrostomy and drainage of a renal abscess.\n",
      "\n",
      "**Assessment:**\n",
      "\n",
      "1. **Therapeutic Duplication:** The patient is prescribed two alpha-blockers, tamsulosin and alfuzosin, for BPH. This can increase the risk of side effects such as hypotension, dizziness, and fainting.\n",
      "\n",
      "2. **Omission of Therapy:** The wound culture shows E. coli resistance to Co-amoxiclav, which the patient is currently taking. Alternative antibiotics sensitive to E. coli, such as piperacillin-tazobactam, ceftriaxone, cefepime, aztreonam, ertapenem, gentamicin, or ciprofloxacin, should be considered.\n",
      "\n",
      "3. **Suboptimal Glycemic Control:** The patient's blood glucose levels range from 5.4 to 9.2 mmol/L, indicating poorly controlled T2DM. The current insulin regimen (Actrapid and Lantus) may need adjustment.\n",
      "\n",
      "4. **Impaired Kidney Function:** The patient's creatinine level is elevated at 127 umol/L, suggesting impaired kidney function. This may affect the dosing and choice of medications that are renally excreted.\n",
      "\n",
      "5. **Anemia:** The patient's hemoglobin level is low at 8.8 g/dL, indicating anemia. Iron supplementation or other appropriate treatment should be considered.\n",
      "\n",
      "6. **Aspirin Suspension:** The patient's Aspirin therapy, which is typically indicated for secondary prevention of cardiovascular events in patients with IHD, is currently suspended. The reason for suspension and the patient's cardiovascular risk should be evaluated.\n",
      "\n",
      "7. **Gabapentin Use:** The patient is prescribed gabapentin for lower limb pain without a clear indication in the clinical notes. The necessity of gabapentin should be reassessed.\n",
      "\n",
      "**Recommendations:**\n",
      "\n",
      "1. **Review Alpha-Blocker Therapy:** The need for both tamsulosin and alfuzosin should be reevaluated. Consider alternative treatment options or adjust doses to minimize the risk of adverse effects.\n",
      "\n",
      "2. **Change Antibiotic Therapy:** Discontinue Co-amoxiclav and initiate an alternative antibiotic based on the wound culture sensitivity results. Monitor the patient's response to the new antibiotic.\n",
      "\n",
      "3. **Optimize Glycemic Control:** Adjust the insulin regimen (Actrapid and Lantus) to achieve better control of blood glucose levels. Provide patient education on diabetes management.\n",
      "\n",
      "4. **Assess Kidney Function:** Review the patient's medication list to ensure they are appropriate for impaired kidney function. Monitor renal function and adjust medications as needed.\n",
      "\n",
      "5. **Address Anemia:** Investigate the cause of anemia and initiate appropriate treatment, such as iron supplementation.\n",
      "\n",
      "6. **Consider Aspirin Reinitiation:** If there are no contraindications, discuss the benefits of restarting Aspirin therapy for cardiovascular risk reduction with the patient.\n",
      "\n",
      "7. **Reevaluate Gabapentin Use:** Assess the source of lower limb pain and determine if gabapentin is the most appropriate treatment. Consider alternative pain management strategies if necessary.\n",
      "Response from Model:  Situation: A 67-year-old male patient is admitted to the urology department with persistent purulent discharge from the left loin. He has a history of hypertension (HTN), type 2 diabetes mellitus (T2DM), and ischemic heart disease (IHD) with a depressed ejection fraction (LVEF 28%). His current medication regimen includes insulin (Actrapid and Lantus), Co-amoxiclav, Aspirin (currently suspended), Bisoprolol, Gabapentin, Lactulose, Paracetamol, Tramadol, Tamsulosin, and Alfuzosin.\n",
      "\n",
      "Background: The patient's wound culture shows Escherichia coli, which is resistant to Ampicillin and Amoxicillin/Clavulanic Acid (Co-amoxiclav), the antibiotic he is currently receiving. He also has elevated creatinine levels, indicating potential kidney dysfunction, and low hemoglobin levels, suggesting anemia.\n",
      "\n",
      "Assessment:\n",
      "1. Therapeutic duplication: Tamsulosin and Alfuzosin are both alpha-1 adrenergic receptor blockers used to treat benign prostatic hyperplasia (BPH). This duplication increases the risk of side effects such as hypotension, dizziness, and fainting.\n",
      "\n",
      "2. Omission of therapy: Co-amoxiclav is ineffective against the resistant E. coli. An alternative antibiotic sensitive to E. coli, such as Piperacillin/Tazobactam, Ceftriaxone, Cefepime, Aztreonam, Ertapenem, Gentamicin, or Ciprofloxacin, should be considered.\n",
      "\n",
      "3. Potential adverse drug reactions: \n",
      "   - Bisoprolol and Alfuzosin: Both can lower blood pressure, increasing the risk of hypotension.\n",
      "   - Tramadol and Paracetamol: Their combined use may increase the risk of side effects like nausea, vomiting, dizziness, and drowsiness. \n",
      "   - Tamsulosin and Alfuzosin: Both can cause orthostatic hypotension, increasing the risk of falls in the elderly patient.\n",
      "   - Gabapentin: Can cause CNS depression, increasing the risk of falls.\n",
      "   - Lactulose: Can cause diarrhea, leading to dehydration and electrolyte imbalances. \n",
      "\n",
      "4. Monitoring parameters: \n",
      "   - Renal function: Monitor creatinine levels to assess kidney function and adjust medication doses if necessary.\n",
      "   - Blood glucose control: Monitor blood glucose levels to ensure adequate diabetes management.\n",
      "   - Blood pressure: Monitor blood pressure to detect hypotension, especially with the combination of Bisoprolol, Tamsulosin, and Alfuzosin.\n",
      "\n",
      "Recommendation:\n",
      "1. Change antibiotic therapy to an E. coli-sensitive antibiotic based on the wound culture results.\n",
      "\n",
      "2. Discontinue either Tamsulosin or Alfuzosin to avoid therapeutic duplication and reduce the risk of adverse effects.\n",
      "\n",
      "3. Monitor renal function, blood glucose control, and blood pressure closely.\n",
      "\n",
      "4. Address anemia and consider iron supplementation or erythropoiesis-stimulating agents.\n",
      "\n",
      "5. Review the need for Aspirin suspension and consider resuming it or an alternative antiplatelet therapy to prevent cardiovascular events.\n",
      "\n",
      "6. Educate the patient about potential side effects and interactions of their medications, emphasizing the importance of adherence and reporting any adverse reactions.\n",
      "Response from Model:  Situation: \n",
      "A 67-year-old male patient is admitted to the urology ward with persistent purulent discharge from a left loin abscess. He has a history of hypertension (HTN), type 2 diabetes mellitus (T2DM), and ischemic heart disease (IHD) with a depressed ejection fraction. The patient is currently on multiple medications, including Co-amoxiclav, Gabapentin, Lactulose, Paracetamol, Tramadol, Tamsulosin, Alfuzosin, Aspirin (suspended), Bisoprolol, Calcium Carb, Vitamin D, and Neurobion.\n",
      "\n",
      "Background: \n",
      "The patient's wound culture shows Escherichia coli, which is resistant to Co-amoxiclav, his current antibiotic therapy. Additionally, the patient's creatinine level is elevated, indicating potential renal impairment.\n",
      "\n",
      "Assessment: \n",
      "1. Therapeutic Duplication: Concomitant use of Tamsulosin and Alfuzosin, both alpha-blockers, may increase the risk of side effects such as hypotension. \n",
      "\n",
      "2. Omission of Therapy: Aspirin, typically used for secondary prevention in IHD, is currently suspended without a clear reason documented. \n",
      "\n",
      "3. Potential Drug-Drug Interaction: Bisoprolol's hypotensive effect may be enhanced by Tamsulosin and Alfuzosin, increasing the risk of hypotension. \n",
      "\n",
      "4. Potential Drug-Disease Interaction: Gabapentin's excretion may be affected by renal impairment, requiring dose adjustment.\n",
      "\n",
      "5. Potential Inappropriate Medication: Co-amoxiclav is ineffective due to E.Coli resistance; alternative antibiotics should be considered.\n",
      "\n",
      "6. Potential Overuse of Medication: Tramadol and Paracetamol may not be necessary given the low pain score.\n",
      "\n",
      "Recommendation: \n",
      "1. Review the need for dual alpha-blocker therapy (Tamsulosin and Alfuzosin).\n",
      "\n",
      "2. Reassess the suspension of Aspirin and consider its resumption or alternative antiplatelet therapy based on IHD history.\n",
      "\n",
      "3. Monitor blood pressure closely due to the potential additive hypotensive effects of Bisoprolol, Tamsulosin, and Alfuzosin.\n",
      "\n",
      "4. Adjust Gabapentin dosage if necessary based on the patient's renal function.\n",
      "\n",
      "5. Change antibiotic therapy to an alternative that the E.Coli is sensitive to, as per culture and sensitivity results. \n",
      "\n",
      "6. Review the necessity of Tramadol and Paracetamol based on the patient's current pain level.\n",
      "\n",
      "7. Review the indications and necessity of Lactulose, Neurobion, Calcium Carb, and Vitamin D.\n",
      "\n",
      "8. Monitor blood glucose levels regularly to ensure adequate glycemic control. \n",
      "\n",
      "The patient's medication regimen should be closely monitored, and any changes should be made in consultation with the healthcare team to optimize therapeutic outcomes and minimize potential drug-related problems.\n"
     ]
    }
   ],
   "source": [
    "import pandas as pd\n",
    "filename3 = \"./data/Pharmbot 23 Clinical scenarios RAG response.csv\"\n",
    "df = pd.read_csv(filename3)\n",
    "df['combine_prompt1'] = df['System Prompts'] + ' ' +df['RAG Results 1'] + ' '+ df['User Question']\n",
    "df['combine_prompt2'] = df['System Prompts'] + ' ' +df['RAG Results 2'] + ' '+ df['User Question']\n",
    "df['combine_prompt3'] = df['System Prompts'] + ' ' +df['RAG Results 3'] + ' '+ df['User Question']\n",
    "\n",
    "\n",
    "for i in range(0, len(df)):\n",
    "\n",
    "    if i<=100:\n",
    "        print(\"iteration #\", i)\n",
    "\n",
    "    # df.loc[i, \"Gemini_ultra_model_output1\"] = generate(df.loc[i,'combine_prompt1'])\n",
    "    # df.loc[i, \"Gemini_ultra_model_output2\"] = generate(df.loc[i,'combine_prompt2'])\n",
    "    # df.loc[i, \"Gemini_ultra_model_output3\"] = generate(df.loc[i,'combine_prompt3'])\n",
    "\n",
    "    df.loc[i, \"Gemini_pro_model_output1\"] = generate_pro(df.loc[i,'combine_prompt1'])\n",
    "    df.loc[i, \"Gemini_pro_model_output2\"] = generate_pro(df.loc[i,'combine_prompt2'])\n",
    "    df.loc[i, \"Gemini_pro_model_output3\"] = generate_pro(df.loc[i,'combine_prompt3'])\n",
    "\n",
    "    # df.loc[i, \"medLM_model_output\"] = generate_medllms_v1(df.loc[i,'combine_prompt'])\n",
    "    df.loc[i, \"medpalm_model_output1\"] = generate_medlpalm(df.loc[i,'combine_prompt1'])\n",
    "    df.loc[i, \"medpalm_model_output2\"] = generate_medlpalm(df.loc[i,'combine_prompt2'])\n",
    "    df.loc[i, \"medpalm_model_output3\"] = generate_medlpalm(df.loc[i,'combine_prompt3'])\n",
    "    \n",
    "    df.loc[i, \"palm_bison32k_output1\"] = generate_palm_bison32k(df.loc[i,'combine_prompt1'])\n",
    "    df.loc[i, \"palm_bison32k_output2\"] = generate_palm_bison32k(df.loc[i,'combine_prompt2'])\n",
    "    df.loc[i, \"palm_bison32k_output3\"] = generate_palm_bison32k(df.loc[i,'combine_prompt3'])\n",
    "\n",
    "    df.loc[i, \"Anthropic_haiko_model_output1\"] = generate_anthropic_response(df.loc[i,'combine_prompt1'])\n",
    "\n",
    "    # df.loc[i, \"palm_unicorn_output\"] = generate_palm_unicorn_v1(df.loc[i,'combine_prompt'])\n",
    "    \n",
    "    # print( \"/n output here ::\" , df['Gemini_ultra_model_output'][i])\n"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 56,
   "id": "07d13087-24dd-4659-8a6f-5f03800e14e1",
   "metadata": {},
   "outputs": [],
   "source": [
    "df = df.drop('combine_prompt1', axis=1)\n",
    "df = df.drop('combine_prompt2', axis=1)\n",
    "df = df.drop('combine_prompt3', axis=1)\n",
    "\n",
    "\n",
    "output3 = \"./output/O_Pharmbot 23 Clinical scenarios RAG response response_output_gemini.csv\"\n",
    "\n",
    "df.to_csv(output3)\n"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "a125e559-b8d3-4391-ad25-39469013fd1a",
   "metadata": {
    "tags": []
   },
   "source": [
    "#### fourth file for Pharmbot2"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 58,
   "id": "7a07ae84-abb1-431c-bbfc-047c022ca1a9",
   "metadata": {
    "scrolled": true,
    "tags": []
   },
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "iteration # 0\n",
      "response\n",
      "response\n",
      "Response from Model:  **Situation:**\n",
      "\n",
      "The patient has poorly controlled diabetes, hypertension, hyperlipidemia, CKD Stage 2, and a history of recurrent deep vein thrombosis (DVT) and pulmonary embolism (PE). He is currently taking warfarin, but it was held due to his recent coronary angiography and stent placement. Enoxaparin was started as a bridge anticoagulant. The patient is also taking aspirin and clopidogrel for secondary prevention of cardiovascular events.\n",
      "\n",
      "**Background:**\n",
      "\n",
      "The patient has a history of poorly controlled diabetes, which can increase the risk of cardiovascular disease and kidney disease. He is also taking multiple medications that may interact with each other, including warfarin, enoxaparin, aspirin, and clopidogrel.\n",
      "\n",
      "**Assessment:**\n",
      "\n",
      "- **Drug-drug interaction:** The patient is taking warfarin, which is a vitamin K antagonist that can interact with several other medications. Enoxaparin, aspirin, and clopidogrel can all increase the risk of bleeding when taken with warfarin.\n",
      "- **Uncontrolled diabetes:** The patient’s diabetes is poorly controlled, which can contribute to the progression of his cardiovascular disease and kidney disease.\n",
      "- **Inadequate pain control:** The patient reports ongoing mild chest discomfort despite taking analgesics.\n",
      "\n",
      "**Recommendation:**\n",
      "\n",
      "1. **Warfarin and enoxaparin:** The patient’s warfarin was held due to his recent coronary angiography and stent placement. Enoxaparin was started as a bridge anticoagulant. It is recommended to continue enoxaparin until the patient’s INR is therapeutic on warfarin. \n",
      "2. **Aspirin and clopidogrel:** The patient is taking aspirin and clopidogrel for secondary prevention of cardiovascular events. It is recommended to continue these medications as prescribed.\n",
      "3. **Control diabetes:** The patient’s diabetes is poorly controlled and should be optimized. This may reduce his risk of cardiovascular disease and kidney disease progression.\n",
      "4. **Consider additional pain control:** The patient reports ongoing mild chest discomfort despite taking analgesics. Additional pain control measures, such as increasing the dose or frequency of analgesics, could be considered.\n",
      "Response from Model: Pharmacist Recommendation Note\n",
      "\n",
      "Date: 12-Sep-2024\n",
      "\n",
      "Patient: X\n",
      "MRN: Y\n",
      "\n",
      "Situation: Patient is a 61-year-old male admitted with chest pain. Bedside echo showed LV impaired systolic function (EF < 45%) and ECG showed evolved anterior MI. Patient underwent PCI with successful implantation of drug eluting stent to the LAD. Patient has a history of recurrent DVT and PE and is on long-term warfarin.\n",
      "\n",
      "Background: Patient has a history of poorly controlled DM, HTN, HLD, CKD Stage 2, and recurrent DVT and PE. Patient is currently on enoxaparin bridge therapy for anticoagulation.\n",
      "\n",
      "Assessment: Patient has a high risk of bleeding due to concomitant use of aspirin, clopidogrel, and enoxaparin. Patient is also at risk for hypoglycemia due to poorly controlled DM and the use of insulin.\n",
      "\n",
      "Recommendation:\n",
      "\n",
      "1. Discontinue enoxaparin and start warfarin 5 mg PO daily.\n",
      "2. Monitor INR closely and adjust warfarin dose as needed.\n",
      "3. Continue aspirin 100 mg PO daily and clopidogrel 75 mg PO daily.\n",
      "4. Monitor blood glucose closely and adjust insulin doses as needed.\n",
      "5. Consider adding a proton pump inhibitor (PPI) to prevent gastrointestinal bleeding.\n",
      "6. Educate patient on the importance of medication adherence and the signs and symptoms of bleeding.<2tuv>\n",
      "iteration # 1\n",
      "response\n",
      "response\n",
      "Response from Model:  **Situation:**\n",
      "The patient has a history of penicillin allergy and is currently prescribed with clarithromycin and metronidazole as part of triple therapy for H. pylori eradication.\n",
      "\n",
      "**Background:**\n",
      "- Clarithromycin and metronidazole are commonly used together to treat H. pylori infection.\n",
      "- Penicillin and erythromycin belong to the same class of antibiotics known as beta-lactams. There is a potential for cross-reactivity between penicillins and other beta-lactam antibiotics, including clarithromycin.\n",
      "- The patient's penicillin allergy history increases the risk of potential cross-sensitivity to clarithromycin.\n",
      "\n",
      "**Assessment:**\n",
      "Potential drug-related problem:\n",
      "- Increased risk of allergic reaction to clarithromycin due to penicillin allergy.\n",
      "\n",
      "**Recommendation:**\n",
      "- Clarithromycin should be discontinued and an alternative antibiotic should be considered for H. pylori eradication. Azithromycin is an alternative antibiotic that can be used in patients with penicillin allergy.\n",
      "- The patient should be closely monitored for any signs and symptoms of an allergic reaction, such as rash, hives, shortness of breath, or swelling of the face, lips, tongue, or throat. If any of these symptoms occur, the patient should discontinue taking the medication and seek medical attention immediately.\n",
      "- Clarithromycin and metronidazole are typically used together, therefore alternative treatment regimens, such as a bismuth-containing quadruple therapy, should be considered in consultation with the relevant specialists.\n",
      "Response from Model: \n",
      "iteration # 2\n",
      "response\n",
      "response\n",
      "Response from Model:  **Situation:** The patient is a 66-year-old male with a history of CAD, hypertension, hyperlipidemia, diabetes, chronic left caudate nucleus infarct, RTA, and left knee osteoarthritis status post left total knee replacement. He presents with left lower extremity (LLE) swelling, fever, and chest tightness. He is currently being treated for evolved inferior ST-elevation myocardial infarction (STEMI) and left lower extremity cellulitis complicated by acute kidney injury (AKI).\n",
      "\n",
      "**Background:** The patient's past medical history is significant for multiple chronic conditions, including cardiovascular disease, hypertension, dyslipidemia, diabetes, and a history of left caudate nucleus infarct. He underwent left total knee replacement in May 2024. \n",
      "\n",
      "**Assessment:**\n",
      "\n",
      "1. **Drug-related problem (DRP):** Increased risk of hyperglycemia due to the use of steroids and discontinuation of metformin\n",
      "\n",
      "2. **Drug-related problem (DRP):** Potential drug-drug interaction between ticagrelor and clarithromycin\n",
      "\n",
      "3. **Drug-related problem (DRP):** Omission of home medications lisinopril and nifedipine due to AKI and Cath\n",
      "\n",
      "**Recommendations:**\n",
      "\n",
      "1. **For the increased risk of hyperglycemia**, recommend close monitoring of blood glucose levels and adjusting the doses of insulin glargine and sitagliptin as needed to maintain target blood glucose levels. Advise the patient on the signs and symptoms of hyperglycemia and hypoglycemia and to promptly report any concerns to the healthcare team.\n",
      "\n",
      "2. **For the potential drug-drug interaction between ticagrelor and clarithromycin**, recommend monitoring for signs and symptoms of increased bleeding or other adverse effects. Consider alternative antibiotics or dose adjustments if necessary. \n",
      "\n",
      "3. **For the omitted home medications lisinopril and nifedipine**, recommend restarting these medications once the AKI has resolved and the patient is hemodynamically stable. Monitor blood pressure and adjust the doses of lisinopril and nifedipine as needed to maintain target blood pressure levels.\n",
      "Response from Model: # Pharmacist Recommendation Note\n",
      "\n",
      "**Patient:** 66M\n",
      "\n",
      "**Height:** 180cm\n",
      "\n",
      "**Weight:** 80kg\n",
      "\n",
      "**Allergies:** Benzylpenicillin\n",
      "\n",
      "**Assessment:**\n",
      "\n",
      "- Evolved inferior STEMI\n",
      "- L LL cellulitis Cx AKI\n",
      "\n",
      "**Renal Impairment:** Moderate (ClCr >50 & <85)\n",
      "\n",
      "**Medications:**\n",
      "\n",
      "- LANTUS [Insulin Glargine] Solostar, Sub-Cutaneous 20 unit, At bedtime\n",
      "- Enoxaparin Sodium Injection, Sub-Cutaneous 20 mg, BD\n",
      "- Clarithromycin Injection, IV Intermittent 500mg, Q12H, In Final Volume Sodium Chloride 0.9% InFUSion 100 mL, Infuse Over 30 minute, Run at 200 mL/hr\n",
      "- Aspirin Tablet, PO 100 mg, OM\n",
      "- Ticagrelor Tablet, PO 90 mg, BD\n",
      "- Lisinopril Tablet, PO 20 mg, OM (Suspended for AKI)\n",
      "- GliCLAzide MR Tablet, PO 60 mg, BD (Pre-meal)\n",
      "- MetFORMIN HCl Tablet, PO 850 mg, BD (Suspended for Cath)\n",
      "- Sitagliptin Tablet, PO 100 mg, OM\n",
      "- Atorvastatin Tablet, PO 40 mg, ON\n",
      "- Bisoprolol Fumarate Tablet, PO 2.5 mg, OM\n",
      "- NiFEdipine LA Capsule/Tablet, PO 30 mg, BD (Suspended)\n",
      "- OMEprazole Capsule, PO 20 mg, OM\n",
      "- Isosorbide Mononitrate Tablet, PO 30mg, OM\n",
      "- Sildenafil Tablet, PO 50mg, PRN Erectile Dysfunction\n",
      "\n",
      "**Drug Related Problems:**\n",
      "\n",
      "1. Lisinopril is suspended due to AKI. However, lisinopril is not contraindicated in AKI and can be used safely in patients with AKI. Lisinopril should be restarted at a lower dose and titrated up as tolerated.\n",
      "2. Metformin is suspended due to Cath. However, metformin is not contraindicated in patients undergoing cardiac catheterization. Metformin should be restarted after the procedure.\n",
      "3. NiFEdipine is suspended. However, there is no clear indication for suspending nifedipine. Nifedipine should be restarted if there is no contraindication.\n",
      "\n",
      "**Recommendations:**\n",
      "\n",
      "1. Restart lisinopril at a lower dose and titrate up as tolerated.\n",
      "2. Restart metformin after the catheterization procedure.\n",
      "3. Restart nifedipine if there is no contraindication.\n",
      "iteration # 3\n",
      "response\n",
      "response\n",
      "Response from Model:  **Situation:**\n",
      "The patient is a 75-year-old male with history of hypertension (HTN), hyperlipidemia (HLD), benign prostatic hyperplasia (BPH), and right occipital parasagittal meningioma. He is currently experiencing atypical chest pain. He is taking multiple medications, including bisoprolol fumarate, clopidogrel, finasteride, omeprazole, terazosin, and atorvastatin.\n",
      "\n",
      "**Background:**\n",
      "The patient's past medical history includes ischemic cardiomyopathy (CMP) with mixed component, and he has undergone coronary artery bypass grafting (CABG) x3, mitral valve (MV) repair and annuloplasty. His last echocardiogram (TTE) showed LVEF 35-40%, RWMA present, and mild-moderate tricuspid regurgitation (TR).\n",
      "\n",
      "**Assessment:**\n",
      "1. **Drug-Related Problem (DRP):** Potential for increased bleeding risk\n",
      "   - **Background**: Clopidogrel is an antiplatelet medication that can increase the risk of bleeding. Omeprazole is a proton pump inhibitor (PPI) that can decrease the absorption of clopidogrel, potentially reducing its effectiveness.\n",
      "   - **Recommendation**: Monitor for signs and symptoms of bleeding, such as easy bruising, nosebleeds, or gastrointestinal bleeding. Consider alternative antiplatelet therapy if bleeding occurs or if the patient is unable to tolerate omeprazole.\n",
      "\n",
      "2. **DRP**: Potential for orthostatic hypotension\n",
      "   - **Background**: Terazosin is an alpha-blocker that can cause orthostatic hypotension, especially upon initiation or with dose increases.\n",
      "   - **Recommendation**: Advise the patient to rise slowly from a sitting or lying position, and to avoid activities that may cause dehydration. Monitor blood pressure and adjust terazosin dose as needed.\n",
      "\n",
      "3. **DRP**: Potential for drug interactions\n",
      "   - **Background**: Bisoprolol fumarate, clopidogrel, omeprazole, and atorvastatin are all metabolized by the liver. Concomitant use of these medications can increase the risk of drug interactions.\n",
      "   - **Recommendation**: Monitor for signs and symptoms of drug interactions, such as increased or decreased therapeutic effects, adverse effects, or changes in laboratory values. Adjust doses or discontinue medications as needed.\n",
      "\n",
      "**Recommendation:**\n",
      "- Monitor for signs and symptoms of bleeding, orthostatic hypotension, and drug interactions.\n",
      "- Consider alternative antiplatelet therapy if bleeding occurs or if the patient is unable to tolerate omeprazole.\n",
      "- Advise the patient to rise slowly from a sitting or lying position and to avoid activities that may cause dehydration. Monitor blood pressure and adjust terazosin dose as needed.\n",
      "- Monitor for signs and symptoms of drug interactions, such as increased or decreased therapeutic effects, adverse effects, or changes in laboratory values. Adjust doses or discontinue medications as needed.\n",
      "Response from Model: **Pharmacist Recommendation Note** \n",
      "\n",
      "**Situation:**\n",
      "Mr. Smith, 75 years old, was admitted to the hospital with atypical chest pain. His past medical history includes hypertension, hyperlipidemia, benign prostatic hyperplasia, and a right occipital parasagittal meningioma. He has a history of ischemic cardiomyopathy with mixed component and underwent coronary artery bypass grafting in 2014 and 2020.\n",
      "\n",
      "**Background:**\n",
      "Mr. Smith's current medication regimen includes the following medications:\n",
      "\n",
      "* Bisoprolol fumarate 1.25 mg orally once daily\n",
      "* Clopidogrel 75 mg orally once daily\n",
      "* Finasteride 5 mg orally once daily\n",
      "* Omeprazole 40 mg orally twice daily\n",
      "* Terazosin 2 mg orally once daily\n",
      "* Atorvastatin 20 mg orally once daily\n",
      "\n",
      "**Assessment:**\n",
      "Mr. Smith's medication regimen is appropriate for his current medical conditions. However, there is one potential drug-related problem:\n",
      "\n",
      "* Mr. Smith is taking omeprazole 40 mg orally twice daily. Omeprazole is a proton pump inhibitor (PPI) that can increase the risk of Clostridium difficile infection (CDI). Mr. Smith is at an increased risk of CDI due to his age and recent hospitalization.\n",
      "\n",
      "**Recommendation:**\n",
      "I recommend that Mr. Smith's omeprazole dose be reduced to 20 mg orally once daily. This dose reduction will help to reduce Mr. Smith's risk of CDI while still providing adequate gastric acid suppression. I will monitor Mr. Smith for any signs or symptoms of CDI and will adjust his medication regimen as needed.\n",
      "iteration # 4\n",
      "response\n",
      "response\n",
      "Response from Model:  Situation:\n",
      "The patient has uncontrolled type 2 diabetes with poor glycemic control (HbA1c of 10.6% in 08/2024), and is now experiencing acute pulmonary edema. His current insulin regimen includes Actrapid and Insulatard, which require frequent blood glucose monitoring and dose adjustments based on capillary blood glucose levels.\n",
      "\n",
      "Background:\n",
      "The patient has a history of left ataxic hemiparesis and is currently on aspirin and dipyridamole for secondary stroke prevention. He is also being treated for hypertension with losartan and bisoprolol.\n",
      "\n",
      "Assessment:\n",
      "1. Hyperglycemia: The patient's blood glucose levels are likely elevated due to his uncontrolled diabetes and acute illness.\n",
      "2. Potential for hypoglycemia: The patient's insulin regimen, particularly Actrapid, can cause hypoglycemia if blood glucose levels drop too low.\n",
      "\n",
      "Recommendation:\n",
      "1. Optimize diabetes management:\n",
      "   - Consider initiating a basal-bolus insulin regimen to provide more consistent insulin coverage and reduce the risk of hypoglycemia.\n",
      "   - Adjust insulin doses based on capillary blood glucose monitoring results.\n",
      "   - Provide patient education on proper insulin administration technique, blood glucose monitoring, and recognizing and managing hypoglycemia.\n",
      "2. Monitor for and manage hypoglycemia:\n",
      "   - Educate the patient and nursing staff about the signs and symptoms of hypoglycemia.\n",
      "   - Have a carbohydrate source readily available for the patient to treat hypoglycemia if it occurs.\n",
      "3. Consider a diabetes consult for further recommendations on optimizing his diabetes management.\n",
      "\n",
      "Note: The recommendations are based on the provided clinical document and medication list and do not account for any additional information that may be available. A comprehensive medication review and assessment by a pharmacist in collaboration with the healthcare team is essential to ensure appropriate medication management for this patient.\n",
      "Response from Model: **Situation**: Patient [Patient ID 67598017] has an elevated blood glucose level (19.7 mmol/L) and is currently NBM (nothing by mouth).\n",
      "\n",
      "**Background:** The patient has a history of diabetes mellitus.\n",
      "\n",
      "**Assessment:** The patient is at risk for developing diabetic ketoacidosis (DKA) due to the combination of elevated blood glucose level and NBM status.\n",
      "\n",
      "**Recommendation**:\n",
      "\n",
      "- Initiate an IV insulin infusion and monitor blood glucose levels closely.\n",
      "- Start the patient on a regular diet as soon as possible.\n",
      "- Consider discontinuing the current NPO order.\n",
      "- Discontinue the metformin order as metformin is contraindicated in patients with renal impairment. The patient's serum creatinine is 118 umol/L, which is above the upper limit of normal for a male patient.\n",
      "\n",
      "**Rationale**:\n",
      "\n",
      "- An IV insulin infusion will help to lower the patient's blood glucose level and prevent the development of DKA.\n",
      "- Starting the patient on a regular diet as soon as possible will help to prevent further episodes of hypoglycemia.\n",
      "- Discontinuing the NPO order will help to prevent further episodes of hypoglycemia.\n",
      "- Metformin is contraindicated in patients with renal impairment as it can increase the risk of lactic acidosis. The patient's serum creatinine is 118 umol/L, which is above the upper limit of normal for a male patient. Therefore, metformin should be discontinued.<ctrl99>\n",
      "iteration # 5\n",
      "response\n",
      "response\n",
      "Response from Model:  **Situation:**\n",
      "The patient is a 58-year-old male with a history of hypertension, who is currently being evaluated for possible posterior circulation stroke. He has several concomitant medical conditions including hyponatremia, acute kidney injury, history of polycythemia, and UTI. The patient’s medication regimen includes medications to treat hypertension, hyperlipidemia, stroke prophylaxis, and antibiotics for UTI.\n",
      "\n",
      "**Background:**\n",
      "The patient presented to the emergency department with a 2-day history of dizziness, which has now resolved. He denies any new weakness, numbness, chest pain, shortness of breath, or gastrointestinal symptoms. He does report a history of long-term giddiness that is worse this time. He is a smoker with a 10-pack year history and a social drinker.\n",
      "\n",
      "**Assessment:**\n",
      "- **Hyponatremia:** The patient has hyponatremia, with a sodium level of 124 mmol/L. This is likely depletional, as he has a history of poor intake and has received IV fluids.\n",
      "- **Acute kidney injury:** The patient has acute kidney injury, with a creatinine level of 46 umol/L. This is likely due to hypovolemia from poor intake and IV fluids.\n",
      "- **Possible posterior circulation stroke:** The patient has symptoms that are suggestive of a posterior circulation stroke, including dizziness, vertigo, and gait instability. However, his CT brain did not reveal any acute intracranial hemorrhage or mass effect. He has a history of small vessel ischemic disease, which may be a contributing factor.\n",
      "- **Polycythemia:** The patient has a history of polycythemia, which is likely secondary to his strong smoking history. His hemoglobin level normalized after IV hydration.\n",
      "- **UTI:** The patient has a UTI, which is being treated with antibiotics.\n",
      "\n",
      "**Recommendations:**\n",
      "- **Sodium Chloride 0.9%:** Continue IV fluids with Sodium Chloride 0.9% to correct hyponatremia. Monitor sodium levels closely and ensure the rate of correction does not exceed 6-8 mmol/L per 24 hours.\n",
      "- **Potassium Chloride:** Start potassium chloride supplements, as the patient is at risk of hypokalemia due to the use of IV fluids and diuretics.\n",
      "- **Lisinopril:** Lisinopril should be resumed, as it is important for controlling the patient’s hypertension. \n",
      "- **Aspirin:** Continue aspirin 300 mg daily for stroke prophylaxis.\n",
      "- **Statin therapy:** Continue simvastatin and atorvastatin for hyperlipidemia management.\n",
      "- **Co-amoxiclav:** Continue co-amoxiclav for the treatment of UTI.\n",
      "- **Consultations:** Obtain consultations with the nephrology and hematology teams for further evaluation and management of the patient’s hyponatremia, acute kidney injury, and possible polycythemia.\n",
      "- **Further investigations:** Order additional investigations as per the plan outlined in the clinical notes, including MRI brain, electrolytes, renal function tests, and hematological tests.\n",
      "- **Patient education:** Provide patient education regarding his medical conditions, medications, and the importance of maintaining adequate hydration and nutrition.\n",
      "Response from Model: **Situation:** The patient is a 58 year old male with history of hypertension and is currently admitted with dizziness. Lisinopril is currently suspended due to suspicion of stroke.\n",
      "\n",
      "**Background:** Lisinopril is a first-line antihypertensive medication and is effective in lowering blood pressure. However, it can also cause side effects such as dizziness, lightheadedness, and fainting.\n",
      "\n",
      "**Assessment:** The patient's dizziness may be due to the lisinopril. It is possible that the lisinopril is causing the patient to have orthostatic hypotension, which is a sudden drop in blood pressure when standing up. This can lead to dizziness, lightheadedness, and fainting.\n",
      "\n",
      "**Recommendation:** It is recommended to restart lisinopril and reassess the patient's blood pressure. If the patient continues to experience dizziness, the dose of lisinopril may need to be adjusted or the medication may need to be discontinued.\n",
      "\n",
      "In addition, it is recommended to monitor the patient's blood pressure closely and to educate the patient about the signs and symptoms of orthostatic hypotension. The patient should be advised to stand up slowly and to avoid sudden changes in position. If the patient experiences dizziness, lightheadedness, or fainting, they should sit or lie down immediately and call for help.\n",
      "iteration # 6\n",
      "response\n",
      "response\n",
      "Response from Model:  **Situation:** \n",
      "The patient is a 65-year-old female with a history of type 2 diabetes, hypertension, hyperlipidemia, osteoarthritis, and a left distal radius fracture status post open reduction and internal fixation, who presented to the emergency department with symptomatic hypoglycemia.\n",
      "\n",
      "**Background:**\n",
      "The patient has a history of group B streptococcus bacteremia and septic shock, which was complicated by elevated troponin T levels and likely type 2 myocardial infarction. She was also recently discharged from the hospital after experiencing deconditioning due to sepsis and prolonged hospital stay. The patient lives with her daughter and takes her medications independently. She is not on insulin for her diabetes and relies on oral hypoglycemic agents (OHGAs) to control her blood glucose levels.\n",
      "\n",
      "**Assessment:**\n",
      "1. Hypoglycemia: The patient's presentation with altered level of consciousness and low blood glucose levels suggests hypoglycemia. Her history of diabetes and reliance on OHGAs, without insulin use, increases her risk of hypoglycemia.\n",
      "\n",
      "2. Metformin-associated acute kidney injury (AKI): The patient's recent AKI is likely due to dehydration and poor oral intake. However, metformin, one of her medications for diabetes, can also contribute to AKI. Metformin is known to cause lactic acidosis, which can lead to AKI. Additionally, the patient's sepsis and hypotension during her previous hospitalization may have further contributed to her risk of AKI.\n",
      "\n",
      "**Recommendation:**\n",
      "1. Hold metformin: Given the patient's AKI and the potential risk of metformin-induced lactic acidosis, it is recommended to temporarily discontinue metformin until her kidney function improves. This can be done in consultation with the patient's primary care provider or hospitalist.\n",
      "\n",
      "2. Adjust insulin therapy: The patient's hypoglycemia episodes suggest that her current OHGA regimen may not be adequately controlling her blood glucose levels. It is recommended to consult with the diabetes team or a pharmacist to optimize her insulin therapy, considering her recent hypoglycemia and AKI. This may involve adjusting the doses of her current OHGAs or adding basal insulin to her regimen.\n",
      "\n",
      "3. Monitor blood glucose levels: Close monitoring of the patient's blood glucose levels is essential to prevent further episodes of hypoglycemia. This can be done by checking her blood glucose levels regularly using a glucometer, especially before and after meals, and at bedtime.\n",
      "\n",
      "4. Patient education: The patient should be educated about the signs and symptoms of hypoglycemia and hyperglycemia, as well as the importance of regular blood glucose monitoring. She should also be advised to promptly report any unusual symptoms to her healthcare provider.\n",
      "\n",
      "5. Follow-up: The patient's response to these interventions should be closely monitored. Her kidney function and blood glucose levels should be reassessed regularly to ensure that her condition is improving.\n",
      "Response from Model: Situation:\n",
      "The patient was admitted for symptomatic hypoglycemia, which was likely caused by her oral hypoglycemic agents (OHGAs).\n",
      "\n",
      "Background:\n",
      "The patient is a 65-year-old female with a history of type 2 diabetes mellitus (T2DM), hypertension (HTN), hyperlipidemia (HLD), osteoarthritis (OA), and a left distal radius fracture status post open reduction internal fixation (ORIF). She was recently admitted for group B streptococcus bacteremia likely secondary to pneumonia. She also has a history of septic shock and a raised troponin T likely secondary to a type 2 myocardial infarction (T2MI).\n",
      "\n",
      "The patient's current medications include:\n",
      "\n",
      "* Dextrose 5%, Sodium Chloride 0.9% Infusion\n",
      "* Enalapril Maleate Tablet\n",
      "* Gabapentin Capsule\n",
      "* GliPIzide Tablet\n",
      "* MetFORMIN HCl Tablet (suspended for acute kidney injury)\n",
      "* Simvastatin Tablet\n",
      "* Ketoprofen 30mg Plaster\n",
      "* Furosemide Tablet (suspended)\n",
      "* Calcium Carb 450mg, Vitamin D 200 unit Tablet\n",
      "* Diclofenac Tablet\n",
      "\n",
      "Assessment:\n",
      "\n",
      "The patient's hypoglycemia was likely caused by her OHGAs, specifically glipizide. Glipizide is a sulfonylurea that works by stimulating the release of insulin from the pancreas. In patients with impaired renal function, glipizide can accumulate and cause hypoglycemia. The patient's acute kidney injury (AKI) is likely due to dehydration and poor oral intake.\n",
      "\n",
      "Recommendation:\n",
      "\n",
      "* Discontinue glipizide.\n",
      "* Start insulin therapy.\n",
      "* Monitor blood glucose levels closely.\n",
      "* Hydrate the patient with intravenous fluids.\n",
      "* Consider starting the patient on a renal diet.\n",
      "\n",
      "The patient should be monitored closely for any signs or symptoms of hypoglycemia. If the patient experiences hypoglycemia, she should be treated with oral glucose or intravenous dextrose.\n",
      "iteration # 7\n",
      "response\n",
      "response\n",
      "Response from Model:  **Situation:**\n",
      "The patient has severe hypercalcemia with a corrected calcium of 3.68 mmol/L and elevated creatinine of 192 umol/L, suggesting AKI. She is currently receiving cinacalcet 12.5 mg once daily for the management of hypercalcemia.\n",
      "\n",
      "**Background:**\n",
      "Cinacalcet is a calcimimetic agent that is used to lower calcium levels in patients with hyperparathyroidism. It works by increasing the sensitivity of the parathyroid glands to calcium, thereby reducing the production of parathyroid hormone (PTH) and ultimately decreasing calcium levels. Cinacalcet is typically well-tolerated, but common adverse effects include nausea, vomiting, diarrhea, and headache.\n",
      "\n",
      "**Assessment:**\n",
      "Given the patient's history of nausea with cinacalcet, it is possible that she is experiencing these adverse effects. Additionally, the patient's elevated creatinine suggests that cinacalcet may be contributing to her AKI.\n",
      "\n",
      "**Recommendation:**\n",
      "I recommend discontinuing cinacalcet and monitoring the patient's calcium levels closely. If her calcium levels remain elevated, alternative therapies for hypercalcemia should be considered, such as intravenous fluids, calcitonin, or bisphosphonates. Additionally, the patient should be encouraged to stay well-hydrated and avoid activities that may cause dehydration. The patient should also be monitored for signs and symptoms of AKI, such as decreased urine output, increased edema, and fatigue. If any of these symptoms develop, further evaluation and treatment may be necessary.\n",
      "Response from Model: Situation: The patient is a 68-year-old Chinese female with a history of hypertension and osteoarthritis of the knee. She was admitted to the hospital for severe symptomatic hypercalcemia, AKI with non-nephrotic range proteinuria, nosocomial fever with UTI, hypertensive urgency, NCNC anemia, and BL LL weakness and numbness 2' cervical myelopathy. The patient is currently taking cinacalcet 12.5mg OM for hypercalcemia and laxatives as ordered for constipation.\n",
      "\n",
      "Background: Cinacalcet is a calcimimetic agent that is used to treat hypercalcemia associated with parathyroid carcinoma and primary hyperparathyroidism. It works by increasing the sensitivity of the calcium-sensing receptor on the parathyroid glands, which leads to a decrease in parathyroid hormone (PTH) secretion and a subsequent decrease in serum calcium levels. Cinacalcet can cause nausea and vomiting, which are common side effects.\n",
      "\n",
      "Assessment: The patient is currently taking cinacalcet 12.5mg OM for hypercalcemia and has a history of nausea with previous cinacalcet use. The patient is also taking laxatives as ordered for constipation.\n",
      "\n",
      "Recommendation: It is recommended to discontinue cinacalcet and consider alternative treatments for hypercalcemia. The patient's constipation should be monitored and treated as needed. Possible alternative treatments for hypercalcemia include bisphosphonates, calcitonin, and gallium nitrate. The choice of treatment will depend on the severity of the hypercalcemia and the patient's underlying medical conditions.\n",
      "\n",
      "It is also recommended to monitor the patient's blood pressure and adjust the dose of nifedipine LA as needed. The patient's blood pressure is currently 166/70 mmHg, which is elevated. The patient is currently taking nifedipine LA 60 mg BD. It is recommended to increase the dose of nifedipine LA to 90 mg BD.\n",
      "\n",
      "Finally, it is recommended to monitor the patient's renal function and adjust the dose of losartan potassium as needed. The patient's serum creatinine is currently 192 umol/L, which is elevated. The patient is currently taking losartan potassium 25 mg OM. It is recommended to decrease the dose of losartan potassium to 12.5 mg OM.\n",
      "iteration # 8\n",
      "response\n",
      "response\n",
      "Response from Model:  **Situation:**\n",
      "- Poorly controlled type 2 diabetes with recent history of multiple hospital admissions for fluid overload.\n",
      "- Currently admitted for fluid overload, with bilateral lower limb swelling and shortness of breath.\n",
      "- CKD stage 4, not suitable for dialysis.\n",
      "- IHD with reduced LVEF of 46%, on IV furosemide and metolazone.\n",
      "\n",
      "**Background:**\n",
      "- Patient has a history of poorly controlled type 2 diabetes and CKD stage 4.\n",
      "- He has been experiencing recurrent episodes of fluid overload, requiring multiple hospital admissions.\n",
      "- His current medications include insulin, furosemide, metolazone, and other supportive medications.\n",
      "\n",
      "**Assessment:**\n",
      "- The patient's fluid overload is likely multifactorial, including fluid indiscretion in the setting of CKD and IHD.\n",
      "- The patient's poorly controlled diabetes may also be contributing to his fluid retention.\n",
      "\n",
      "**Recommendation:**\n",
      "- Continue to monitor the patient's fluid status closely, with daily weights and strict input/output charting.\n",
      "- Continue IV furosemide and metolazone as prescribed.\n",
      "- Consider increasing the patient's insulin doses to improve glycemic control and reduce fluid retention.\n",
      "- Provide dietary counseling and education on fluid restriction and healthy eating to prevent future episodes of fluid overload.\n",
      "Response from Model: Situation\n",
      "    The patient is a 71-year-old male who has been admitted to the hospital with fluid overload. His vital signs are stable, but his oxygen saturation is 93-96% on 2 liters of nasal prong oxygen. He has a history of poorly controlled type 2 diabetes, ischemic heart disease with a reduced left ventricular ejection fraction of 46%, peripheral vascular disease, and chronic kidney disease stage 4.\n",
      "\n",
      "Background\n",
      "    The patient's fluid overload is likely due to a combination of factors, including his chronic kidney disease, heart failure, and fluid indiscretion. He is currently on intravenous furosemide 120 mg three times daily and was given a one-time dose of metolazone 2.5 mg. His dry weight on previous discharge was 69 kg, and he was admitted with a weight of 83 kg.\n",
      "\n",
      "Assessment\n",
      "    The patient's fluid overload is a serious problem that could lead to complications such as pulmonary edema and heart failure. He needs to be closely monitored and his fluid intake and output should be carefully tracked. He may need to be given additional diuretics or other medications to help him lose fluid. His blood sugar levels should also be monitored closely and he may need to be given insulin to keep his blood sugar levels under control.\n",
      "\n",
      "Recommendation\n",
      "    I recommend the following changes to the patient's medication regimen:\n",
      "\n",
      "    - Continue intravenous furosemide 120 mg three times daily.\n",
      "    - Consider adding metolazone 2.5 mg daily to the patient's medication regimen.\n",
      "    - Discontinue the patient's oral furosemide.\n",
      "    - Start the patient on a sliding scale insulin regimen to keep his blood sugar levels under control.\n",
      "    - Consider starting the patient on a low-sodium diet.\n",
      "    - Consider starting the patient on a fluid restriction.\n",
      "\n",
      "    I also recommend that the patient be closely monitored for any signs or symptoms of dehydration or electrolyte imbalances.\n",
      "iteration # 9\n",
      "response\n",
      "response\n",
      "Response from Model:  **Situation:** The patient is a known case of right phacomorphic glaucoma, with a history of elevated intraocular pressure (IOP) and zonulysis. They are currently on maximal medical therapy including Brimonidine, Brinzolamide, Latanoprost, and Acetazolamide. Despite this, their IOP remains uncontrolled at 40 mmHg.\n",
      "\n",
      "**Background:** Phacomorphic glaucoma is a type of secondary glaucoma that occurs due to the progressive opacification and hardening of the lens, leading to the narrowing of the iridocorneal angle and obstruction of the aqueous outflow pathway. This can result in increased IOP and glaucomatous damage to the optic nerve.\n",
      "\n",
      "**Assessment:** Based on the patient's current IOP and the failure of maximal medical therapy to adequately control it, it is recommended to proceed with surgical intervention in the form of phacoemulsification with intraocular lens (IOL) implantation and cataract extraction with trabeculectomy (Phaco IOL CTR CTS). This procedure aims to remove the cataract and improve the outflow of aqueous humor, thereby reducing IOP and preventing further damage to the optic nerve.\n",
      "\n",
      "**Recommendation:** It is recommended to schedule the patient for phacoemulsification with IOL implantation and trabeculectomy as soon as possible. The patient should be adequately counseled regarding the procedure, its risks, benefits, and alternative options. Post-operative care and follow-up appointments should be planned to monitor the IOP and assess the success of the intervention. Additionally, the patient should continue using their current glaucoma medications until the surgery and adhere to the prescribed post-operative regimen to optimize the outcome.\n",
      "Response from Model: Pharmacotherapy Consultation Note\n",
      "\n",
      "Subject: Drug related problems\n",
      "Date: [Date]\n",
      "\n",
      "Situation\n",
      "The patient is currently receiving the following medications:\n",
      "Acetazolamide 250 mg PO QDS\n",
      "Potassium chloride 600 mg PO OM\n",
      "Aqueous cream topical 1 application BD PRN dry skin\n",
      "Atorvastatin 20 mg PO ON\n",
      "Betamethasone 0.1%, clioquinol 3% cream topical 1 application BD\n",
      "Brimonidine tartrate 0.15% eye drops ophthalmic 1 drop to right eye TDS\n",
      "Brinzolamide 1% eye drops ophthalmic 1 drop to right eye TDS\n",
      "Enalapril maleate 20 mg PO BD\n",
      "Gliclazide 160 mg PO BD (pre-meal)\n",
      "Hydroxyzine HCl 25 mg PO TDS for itch\n",
      "Latanoprost 0.005% eye drops ophthalmic 1 drop to right eye ON\n",
      "Dapagliflozin 10 mg PO OM\n",
      "Metformin HCl 500 mg PO BD\n",
      "Spironolactone 12.5 mg PO OM (suspended)\n",
      "XalaCOM eye drops [Latanoprost 0.005%, timolol 0.5%] ophthalmic 1 drop to left eye OM\n",
      "\n",
      "\n",
      "Background\n",
      "The patient was admitted to the hospital with a diagnosis of right phacomorphic glaucoma. The patient is also being treated for diabetes mellitus and hypertension.\n",
      "\n",
      "Assessment\n",
      "There are several potential drug related problems that need to be addressed.\n",
      "\n",
      "First, the patient is currently receiving acetazolamide, which is a carbonic anhydrase inhibitor. This medication can cause metabolic acidosis, which can be a serious side effect. The patient's serum bicarbonate level should be monitored closely while they are taking acetazolamide.\n",
      "\n",
      "Second, the patient is currently receiving spironolactone, which is a potassium-sparing diuretic. This medication can cause hyperkalemia, which can be a serious side effect. The patient's serum potassium level should be monitored closely while they are taking spironolactone.\n",
      "\n",
      "Third, the patient is currently receiving gliclazide, which is a sulfonylurea. This medication can cause hypoglycemia, which can be a serious side effect. The patient's blood glucose level should be monitored closely while they are taking gliclazide.\n",
      "\n",
      "Recommendation\n",
      "The following recommendations are made:\n",
      "\n",
      "Discontinue spironolactone.\n",
      "Reduce the dose of acetazolamide to 250 mg PO BID.\n",
      "Monitor the patient's serum bicarbonate level closely.\n",
      "Monitor the patient's serum potassium level closely.\n",
      "Monitor the patient's blood glucose level closely.\n",
      "Educate the patient about the signs and symptoms of hypoglycemia.\n",
      "Instruct the patient to contact their healthcare provider if they experience any of the following symptoms:\n",
      "\n",
      "Confusion\n",
      "Dizziness\n",
      "Fatigue\n",
      "Headache\n",
      "Hunger\n",
      "Nausea\n",
      "Sweating\n",
      "Tremors\n",
      "Convulsions<ctrl99>\n",
      "iteration # 10\n",
      "response\n",
      "response\n",
      "Response from Model:  **Situation:**\n",
      "Potential drug-related problem: Concomitant use of high-dose corticosteroids (methylprednisolone) and etoricoxib.\n",
      "\n",
      "**Background:**\n",
      "The patient is a 65-year-old female with Graves' disease complicated by thyroid eye disease (TED). She has undergone bilateral orbital decompression surgery and is currently receiving intravenous methylprednisolone 250 mg every 6 hours for a total of 4 doses, as well as oral etoricoxib 90 mg once daily for pain management.\n",
      "\n",
      "**Assessment:**\n",
      "The concomitant use of high-dose corticosteroids and etoricoxib may increase the risk of gastrointestinal adverse effects, including gastrointestinal bleeding and ulceration. Etoricoxib is a selective inhibitor of cyclooxygenase-2 (COX-2), which can reduce inflammation and pain. However, it can also inhibit COX-1, which is involved in the production of prostaglandins that protect the gastric mucosa. High-dose corticosteroids can also reduce prostaglandin production, further increasing the risk of gastrointestinal adverse effects.\n",
      "\n",
      "**Recommendation:**\n",
      "To mitigate the risk of gastrointestinal adverse effects, the following changes to the medication regimen are recommended:\n",
      "\n",
      "- Etoricoxib should be discontinued.\n",
      "- Omeprazole 40 mg once daily should be continued for gastroprotection.\n",
      "- The patient should be monitored for gastrointestinal symptoms, such as abdominal pain, heartburn, nausea, and vomiting. If any of these symptoms develop, she should be advised to stop taking the medications and seek medical attention.\n",
      "\n",
      "The patient should also be advised to avoid alcohol consumption and smoking, which can further increase the risk of gastrointestinal adverse effects.\n",
      "Response from Model: Situation: The patient is currently admitted to the hospital post-operatively following bilateral orbital decompression. She is receiving IV methylprednisolone (250mg Q6H) for a total of 4 doses, and is also on PO prednisolone (60mg OM).\n",
      "\n",
      "Background: Methylprednisolone and prednisolone are both corticosteroids that can have additive effects when used together. This can increase the risk of side effects, such as fluid retention, hypertension, and hyperglycemia.\n",
      "\n",
      "Assessment: The patient is currently on a high dose of corticosteroids, which is likely to increase her risk of side effects. The concurrent use of methylprednisolone and prednisolone is unnecessary and can increase the risk of side effects.\n",
      "\n",
      "Recommendation: Discontinue PO prednisolone. The patient will still receive a high dose of corticosteroids from the IV methylprednisolone, and this will be sufficient for her current condition.\n",
      "\n",
      "Additionally, recommend monitoring the patient's blood glucose levels, blood pressure, and fluid status closely. If necessary, the dose of IV methylprednisolone can be adjusted to minimize the risk of side effects.\n",
      "iteration # 11\n",
      "response\n",
      "response\n",
      "Response from Model:  **Situation:**\n",
      "The patient is a 45-year-old male with a history of valvular cardiomyopathy, bilateral pseudophakia, and left carotid stenosis, who is currently being treated for right acute endophthalmitis. He is currently receiving intravenous (IV) imipenem, oral linezolid, and oral azithromycin for presumed Mycobacterium abscessus infection.\n",
      "\n",
      "**Background:**\n",
      "The patient's endophthalmitis was initially treated with intravitreal vancomycin and ceftazidime, but cultures revealed Mycobacterium spp. He has also received oral ciprofloxacin and topical atropine sulfate, prednisolone acetate, and dexamethasone.\n",
      "\n",
      "**Assessment:**\n",
      "The patient is at risk for drug-related problems due to the multiple medications he is receiving, including the potential for:\n",
      "\n",
      "- **Drug interactions:** Imipenem and linezolid are both known to interact with several other medications, including warfarin, phenytoin, and carbamazepine. Azithromycin may also interact with warfarin and digoxin.\n",
      "- **QTc prolongation:** Imipenem, linezolid, and azithromycin can all prolong the QTc interval, which can increase the risk of potentially fatal arrhythmias such as torsades de pointes.\n",
      "- **Myelosuppression:** Linezolid and azithromycin can both cause myelosuppression, which can lead to anemia, neutropenia, and thrombocytopenia.\n",
      "- **Hepatotoxicity:** Linezolid can cause hepatotoxicity, which can lead to liver damage and failure.\n",
      "- **Renal impairment:** Imipenem and linezolid can both cause renal impairment, which can lead to fluid retention, electrolyte imbalances, and kidney failure.\n",
      "- **Ocular toxicity:** Prolonged use of topical steroids, such as prednisolone acetate and dexamethasone, can increase the risk of ocular toxicity, including glaucoma, cataracts, and corneal ulceration.\n",
      "- **Mycobacterium abscessus** - difficult to treat, prolonged treatment (1-2 years) with multiple medications, risk of resistance\n",
      "\n",
      "**Recommendation:**\n",
      "\n",
      "1. **Monitor for drug interactions:** The patient should be closely monitored for signs and symptoms of drug interactions, including bleeding, seizures, and arrhythmias. Dosing adjustments or discontinuation of one or more medications may be necessary if a drug interaction is suspected.\n",
      "2. **Monitor for QTc prolongation:** The patient's QTc interval should be monitored regularly to assess for prolongation. Dosing adjustments or discontinuation of one or more medications may be necessary if the QTc interval becomes too long.\n",
      "3. **Monitor for myelosuppression:** The patient's complete blood count should be monitored regularly to assess for myelosuppression. Dosing adjustments or discontinuation of one or more medications may be necessary if myelosuppression occurs.\n",
      "4. **Monitor for hepatotoxicity:** The patient's liver function tests should be monitored regularly to assess for hepatotoxicity. Dosing adjustments or discontinuation of linezolid may be necessary if hepatotoxicity occurs.\n",
      "5. **Monitor for renal impairment:** The patient's renal function should be monitored regularly to assess for renal impairment. Dosing adjustments or discontinuation of one or more medications may be necessary if renal impairment occurs.\n",
      "6. **Limit the use of topical steroids:** The patient should be advised to use topical steroids only as directed and to avoid prolonged use.\n",
      "7. **Consult an infectious disease specialist:** Given the complexity of the patient's case and the difficulty in treating Mycobacterium abscessus, it is recommended that an infectious disease specialist be consulted to assist in managing his care.\n",
      "Response from Model: Situation: A 45 year old male patient is being treated for right acute endophthalmitis. The patient is currently receiving topical atropine 1%, prednisolone acetate 1%, and dexamethasone 0.1% ointment, as well as oral ciprofloxacin and linezolid.\n",
      "\n",
      "Background: The patient has a history of ischemic heart disease. The patient is not currently taking any antiplatelet medications.\n",
      "\n",
      "Assessment: The patient is at risk for developing a myocardial infarction due to the combination of ischemic heart disease and the use of linezolid. Linezolid is a monoamine oxidase (MAO) inhibitor, and can increase the risk of serotonin syndrome when combined with other serotonergic agents. Tramadol is a serotonergic agent, and can increase the risk of serotonin syndrome when combined with linezolid.\n",
      "\n",
      "Recommendation: Discontinue tramadol. Initiate an alternative analgesic, such as acetaminophen or ibuprofen. Monitor the patient closely for signs and symptoms of serotonin syndrome, such as agitation, confusion, hallucinations, hyperthermia, and diaphoresis. If serotonin syndrome is suspected, discontinue linezolid and initiate supportive care.\n",
      "\n",
      "References:\n",
      "\n",
      "1. Lexicomp. Linezolid. Accessed on 7/5/2023.\n",
      "2. Lexicomp. Tramadol. Accessed on 7/5/2023.\n",
      "iteration # 12\n",
      "response\n",
      "response\n",
      "Response from Model:  **Situation:**\n",
      "The patient has a history of chronic ulcerative pancolitis (UC) and is currently being treated with oral mesalazine enemas, oral azathioprine, and oral omeprazole. She was recently admitted to the hospital for cholelithiasis and treated with intravenous antibiotics. She is now experiencing left knee pain and swelling, with a fever of 39.1°C. The working diagnosis is gout flare.\n",
      "\n",
      "**Background:**\n",
      "The patient has a history of non-compliance with her UC treatment, which has resulted in recurrent flares. She has also experienced anemia in the past. The patient is allergic to co-amoxiclav, which limits her medication options.\n",
      "\n",
      "**Assessment:**\n",
      "- Drug-related problem: Potential inappropriate use of azathioprine in the setting of gout.\n",
      "- Drug-related problem: Potential drug interaction between azathioprine and allopurinol.\n",
      "\n",
      "**Recommendation:**\n",
      "- Azathioprine: Assess the appropriateness of continuing azathioprine in the setting of gout. Consider alternative immunosuppressive medications that are less likely to exacerbate gout.\n",
      "- Allopurinol and azathioprine: Monitor for potential drug interaction. Allopurinol can increase the risk of bone marrow suppression and hepatotoxicity when used with azathioprine. Closely monitor the patient's blood counts and liver function tests.\n",
      "\n",
      "**Additional recommendations:**\n",
      "- Provide patient education on the importance of compliance with UC treatment to prevent flares.\n",
      "- Encourage the patient to maintain a healthy diet and lifestyle to reduce the risk of gout attacks.\n",
      "- Monitor the patient's pain and adjust the dose of allopurinol as needed to manage her gout symptoms.\n",
      "Response from Model: __Situation__:\n",
      "This 20 year-old female patient was admitted with a left knee pain with suspicion of gout flare and has been prescribed Allopurinol.\n",
      "\n",
      "__Background__:\n",
      "Allopurinol is a xanthine oxidase inhibitor that is used to lower uric acid levels in the blood. It is typically used to treat gout and kidney stones. Allopurinol is typically started at a low dose (100 mg once daily) and gradually increased over time. This is done to minimize the risk of side effects, such as skin rash and gastrointestinal upset.\n",
      "\n",
      "__Assessment__:\n",
      "The patient is currently on 100 mg of Allopurinol once daily. This is a low dose and it is likely that the patient will need to have their dose increased over time. The patient should be monitored for any side effects, such as skin rash and gastrointestinal upset.\n",
      "\n",
      "__Recommendation__:\n",
      "I recommend that the Allopurinol dose be increased to 200 mg once daily. This dose is more likely to be effective in controlling the patient's gout symptoms. The patient should be monitored for any side effects, such as skin rash and gastrointestinal upset.\n",
      "\n",
      "I would also like to recommend that the patient be started on a low-purine diet. This type of diet can help to reduce the amount of uric acid in the blood and prevent future gout flares. A low-purine diet should include foods that are low in purines, such as fruits, vegetables, and whole grains. It should also avoid foods that are high in purines, such as red meat, seafood, and alcohol.\n",
      "iteration # 13\n",
      "response\n",
      "response\n",
      "Response from Model:  **Situation:**\n",
      "The patient is a 45-year-old male with hepatitis C genotype 3A and Child’s B cirrhosis who is admitted for deranged liver function tests (LFTs) with raised bilirubin. He has started treatment with Epclusa for hepatitis C.\n",
      "\n",
      "**Background:**\n",
      "- The patient has a history of hepatitis C and hypertension. He drinks 3 large cans of beer daily.\n",
      "- He was admitted to the hospital due to deranged LFTs and presented with jaundice.\n",
      "- An ultrasound of the hepatobiliary system performed during a previous admission showed evidence of possible acute cholecystitis.\n",
      "- The patient has been treated with various antibiotics for presumed cholecystitis, including Rocephin/Flagyl, Tazo, ciprofloxacin, and Tazo. His symptoms resolved after antibiotics.\n",
      "\n",
      "**Assessment:**\n",
      "- The patient’s current medications include:\n",
      " - Epclusa (sofosbuvir/velpatasvir) for hepatitis C\n",
      " - Furosemide (Lasix) for fluid retention\n",
      " - Spironolactone for fluid retention\n",
      " - Omeprazole for gastric discomfort\n",
      " - Neurobion (vitamin B complex)\n",
      " - Sodium phosphate to replace phosphate\n",
      " - Paracetamol (acetaminophen) for pain\n",
      "\n",
      "**Recommendation:**\n",
      "- The patient’s medication regimen appears appropriate for his current medical conditions. No changes are recommended at this time.\n",
      "- The patient should continue to be closely monitored for any signs or symptoms of worsening liver disease or cholecystitis.\n",
      "Response from Model: **Pharmacist Recommendation Note**\n",
      "\n",
      "**Situation:** The patient is a 45-year-old male with a history of hepatitis C genotype 3A and Child's B cirrhosis. He is currently admitted for evaluation of deranged liver function tests and jaundice. He has been started on Epclusa for treatment of hepatitis C.\n",
      "\n",
      "**Background:** The patient's blood pressure is elevated (162/94 mmHg). He is not currently taking any medications for hypertension.\n",
      "\n",
      "**Assessment:** The patient's elevated blood pressure may be due to fluid overload. He is currently on a fluid restriction of 1L/day, but he may need additional diuretic therapy to control his blood pressure.\n",
      "\n",
      "**Recommendation:** I recommend starting the patient on spironolactone 100 mg twice daily. Spironolactone is a potassium-sparing diuretic that is effective in lowering blood pressure in patients with cirrhosis and fluid overload. It is also effective in reducing the risk of ascites, which is a common complication of cirrhosis.\n",
      "\n",
      "I would also recommend monitoring the patient's blood pressure closely, and adjusting the dose of spironolactone as needed. It is important to monitor the patient's potassium levels as well, as spironolactone can cause hyperkalemia.\n",
      "iteration # 14\n",
      "response\n",
      "response\n",
      "Response from Model:  **Situation:**\n",
      "\n",
      "A 64-year-old male with decompensated Child's B8 cirrhosis, history of spontaneous bacterial peritonitis, and recurrent ascites, is currently admitted for elective bedside paracentesis. He has been on lifelong ciprofloxacin prophylaxis for SBP, but it was held while he was on Augmentin for a urinary tract infection.\n",
      "\n",
      "**Background:**\n",
      "\n",
      "- Medical history:\n",
      " - Hypertension\n",
      " - Diabetes\n",
      " - Hyperlipidemia\n",
      " - Ischemic heart disease with HFrEF, status post CABG x4, LVEF 17%\n",
      " - Atrial fibrillation, CHADSVasc score 5, not on anticoagulation due to high fall risk\n",
      " - Stage 3 CKD\n",
      " - Hypothyroidism\n",
      "- Medications:\n",
      " - Isosorbide mononitrate\n",
      " - Linagliptin\n",
      " - Allopurinol\n",
      " - Omeprazole\n",
      " - Aspirin\n",
      " - Carvedilol\n",
      " - Digoxin\n",
      " - Sodium bicarbonate\n",
      " - Levothyroxine\n",
      " - Lactulose\n",
      " - Sennosides\n",
      "- Labs:\n",
      " - Creatinine: 230 umol/L (elevated)\n",
      " - AST: 31 U/L\n",
      " - ALT: 19 U/L\n",
      " - Albumin: 26 g/L\n",
      " - INR: 1.2\n",
      "\n",
      "**Assessment:**\n",
      "\n",
      "- Drug-related problem:\n",
      " - Ciprofloxacin, which is used for SBP prophylaxis, was suspended while the patient was on Augmentin for a UTI. This may increase his risk of SBP.\n",
      "\n",
      "**Recommendation:**\n",
      "\n",
      "- Re-initiate ciprofloxacin 250 mg once daily for SBP prophylaxis, unless contraindicated, after completion of Augmentin therapy. Closely monitor the patient for any signs and symptoms of SBP, such as abdominal pain, fever, and cloudy urine.\n",
      "Response from Model: **Potential drug related problems:**\n",
      "\n",
      "* **Potential drug interaction:** Carvedilol and digoxin may interact to cause bradycardia and AV block. Monitor the patient's heart rate and rhythm closely. If bradycardia or AV block occurs, the dose of one or both medications may need to be adjusted.\n",
      "* **Potential adverse effect:** Carvedilol may cause hypotension, especially in patients with heart failure. Monitor the patient's blood pressure closely. If hypotension occurs, the dose of carvedilol may need to be adjusted.\n",
      "* **Potential adverse effect:** Digoxin may cause digoxin toxicity, especially in patients with renal impairment. Monitor the patient's digoxin levels and renal function closely. If digoxin toxicity occurs, the dose of digoxin may need to be adjusted.\n",
      "* **Potential adverse effect:** Sodium bicarbonate may cause metabolic alkalosis. Monitor the patient's serum bicarbonate levels closely. If metabolic alkalosis occurs, the dose of sodium bicarbonate may need to be adjusted.\n",
      "\n",
      "**Recommendations:**\n",
      "\n",
      "* Monitor the patient's heart rate and rhythm closely. If bradycardia or AV block occurs, the dose of one or both medications may need to be adjusted.\n",
      "* Monitor the patient's blood pressure closely. If hypotension occurs, the dose of carvedilol may need to be adjusted.\n",
      "* Monitor the patient's digoxin levels and renal function closely. If digoxin toxicity occurs, the dose of digoxin may need to be adjusted.\n",
      "* Monitor the patient's serum bicarbonate levels closely. If metabolic alkalosis occurs, the dose of sodium bicarbonate may need to be adjusted.\n",
      "iteration # 15\n",
      "response\n",
      "response\n",
      "Response from Model:  **Situation**:\n",
      "The patient has decompensated Child's class C10 cryptogenic liver cirrhosis complicated by diuretic-intolerant ascites and H. Pylori infection. She is currently on multiple medications, including antibiotics, proton pump inhibitors, and diuretics.\n",
      "\n",
      "**Background**:\n",
      "- Cirrhosis of the liver is a chronic liver disease characterized by the replacement of healthy liver tissue with scar tissue. Decompensated cirrhosis occurs when liver function becomes severely impaired, leading to complications such as ascites (fluid accumulation in the abdomen), encephalopathy (brain dysfunction), and variceal bleeding.\n",
      "- Ascites is a common complication of cirrhosis and can be difficult to manage, especially in patients who are intolerant of diuretics. Diuretics help to remove excess fluid from the body, but they can also worsen kidney function and electrolyte imbalances.\n",
      "- H. Pylori infection is a common bacterial infection of the stomach that can cause inflammation and ulcers. It is associated with an increased risk of developing stomach cancer.\n",
      "\n",
      "**Assessment**:\n",
      "- The patient's current medication regimen includes multiple antibiotics for H. Pylori eradication therapy (Rifaximin, Metronidazole, Tetracycline, Omperazole, Bismuth Subcitrate).\n",
      "- The patient has been prescribed furosemide, a loop diuretic, for the management of ascites, however, it is currently suspended due to diuretic intolerance. This can lead to fluid retention and worsening of ascites.\n",
      "\n",
      "**Recommendation**:\n",
      "- Monitor the patient's response to the current H. Pylori eradication therapy and adjust medications as necessary based on culture and sensitivity results.\n",
      "- For the management of ascites, consider alternative diuretic options such as spironolactone, a potassium-sparing diuretic, or metolazone, a thiazide diuretic, which may be better tolerated and still effective in promoting diuresis.\n",
      "- Careful monitoring of the patient's fluid status, electrolyte levels, and renal function is crucial to ensure the safe and effective management of her condition.\n",
      "- Provide patient education on the importance of diet modification, including low sodium intake and adequate protein consumption, to help manage ascites and improve overall liver function.\n",
      "Response from Model: Situation: The patient is currently on H. pylori eradication therapy with a regimen of rifaximin, metronidazole, tripotassium dicitratobismuthate, omeprazole, and tetracycline.\n",
      "\n",
      "Background: Rifaximin is a non-absorbable antibiotic that is used to treat traveler's diarrhea and hepatic encephalopathy. Metronidazole is an antibiotic that is used to treat a variety of infections, including H. pylori infection. Tripotassium dicitratobismuthate is a bismuth compound that is used to treat H. pylori infection. Omeprazole is a proton pump inhibitor that is used to treat acid reflux and peptic ulcers. Tetracycline is an antibiotic that is used to treat a variety of infections, including H. pylori infection.\n",
      "\n",
      "Assessment: The patient's current H. pylori eradication therapy regimen is appropriate and is in line with current guidelines. However, the patient is also taking ciprofloxacin for SBP prophylaxis. Ciprofloxacin is an antibiotic that is used to treat a variety of infections, including SBP. The use of ciprofloxacin in combination with metronidazole can increase the risk of adverse effects, including neuropathy and seizures.\n",
      "\n",
      "Recommendation: Discontinue ciprofloxacin and consider alternative agents for SBP prophylaxis. Rifaximin or trimethoprim-sulfamethoxazole are both options that do not interact with metronidazole. Monitor the patient closely for any signs of adverse effects.\n",
      "iteration # 16\n",
      "response\n",
      "response\n",
      "Response from Model:  **Situation:**\n",
      "- The patient has type 2 diabetes.\n",
      "- The patient is currently on multiple medications including insulin.\n",
      "- The patient's current insulin regimen does not appear to be adequately controlling their blood glucose levels.\n",
      "\n",
      "**Background:**\n",
      "- Type 2 diabetes is a chronic condition that affects the body's ability to produce or use insulin, which is a hormone that regulates blood sugar levels.\n",
      "- Insulin is used to lower blood glucose levels by allowing glucose to enter cells for energy.\n",
      "- The patient's current medications include basal insulin (glargine) and mealtime insulin (lispro).\n",
      "\n",
      "**Assessment:**\n",
      "- The patient's current insulin regimen does not appear to be adequately controlling their blood glucose levels, as evidenced by elevated glucose levels.\n",
      "- The patient's blood glucose levels are fluctuating, which may be due to the patient's inconsistent eating habits.\n",
      "\n",
      "**Recommendation:**\n",
      "- I recommend adjusting the patient's insulin regimen to improve blood glucose control.\n",
      "- Specifically, I recommend increasing the dose of basal insulin (glargine) to 24 units at night.\n",
      "- I also recommend adding a rapid-acting insulin (lispro) at mealtimes, with the dose adjusted based on the patient's blood glucose levels.\n",
      "- The patient should be encouraged to monitor their blood glucose levels regularly and adjust their insulin doses accordingly.\n",
      "Response from Model: Pharmacist recommendation note\n",
      "\n",
      "**Situation** This is a 55-year-old Chinese male with a history of a perforated duodenal ulcer that was repaired with laparoscopic omental patch, metastatic relapse of salivary gland-epithelial myoepithelial carcinoma with liver visceral crisis, and neutropenia sepsis. He is currently on TPN and is NPO. His blood glucose levels have been elevated in the past 24 hours, with the most recent reading being 14.7 mmol/L.\n",
      "\n",
      "**Background** The patient is currently on a sliding scale of insulin aspart to manage his blood glucose levels. The scale is as follows:\n",
      "\n",
      "- 2 units if Capillary Blood Glucose (mmol/L) 10.1 - 14\n",
      "- 4 units if Capillary Blood Glucose (mmol/L) 14.1 - 18\n",
      "- 6 units if Capillary Blood Glucose (mmol/L) 18.1 - 22\n",
      "- 8 units if Capillary Blood Glucose (mmol/L) > 22\n",
      "\n",
      "**Assessment** The patient's blood glucose levels have been elevated in the past 24 hours, despite being on a sliding scale of insulin aspart. This suggests that the current insulin regimen is not adequately controlling his blood glucose levels.\n",
      "\n",
      "**Recommendation** I recommend the following changes to the patient's medication regimen:\n",
      "\n",
      "- Increase the frequency of the sliding scale of insulin aspart to every 6 hours.\n",
      "- If the patient's blood glucose levels remain elevated despite the increased frequency of the sliding scale, consider starting a basal-bolus insulin regimen.\n",
      "- Continue to monitor the patient's blood glucose levels closely and adjust the insulin regimen as needed.\n",
      "\n",
      "In addition, I recommend the following:\n",
      "\n",
      "- The patient should be educated on the importance of monitoring his blood glucose levels and how to adjust his insulin doses accordingly.\n",
      "- The patient should be encouraged to eat a healthy diet and exercise regularly to help control his blood glucose levels.\n",
      "- The patient should be aware of the signs and symptoms of hypoglycemia and hyperglycemia and what to do if they occur.\n",
      "iteration # 17\n",
      "response\n",
      "response\n",
      "Response from Model:  **Situation:** Uncontrolled hyperlipidemia in a patient with history of CKD, hypertension, and type 2 diabetes mellitus.\n",
      "\n",
      "**Background:**\n",
      "- The patient's current lipid profile shows elevated total cholesterol (6.53 mmol/L), LDL cholesterol (4.99 mmol/L), and low HDL cholesterol (1.27 mmol/L).\n",
      "- The patient was previously on atorvastatin 40 mg and ezetimibe 10 mg, which were not adequately controlling his lipid levels.\n",
      "- The patient claims to be compliant with his medications.\n",
      "\n",
      "**Assessment:**\n",
      "The patient's uncontrolled hyperlipidemia may be attributed to inadequate medication dosage and/or poor compliance with the previous lipid-lowering regimen. Additionally, his underlying medical conditions, such as CKD and diabetes, may also contribute to the difficulty in achieving lipid goals.\n",
      "\n",
      "**Recommendation:**\n",
      "1. **Increase atorvastatin dosage:** The dose of atorvastatin should be increased to 80 mg once daily. This is a recommended dose for patients with severe hyperlipidemia who have not achieved their lipid goals on lower doses.\n",
      "2. **Continue ezetimibe:** Ezetimibe should be continued at the current dose of 10 mg once daily. It can be taken in combination with atorvastatin to enhance the lipid-lowering effect.\n",
      "3. **Monitor lipid levels and adjust medication accordingly:** The patient's lipid levels should be monitored regularly, and the medication doses should be adjusted as needed to achieve the target lipid goals.\n",
      "4. **Lifestyle modifications:** The patient should be advised on lifestyle modifications that can help improve his lipid profile, such as a healthy diet, regular exercise, and weight management.\n",
      "5. **Patient education:** The patient should be educated about the importance of medication compliance and maintaining a healthy lifestyle to manage his hyperlipidemia.\n",
      "\n",
      "By implementing these recommendations, we aim to optimize the patient's lipid profile and reduce his risk of cardiovascular complications.\n",
      "Response from Model: Pharmacist Recommendation:\n",
      "\n",
      "**Situation:**\n",
      "The patient is a 71-year-old Chinese male with a history of chronic kidney disease (CKD) of allograft, end-stage kidney disease (ESKD), hypertension, type 2 diabetes mellitus (T2DM), and benign prostatic hyperplasia (BPH). He is currently admitted to the hospital for right 1st toe dry gangrene and uncontrolled hyperlipidemia.\n",
      "\n",
      "**Background:**\n",
      "The patient's medications include:\n",
      "\n",
      "* ACTRAPID [Insulin Soluble] Injection\n",
      "* Atenolol Tablet\n",
      "* Atorvastatin Tablet\n",
      "* Ciclosporin [NEORAL] Capsule\n",
      "* Cinacalcet Tablet\n",
      "* Clopidogrel Tablet\n",
      "* Co-trimoxazole Tablet\n",
      "* Everolimus [CERTICAN] Tablet (suspended)\n",
      "* Ezetimibe Tablet\n",
      "* Folic Acid Tablet\n",
      "* Furosemide [Frusemide] Tablet\n",
      "* GliPIzide Tablet\n",
      "* Linagliptin Tablet\n",
      "* Lisinopril Tablet\n",
      "* Magnesium (Elemental) Capsule/Tablet\n",
      "* Mycophenolate Mofetil [CELLCEPT] Capsule/Tablet\n",
      "* Omega-3 Fish Oil Capsule\n",
      "* OMEprazole Capsule\n",
      "* Tamsulosin HCl Prolonged Release Tablet\n",
      "\n",
      "**Assessment:**\n",
      "The patient's current medications are appropriate for his conditions. However, there are a few potential drug-related problems that should be addressed.\n",
      "\n",
      "* The patient is taking ciclosporin, which is a calcineurin inhibitor. Calcineurin inhibitors can increase the risk of hyperkalemia. The patient's potassium level should be monitored closely and potassium supplements should be used with caution.\n",
      "* The patient is also taking cinacalcet, which is a calcimimetic agent. Calcimimetic agents can increase the risk of hypocalcemia. The patient's calcium level should be monitored closely and calcium supplements should be used as needed.\n",
      "* The patient is taking atenolol, which is a beta-blocker. Beta-blockers can worsen peripheral arterial disease (PAD). The patient's PAD symptoms should be monitored closely and the dose of atenolol should be adjusted as needed.\n",
      "\n",
      "**Recommendation:**\n",
      "* Monitor the patient's potassium and calcium levels closely.\n",
      "* Use potassium supplements with caution.\n",
      "* Use calcium supplements as needed.\n",
      "* Monitor the patient's PAD symptoms closely.\n",
      "* Adjust the dose of atenolol as needed.\n",
      "iteration # 18\n",
      "response\n",
      "response\n",
      "Response from Model:  **Situation:**\n",
      "The patient is a 60-year-old male with a history of diabetes, hypertension, hyperlipidemia, polycythemia rubra vera, end-stage renal failure, diverticular disease, recurrent cutaneous vasculitis, and bilateral lower limb pain. He is currently admitted for lower abdominal pain and constipation.\n",
      "\n",
      "**Background:**\n",
      "The patient has a history of polycythemia rubra vera and is taking aspirin for thromboprophylaxis. He is also on hemodialysis three times per week. His current medications include lactulose, paracetamol, sennosides, bisacodyl, lidocaine gel, tramadol, atorvastatin, gabapentin, linagliptin, glipizide, metoclopramide, cinacalcet, pentoxifylline, sevelamer, glyceryl trinitrate, neurobion, renal vitamin, and ciprofloxacin.\n",
      "\n",
      "**Assessment:**\n",
      "The patient's abdominal pain is likely due to constipation. He has a history of constipation and has been experiencing difficulty passing stools for the past week. He has tried self-digitation and Fleet enemas, but these have not been effective. He is currently taking lactulose, sennosides, and bisacodyl, but these medications may not be adequate to relieve his constipation.\n",
      "\n",
      "**Recommendation:**\n",
      "1. Increase the dose of lactulose to 20 mL three times daily.\n",
      "2. Add polyethylene glycol 3350 (PEG 3350) powder for oral solution to the patient's medication regimen. PEG 3350 is a laxative that can help to relieve constipation by increasing the amount of water in the stool. The recommended dose is 17 grams once daily, dissolved in 8 ounces of water.\n",
      "3. Encourage the patient to drink plenty of fluids and eat a diet high in fiber.\n",
      "4. Monitor the patient's bowel movements and adjust the laxative regimen as needed.\n",
      "Response from Model: **Situation:** The patient is admitted to the hospital with constipation and abdominal pain. The patient has a history of diverticulitis and ESRD. The patient is currently taking lactulose, senna, and bisacodyl for constipation.\n",
      "\n",
      "**Background:** The patient's current constipation is likely due to the combination of medications that they are taking. Lactulose is a hyperosmotic laxative that can cause diarrhea, abdominal cramping, and bloating. Senna is a stimulant laxative that can cause cramping, nausea, and vomiting. Bisacodyl is a stimulant laxative that can cause cramping, nausea, and vomiting.\n",
      "\n",
      "**Assessment:** The patient's current constipation is likely due to the combination of medications that they are taking. The patient's constipation is also likely contributing to their abdominal pain.\n",
      "\n",
      "**Recommendation:** I recommend that the patient's lactulose, senna, and bisacodyl be discontinued. The patient should be started on a bulk-forming laxative, such as psyllium or methylcellulose. The patient should also be encouraged to increase their fluid intake and to exercise regularly.\n",
      "\n",
      "**Rationale:** The patient's current constipation is likely due to the combination of medications that they are taking. Lactulose, senna, and bisacodyl are all laxatives that can cause diarrhea, abdominal cramping, and bloating. The patient's constipation is also likely contributing to their abdominal pain.\n",
      "\n",
      "Bulk-forming laxatives, such as psyllium or methylcellulose, work by absorbing water in the intestines and forming a gel-like substance that helps to soften the stool and make it easier to pass. Bulk-forming laxatives are generally well-tolerated and do not cause the side effects that are associated with stimulant laxatives.\n",
      "\n",
      "Increasing fluid intake and exercising regularly can also help to relieve constipation. Fluid helps to soften the stool and make it easier to pass. Exercise helps to stimulate the bowels and promote regular bowel movements.\n",
      "iteration # 19\n",
      "response\n",
      "response\n",
      "Response from Model:  **Situation:**\n",
      "\n",
      "The patient has a history of hypertension and is currently being treated with amlodipine and enalapril. He was admitted to the hospital with perforated appendicitis and underwent a limited right hemicolectomy. Post-operatively, he developed hypertensive urgency with blood pressure readings up to 200/110 mmHg. Hydralazine was added to his medication regimen to control his blood pressure.\n",
      "\n",
      "**Background:**\n",
      "\n",
      "- Hypertension is a common chronic condition characterized by elevated blood pressure.\n",
      "- Amlodipine and enalapril are commonly used antihypertensive medications that work by relaxing blood vessels and reducing peripheral resistance.\n",
      "- Hydralazine is another antihypertensive medication that works by directly relaxing arterioles and reducing systemic vascular resistance.\n",
      "\n",
      "**Assessment:**\n",
      "\n",
      "The patient's current medication regimen includes multiple antihypertensive medications, including amlodipine, enalapril, and hydralazine. This combination of medications may increase the risk of hypotension, especially in the setting of volume depletion or impaired renal function. Additionally, the patient has a history of lupus nephritis, which may further increase his susceptibility to medication-induced hypotension.\n",
      "\n",
      "**Recommendation:**\n",
      "\n",
      "- Monitor the patient's blood pressure closely, especially after initiating or adjusting antihypertensive medications.\n",
      "- Assess the patient for signs and symptoms of hypotension, such as dizziness, lightheadedness, or fainting.\n",
      "- Encourage adequate fluid intake to maintain hydration and minimize the risk of hypotension.\n",
      "- Consider reducing the doses of amlodipine, enalapril, or hydralazine if the patient develops hypotension or if his blood pressure is well-controlled.\n",
      "- Avoid the use of other medications that can lower blood pressure, such as nitrates or phosphodiesterase-5 inhibitors (e.g., sildenafil, tadalafil), unless they are specifically indicated and the potential benefits outweigh the risks.\n",
      "Response from Model: **Pharmacist Recommendation Note**\n",
      "**Situation**: The patient is a 46-year-old male who recently underwent an open limited right hemicolectomy. He has a history of hypertension and lupus nephritis, and is currently taking amlodipine and enalapril for his hypertension. The patient's blood pressure is currently elevated (190/100 mmHg), and he is experiencing mild abdominal pain.\n",
      "\n",
      "**Background**: The patient's current medication regimen includes amlodipine and enalapril, which are both used to treat hypertension. Amlodipine is a calcium channel blocker, and enalapril is an ACE inhibitor. Both of these medications can cause hypotension, which can be exacerbated by the patient's current condition.\n",
      "\n",
      "**Assessment**: The patient's current medication regimen is not optimal for his current condition. The amlodipine and enalapril are both likely contributing to his hypotension, which is likely exacerbating his abdominal pain.\n",
      "\n",
      "**Recommendation**: I recommend discontinuing the amlodipine and enalapril. These medications are likely contributing to the patient's hypotension, which is likely exacerbating his abdominal pain. I recommend starting the patient on hydralazine 25 mg TDS. Hydralazine is a vasodilator that can be used to treat hypertension. It is less likely to cause hypotension than amlodipine or enalapril.\n",
      "\n",
      "I also recommend continuing the patient's current pain medication regimen. The patient is currently taking celecoxib and etoricoxib for his abdominal pain. These medications are both NSAIDs, which can help to reduce inflammation and pain. I recommend continuing these medications at their current doses.\n",
      "\n",
      "I will continue to monitor the patient's blood pressure and abdominal pain. If the patient's blood pressure remains elevated, I may recommend increasing the dose of hydralazine. If the patient's abdominal pain does not improve, I may recommend adding a different pain medication.\n",
      "iteration # 20\n",
      "response\n",
      "response\n",
      "Response from Model:  **Situation:**\n",
      "\n",
      "The patient is a 71-year-old male with a history of BPH, HTN, and HLD, who presented with right iliac fossa (RIF) pain and was diagnosed with cecal diverticulitis with a small diverticular abscess. He is currently receiving IV ceftriaxone, metronidazole, omeprazole, and fluids, and is being managed conservatively with plans for interval CT and outpatient colonoscopy.\n",
      "\n",
      "**Background:**\n",
      "\n",
      "The patient's current medications include:\n",
      "\n",
      "- Potassium Chloride (Premixed in NaCl 0.9%) 10mmol/500mL Infusion: IV Continuous 1,000 mL, <Continuous>, Equivalent Dose: 20 mmol, Infuse Over 24 hour, 41.7 mL/hr\n",
      "- CeftriaXONE Injection, IV Intermittent 2g, Q24H, In Final Volume Sodium Chloride 0.9% InFUSion 100 mL, Infuse Over 30 minute, Run at 200 mL/hr -- For 9 Doses\n",
      "- MetroNIDAzole Injection, IV Intermittent 500 mg, Q8H, Infuse Over 60 minute, 100 mL/hr -- For 10 Days\n",
      "- OMEprazole Injection, IV Bolus 400 mg, OM\n",
      "- MetoCLOPramide HCl Injection, IV Bolus 10 mg, Q8H PRN Nausea or Vomiting\n",
      "- Finasteride [Proscar] Tablet, PO 5 mg, OM\n",
      "- Tamsulosin HCl Prolonged Release Tablet, PO 400 mcg, ON\n",
      "- Paracetamol Tablet, PO 1 g, QDS\n",
      "- Tramadol HCl Capsule/Tablet, PO 50 mg, TDS PRN Pain\n",
      "- Indapamide SR Tablet, PO 1.5 mg, OM\n",
      "- Prochlorperazine Tablet, PO 10mg TDS PRN Nausea or Vomitting\n",
      "\n",
      "**Assessment:**\n",
      "\n",
      "1. Potential for drug-induced hypoglycemia with the combination of ceftriaxone and metronidazole: Both ceftriaxone and metronidazole can cause hypoglycemia, especially in patients with impaired glucose tolerance or diabetes. The patient should be monitored closely for signs and symptoms of hypoglycemia, and his blood glucose levels should be checked regularly. \n",
      "2. Risk of bleeding with the combination of ceftriaxone, metronidazole, and tamsulosin: Ceftriaxone, metronidazole, and tamsulosin can all increase the risk of bleeding. The patient should be monitored for signs of bleeding, and his coagulation parameters should be checked regularly.\n",
      "3. Potential for QT prolongation with the combination of ceftriaxone, metronidazole, and prochlorperazine: Ceftriaxone, metronidazole, and prochlorperazine can all prolong the QT interval. The patient should be monitored for signs of QT prolongation, and his electrolytes should be checked regularly.\n",
      "\n",
      "**Recommendations:**\n",
      "\n",
      "1. Monitor blood glucose levels regularly and adjust insulin or anti-diabetic medication doses as needed to maintain euglycemia.\n",
      "2. Monitor for signs of bleeding and check coagulation parameters regularly, especially if the patient has a history of bleeding or is taking other medications that increase the risk of bleeding.\n",
      "3. Monitor for signs of QT prolongation and check electrolytes regularly, especially if the patient has a history of cardiac arrhythmias or is taking other medications that prolong the QT interval.\n",
      "4. Consider an alternative antibiotic if the patient develops hypoglycemia, bleeding, or QT prolongation.\n",
      "Response from Model: **Pharmacist Recommendation Note**\n",
      "\n",
      "**Date:** 2024-11-07\n",
      "\n",
      "**Time:** 4:30 PM\n",
      "\n",
      "**Patient:** [71yo/Male]\n",
      "\n",
      "**Situation:** The patient is a 71-year-old male who is being treated for cecal diverticulitis with a small diverticular abscess. He is currently receiving intravenous (IV) ceftriaxone, metronidazole, and omeprazole, as well as oral paracetamol and tramadol.\n",
      "\n",
      "**Background:** The patient has a history of benign prostatic hyperplasia (BPH), hypertension (HTN), and hyperlipidemia (HLD). He is not on any blood thinners.\n",
      "\n",
      "**Assessment:** There are two potential drug-related problems identified:\n",
      "\n",
      "1. **Potential for drug interaction:** Ceftriaxone and metronidazole have been shown to interact with each other, potentially leading to increased risk of adverse effects such as nausea, vomiting, and diarrhea. It is recommended to monitor the patient closely for any signs of these adverse effects, and to consider adjusting the doses or changing the medications if necessary.\n",
      "2. **Potential for over-sedation:** The patient is receiving both IV metoclopramide and prochlorperazine for nausea and vomiting. These medications can both cause sedation, and the combination of the two could increase the risk of over-sedation. It is recommended to monitor the patient's level of sedation closely, and to consider reducing the dose or frequency of one or both medications if necessary.\n",
      "\n",
      "**Recommendation:**\n",
      "\n",
      "1. **Monitor for drug interaction:** The patient should be monitored closely for any signs of adverse effects from the interaction between ceftriaxone and metronidazole. If the patient experiences any significant adverse effects, the doses or medications should be adjusted as needed.\n",
      "2. **Monitor for over-sedation:** The patient should be monitored closely for any signs of over-sedation from the combination of metoclopramide and prochlorperazine. If the patient experiences any significant sedation, the dose or frequency of one or both medications should be reduced.\n",
      "\n",
      "**Follow-up:** The patient should be monitored closely for any signs of drug-related problems. The pharmacist should be consulted if any concerns arise.\n",
      "iteration # 21\n",
      "response\n",
      "response\n",
      "Response from Model:  **Situation:**\n",
      "The patient is a 75-year-old male with a history of prostate cancer, ischemic cardiomyopathy, and hypertension who is currently experiencing gross hematuria. He is currently receiving IV tazocin and has aspirin, which has been stopped, and abiraterone acetate on his medication list.\n",
      "\n",
      "**Background:**\n",
      "The patient has a history of prostate cancer and has undergone several procedures, including a cystoscopy and cystourethrotomy. He is currently on abiraterone acetate for his prostate cancer. He also has a history of ischemic cardiomyopathy and hypertension and has undergone coronary artery bypass graft surgery three times.\n",
      "\n",
      "**Assessment:**\n",
      "The patient's gross hematuria is likely due to his prostate cancer or a urinary tract infection. His recent flex scope showed bleeding from prostatic tumor regrowth. He is also at an increased risk for cardiovascular events due to his history of ischemic cardiomyopathy and hypertension.\n",
      "\n",
      "**Recommendation:**\n",
      "1. Continue to monitor the patient's vital signs and urine output.\n",
      "2. Continue IV tazocin and consider obtaining a urine culture to rule out a urinary tract infection.\n",
      "3. Consider restarting aspirin after the patient's hematuria has resolved to reduce his cardiovascular risk.\n",
      "4. Consider additional prostate cancer treatments such as radiation therapy or chemotherapy.\n",
      "Response from Model: ### Pharmacist Recommendation\n",
      "*Situation*: The patient has a history of NSTEMI. He is currently taking aspirin for secondary prevention of cardiovascular events. It is unclear why aspirin has been suspended during this admission.\n",
      "\n",
      "*Background*: Aspirin is a cyclooxygenase (COX) inhibitor that is used for the prevention of cardiovascular events. It is recommended for all patients with a history of NSTEMI. Aspirin has been shown to reduce the risk of recurrent cardiovascular events by about 25%.\n",
      "\n",
      "*Assessment*: The patient is currently at increased risk of a cardiovascular event due to his history of NSTEMI. Aspirin should be restarted unless there is a contraindication.\n",
      "\n",
      "*Recommendation*: Restart aspirin 100 mg PO once daily. If there is a contraindication to aspirin, consider an alternative antiplatelet agent, such as clopidogrel or prasugrel.\n",
      "iteration # 22\n",
      "response\n",
      "response\n",
      "Response from Model:  Situation:\n",
      "The patient is a 67-year-old male with a history of hypertension, type 2 diabetes, and ischemic heart disease with depressed ejection fraction, who is currently being treated for left emphysematous pyelonephritis with purulent discharge status post POD9 open drainage of the left renal abscess. He is currently receiving Augmentin PO.\n",
      "\n",
      "Background:\n",
      "The patient has a history of multiple urological issues, including BPH, lower urinary tract symptoms, and pyelonephritis. He has undergone several procedures, including a left percutaneous nephrostomy and drainage of a renal abscess. His current admission is due to persistent purulent discharge from the left loin.\n",
      "\n",
      "Assessment:\n",
      "There is a potential drug-related problem with the use of Augmentin (co-amoxiclav) due to the presence of E. coli that is resistant to amoxicillin-clavulanic acid as per the wound culture and sensitivity results.\n",
      "\n",
      "Recommendation:\n",
      "It is recommended to discontinue Augmentin and consider alternative antibiotic therapy based on the culture and sensitivity results. Piperacillin-tazobactam or a cephalosporin such as ceftriaxone or cefepime may be appropriate options based on the sensitivity profile of the isolated E. coli. The duration of antibiotic therapy should be guided by clinical response and microbiological surveillance.\n",
      "Response from Model: **SITUATION**\n",
      "The patient is a 67-year-old male with a history of hypertension, type 2 diabetes, and ischemic heart disease. He is currently admitted for left emphysematous pyelonephritis with purulent discharge. He underwent open drainage of left renal abscess 9 days ago, but the wound is still noted to have purulent discharge.\n",
      "\n",
      "**BACKGROUND**\n",
      "\n",
      "- **Wound culture:** E. coli resistant to ampicillin and amoxicillin-clavulanate acid, but sensitive to piperacillin-tazobactam, ceftriaxone, cefipine, aztreonam, ertapenem, gentamicin, and ciprofloxacin.\n",
      "- **Medications:** Co-amoxiclav 1g tablet [Amoxicillin 875mg, Clavulanic Acid 125mg] PO 1 tablet BD\n",
      "\n",
      "**ASSESSMENT**\n",
      "The current antibiotic regimen is not effective in treating the patient's infection. The wound culture shows that the E. coli is resistant to amoxicillin-clavulanate acid.\n",
      "\n",
      "**RECOMMENDATION**\n",
      "\n",
      "- Discontinue Co-amoxiclav.\n",
      "- Start piperacillin-tazobactam 4.5 grams IV every 8 hours.\n",
      "- Monitor the patient for signs and symptoms of infection, including fever, pain, and purulent discharge.\n",
      "- Adjust antibiotic therapy as needed based on the results of culture and sensitivity testing.\n"
     ]
    }
   ],
   "source": [
    "import pandas as pd\n",
    "filename4 = \"./data/Pharmbot 23 Clinical scenarios response base.csv\"\n",
    "df = pd.read_csv(filename4)\n",
    "df['combine_prompt'] = df['System Prompts'] + ' ' + df['User Prompts']\n",
    "\n",
    "\n",
    "for i in range(0, len(df)):\n",
    "\n",
    "    if i<=100:\n",
    "        print(\"iteration #\", i)\n",
    "\n",
    "    # df.loc[i, \"Gemini_ultra_model_output\"] = generate(df.loc[i,'combine_prompt'])\n",
    "    # df.loc[i, \"Gemini_ultra_model_output_v1\"] = generate(df.loc[i,'combine_prompt'])\n",
    "    # df.loc[i, \"Gemini_ultra_model_output_v2\"] = generate(df.loc[i,'combine_prompt'])\n",
    "    \n",
    "    df.loc[i, \"Gemini_pro_model_output\"] = generate_pro(df.loc[i,'combine_prompt'])\n",
    "    df.loc[i, \"Anthropic_haiko_model_output\"] = generate_anthropic_response(df.loc[i,'combine_prompt'])\n",
    "\n",
    "    # df.loc[i, \"medLM_model_output\"] = generate_medllms_v1(df.loc[i,'combine_prompt'])\n",
    "    df.loc[i, \"medpalm_model_output\"] = generate_medlpalm(df.loc[i,'combine_prompt'])\n",
    "    df.loc[i, \"palm_bison32k_output\"] = generate_palm_bison32k(df.loc[i,'combine_prompt'])\n",
    "    df.loc[i, \"palm_unicorn_output\"] = generate_palm_unicorn_v1(df.loc[i,'combine_prompt'])\n",
    "\n",
    "df = df.drop('combine_prompt', axis=1)\n",
    "\n",
    "output4 = \"./output/O_Pharmbot 23 Clinical scenarios response base response_output_gemini.csv\"\n",
    "\n",
    "df.to_csv(output4)\n"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "id": "2acb25d1-141f-46a2-a8b8-a6d2bb562c3f",
   "metadata": {},
   "outputs": [],
   "source": []
  },
  {
   "cell_type": "markdown",
   "id": "1b0988fd-674c-4e48-bd3c-7a6f7125f002",
   "metadata": {},
   "source": [
    "### Trying the Claude Anthropic model"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "id": "0f512fd0-3f1a-460a-b5d0-81545996ba58",
   "metadata": {},
   "outputs": [],
   "source": []
  }
 ],
 "metadata": {
  "environment": {
   "kernel": "conda-root-py",
   "name": "workbench-notebooks.m113",
   "type": "gcloud",
   "uri": "gcr.io/deeplearning-platform-release/workbench-notebooks:m113"
  },
  "kernelspec": {
   "display_name": "Python 3 (ipykernel) (Local)",
   "language": "python",
   "name": "conda-root-py"
  },
  "language_info": {
   "codemirror_mode": {
    "name": "ipython",
    "version": 3
   },
   "file_extension": ".py",
   "mimetype": "text/x-python",
   "name": "python",
   "nbconvert_exporter": "python",
   "pygments_lexer": "ipython3",
   "version": "3.10.13"
  }
 },
 "nbformat": 4,
 "nbformat_minor": 5
}
